Ravgen, Inc. v. Laboratory Corporation of America Holdings > Documents

Date Field	Doc. No.	Description (Pages)
Mar 19, 2025	319	Notice of Appeal* (1)
Mar 18, 2025	317	Unopposed MOTION to Approve Supersedeas Bond and Stay Execution on and Proceedings to Enforce Judgment by Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit A - Supersedeas Bond, # 2 Proposed Order)(Castanias, Gregory) (Entered: 03/18/2025) (0)
Mar 18, 2025	318	ORDER GRANTING 317 MOTION to Approve Supersedeas Bond and Stay Execution on and Proceedings to Enforce Judgment. Signed by Judge Alan D Albright. (cav) (Entered: 03/18/2025) (1)
Feb 24, 2025	316	ORDER TO PAY TECHNICAL ADVISOR. Signed by Judge Alan D Albright. (cav) (Entered: 02/24/2025) (1)
Feb 19, 2025	315	FINAL JUDGMENT. Signed by Judge Alan D Albright. (bw) (Entered: 02/19/2025) (3)
Feb 12, 2025	314	ORDER DENYING 263 Motion for New Trial. Signed by Judge Alan D Albright. (cap) (Entered: 02/12/2025) (9)
Jan 29, 2025	313	Unopposed MOTION to Withdraw as Attorney Vi T. Tran as Counsel for Plaintiff by Ravgen, Inc.. (Attachments: # 1 Proposed Order)(Ding, Frederick) (Entered: 01/29/2025) (0)
Jan 23, 2025	309	MEMORANDUM OPINION AND ORDER Granting in part 238 Ravgen, Inc.'s Motion to Amend Judgment to Include Supplemental Damages, Pre-Judgment Interest, and Post-Judgment Interest, and to Adjudge Claim 132 Not Invalid. Signed by Judge Alan D Albright. (lad) (Entered: 01/23/2025) (7)
Jan 23, 2025	310	MEMORANDUM OPINION AND ORDER Granting in part 297 Labcorps Motion to Maintain Certain Trial Exhibits Under Seal in Part or in Full. Signed by Judge Alan D Albright. (lad) (Entered: 01/23/2025) (5)
Jan 23, 2025	311	MEMORANDUM OPINION AND ORDER GRANTING-IN-PART 271 Motion approving the costs identified in Ravgens amended Bill of Costs. Signed by Judge Alan D Albright. (lad) (Entered: 01/23/2025) (7)
Jan 23, 2025	312	MEMORANDUM OPINION AND ORDER Denying DEFENDANTS 261 Sealed RENEWED MOTION FOR JUDGMENT AS A MATTER OF LAW. Signed by Judge Alan D Albright. (lad) (Entered: 01/23/2025) (10)
Dec 31, 2024	308	Unopposed MOTION to Withdraw as Attorney of Record by Laboratory Corporation of America Holdings. (Attachments: # 1 Proposed Order)(Galvan, Hilda) (Entered: 12/31/2024) (0)
May 8, 2024	307	Report on Patent/Trademark sent to U.S. Patent and Trademark Office. (bot1) (Entered: 05/08/2024) (1)
May 6, 2024	306	Unopposed MOTION to Withdraw as Attorney Julianne M. Thomsen and Peter Zhu as Counsel for Plaintiff by Ravgen, Inc.. (Attachments: # 1 Proposed Order)(Ding, Frederick) (Entered: 05/06/2024) (0)
Aug 29, 2023	305	TRANSCRIPT REQUEST for proceedings held on 9/14/22. Proceedings Transcribed: Jury Selection. Court Reporter: Judy Werlinger. (lad) (Entered: 08/29/2023) (3)
Aug 4, 2023	304	MOTION to Withdraw as Attorney by Laboratory Corporation of America Holdings. (Attachments: # 1 Proposed Order)(Galvan, Hilda) (Entered: 08/04/2023) (0)
May 12, 2023	303	ORDER GRANTING IN PART 232 Motion enhanced damages. Signed by Judge Alan D Albright. (ad3) (Entered: 05/12/2023) (11)
May 1, 2023	302	MOTION to Withdraw as Attorney - LabCorp's Motion to Withdraw Erik J. Carlson as Counsel for Defendant by Laboratory Corporation of America Holdings. (Attachments: # 1 Proposed Order)(Ferrario, Matias) (Entered: 05/01/2023) (0)
Mar 7, 2023	300	NOTICE of Attorney Appearance by Hilda C. Galvan on behalf of Laboratory Corporation of America Holdings. Attorney Hilda C. Galvan added to party Laboratory Corporation of America Holdings(pty:dft) (Galvan, Hilda) (Entered: 03/07/2023) (2)
Mar 7, 2023	301	MOTION to Withdraw as Attorney - LabCorp's Motion to Withdraw Nicole W. Stafford, Edward G. Poplawski and Olivia M. Kim as Counsel for Defendant by Laboratory Corporation of America Holdings. (Attachments: # 1 Proposed Order)(Ferrario, Matias) (Entered: 03/07/2023) (0)
Feb 21, 2023	299	REPLY to Response to Motion, filed by Laboratory Corporation of America Holdings, re 297 Opposed MOTION to Maintain Certain Trial Exhibits Under Seal in Part or in Full filed by Defendant Laboratory Corporation of America Holdings (Attachments: # 1 Exhibit I)(Son, Naoya) (Entered: 02/21/2023) (0)
Feb 14, 2023	298	Sealed Document: Plaintiff's Partial Opposition of 297 Opposed MOTION to Maintain Certain Trial Exhibits Under Seal in Part or in Full by Ravgen, Inc. (Attachments: # 1 Proposed Order, # 2 Exhibit 1 - Proposed Redactions to DTX-0612, # 3 Exhibit 2 - Proposed Redactions to PTX-0716, # 4 Exhibit 3 - Proposed Redactions to PTX-0766, # 5 Exhibit 4 - Proposed Redactions to DTX-0312, # 6 Exhibit 5 - Proposed Redactions to DTX-0338, # 7 Exhibit 6 - Proposed Redactions to PTX-0176, # 8 Exhibit 7 - Proposed Redactions to PTX-0563, # 9 Exhibit DTX-0751 (unredacted), # 10 Exhibit PTX-0255 (unredacted)) (Ding, Frederick) (Entered: 02/14/2023) (0)
Jan 31, 2023	297	Opposed MOTION to Maintain Certain Trial Exhibits Under Seal in Part or in Full by Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Proposed Order)(Son, Naoya) (Entered: 02/01/2023) (0)
Jan 23, 2023	296	ORDER GRANTING 295 Joint Motion to Maintain Certain Trial Exhibits Under Seal in Part or in Full. Signed by Judge Alan D Albright. (zv) (Entered: 01/23/2023) (2)
Jan 20, 2023	295	Joint MOTION to Maintain Certain Trial Exhibits Under Seal in Part or in Full re 221 Exhibit List,,,,,,,,,,,, by Ravgen, Inc.. (Attachments: # 1 Exhibit A - Redacted PTX-719, # 2 Exhibit B - Redacted DTX-919, # 3 Proposed Order)(Ding, Frederick) (Entered: 01/20/2023) (0)
Dec 15, 2022	294	Transcript filed of Proceedings held on 12-14-22, Proceedings Transcribed: Motion Hearing. Court Reporter/Transcriber: Kristie Davis (kmdaviscsr@yahoo.com), Telephone number: 2546660904. Parties are notified of their duty to review the transcript to ensure compliance with the FRCP 5.2(a)/FRCrP 49.1(a). A copy may be purchased from the court reporter or viewed at the clerk's office public terminal. If redaction is necessary, a Notice of Redaction Request must be filed within 21 days. If no such Notice is filed, the transcript will be made available via PACER without redaction after 90 calendar days. The clerk will mail a copy of this notice to parties not electronically noticed Redaction Request due 1/5/2023, Redacted Transcript Deadline set for 1/17/2023, Release of Transcript Restriction set for 3/15/2023, (kd) (Entered: 12/15/2022) (98)
Dec 14, 2022	293	Minute Entry for proceedings held before Judge Alan D Albright: Motion Hearing held on 12/14/2022 re 271 Opposed MOTION In Support Of Its Amended Bill of Costs re 270 Bill of Costs filed by Ravgen, Inc., 263 MOTION for New Trial Pursuant to Fed. R. Civ. P. 59 filed by Laboratory Corporation of America Holdings, 261 Sealed Motion Defendant Labcorp's Renewed Motion for Judgment as a Matter of Law Pursuant to Fed. R. Civ. P. 50(b) by Laboratory Corporation of America Holdings filed by Laboratory Corporation of America Holdings, 238 MOTION to Amend Judgment to Include Supplemental Damages, Pre-Judgment Interest, and Post-Judgment Interest, and to Adjudge Claim 132 Not Invalid filed by Ravgen, Inc., 232 MOTION for Enhanced Damages Pursuant to 35 U.S.C. � 284 filed by Ravgen, Inc., 266 MOTION to Amend Judgment and for a Bench Trial and Subsequent Submissions Regarding Equitable Estoppel, and in the Alternative, an Offer of Proof Regarding Equitable Estoppel filed by Laboratory Corporation of America Holdings. Motion 266 for Amended Judgment is DENIED. A Written Order will be forthcoming on other motions. (Minute entry documents are not available electronically.) (Court Reporter Kristie Davis.)(sm3) (Entered: 12/14/2022) (0)
Dec 13, 2022	292	STIPULATION Joint Stipulation for Extension of Stay of Execution of Judgment Pending Post-Judgment Motions by Laboratory Corporation of America Holdings. (Attachments: # 1 Proposed Order)(Kim, Olivia) (Entered: 12/13/2022) (0)
Dec 8, 2022	291	ORDER GRANTING 290 Motion to Appear Pro Hac Vice for Attorney Tracy Ann Stitt for Laboratory Corporation of America Holdings,Tracy Ann Stitt for Laboratory Corporation of America Holdings. Pursuant to our Administrative Policies and Procedures for Electronic Filing, the attorney hereby granted to practice pro hac vice in this case must register for electronic filing with our court within 10 days of this order. Registration is managed by the PACER Service Center. Signed by Judge Alan D Albright. (ad) (Entered: 12/09/2022) (1)
Dec 7, 2022	290	MOTION to Appear Pro Hac Vice by Nicole W. Stafford on behalf of Tracy A. Stitt ( Filing fee $ 100 receipt number ATXWDC-16831637) by on behalf of Laboratory Corporation of America Holdings. (Attachments: # 1 Proposed Order)(Stafford, Nicole) (Entered: 12/07/2022) (0)
Nov 30, 2022	289	Redacted Public Version of Defendant Labcorp's Reply in Support of Renewed Motion for Judgment as a Matter of Law Pursuant to Fed. R. Civ. P. 50(b) of 286 Sealed Document, by Laboratory Corporation of America Holdings. (Kim, Olivia) (Entered: 11/30/2022) (17)
Nov 23, 2022	285	Redacted Public Version of Plaintiff Ravgen, Inc.'s Opposition to Defendant LabCorp's Renewed Motion for Judgment As a Matter of Law Pursuant to Fed. R. Civ. P. 50(b)(6) of 278 Sealed Document, by Ravgen, Inc.. (Limbeek, Kerri-Ann) (Entered: 11/23/2022) (28)
Nov 23, 2022	286	Sealed Document: Reply in Support of 261 Sealed Motion Defendant Labcorp's Renewed Motion for Judgment as a Matter of Law Pursuant to Fed. R. Civ. P. 50(b) by Laboratory Corporation of America Holdings by Laboratory Corporation of America Holdings (Kim, Olivia) (Entered: 11/23/2022) (0)
Nov 23, 2022	287	REPLY to Response to Motion, filed by Laboratory Corporation of America Holdings, re 263 MOTION for New Trial Pursuant to Fed. R. Civ. P. 59 filed by Defendant Laboratory Corporation of America Holdings (Kim, Olivia) (Entered: 11/23/2022) (17)
Nov 23, 2022	288	REPLY to Response to Motion, filed by Laboratory Corporation of America Holdings, re 266 MOTION to Amend Judgment and for a Bench Trial and Subsequent Submissions Regarding Equitable Estoppel, and in the Alternative, an Offer of Proof Regarding Equitable Estoppel filed by Defendant Laboratory Corporation of America Holdings (Attachments: # 1 Exhibit F)(Kim, Olivia) (Entered: 11/23/2022) (0)
Nov 18, 2022	283	ORDER GRANTING 276 Motion to Stay EXECUTION OF JUDGMENT PENDING POST-JUDGMENT MOTIONS. Signed by Judge Alan D Albright. (lad) (Entered: 11/18/2022) (1)
Nov 18, 2022	284	NOTICE That Plaintiff's Motion For Costs Is Ripe by Ravgen, Inc. re 271 Opposed MOTION In Support Of Its Amended Bill of Costs re 270 Bill of Costs (Ding, Frederick) (Entered: 11/18/2022) (2)
Nov 17, 2022	282	Response in Opposition to Motion, filed by Laboratory Corporation of America Holdings, re 271 Opposed MOTION In Support Of Its Amended Bill of Costs re 270 Bill of Costs filed by Ravgen, Inc. (Kim, Olivia) (Entered: 11/17/2022) (12)
Nov 16, 2022	277	Response in Opposition to Motion, filed by Ravgen, Inc., re 266 MOTION to Amend Judgment and for a Bench Trial and Subsequent Submissions Regarding Equitable Estoppel, and in the Alternative, an Offer of Proof Regarding Equitable Estoppel filed by Defendant Laboratory Corporation of America Holdings (Attachments: # 1 Exhibit 1 - Meltzer Deposition Transcript, # 2 Exhibit 2 - Labcorp Responses to 30(b)(6) Notice, # 3 Exhibit 3 - Watson Deposition Transcript, # 4 Exhibit 4 - Tatman Deposition Transcript, # 5 Exhibit Pretrial Conference Transcript Excerpts, # 6 Exhibit Trial Transcript Excerpts, # 7 Exhibit DTX-0064, # 8 Exhibit DTX-0908, # 9 Exhibit PTX-0234, # 10 Exhibit PTX-0238, # 11 Exhibit PTX-0719 - cover page, # 12 Exhibit PTX-1232, # 13 Exhibit PTX-1233, # 14 Exhibit PTX-1268, # 15 Exhibit PTX-1301, # 16 Exhibit PTX-1480, # 17 Exhibit PTX-1549)(Ding, Frederick) (Entered: 11/16/2022) (0)
Nov 16, 2022	278	Sealed Document: Plaintiff Ravgen, Inc.'s Opposition to Defendant LabCorp's Renewed Motion for Judgment as a Matter of Law Pursuant to Fed. R. Civ. P. 50(b) of 261 Sealed Motion Defendant Labcorp's Renewed Motion for Judgment as a Matter of Law Pursuant to Fed. R. Civ. P. 50(b) by Laboratory Corporation of America Holdings by Ravgen, Inc. (Limbeek, Kerri-Ann) (Entered: 11/16/2022) (0)
Nov 16, 2022	279	Response in Opposition to Motion, filed by Ravgen, Inc., re 263 MOTION for New Trial Pursuant to Fed. R. Civ. P. 59 filed by Defendant Laboratory Corporation of America Holdings (Limbeek, Kerri-Ann) (Entered: 11/16/2022) (28)
Nov 16, 2022	280	Sealed Document: OMNIBUS DECLARATION of Frederick J. Ding in Support of 278 Sealed Document, 279 Response in Opposition to Motion by Ravgen, Inc. (Attachments: # 1 Exhibit PTX-0176 excerpted, # 2 Exhibit PTX-0719 excerpted, # 3 Exhibit PTX-0758, # 4 Exhibit PTX-0766 excerpted, # 5 Exhibit PTX-0911 excerpted, # 6 Exhibit PTX-0913 excerpted, # 7 Exhibit DTX-0919) (Ding, Frederick) (Entered: 11/16/2022) (0)
Nov 16, 2022	281	AFFIDAVIT in Support of 279 Response in Opposition to Motion, 278 Sealed Document, OMNIBUS DECLARATION OF FREDERICK J. DING IN SUPPORT OF PLAINTIFF'S OPPOSITION TO RENEWED JMOL AND MOTION FOR NEW TRIAL by Ravgen, Inc.. (Attachments: # 1 Exhibit 1 - Labcorp Prelim Invalidity Contentions, # 2 Exhibit 2 - 6/21/2022 Transcript, # 3 Exhibit 3 - 8/31/2022 Transcript, # 4 Exhibit PTX-0002, # 5 Exhibit PTX-0014, # 6 Exhibit PTX-0175 excerpted, # 7 Exhibit PTX-0234, # 8 Exhibit PTX-0255 excerpted, # 9 Exhibit PTX-0721 excerpted, # 10 Exhibit PTX-0742, # 11 Exhibit PTX-0749, # 12 Exhibit PTX-0785, # 13 Exhibit PTX-0789, # 14 Exhibit PTX-0802, # 15 Exhibit PTX-1085, # 16 Exhibit PTX-1229, # 17 Exhibit PTX-1231, # 18 Exhibit PTX-1232, # 19 Exhibit PTX-1233, # 20 Exhibit PTX-1270, # 21 Exhibit PTX-1271, # 22 Exhibit PTX-1301, # 23 Exhibit PTX-1480, # 24 Exhibit PTX-1549, # 25 Exhibit DTX-0908, # 26 Exhibit PDX-1 demonstrative, # 27 Exhibit PDX-11 demonstrative, # 28 Exhibit PDX-12 demonstrative, # 29 Exhibit PTX-1633 demonstrative)(Ding, Frederick) (Entered: 11/16/2022) (0)
Nov 15, 2022	276	MOTION TO STAY: (Joint Stipulation for Stay of Execution of Judgment Pending Post-Judgment Motions) by Laboratory Corporation of America Holdings. (Attachments: # 1 Proposed Order)(Kim, Olivia) Modified on 11/15/2022 due to incorrect event entry used (zv). (Entered: 11/15/2022) (0)
Nov 14, 2022	275	ORDER Setting Motion Hearing for 12/14/2022 01:30 PM before Judge Alan D Albright. Signed by Judge Alan D Albright. (bot1) (Entered: 11/14/2022) (1)
Nov 11, 2022	274	Unopposed MOTION to Withdraw as Attorney (Savannah Carnes) by Ravgen, Inc.. (Attachments: # 1 Proposed Order)(Dacus, Deron) (Entered: 11/11/2022) (0)
Nov 9, 2022	273	Redacted Public Version of 261 Sealed Motion Defendant Labcorp's Renewed Motion for Judgment as a Matter of Law Pursuant to Fed. R. Civ. P. 50(b) by Laboratory Corporation of America Holdings by Laboratory Corporation of America Holdings. (Kim, Olivia) (Entered: 11/09/2022) (30)
Nov 3, 2022	269	REPLY to Response to Motion, filed by Ravgen, Inc., re 238 MOTION to Amend Judgment to Include Supplemental Damages, Pre-Judgment Interest, and Post-Judgment Interest, and to Adjudge Claim 132 Not Invalid filed by Ravgen, Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D)(Ding, Frederick) (Entered: 11/03/2022) (Main Document) (16)
Nov 3, 2022	270	BILL OF COSTS (Amended) by Ravgen, Inc.. (Kringstein, Jamie) (Entered: 11/03/2022) (2)
Nov 3, 2022	271	Opposed MOTION In Support Of Its Amended Bill of Costs re 270 Bill of Costs by Ravgen, Inc.. (Attachments: # 1 Declaration of Jamie L. Kringstein, # 2 Exhibit 1, # 3 Proposed Order)(Kringstein, Jamie) (Entered: 11/03/2022) (Main Document) (27)
Nov 3, 2022	272	Redacted Public Version Defendant Labcorp's Opposition to Plaintiff Ravgen's Motion to Amend the Judgment of 250 Sealed Document, by Laboratory Corporation of America Holdings. (Kim, Olivia) (Entered: 11/03/2022) (20)
Nov 3, 2022	271	Opposed MOTION In Support Of Its Amended Bill of Costs re 270 Bill of Costs by Ravgen, Inc.. (Attachments: # 1 Declaration of Jamie L. Kringstein, # 2 Exhibit 1, # 3 Proposed Order)(Kringstein, Jamie) (Entered: 11/03/2022) (Declaration of Jamie L. Kringstein) (8)
Nov 3, 2022	271	Opposed MOTION In Support Of Its Amended Bill of Costs re 270 Bill of Costs by Ravgen, Inc.. (Attachments: # 1 Declaration of Jamie L. Kringstein, # 2 Exhibit 1, # 3 Proposed Order)(Kringstein, Jamie) (Entered: 11/03/2022) (Exhibit 1) (11)
Nov 3, 2022	271	Opposed MOTION In Support Of Its Amended Bill of Costs re 270 Bill of Costs by Ravgen, Inc.. (Attachments: # 1 Declaration of Jamie L. Kringstein, # 2 Exhibit 1, # 3 Proposed Order)(Kringstein, Jamie) (Entered: 11/03/2022) (Proposed Order) (1)
Nov 3, 2022	269	REPLY to Response to Motion, filed by Ravgen, Inc., re 238 MOTION to Amend Judgment to Include Supplemental Damages, Pre-Judgment Interest, and Post-Judgment Interest, and to Adjudge Claim 132 Not Invalid filed by Ravgen, Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D)(Ding, Frederick) (Entered: 11/03/2022) (Exhibit A) (30)
Nov 3, 2022	269	REPLY to Response to Motion, filed by Ravgen, Inc., re 238 MOTION to Amend Judgment to Include Supplemental Damages, Pre-Judgment Interest, and Post-Judgment Interest, and to Adjudge Claim 132 Not Invalid filed by Ravgen, Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D)(Ding, Frederick) (Entered: 11/03/2022) (Exhibit B) (30)
Nov 3, 2022	269	REPLY to Response to Motion, filed by Ravgen, Inc., re 238 MOTION to Amend Judgment to Include Supplemental Damages, Pre-Judgment Interest, and Post-Judgment Interest, and to Adjudge Claim 132 Not Invalid filed by Ravgen, Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D)(Ding, Frederick) (Entered: 11/03/2022) (Exhibit C) (30)
Nov 3, 2022	269	REPLY to Response to Motion, filed by Ravgen, Inc., re 238 MOTION to Amend Judgment to Include Supplemental Damages, Pre-Judgment Interest, and Post-Judgment Interest, and to Adjudge Claim 132 Not Invalid filed by Ravgen, Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D)(Ding, Frederick) (Entered: 11/03/2022) (Exhibit D) (22)
Nov 2, 2022	261	Sealed Motion Defendant Labcorp's Renewed Motion for Judgment as a Matter of Law Pursuant to Fed. R. Civ. P. 50(b) by Laboratory Corporation of America Holdings (Attachments: # 1 Exhibit B, # 2 Exhibit DTX-0312, # 3 Exhibit DTX-0338, # 4 Exhibit DTX-0612, # 5 Exhibit DTX-0919, # 6 Exhibit PTX-0145, # 7 Exhibit PTX-0176, # 8 Exhibit PTX-0236, # 9 Exhibit PTX-0255, # 10 Exhibit PTX-0719, # 11 Exhibit PTX-0758, # 12 Exhibit PTX-0766, # 13 Exhibit PTX-1130, # 14 Exhibit PTX-1141, # 15 Exhibit PTX-1374, # 16 Exhibit PTX-1381, # 17 Exhibit PTX-1382, # 18 Exhibit PTX-1386, # 19 Exhibit PTX-1387) (Kim, Olivia) (Entered: 11/02/2022) (0)
Nov 2, 2022	262	SUPPLEMENT to 261 Sealed Motion Defendant Labcorp's Renewed Motion for Judgment as a Matter of Law Pursuant to Fed. R. Civ. P. 50(b) by Laboratory Corporation of America Holdings by Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit A, # 2 Exhibit C, # 3 Exhibit DTX-0135, # 4 Exhibit DTX-0218, # 5 Exhibit DTX-618, # 6 Exhibit DTX-0638, # 7 Exhibit DTX-0904, # 8 Exhibit DTX-0988, # 9 Exhibit PTX-0002, # 10 Exhibit PTX-0175, # 11 Exhibit PTX-0228, # 12 Exhibit PTX-0234, # 13 Exhibit PTX-0721, # 14 Exhibit PTX-0742, # 15 Exhibit PTX-0785, # 16 Exhibit PTX-0789, # 17 Exhibit PTX-1231, # 18 Exhibit PTX-1232, # 19 Exhibit PTX-1233, # 20 Exhibit PTX-1271, # 21 Exhibit PTX-1301, # 22 Exhibit PTX-1549, # 23 Proposed Order)(Kim, Olivia) (Entered: 11/02/2022) (Main Document) (4)
Nov 2, 2022	263	MOTION for New Trial Pursuant to Fed. R. Civ. P. 59 by Laboratory Corporation of America Holdings. (Kim, Olivia) (Entered: 11/02/2022) (29)
Nov 2, 2022	264	Sealed Document: Exhibit B of 263 MOTION for New Trial Pursuant to Fed. R. Civ. P. 59 by Laboratory Corporation of America Holdings (Attachments: # 1 Exhibit B) (Kim, Olivia) (Entered: 11/02/2022) (0)
Nov 2, 2022	265	SUPPLEMENT to 263 MOTION for New Trial Pursuant to Fed. R. Civ. P. 59 by Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit A, # 2 Exhibit C, # 3 Exhibit D, # 4 Exhibit DTX-0903, # 5 Exhibit DTX-904, # 6 Exhibit PTX-1231, # 7 Exhibit PTX-1271, # 8 Proposed Order)(Kim, Olivia) (Entered: 11/02/2022) (Main Document) (4)
Nov 2, 2022	266	MOTION to Amend Judgment and for a Bench Trial and Subsequent Submissions Regarding Equitable Estoppel, and in the Alternative, an Offer of Proof Regarding Equitable Estoppel by Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit D, # 4 Exhibit E, # 5 Exhibit PTX-0234, # 6 Proposed Order)(Kim, Olivia) (Entered: 11/02/2022) (Main Document) (23)
Nov 2, 2022	267	Sealed Document: Exhibit C of 266 MOTION to Amend Judgment and for a Bench Trial and Subsequent Submissions Regarding Equitable Estoppel, and in the Alternative, an Offer of Proof Regarding Equitable Estoppel by Laboratory Corporation of America Holdings (Attachments: # 1 Exhibit C) (Kim, Olivia) (Entered: 11/02/2022) (0)
Nov 2, 2022	268	SUPPLEMENT to 263 MOTION for New Trial Pursuant to Fed. R. Civ. P. 59 by Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit PTX-0014)(Kim, Olivia) (Entered: 11/02/2022) (Main Document) (4)
Nov 2, 2022	265	SUPPLEMENT to 263 MOTION for New Trial Pursuant to Fed. R. Civ. P. 59 by Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit A, # 2 Exhibit C, # 3 Exhibit D, # 4 Exhibit DTX-0903, # 5 Exhibit DTX-904, # 6 Exhibit PTX-1231, # 7 Exhibit PTX-1271, # 8 Proposed Order)(Kim, Olivia) (Entered: 11/02/2022) (Exhibit A) (30)
Nov 2, 2022	265	SUPPLEMENT to 263 MOTION for New Trial Pursuant to Fed. R. Civ. P. 59 by Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit A, # 2 Exhibit C, # 3 Exhibit D, # 4 Exhibit DTX-0903, # 5 Exhibit DTX-904, # 6 Exhibit PTX-1231, # 7 Exhibit PTX-1271, # 8 Proposed Order)(Kim, Olivia) (Entered: 11/02/2022) (Exhibit C) (3)
Nov 2, 2022	265	SUPPLEMENT to 263 MOTION for New Trial Pursuant to Fed. R. Civ. P. 59 by Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit A, # 2 Exhibit C, # 3 Exhibit D, # 4 Exhibit DTX-0903, # 5 Exhibit DTX-904, # 6 Exhibit PTX-1231, # 7 Exhibit PTX-1271, # 8 Proposed Order)(Kim, Olivia) (Entered: 11/02/2022) (Exhibit D) (3)
Nov 2, 2022	265	SUPPLEMENT to 263 MOTION for New Trial Pursuant to Fed. R. Civ. P. 59 by Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit A, # 2 Exhibit C, # 3 Exhibit D, # 4 Exhibit DTX-0903, # 5 Exhibit DTX-904, # 6 Exhibit PTX-1231, # 7 Exhibit PTX-1271, # 8 Proposed Order)(Kim, Olivia) (Entered: 11/02/2022) (Exhibit DTX-0903) (2)
Nov 2, 2022	265	SUPPLEMENT to 263 MOTION for New Trial Pursuant to Fed. R. Civ. P. 59 by Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit A, # 2 Exhibit C, # 3 Exhibit D, # 4 Exhibit DTX-0903, # 5 Exhibit DTX-904, # 6 Exhibit PTX-1231, # 7 Exhibit PTX-1271, # 8 Proposed Order)(Kim, Olivia) (Entered: 11/02/2022) (Exhibit DTX-904) (5)
Nov 2, 2022	265	SUPPLEMENT to 263 MOTION for New Trial Pursuant to Fed. R. Civ. P. 59 by Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit A, # 2 Exhibit C, # 3 Exhibit D, # 4 Exhibit DTX-0903, # 5 Exhibit DTX-904, # 6 Exhibit PTX-1231, # 7 Exhibit PTX-1271, # 8 Proposed Order)(Kim, Olivia) (Entered: 11/02/2022) (Exhibit PTX-1231) (2)
Nov 2, 2022	265	SUPPLEMENT to 263 MOTION for New Trial Pursuant to Fed. R. Civ. P. 59 by Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit A, # 2 Exhibit C, # 3 Exhibit D, # 4 Exhibit DTX-0903, # 5 Exhibit DTX-904, # 6 Exhibit PTX-1231, # 7 Exhibit PTX-1271, # 8 Proposed Order)(Kim, Olivia) (Entered: 11/02/2022) (Exhibit PTX-1271) (1)
Nov 2, 2022	265	SUPPLEMENT to 263 MOTION for New Trial Pursuant to Fed. R. Civ. P. 59 by Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit A, # 2 Exhibit C, # 3 Exhibit D, # 4 Exhibit DTX-0903, # 5 Exhibit DTX-904, # 6 Exhibit PTX-1231, # 7 Exhibit PTX-1271, # 8 Proposed Order)(Kim, Olivia) (Entered: 11/02/2022) (Proposed Order) (1)
Nov 2, 2022	268	SUPPLEMENT to 263 MOTION for New Trial Pursuant to Fed. R. Civ. P. 59 by Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit PTX-0014)(Kim, Olivia) (Entered: 11/02/2022) (Exhibit PTX-0014) (30)
Nov 2, 2022	266	MOTION to Amend Judgment and for a Bench Trial and Subsequent Submissions Regarding Equitable Estoppel, and in the Alternative, an Offer of Proof Regarding Equitable Estoppel by Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit D, # 4 Exhibit E, # 5 Exhibit PTX-0234, # 6 Proposed Order)(Kim, Olivia) (Entered: 11/02/2022) (Exhibit A) (30)
Nov 2, 2022	266	MOTION to Amend Judgment and for a Bench Trial and Subsequent Submissions Regarding Equitable Estoppel, and in the Alternative, an Offer of Proof Regarding Equitable Estoppel by Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit D, # 4 Exhibit E, # 5 Exhibit PTX-0234, # 6 Proposed Order)(Kim, Olivia) (Entered: 11/02/2022) (Exhibit B) (6)
Nov 2, 2022	266	MOTION to Amend Judgment and for a Bench Trial and Subsequent Submissions Regarding Equitable Estoppel, and in the Alternative, an Offer of Proof Regarding Equitable Estoppel by Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit D, # 4 Exhibit E, # 5 Exhibit PTX-0234, # 6 Proposed Order)(Kim, Olivia) (Entered: 11/02/2022) (Exhibit D) (5)
Nov 2, 2022	266	MOTION to Amend Judgment and for a Bench Trial and Subsequent Submissions Regarding Equitable Estoppel, and in the Alternative, an Offer of Proof Regarding Equitable Estoppel by Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit D, # 4 Exhibit E, # 5 Exhibit PTX-0234, # 6 Proposed Order)(Kim, Olivia) (Entered: 11/02/2022) (Exhibit E) (7)
Nov 2, 2022	266	MOTION to Amend Judgment and for a Bench Trial and Subsequent Submissions Regarding Equitable Estoppel, and in the Alternative, an Offer of Proof Regarding Equitable Estoppel by Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit D, # 4 Exhibit E, # 5 Exhibit PTX-0234, # 6 Proposed Order)(Kim, Olivia) (Entered: 11/02/2022) (Exhibit PTX-0234) (1)
Nov 2, 2022	266	MOTION to Amend Judgment and for a Bench Trial and Subsequent Submissions Regarding Equitable Estoppel, and in the Alternative, an Offer of Proof Regarding Equitable Estoppel by Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit D, # 4 Exhibit E, # 5 Exhibit PTX-0234, # 6 Proposed Order)(Kim, Olivia) (Entered: 11/02/2022) (Proposed Order) (1)
Nov 2, 2022	262	SUPPLEMENT to 261 Sealed Motion Defendant Labcorp's Renewed Motion for Judgment as a Matter of Law Pursuant to Fed. R. Civ. P. 50(b) by Laboratory Corporation of America Holdings by Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit A, # 2 Exhibit C, # 3 Exhibit DTX-0135, # 4 Exhibit DTX-0218, # 5 Exhibit DTX-618, # 6 Exhibit DTX-0638, # 7 Exhibit DTX-0904, # 8 Exhibit DTX-0988, # 9 Exhibit PTX-0002, # 10 Exhibit PTX-0175, # 11 Exhibit PTX-0228, # 12 Exhibit PTX-0234, # 13 Exhibit PTX-0721, # 14 Exhibit PTX-0742, # 15 Exhibit PTX-0785, # 16 Exhibit PTX-0789, # 17 Exhibit PTX-1231, # 18 Exhibit PTX-1232, # 19 Exhibit PTX-1233, # 20 Exhibit PTX-1271, # 21 Exhibit PTX-1301, # 22 Exhibit PTX-1549, # 23 Proposed Order)(Kim, Olivia) (Entered: 11/02/2022) (Exhibit A) (30)
Nov 2, 2022	262	SUPPLEMENT to 261 Sealed Motion Defendant Labcorp's Renewed Motion for Judgment as a Matter of Law Pursuant to Fed. R. Civ. P. 50(b) by Laboratory Corporation of America Holdings by Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit A, # 2 Exhibit C, # 3 Exhibit DTX-0135, # 4 Exhibit DTX-0218, # 5 Exhibit DTX-618, # 6 Exhibit DTX-0638, # 7 Exhibit DTX-0904, # 8 Exhibit DTX-0988, # 9 Exhibit PTX-0002, # 10 Exhibit PTX-0175, # 11 Exhibit PTX-0228, # 12 Exhibit PTX-0234, # 13 Exhibit PTX-0721, # 14 Exhibit PTX-0742, # 15 Exhibit PTX-0785, # 16 Exhibit PTX-0789, # 17 Exhibit PTX-1231, # 18 Exhibit PTX-1232, # 19 Exhibit PTX-1233, # 20 Exhibit PTX-1271, # 21 Exhibit PTX-1301, # 22 Exhibit PTX-1549, # 23 Proposed Order)(Kim, Olivia) (Entered: 11/02/2022) (Exhibit C) (3)
Nov 2, 2022	262	SUPPLEMENT to 261 Sealed Motion Defendant Labcorp's Renewed Motion for Judgment as a Matter of Law Pursuant to Fed. R. Civ. P. 50(b) by Laboratory Corporation of America Holdings by Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit A, # 2 Exhibit C, # 3 Exhibit DTX-0135, # 4 Exhibit DTX-0218, # 5 Exhibit DTX-618, # 6 Exhibit DTX-0638, # 7 Exhibit DTX-0904, # 8 Exhibit DTX-0988, # 9 Exhibit PTX-0002, # 10 Exhibit PTX-0175, # 11 Exhibit PTX-0228, # 12 Exhibit PTX-0234, # 13 Exhibit PTX-0721, # 14 Exhibit PTX-0742, # 15 Exhibit PTX-0785, # 16 Exhibit PTX-0789, # 17 Exhibit PTX-1231, # 18 Exhibit PTX-1232, # 19 Exhibit PTX-1233, # 20 Exhibit PTX-1271, # 21 Exhibit PTX-1301, # 22 Exhibit PTX-1549, # 23 Proposed Order)(Kim, Olivia) (Entered: 11/02/2022) (Exhibit DTX-0135) (17)
Nov 2, 2022	262	SUPPLEMENT to 261 Sealed Motion Defendant Labcorp's Renewed Motion for Judgment as a Matter of Law Pursuant to Fed. R. Civ. P. 50(b) by Laboratory Corporation of America Holdings by Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit A, # 2 Exhibit C, # 3 Exhibit DTX-0135, # 4 Exhibit DTX-0218, # 5 Exhibit DTX-618, # 6 Exhibit DTX-0638, # 7 Exhibit DTX-0904, # 8 Exhibit DTX-0988, # 9 Exhibit PTX-0002, # 10 Exhibit PTX-0175, # 11 Exhibit PTX-0228, # 12 Exhibit PTX-0234, # 13 Exhibit PTX-0721, # 14 Exhibit PTX-0742, # 15 Exhibit PTX-0785, # 16 Exhibit PTX-0789, # 17 Exhibit PTX-1231, # 18 Exhibit PTX-1232, # 19 Exhibit PTX-1233, # 20 Exhibit PTX-1271, # 21 Exhibit PTX-1301, # 22 Exhibit PTX-1549, # 23 Proposed Order)(Kim, Olivia) (Entered: 11/02/2022) (Exhibit DTX-0218) (6)
Nov 2, 2022	262	SUPPLEMENT to 261 Sealed Motion Defendant Labcorp's Renewed Motion for Judgment as a Matter of Law Pursuant to Fed. R. Civ. P. 50(b) by Laboratory Corporation of America Holdings by Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit A, # 2 Exhibit C, # 3 Exhibit DTX-0135, # 4 Exhibit DTX-0218, # 5 Exhibit DTX-618, # 6 Exhibit DTX-0638, # 7 Exhibit DTX-0904, # 8 Exhibit DTX-0988, # 9 Exhibit PTX-0002, # 10 Exhibit PTX-0175, # 11 Exhibit PTX-0228, # 12 Exhibit PTX-0234, # 13 Exhibit PTX-0721, # 14 Exhibit PTX-0742, # 15 Exhibit PTX-0785, # 16 Exhibit PTX-0789, # 17 Exhibit PTX-1231, # 18 Exhibit PTX-1232, # 19 Exhibit PTX-1233, # 20 Exhibit PTX-1271, # 21 Exhibit PTX-1301, # 22 Exhibit PTX-1549, # 23 Proposed Order)(Kim, Olivia) (Entered: 11/02/2022) (Exhibit DTX-618) (6)
Nov 2, 2022	262	SUPPLEMENT to 261 Sealed Motion Defendant Labcorp's Renewed Motion for Judgment as a Matter of Law Pursuant to Fed. R. Civ. P. 50(b) by Laboratory Corporation of America Holdings by Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit A, # 2 Exhibit C, # 3 Exhibit DTX-0135, # 4 Exhibit DTX-0218, # 5 Exhibit DTX-618, # 6 Exhibit DTX-0638, # 7 Exhibit DTX-0904, # 8 Exhibit DTX-0988, # 9 Exhibit PTX-0002, # 10 Exhibit PTX-0175, # 11 Exhibit PTX-0228, # 12 Exhibit PTX-0234, # 13 Exhibit PTX-0721, # 14 Exhibit PTX-0742, # 15 Exhibit PTX-0785, # 16 Exhibit PTX-0789, # 17 Exhibit PTX-1231, # 18 Exhibit PTX-1232, # 19 Exhibit PTX-1233, # 20 Exhibit PTX-1271, # 21 Exhibit PTX-1301, # 22 Exhibit PTX-1549, # 23 Proposed Order)(Kim, Olivia) (Entered: 11/02/2022) (Exhibit DTX-0638) (6)
Nov 2, 2022	262	SUPPLEMENT to 261 Sealed Motion Defendant Labcorp's Renewed Motion for Judgment as a Matter of Law Pursuant to Fed. R. Civ. P. 50(b) by Laboratory Corporation of America Holdings by Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit A, # 2 Exhibit C, # 3 Exhibit DTX-0135, # 4 Exhibit DTX-0218, # 5 Exhibit DTX-618, # 6 Exhibit DTX-0638, # 7 Exhibit DTX-0904, # 8 Exhibit DTX-0988, # 9 Exhibit PTX-0002, # 10 Exhibit PTX-0175, # 11 Exhibit PTX-0228, # 12 Exhibit PTX-0234, # 13 Exhibit PTX-0721, # 14 Exhibit PTX-0742, # 15 Exhibit PTX-0785, # 16 Exhibit PTX-0789, # 17 Exhibit PTX-1231, # 18 Exhibit PTX-1232, # 19 Exhibit PTX-1233, # 20 Exhibit PTX-1271, # 21 Exhibit PTX-1301, # 22 Exhibit PTX-1549, # 23 Proposed Order)(Kim, Olivia) (Entered: 11/02/2022) (Exhibit DTX-0904) (5)
Nov 2, 2022	262	SUPPLEMENT to 261 Sealed Motion Defendant Labcorp's Renewed Motion for Judgment as a Matter of Law Pursuant to Fed. R. Civ. P. 50(b) by Laboratory Corporation of America Holdings by Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit A, # 2 Exhibit C, # 3 Exhibit DTX-0135, # 4 Exhibit DTX-0218, # 5 Exhibit DTX-618, # 6 Exhibit DTX-0638, # 7 Exhibit DTX-0904, # 8 Exhibit DTX-0988, # 9 Exhibit PTX-0002, # 10 Exhibit PTX-0175, # 11 Exhibit PTX-0228, # 12 Exhibit PTX-0234, # 13 Exhibit PTX-0721, # 14 Exhibit PTX-0742, # 15 Exhibit PTX-0785, # 16 Exhibit PTX-0789, # 17 Exhibit PTX-1231, # 18 Exhibit PTX-1232, # 19 Exhibit PTX-1233, # 20 Exhibit PTX-1271, # 21 Exhibit PTX-1301, # 22 Exhibit PTX-1549, # 23 Proposed Order)(Kim, Olivia) (Entered: 11/02/2022) (Exhibit DTX-0988) (17)
Nov 2, 2022	262	SUPPLEMENT to 261 Sealed Motion Defendant Labcorp's Renewed Motion for Judgment as a Matter of Law Pursuant to Fed. R. Civ. P. 50(b) by Laboratory Corporation of America Holdings by Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit A, # 2 Exhibit C, # 3 Exhibit DTX-0135, # 4 Exhibit DTX-0218, # 5 Exhibit DTX-618, # 6 Exhibit DTX-0638, # 7 Exhibit DTX-0904, # 8 Exhibit DTX-0988, # 9 Exhibit PTX-0002, # 10 Exhibit PTX-0175, # 11 Exhibit PTX-0228, # 12 Exhibit PTX-0234, # 13 Exhibit PTX-0721, # 14 Exhibit PTX-0742, # 15 Exhibit PTX-0785, # 16 Exhibit PTX-0789, # 17 Exhibit PTX-1231, # 18 Exhibit PTX-1232, # 19 Exhibit PTX-1233, # 20 Exhibit PTX-1271, # 21 Exhibit PTX-1301, # 22 Exhibit PTX-1549, # 23 Proposed Order)(Kim, Olivia) (Entered: 11/02/2022) (Exhibit PTX-0002) (30)
Nov 2, 2022	262	SUPPLEMENT to 261 Sealed Motion Defendant Labcorp's Renewed Motion for Judgment as a Matter of Law Pursuant to Fed. R. Civ. P. 50(b) by Laboratory Corporation of America Holdings by Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit A, # 2 Exhibit C, # 3 Exhibit DTX-0135, # 4 Exhibit DTX-0218, # 5 Exhibit DTX-618, # 6 Exhibit DTX-0638, # 7 Exhibit DTX-0904, # 8 Exhibit DTX-0988, # 9 Exhibit PTX-0002, # 10 Exhibit PTX-0175, # 11 Exhibit PTX-0228, # 12 Exhibit PTX-0234, # 13 Exhibit PTX-0721, # 14 Exhibit PTX-0742, # 15 Exhibit PTX-0785, # 16 Exhibit PTX-0789, # 17 Exhibit PTX-1231, # 18 Exhibit PTX-1232, # 19 Exhibit PTX-1233, # 20 Exhibit PTX-1271, # 21 Exhibit PTX-1301, # 22 Exhibit PTX-1549, # 23 Proposed Order)(Kim, Olivia) (Entered: 11/02/2022) (Exhibit PTX-0175) (18)
Nov 2, 2022	262	SUPPLEMENT to 261 Sealed Motion Defendant Labcorp's Renewed Motion for Judgment as a Matter of Law Pursuant to Fed. R. Civ. P. 50(b) by Laboratory Corporation of America Holdings by Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit A, # 2 Exhibit C, # 3 Exhibit DTX-0135, # 4 Exhibit DTX-0218, # 5 Exhibit DTX-618, # 6 Exhibit DTX-0638, # 7 Exhibit DTX-0904, # 8 Exhibit DTX-0988, # 9 Exhibit PTX-0002, # 10 Exhibit PTX-0175, # 11 Exhibit PTX-0228, # 12 Exhibit PTX-0234, # 13 Exhibit PTX-0721, # 14 Exhibit PTX-0742, # 15 Exhibit PTX-0785, # 16 Exhibit PTX-0789, # 17 Exhibit PTX-1231, # 18 Exhibit PTX-1232, # 19 Exhibit PTX-1233, # 20 Exhibit PTX-1271, # 21 Exhibit PTX-1301, # 22 Exhibit PTX-1549, # 23 Proposed Order)(Kim, Olivia) (Entered: 11/02/2022) (Exhibit PTX-0228) (30)
Nov 2, 2022	262	SUPPLEMENT to 261 Sealed Motion Defendant Labcorp's Renewed Motion for Judgment as a Matter of Law Pursuant to Fed. R. Civ. P. 50(b) by Laboratory Corporation of America Holdings by Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit A, # 2 Exhibit C, # 3 Exhibit DTX-0135, # 4 Exhibit DTX-0218, # 5 Exhibit DTX-618, # 6 Exhibit DTX-0638, # 7 Exhibit DTX-0904, # 8 Exhibit DTX-0988, # 9 Exhibit PTX-0002, # 10 Exhibit PTX-0175, # 11 Exhibit PTX-0228, # 12 Exhibit PTX-0234, # 13 Exhibit PTX-0721, # 14 Exhibit PTX-0742, # 15 Exhibit PTX-0785, # 16 Exhibit PTX-0789, # 17 Exhibit PTX-1231, # 18 Exhibit PTX-1232, # 19 Exhibit PTX-1233, # 20 Exhibit PTX-1271, # 21 Exhibit PTX-1301, # 22 Exhibit PTX-1549, # 23 Proposed Order)(Kim, Olivia) (Entered: 11/02/2022) (Exhibit PTX-0234) (1)
Nov 2, 2022	262	SUPPLEMENT to 261 Sealed Motion Defendant Labcorp's Renewed Motion for Judgment as a Matter of Law Pursuant to Fed. R. Civ. P. 50(b) by Laboratory Corporation of America Holdings by Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit A, # 2 Exhibit C, # 3 Exhibit DTX-0135, # 4 Exhibit DTX-0218, # 5 Exhibit DTX-618, # 6 Exhibit DTX-0638, # 7 Exhibit DTX-0904, # 8 Exhibit DTX-0988, # 9 Exhibit PTX-0002, # 10 Exhibit PTX-0175, # 11 Exhibit PTX-0228, # 12 Exhibit PTX-0234, # 13 Exhibit PTX-0721, # 14 Exhibit PTX-0742, # 15 Exhibit PTX-0785, # 16 Exhibit PTX-0789, # 17 Exhibit PTX-1231, # 18 Exhibit PTX-1232, # 19 Exhibit PTX-1233, # 20 Exhibit PTX-1271, # 21 Exhibit PTX-1301, # 22 Exhibit PTX-1549, # 23 Proposed Order)(Kim, Olivia) (Entered: 11/02/2022) (Exhibit PTX-0721) (30)
Nov 2, 2022	262	SUPPLEMENT to 261 Sealed Motion Defendant Labcorp's Renewed Motion for Judgment as a Matter of Law Pursuant to Fed. R. Civ. P. 50(b) by Laboratory Corporation of America Holdings by Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit A, # 2 Exhibit C, # 3 Exhibit DTX-0135, # 4 Exhibit DTX-0218, # 5 Exhibit DTX-618, # 6 Exhibit DTX-0638, # 7 Exhibit DTX-0904, # 8 Exhibit DTX-0988, # 9 Exhibit PTX-0002, # 10 Exhibit PTX-0175, # 11 Exhibit PTX-0228, # 12 Exhibit PTX-0234, # 13 Exhibit PTX-0721, # 14 Exhibit PTX-0742, # 15 Exhibit PTX-0785, # 16 Exhibit PTX-0789, # 17 Exhibit PTX-1231, # 18 Exhibit PTX-1232, # 19 Exhibit PTX-1233, # 20 Exhibit PTX-1271, # 21 Exhibit PTX-1301, # 22 Exhibit PTX-1549, # 23 Proposed Order)(Kim, Olivia) (Entered: 11/02/2022) (Exhibit PTX-0742) (17)
Nov 2, 2022	262	SUPPLEMENT to 261 Sealed Motion Defendant Labcorp's Renewed Motion for Judgment as a Matter of Law Pursuant to Fed. R. Civ. P. 50(b) by Laboratory Corporation of America Holdings by Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit A, # 2 Exhibit C, # 3 Exhibit DTX-0135, # 4 Exhibit DTX-0218, # 5 Exhibit DTX-618, # 6 Exhibit DTX-0638, # 7 Exhibit DTX-0904, # 8 Exhibit DTX-0988, # 9 Exhibit PTX-0002, # 10 Exhibit PTX-0175, # 11 Exhibit PTX-0228, # 12 Exhibit PTX-0234, # 13 Exhibit PTX-0721, # 14 Exhibit PTX-0742, # 15 Exhibit PTX-0785, # 16 Exhibit PTX-0789, # 17 Exhibit PTX-1231, # 18 Exhibit PTX-1232, # 19 Exhibit PTX-1233, # 20 Exhibit PTX-1271, # 21 Exhibit PTX-1301, # 22 Exhibit PTX-1549, # 23 Proposed Order)(Kim, Olivia) (Entered: 11/02/2022) (Exhibit PTX-0785) (10)
Nov 2, 2022	262	SUPPLEMENT to 261 Sealed Motion Defendant Labcorp's Renewed Motion for Judgment as a Matter of Law Pursuant to Fed. R. Civ. P. 50(b) by Laboratory Corporation of America Holdings by Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit A, # 2 Exhibit C, # 3 Exhibit DTX-0135, # 4 Exhibit DTX-0218, # 5 Exhibit DTX-618, # 6 Exhibit DTX-0638, # 7 Exhibit DTX-0904, # 8 Exhibit DTX-0988, # 9 Exhibit PTX-0002, # 10 Exhibit PTX-0175, # 11 Exhibit PTX-0228, # 12 Exhibit PTX-0234, # 13 Exhibit PTX-0721, # 14 Exhibit PTX-0742, # 15 Exhibit PTX-0785, # 16 Exhibit PTX-0789, # 17 Exhibit PTX-1231, # 18 Exhibit PTX-1232, # 19 Exhibit PTX-1233, # 20 Exhibit PTX-1271, # 21 Exhibit PTX-1301, # 22 Exhibit PTX-1549, # 23 Proposed Order)(Kim, Olivia) (Entered: 11/02/2022) (Exhibit PTX-0789) (15)
Nov 2, 2022	262	SUPPLEMENT to 261 Sealed Motion Defendant Labcorp's Renewed Motion for Judgment as a Matter of Law Pursuant to Fed. R. Civ. P. 50(b) by Laboratory Corporation of America Holdings by Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit A, # 2 Exhibit C, # 3 Exhibit DTX-0135, # 4 Exhibit DTX-0218, # 5 Exhibit DTX-618, # 6 Exhibit DTX-0638, # 7 Exhibit DTX-0904, # 8 Exhibit DTX-0988, # 9 Exhibit PTX-0002, # 10 Exhibit PTX-0175, # 11 Exhibit PTX-0228, # 12 Exhibit PTX-0234, # 13 Exhibit PTX-0721, # 14 Exhibit PTX-0742, # 15 Exhibit PTX-0785, # 16 Exhibit PTX-0789, # 17 Exhibit PTX-1231, # 18 Exhibit PTX-1232, # 19 Exhibit PTX-1233, # 20 Exhibit PTX-1271, # 21 Exhibit PTX-1301, # 22 Exhibit PTX-1549, # 23 Proposed Order)(Kim, Olivia) (Entered: 11/02/2022) (Exhibit PTX-1231) (2)
Nov 2, 2022	262	SUPPLEMENT to 261 Sealed Motion Defendant Labcorp's Renewed Motion for Judgment as a Matter of Law Pursuant to Fed. R. Civ. P. 50(b) by Laboratory Corporation of America Holdings by Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit A, # 2 Exhibit C, # 3 Exhibit DTX-0135, # 4 Exhibit DTX-0218, # 5 Exhibit DTX-618, # 6 Exhibit DTX-0638, # 7 Exhibit DTX-0904, # 8 Exhibit DTX-0988, # 9 Exhibit PTX-0002, # 10 Exhibit PTX-0175, # 11 Exhibit PTX-0228, # 12 Exhibit PTX-0234, # 13 Exhibit PTX-0721, # 14 Exhibit PTX-0742, # 15 Exhibit PTX-0785, # 16 Exhibit PTX-0789, # 17 Exhibit PTX-1231, # 18 Exhibit PTX-1232, # 19 Exhibit PTX-1233, # 20 Exhibit PTX-1271, # 21 Exhibit PTX-1301, # 22 Exhibit PTX-1549, # 23 Proposed Order)(Kim, Olivia) (Entered: 11/02/2022) (Exhibit PTX-1232) (2)
Nov 2, 2022	262	SUPPLEMENT to 261 Sealed Motion Defendant Labcorp's Renewed Motion for Judgment as a Matter of Law Pursuant to Fed. R. Civ. P. 50(b) by Laboratory Corporation of America Holdings by Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit A, # 2 Exhibit C, # 3 Exhibit DTX-0135, # 4 Exhibit DTX-0218, # 5 Exhibit DTX-618, # 6 Exhibit DTX-0638, # 7 Exhibit DTX-0904, # 8 Exhibit DTX-0988, # 9 Exhibit PTX-0002, # 10 Exhibit PTX-0175, # 11 Exhibit PTX-0228, # 12 Exhibit PTX-0234, # 13 Exhibit PTX-0721, # 14 Exhibit PTX-0742, # 15 Exhibit PTX-0785, # 16 Exhibit PTX-0789, # 17 Exhibit PTX-1231, # 18 Exhibit PTX-1232, # 19 Exhibit PTX-1233, # 20 Exhibit PTX-1271, # 21 Exhibit PTX-1301, # 22 Exhibit PTX-1549, # 23 Proposed Order)(Kim, Olivia) (Entered: 11/02/2022) (Exhibit PTX-1233) (2)
Nov 2, 2022	262	SUPPLEMENT to 261 Sealed Motion Defendant Labcorp's Renewed Motion for Judgment as a Matter of Law Pursuant to Fed. R. Civ. P. 50(b) by Laboratory Corporation of America Holdings by Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit A, # 2 Exhibit C, # 3 Exhibit DTX-0135, # 4 Exhibit DTX-0218, # 5 Exhibit DTX-618, # 6 Exhibit DTX-0638, # 7 Exhibit DTX-0904, # 8 Exhibit DTX-0988, # 9 Exhibit PTX-0002, # 10 Exhibit PTX-0175, # 11 Exhibit PTX-0228, # 12 Exhibit PTX-0234, # 13 Exhibit PTX-0721, # 14 Exhibit PTX-0742, # 15 Exhibit PTX-0785, # 16 Exhibit PTX-0789, # 17 Exhibit PTX-1231, # 18 Exhibit PTX-1232, # 19 Exhibit PTX-1233, # 20 Exhibit PTX-1271, # 21 Exhibit PTX-1301, # 22 Exhibit PTX-1549, # 23 Proposed Order)(Kim, Olivia) (Entered: 11/02/2022) (Exhibit PTX-1271) (1)
Nov 2, 2022	262	SUPPLEMENT to 261 Sealed Motion Defendant Labcorp's Renewed Motion for Judgment as a Matter of Law Pursuant to Fed. R. Civ. P. 50(b) by Laboratory Corporation of America Holdings by Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit A, # 2 Exhibit C, # 3 Exhibit DTX-0135, # 4 Exhibit DTX-0218, # 5 Exhibit DTX-618, # 6 Exhibit DTX-0638, # 7 Exhibit DTX-0904, # 8 Exhibit DTX-0988, # 9 Exhibit PTX-0002, # 10 Exhibit PTX-0175, # 11 Exhibit PTX-0228, # 12 Exhibit PTX-0234, # 13 Exhibit PTX-0721, # 14 Exhibit PTX-0742, # 15 Exhibit PTX-0785, # 16 Exhibit PTX-0789, # 17 Exhibit PTX-1231, # 18 Exhibit PTX-1232, # 19 Exhibit PTX-1233, # 20 Exhibit PTX-1271, # 21 Exhibit PTX-1301, # 22 Exhibit PTX-1549, # 23 Proposed Order)(Kim, Olivia) (Entered: 11/02/2022) (Exhibit PTX-1301) (1)
Nov 2, 2022	262	SUPPLEMENT to 261 Sealed Motion Defendant Labcorp's Renewed Motion for Judgment as a Matter of Law Pursuant to Fed. R. Civ. P. 50(b) by Laboratory Corporation of America Holdings by Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit A, # 2 Exhibit C, # 3 Exhibit DTX-0135, # 4 Exhibit DTX-0218, # 5 Exhibit DTX-618, # 6 Exhibit DTX-0638, # 7 Exhibit DTX-0904, # 8 Exhibit DTX-0988, # 9 Exhibit PTX-0002, # 10 Exhibit PTX-0175, # 11 Exhibit PTX-0228, # 12 Exhibit PTX-0234, # 13 Exhibit PTX-0721, # 14 Exhibit PTX-0742, # 15 Exhibit PTX-0785, # 16 Exhibit PTX-0789, # 17 Exhibit PTX-1231, # 18 Exhibit PTX-1232, # 19 Exhibit PTX-1233, # 20 Exhibit PTX-1271, # 21 Exhibit PTX-1301, # 22 Exhibit PTX-1549, # 23 Proposed Order)(Kim, Olivia) (Entered: 11/02/2022) (Exhibit PTX-1549) (1)
Nov 2, 2022	262	SUPPLEMENT to 261 Sealed Motion Defendant Labcorp's Renewed Motion for Judgment as a Matter of Law Pursuant to Fed. R. Civ. P. 50(b) by Laboratory Corporation of America Holdings by Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit A, # 2 Exhibit C, # 3 Exhibit DTX-0135, # 4 Exhibit DTX-0218, # 5 Exhibit DTX-618, # 6 Exhibit DTX-0638, # 7 Exhibit DTX-0904, # 8 Exhibit DTX-0988, # 9 Exhibit PTX-0002, # 10 Exhibit PTX-0175, # 11 Exhibit PTX-0228, # 12 Exhibit PTX-0234, # 13 Exhibit PTX-0721, # 14 Exhibit PTX-0742, # 15 Exhibit PTX-0785, # 16 Exhibit PTX-0789, # 17 Exhibit PTX-1231, # 18 Exhibit PTX-1232, # 19 Exhibit PTX-1233, # 20 Exhibit PTX-1271, # 21 Exhibit PTX-1301, # 22 Exhibit PTX-1549, # 23 Proposed Order)(Kim, Olivia) (Entered: 11/02/2022) (Proposed Order) (1)
Nov 1, 2022	252	Transcript filed of Proceedings held on 9-19-22, Proceedings Transcribed: Jury Trial Volume 1. Court Reporter/Transcriber: Kristie Davis (kmdaviscsr@yahoo.com), Telephone number: 2546660904. Parties are notified of their duty to review the transcript to ensure compliance with the FRCP 5.2(a)/FRCrP 49.1(a). A copy may be purchased from the court reporter or viewed at the clerk's office public terminal. If redaction is necessary, a Notice of Redaction Request must be filed within 21 days. If no such Notice is filed, the transcript will be made available via PACER without redaction after 90 calendar days. The clerk will mail a copy of this notice to parties not electronically noticed Redaction Request due 11/22/2022, Redacted Transcript Deadline set for 12/2/2022, Release of Transcript Restriction set for 1/30/2023, (kd) (Entered: 11/01/2022) (0)
Nov 1, 2022	253	Jury Trial Volume 2, 9-20-23 Sealed Transcript filed (This transcript is not available electronically) (kd) (Entered: 11/01/2022) (0)
Nov 1, 2022	254	Jury Trial Volume 3, 9-21-22, Sealed Transcript filed (This transcript is not available electronically) (kd) (Entered: 11/01/2022) (0)
Nov 1, 2022	255	Jury Trial Volume 4, 9-22-22, Sealed Transcript filed (This transcript is not available electronically) (kd) (Entered: 11/01/2022) (0)
Nov 1, 2022	256	Jury Trial Volume 5, 9-23-22, Sealed Transcript filed (This transcript is not available electronically) (kd) (Entered: 11/01/2022) (0)
Nov 1, 2022	257	Transcript filed of Proceedings held on 9-20-22, Proceedings Transcribed: Jury Trial Volume 2. Court Reporter/Transcriber: Kristie Davis (kmdaviscsr@yahoo.com), Telephone number: 2546660904. Parties are notified of their duty to review the transcript to ensure compliance with the FRCP 5.2(a)/FRCrP 49.1(a). A copy may be purchased from the court reporter or viewed at the clerk's office public terminal. If redaction is necessary, a Notice of Redaction Request must be filed within 21 days. If no such Notice is filed, the transcript will be made available via PACER without redaction after 90 calendar days. The clerk will mail a copy of this notice to parties not electronically noticed Redaction Request due 11/22/2022, Redacted Transcript Deadline set for 12/2/2022, Release of Transcript Restriction set for 1/30/2023, (kd) (Entered: 11/01/2022) (0)
Nov 1, 2022	258	Transcript filed of Proceedings held on 9-21-22, Proceedings Transcribed: Jury Trial Volume 3. Court Reporter/Transcriber: Kristie Davis (kmdaviscsr@yahoo.com), Telephone number: 2546660904. Parties are notified of their duty to review the transcript to ensure compliance with the FRCP 5.2(a)/FRCrP 49.1(a). A copy may be purchased from the court reporter or viewed at the clerk's office public terminal. If redaction is necessary, a Notice of Redaction Request must be filed within 21 days. If no such Notice is filed, the transcript will be made available via PACER without redaction after 90 calendar days. The clerk will mail a copy of this notice to parties not electronically noticed Redaction Request due 11/22/2022, Redacted Transcript Deadline set for 12/2/2022, Release of Transcript Restriction set for 1/30/2023, (kd) (Entered: 11/01/2022) (0)
Nov 1, 2022	259	Transcript filed of Proceedings held on 9-22-22, Proceedings Transcribed: Jury Trial Volume 4. Court Reporter/Transcriber: Kristie Davis (kmdaviscsr@yahoo.com), Telephone number: 2546660904. Parties are notified of their duty to review the transcript to ensure compliance with the FRCP 5.2(a)/FRCrP 49.1(a). A copy may be purchased from the court reporter or viewed at the clerk's office public terminal. If redaction is necessary, a Notice of Redaction Request must be filed within 21 days. If no such Notice is filed, the transcript will be made available via PACER without redaction after 90 calendar days. The clerk will mail a copy of this notice to parties not electronically noticed Redaction Request due 11/22/2022, Redacted Transcript Deadline set for 12/2/2022, Release of Transcript Restriction set for 1/30/2023, (kd) (Entered: 11/01/2022) (0)
Nov 1, 2022	260	Transcript filed of Proceedings held on 9-23-22, Proceedings Transcribed: Jury Trial Volume 5. Court Reporter/Transcriber: Kristie Davis (kmdaviscsr@yahoo.com), Telephone number: 2546660904. Parties are notified of their duty to review the transcript to ensure compliance with the FRCP 5.2(a)/FRCrP 49.1(a). A copy may be purchased from the court reporter or viewed at the clerk's office public terminal. If redaction is necessary, a Notice of Redaction Request must be filed within 21 days. If no such Notice is filed, the transcript will be made available via PACER without redaction after 90 calendar days. The clerk will mail a copy of this notice to parties not electronically noticed Redaction Request due 11/22/2022, Redacted Transcript Deadline set for 12/2/2022, Release of Transcript Restriction set for 1/30/2023, (kd) (Entered: 11/01/2022) (0)
Oct 27, 2022	250	Sealed Document: Defendant Labcorp's Opposition of 238 MOTION to Amend Judgment to Include Supplemental Damages, Pre-Judgment Interest, and Post-Judgment Interest, and to Adjudge Claim 132 Not Invalid by Laboratory Corporation of America Holdings (Attachments: # 1 Exhibit B, # 2 Exhibit C, # 3 Exhibit D, # 4 Exhibit PTX-1374, # 5 Exhibit PTX-1381, # 6 Exhibit PTX-1382) (Kim, Olivia) (Entered: 10/27/2022) (0)
Oct 27, 2022	251	SUPPLEMENT to 250 Sealed Document, Exhibits A, E, PTX-0234, PTX-1549 to Defendant Labcorp's Opposition of 238 MOTION to Amend Judgment to Include Supplemental Damages, Pre-Judgment Interest, and Post-Judgment Interest, and to Adjudge Claim 132 Not Invalid by Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit A, # 2 Exhibit E, # 3 Exhibit PTX-0234, # 4 Exhibit PTX-1549)(Kim, Olivia) (Entered: 10/27/2022) (Main Document) (4)
Oct 27, 2022	251	SUPPLEMENT to 250 Sealed Document, Exhibits A, E, PTX-0234, PTX-1549 to Defendant Labcorp's Opposition of 238 MOTION to Amend Judgment to Include Supplemental Damages, Pre-Judgment Interest, and Post-Judgment Interest, and to Adjudge Claim 132 Not Invalid by Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit A, # 2 Exhibit E, # 3 Exhibit PTX-0234, # 4 Exhibit PTX-1549)(Kim, Olivia) (Entered: 10/27/2022) (Exhibit A) (24)
Oct 27, 2022	251	SUPPLEMENT to 250 Sealed Document, Exhibits A, E, PTX-0234, PTX-1549 to Defendant Labcorp's Opposition of 238 MOTION to Amend Judgment to Include Supplemental Damages, Pre-Judgment Interest, and Post-Judgment Interest, and to Adjudge Claim 132 Not Invalid by Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit A, # 2 Exhibit E, # 3 Exhibit PTX-0234, # 4 Exhibit PTX-1549)(Kim, Olivia) (Entered: 10/27/2022) (Exhibit E) (2)
Oct 27, 2022	251	SUPPLEMENT to 250 Sealed Document, Exhibits A, E, PTX-0234, PTX-1549 to Defendant Labcorp's Opposition of 238 MOTION to Amend Judgment to Include Supplemental Damages, Pre-Judgment Interest, and Post-Judgment Interest, and to Adjudge Claim 132 Not Invalid by Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit A, # 2 Exhibit E, # 3 Exhibit PTX-0234, # 4 Exhibit PTX-1549)(Kim, Olivia) (Entered: 10/27/2022) (Exhibit PTX-0234) (1)
Oct 27, 2022	251	SUPPLEMENT to 250 Sealed Document, Exhibits A, E, PTX-0234, PTX-1549 to Defendant Labcorp's Opposition of 238 MOTION to Amend Judgment to Include Supplemental Damages, Pre-Judgment Interest, and Post-Judgment Interest, and to Adjudge Claim 132 Not Invalid by Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit A, # 2 Exhibit E, # 3 Exhibit PTX-0234, # 4 Exhibit PTX-1549)(Kim, Olivia) (Entered: 10/27/2022) (Exhibit PTX-1549) (1)
Oct 26, 2022	249	REPLY to Response to Motion, filed by Ravgen, Inc., re 232 MOTION for Enhanced Damages Pursuant to 35 U.S.C. � 284 filed by Plaintiff Ravgen, Inc. (Attachments: # 1 Exhibit 6 - Additional Trial Transcript Excerpts)(Ding, Frederick) (Entered: 10/26/2022) (Main Document) (16)
Oct 26, 2022	249	REPLY to Response to Motion, filed by Ravgen, Inc., re 232 MOTION for Enhanced Damages Pursuant to 35 U.S.C. � 284 filed by Plaintiff Ravgen, Inc. (Attachments: # 1 Exhibit 6 - Additional Trial Transcript Excerpts)(Ding, Frederick) (Entered: 10/26/2022) (Exhibit 6 - Additional Trial Transcript Excerpts) (30)
Oct 25, 2022	247	ORDER GRANTING 245 Motion to Appear Pro Hac Vice for Attorney Jennifer L. Swize. Attorney added for Laboratory Corporation of America Holdings. Pursuant to our Administrative Policies and Procedures for Electronic Filing, the attorney hereby granted to practice pro hac vice in this case must register for electronic filing with our court within 10 days of this order, if he/she has not previously done so for a prior case in this District. Registration is managed by the PACER Service Center. Signed by Judge Alan D Albright. (bot1) (Entered: 10/25/2022) (1)
Oct 25, 2022	248	ORDER GRANTING 246 Motion to Appear Pro Hac Vice for Attorney Gregory A. Castanias. Attorney added for Laboratory Corporation of America Holdings. Pursuant to our Administrative Policies and Procedures for Electronic Filing, the attorney hereby granted to practice pro hac vice in this case must register for electronic filing with our court within 10 days of this order, if he/she has not previously done so for a prior case in this District. Registration is managed by the PACER Service Center. Signed by Judge Alan D Albright. (bot1) (Entered: 10/25/2022) (1)
Oct 21, 2022	245	MOTION to Appear Pro Hac Vice by Nicole W. Stafford on behalf of Jennifer L. Swize ( Filing fee $ 100 receipt number ATXWDC-16665624) by on behalf of Laboratory Corporation of America Holdings. (Attachments: # 1 Proposed Order)(Stafford, Nicole) (Entered: 10/21/2022) (Main Document) (4)
Oct 21, 2022	246	MOTION to Appear Pro Hac Vice by Nicole W. Stafford on behalf of Gregory A. Castanias ( Filing fee $ 100 receipt number ATXWDC-16666329) by on behalf of Laboratory Corporation of America Holdings. (Attachments: # 1 Proposed Order)(Stafford, Nicole) (Entered: 10/21/2022) (Main Document) (4)
Oct 21, 2022	246	MOTION to Appear Pro Hac Vice by Nicole W. Stafford on behalf of Gregory A. Castanias ( Filing fee $ 100 receipt number ATXWDC-16666329) by on behalf of Laboratory Corporation of America Holdings. (Attachments: # 1 Proposed Order)(Stafford, Nicole) (Entered: 10/21/2022) (Proposed Order) (1)
Oct 21, 2022	245	MOTION to Appear Pro Hac Vice by Nicole W. Stafford on behalf of Jennifer L. Swize ( Filing fee $ 100 receipt number ATXWDC-16665624) by on behalf of Laboratory Corporation of America Holdings. (Attachments: # 1 Proposed Order)(Stafford, Nicole) (Entered: 10/21/2022) (Proposed Order) (1)
Oct 20, 2022	244	NOTICE of Attorney Appearance by Nicole W. Stafford on behalf of Laboratory Corporation of America Holdings. Attorney Nicole W. Stafford added to party Laboratory Corporation of America Holdings(pty:dft) (Stafford, Nicole) (Entered: 10/20/2022) (2)
Oct 19, 2022	242	Response in Opposition to Motion, filed by Laboratory Corporation of America Holdings, re 232 MOTION for Enhanced Damages Pursuant to 35 U.S.C. � 284 filed by Plaintiff Ravgen, Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit DTX-0020, # 3 Exhibit DTX-0054, # 4 Exhibit DTX-0618, # 5 Exhibit DTX-904, # 6 Exhibit DTX-0919, # 7 Exhibit DTX-0988, # 8 Exhibit PTX-0228, # 9 Exhibit PTX-1549)(Kim, Olivia) (Entered: 10/19/2022) (Main Document) (29)
Oct 19, 2022	243	Sealed Document: Exhibits of 242 Response in Opposition to Motion, by Laboratory Corporation of America Holdings (Attachments: # 1 Exhibit B, # 2 Exhibit DTX-0312, # 3 Exhibit DTX-0338, # 4 Exhibit DTX-0612) (Kim, Olivia) (Entered: 10/19/2022) (0)
Oct 19, 2022	242	Response in Opposition to Motion, filed by Laboratory Corporation of America Holdings, re 232 MOTION for Enhanced Damages Pursuant to 35 U.S.C. � 284 filed by Plaintiff Ravgen, Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit DTX-0020, # 3 Exhibit DTX-0054, # 4 Exhibit DTX-0618, # 5 Exhibit DTX-904, # 6 Exhibit DTX-0919, # 7 Exhibit DTX-0988, # 8 Exhibit PTX-0228, # 9 Exhibit PTX-1549)(Kim, Olivia) (Entered: 10/19/2022) (Exhibit A) (30)
Oct 19, 2022	242	Response in Opposition to Motion, filed by Laboratory Corporation of America Holdings, re 232 MOTION for Enhanced Damages Pursuant to 35 U.S.C. � 284 filed by Plaintiff Ravgen, Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit DTX-0020, # 3 Exhibit DTX-0054, # 4 Exhibit DTX-0618, # 5 Exhibit DTX-904, # 6 Exhibit DTX-0919, # 7 Exhibit DTX-0988, # 8 Exhibit PTX-0228, # 9 Exhibit PTX-1549)(Kim, Olivia) (Entered: 10/19/2022) (Exhibit DTX-0020) (4)
Oct 19, 2022	242	Response in Opposition to Motion, filed by Laboratory Corporation of America Holdings, re 232 MOTION for Enhanced Damages Pursuant to 35 U.S.C. � 284 filed by Plaintiff Ravgen, Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit DTX-0020, # 3 Exhibit DTX-0054, # 4 Exhibit DTX-0618, # 5 Exhibit DTX-904, # 6 Exhibit DTX-0919, # 7 Exhibit DTX-0988, # 8 Exhibit PTX-0228, # 9 Exhibit PTX-1549)(Kim, Olivia) (Entered: 10/19/2022) (Exhibit DTX-0054) (28)
Oct 19, 2022	242	Response in Opposition to Motion, filed by Laboratory Corporation of America Holdings, re 232 MOTION for Enhanced Damages Pursuant to 35 U.S.C. � 284 filed by Plaintiff Ravgen, Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit DTX-0020, # 3 Exhibit DTX-0054, # 4 Exhibit DTX-0618, # 5 Exhibit DTX-904, # 6 Exhibit DTX-0919, # 7 Exhibit DTX-0988, # 8 Exhibit PTX-0228, # 9 Exhibit PTX-1549)(Kim, Olivia) (Entered: 10/19/2022) (Exhibit DTX-0618) (6)
Oct 19, 2022	242	Response in Opposition to Motion, filed by Laboratory Corporation of America Holdings, re 232 MOTION for Enhanced Damages Pursuant to 35 U.S.C. � 284 filed by Plaintiff Ravgen, Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit DTX-0020, # 3 Exhibit DTX-0054, # 4 Exhibit DTX-0618, # 5 Exhibit DTX-904, # 6 Exhibit DTX-0919, # 7 Exhibit DTX-0988, # 8 Exhibit PTX-0228, # 9 Exhibit PTX-1549)(Kim, Olivia) (Entered: 10/19/2022) (Exhibit DTX-904) (5)
Oct 19, 2022	242	Response in Opposition to Motion, filed by Laboratory Corporation of America Holdings, re 232 MOTION for Enhanced Damages Pursuant to 35 U.S.C. � 284 filed by Plaintiff Ravgen, Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit DTX-0020, # 3 Exhibit DTX-0054, # 4 Exhibit DTX-0618, # 5 Exhibit DTX-904, # 6 Exhibit DTX-0919, # 7 Exhibit DTX-0988, # 8 Exhibit PTX-0228, # 9 Exhibit PTX-1549)(Kim, Olivia) (Entered: 10/19/2022) (Exhibit DTX-0919) (11)
Oct 19, 2022	242	Response in Opposition to Motion, filed by Laboratory Corporation of America Holdings, re 232 MOTION for Enhanced Damages Pursuant to 35 U.S.C. � 284 filed by Plaintiff Ravgen, Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit DTX-0020, # 3 Exhibit DTX-0054, # 4 Exhibit DTX-0618, # 5 Exhibit DTX-904, # 6 Exhibit DTX-0919, # 7 Exhibit DTX-0988, # 8 Exhibit PTX-0228, # 9 Exhibit PTX-1549)(Kim, Olivia) (Entered: 10/19/2022) (Exhibit DTX-0988) (17)
Oct 19, 2022	242	Response in Opposition to Motion, filed by Laboratory Corporation of America Holdings, re 232 MOTION for Enhanced Damages Pursuant to 35 U.S.C. � 284 filed by Plaintiff Ravgen, Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit DTX-0020, # 3 Exhibit DTX-0054, # 4 Exhibit DTX-0618, # 5 Exhibit DTX-904, # 6 Exhibit DTX-0919, # 7 Exhibit DTX-0988, # 8 Exhibit PTX-0228, # 9 Exhibit PTX-1549)(Kim, Olivia) (Entered: 10/19/2022) (Exhibit PTX-0228) (30)
Oct 19, 2022	242	Response in Opposition to Motion, filed by Laboratory Corporation of America Holdings, re 232 MOTION for Enhanced Damages Pursuant to 35 U.S.C. � 284 filed by Plaintiff Ravgen, Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit DTX-0020, # 3 Exhibit DTX-0054, # 4 Exhibit DTX-0618, # 5 Exhibit DTX-904, # 6 Exhibit DTX-0919, # 7 Exhibit DTX-0988, # 8 Exhibit PTX-0228, # 9 Exhibit PTX-1549)(Kim, Olivia) (Entered: 10/19/2022) (Exhibit PTX-1549) (1)
Oct 14, 2022	241	BILL OF COSTS by Ravgen, Inc.. (Attachments: # 1 Declaration of Jamie L. Kringstein, # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D, # 6 Exhibit E)(Kringstein, Jamie) (Entered: 10/14/2022) (Main Document) (2)
Oct 14, 2022	241	BILL OF COSTS by Ravgen, Inc.. (Attachments: # 1 Declaration of Jamie L. Kringstein, # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D, # 6 Exhibit E)(Kringstein, Jamie) (Entered: 10/14/2022) (Declaration of Jamie L. Kringstein) (14)
Oct 14, 2022	241	BILL OF COSTS by Ravgen, Inc.. (Attachments: # 1 Declaration of Jamie L. Kringstein, # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D, # 6 Exhibit E)(Kringstein, Jamie) (Entered: 10/14/2022) (Exhibit A) (2)
Oct 14, 2022	241	BILL OF COSTS by Ravgen, Inc.. (Attachments: # 1 Declaration of Jamie L. Kringstein, # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D, # 6 Exhibit E)(Kringstein, Jamie) (Entered: 10/14/2022) (Exhibit B) (8)
Oct 14, 2022	241	BILL OF COSTS by Ravgen, Inc.. (Attachments: # 1 Declaration of Jamie L. Kringstein, # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D, # 6 Exhibit E)(Kringstein, Jamie) (Entered: 10/14/2022) (Exhibit C) (30)
Oct 14, 2022	241	BILL OF COSTS by Ravgen, Inc.. (Attachments: # 1 Declaration of Jamie L. Kringstein, # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D, # 6 Exhibit E)(Kringstein, Jamie) (Entered: 10/14/2022) (Exhibit D) (25)
Oct 14, 2022	241	BILL OF COSTS by Ravgen, Inc.. (Attachments: # 1 Declaration of Jamie L. Kringstein, # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D, # 6 Exhibit E)(Kringstein, Jamie) (Entered: 10/14/2022) (Exhibit E) (30)
Oct 13, 2022	238	MOTION to Amend Judgment re 231 to Include Supplemental Damages, Pre-Judgment Interest, and Post-Judgment Interest, and to Adjudge Claim 132 Not Invalid by Ravgen, Inc.. (Attachments: # 1 Affidavit Declaration of Frederick J. Ding, # 2 Exhibit 1 - Public Trial Transcript Excerpts, # 3 Exhibit 2 - Redacted in Entirety, # 4 Affidavit Declaration of Paul K. Meyer, # 5 Exhibit A - Prejudgment Interest Calculation, # 6 Exhibit B - Prejudgment Interest Calculation - Royalty Damages By Year, # 7 Exhibit C - Redacted in Entirety, # 8 Proposed Order Final Judgment)(Ding, Frederick) Modified on 10/14/2022 to link to Judgment(zv). (Entered: 10/13/2022) (Main Document) (19)
Oct 13, 2022	239	Sealed Document: DECLARATION of Frederick J. Ding in Support of 238 MOTION to Amend Judgment to Include Supplemental Damages, Pre-Judgment Interest, and Post-Judgment Interest, and to Adjudge Claim 132 Not Invalid by Ravgen, Inc. (Attachments: # 1 Exhibit 2 - Sealed Trial Transcript Excerpts) (Ding, Frederick) (Entered: 10/13/2022) (0)
Oct 13, 2022	240	Sealed Document: DECLARATION of Paul K. Meyer in Support of 238 MOTION to Amend Judgment to Include Supplemental Damages, Pre-Judgment Interest, and Post-Judgment Interest, and to Adjudge Claim 132 Not Invalid by Ravgen, Inc. (Attachments: # 1 Exhibit C - PDX-8 (Meyer Direct Examination Demonstratives)) (Ding, Frederick) (Entered: 10/13/2022) (0)
Oct 13, 2022	238	MOTION to Amend Judgment re 231 to Include Supplemental Damages, Pre-Judgment Interest, and Post-Judgment Interest, and to Adjudge Claim 132 Not Invalid by Ravgen, Inc.. (Attachments: # 1 Affidavit Declaration of Frederick J. Ding, # 2 Exhibit 1 - Public Trial Transcript Excerpts, # 3 Exhibit 2 - Redacted in Entirety, # 4 Affidavit Declaration of Paul K. Meyer, # 5 Exhibit A - Prejudgment Interest Calculation, # 6 Exhibit B - Prejudgment Interest Calculation - Royalty Damages By Year, # 7 Exhibit C - Redacted in Entirety, # 8 Proposed Order Final Judgment)(Ding, Frederick) Modified on 10/14/2022 to link to Judgment(zv). (Entered: 10/13/2022) (Affidavit Declaration of Frederick J. Ding) (2)
Oct 13, 2022	238	MOTION to Amend Judgment re 231 to Include Supplemental Damages, Pre-Judgment Interest, and Post-Judgment Interest, and to Adjudge Claim 132 Not Invalid by Ravgen, Inc.. (Attachments: # 1 Affidavit Declaration of Frederick J. Ding, # 2 Exhibit 1 - Public Trial Transcript Excerpts, # 3 Exhibit 2 - Redacted in Entirety, # 4 Affidavit Declaration of Paul K. Meyer, # 5 Exhibit A - Prejudgment Interest Calculation, # 6 Exhibit B - Prejudgment Interest Calculation - Royalty Damages By Year, # 7 Exhibit C - Redacted in Entirety, # 8 Proposed Order Final Judgment)(Ding, Frederick) Modified on 10/14/2022 to link to Judgment(zv). (Entered: 10/13/2022) (Exhibit 1 - Public Trial Transcript Excerpts) (30)
Oct 13, 2022	238	MOTION to Amend Judgment re 231 to Include Supplemental Damages, Pre-Judgment Interest, and Post-Judgment Interest, and to Adjudge Claim 132 Not Invalid by Ravgen, Inc.. (Attachments: # 1 Affidavit Declaration of Frederick J. Ding, # 2 Exhibit 1 - Public Trial Transcript Excerpts, # 3 Exhibit 2 - Redacted in Entirety, # 4 Affidavit Declaration of Paul K. Meyer, # 5 Exhibit A - Prejudgment Interest Calculation, # 6 Exhibit B - Prejudgment Interest Calculation - Royalty Damages By Year, # 7 Exhibit C - Redacted in Entirety, # 8 Proposed Order Final Judgment)(Ding, Frederick) Modified on 10/14/2022 to link to Judgment(zv). (Entered: 10/13/2022) (Exhibit 2 - Redacted in Entirety) (1)
Oct 13, 2022	238	MOTION to Amend Judgment re 231 to Include Supplemental Damages, Pre-Judgment Interest, and Post-Judgment Interest, and to Adjudge Claim 132 Not Invalid by Ravgen, Inc.. (Attachments: # 1 Affidavit Declaration of Frederick J. Ding, # 2 Exhibit 1 - Public Trial Transcript Excerpts, # 3 Exhibit 2 - Redacted in Entirety, # 4 Affidavit Declaration of Paul K. Meyer, # 5 Exhibit A - Prejudgment Interest Calculation, # 6 Exhibit B - Prejudgment Interest Calculation - Royalty Damages By Year, # 7 Exhibit C - Redacted in Entirety, # 8 Proposed Order Final Judgment)(Ding, Frederick) Modified on 10/14/2022 to link to Judgment(zv). (Entered: 10/13/2022) (Affidavit Declaration of Paul K. Meyer) (4)
Oct 13, 2022	238	MOTION to Amend Judgment re 231 to Include Supplemental Damages, Pre-Judgment Interest, and Post-Judgment Interest, and to Adjudge Claim 132 Not Invalid by Ravgen, Inc.. (Attachments: # 1 Affidavit Declaration of Frederick J. Ding, # 2 Exhibit 1 - Public Trial Transcript Excerpts, # 3 Exhibit 2 - Redacted in Entirety, # 4 Affidavit Declaration of Paul K. Meyer, # 5 Exhibit A - Prejudgment Interest Calculation, # 6 Exhibit B - Prejudgment Interest Calculation - Royalty Damages By Year, # 7 Exhibit C - Redacted in Entirety, # 8 Proposed Order Final Judgment)(Ding, Frederick) Modified on 10/14/2022 to link to Judgment(zv). (Entered: 10/13/2022) (Exhibit A - Prejudgment Interest Calculation) (4)
Oct 13, 2022	238	MOTION to Amend Judgment re 231 to Include Supplemental Damages, Pre-Judgment Interest, and Post-Judgment Interest, and to Adjudge Claim 132 Not Invalid by Ravgen, Inc.. (Attachments: # 1 Affidavit Declaration of Frederick J. Ding, # 2 Exhibit 1 - Public Trial Transcript Excerpts, # 3 Exhibit 2 - Redacted in Entirety, # 4 Affidavit Declaration of Paul K. Meyer, # 5 Exhibit A - Prejudgment Interest Calculation, # 6 Exhibit B - Prejudgment Interest Calculation - Royalty Damages By Year, # 7 Exhibit C - Redacted in Entirety, # 8 Proposed Order Final Judgment)(Ding, Frederick) Modified on 10/14/2022 to link to Judgment(zv). (Entered: 10/13/2022) (Exhibit B - Prejudgment Interest Calculation - Royalty Damages By Year) (2)
Oct 13, 2022	238	MOTION to Amend Judgment re 231 to Include Supplemental Damages, Pre-Judgment Interest, and Post-Judgment Interest, and to Adjudge Claim 132 Not Invalid by Ravgen, Inc.. (Attachments: # 1 Affidavit Declaration of Frederick J. Ding, # 2 Exhibit 1 - Public Trial Transcript Excerpts, # 3 Exhibit 2 - Redacted in Entirety, # 4 Affidavit Declaration of Paul K. Meyer, # 5 Exhibit A - Prejudgment Interest Calculation, # 6 Exhibit B - Prejudgment Interest Calculation - Royalty Damages By Year, # 7 Exhibit C - Redacted in Entirety, # 8 Proposed Order Final Judgment)(Ding, Frederick) Modified on 10/14/2022 to link to Judgment(zv). (Entered: 10/13/2022) (Exhibit C - Redacted in Entirety) (1)
Oct 13, 2022	238	MOTION to Amend Judgment re 231 to Include Supplemental Damages, Pre-Judgment Interest, and Post-Judgment Interest, and to Adjudge Claim 132 Not Invalid by Ravgen, Inc.. (Attachments: # 1 Affidavit Declaration of Frederick J. Ding, # 2 Exhibit 1 - Public Trial Transcript Excerpts, # 3 Exhibit 2 - Redacted in Entirety, # 4 Affidavit Declaration of Paul K. Meyer, # 5 Exhibit A - Prejudgment Interest Calculation, # 6 Exhibit B - Prejudgment Interest Calculation - Royalty Damages By Year, # 7 Exhibit C - Redacted in Entirety, # 8 Proposed Order Final Judgment)(Ding, Frederick) Modified on 10/14/2022 to link to Judgment(zv). (Entered: 10/13/2022) (Proposed Order Final Judgment) (2)
Oct 12, 2022	236	Redacted Copy of 227 Sealed Order GRANTING PLAINTIFF RAVGEN, INC.S MOTION TO STRIKE AND EXCLUDE DEFENDANT LABCORPS FED. R. CIV. P. 26(A)(2)(C) DISCLOSURE [ECF NO. 122 ]. (zv) (Entered: 10/12/2022) (12)
Oct 12, 2022	237	Redacted Copy of 229 Sealed Order DENYING DEFENDANT LABCORPS MOTION TO EXCLUDE OPINIONS OF PAUL K. MEYER [ECF NO. 113 ]. (zv) (Entered: 10/12/2022) (8)
Oct 6, 2022	234	Proposed Order to 232 MOTION for Enhanced Damages Pursuant to 35 U.S.C. � 284 by Ravgen, Inc.. (Attachments: # 1 Proposed Order)(Ding, Frederick) (Entered: 10/06/2022) (Main Document) (2)
Oct 6, 2022	235	MOTION to Withdraw as Attorney Aden M. Allen by Laboratory Corporation of America Holdings. (Attachments: # 1 Proposed Order)(Son, Naoya) (Entered: 10/06/2022) (Main Document) (3)
Oct 6, 2022	235	MOTION to Withdraw as Attorney Aden M. Allen by Laboratory Corporation of America Holdings. (Attachments: # 1 Proposed Order)(Son, Naoya) (Entered: 10/06/2022) (Proposed Order) (1)
Oct 6, 2022	234	Proposed Order to 232 MOTION for Enhanced Damages Pursuant to 35 U.S.C. � 284 by Ravgen, Inc.. (Attachments: # 1 Proposed Order)(Ding, Frederick) (Entered: 10/06/2022) (Proposed Order) (1)
Oct 5, 2022	231	JUDGMENT in favor of Plaintiff against Labcorp.. Signed by Judge Alan D Albright. (sv) (Entered: 10/05/2022) (2)
Oct 5, 2022	232	MOTION for Enhanced Damages Pursuant to 35 U.S.C. � 284 by Ravgen, Inc.. (Attachments: # 1 Affidavit Declaration of Frederick J. Ding, # 2 Exhibit 1 - 9/19/22 Trial Transcript Excerpts, # 3 Exhibit 2 - 9/20/22 Trial Transcript Excerpts, # 4 Exhibit 2A - Redacted in Entirety, # 5 Exhibit 3 - 9/21/22 Trial Transcript Excerpts, # 6 Exhibit 3A - Redacted in Entirety, # 7 Exhibit 4 - 9/22/22 Trial Transcript Excerpts, # 8 Exhibit 5 - 9/23/22 Trial Transcript Excerpts, # 9 Exhibit PTX-0002, # 10 Exhibit PTX-0175, # 11 Exhibit PTX-0176 Excerpts, # 12 Exhibit PTX-0234, # 13 Exhibit PTX-0238, # 14 Exhibit PTX-0239, # 15 Exhibit PTX-0255 Excerpts, # 16 Exhibit PTX-0381, # 17 Exhibit PTX-0383, # 18 Exhibit PTX-0719 Excerpts, # 19 Exhibit PTX-0749, # 20 Exhibit PTX-0917, # 21 Exhibit PTX-1140 Excerpts, # 22 Exhibit PTX-1141, # 23 Exhibit PTX-1221, # 24 Exhibit PTX-1229, # 25 Exhibit PTX-1231, # 26 Exhibit PTX-1232, # 27 Exhibit PTX-1233, # 28 Exhibit PTX-1271, # 29 Exhibit PTX-1294, # 30 Exhibit PTX-1301, # 31 Exhibit PTX-1334, # 32 Exhibit PTX-1480, # 33 Exhibit DTX-0908)(Ding, Frederick) (Entered: 10/05/2022) (Main Document) (27)
Oct 5, 2022	233	Sealed Document: DECLARATION of Frederick J. Ding in Support of 232 MOTION for Enhanced Damages Pursuant to 35 U.S.C. � 284 by Ravgen, Inc. (Attachments: # 1 Exhibit 2A - Sealed 9/20/22 Trial Transcript Excerpts, # 2 Exhibit 3A - Sealed 9/21/22 Trial Transcript Excerpts) (Ding, Frederick) (Entered: 10/05/2022) (0)
Oct 5, 2022	232	MOTION for Enhanced Damages Pursuant to 35 U.S.C. � 284 by Ravgen, Inc.. (Attachments: # 1 Affidavit Declaration of Frederick J. Ding, # 2 Exhibit 1 - 9/19/22 Trial Transcript Excerpts, # 3 Exhibit 2 - 9/20/22 Trial Transcript Excerpts, # 4 Exhibit 2A - Redacted in Entirety, # 5 Exhibit 3 - 9/21/22 Trial Transcript Excerpts, # 6 Exhibit 3A - Redacted in Entirety, # 7 Exhibit 4 - 9/22/22 Trial Transcript Excerpts, # 8 Exhibit 5 - 9/23/22 Trial Transcript Excerpts, # 9 Exhibit PTX-0002, # 10 Exhibit PTX-0175, # 11 Exhibit PTX-0176 Excerpts, # 12 Exhibit PTX-0234, # 13 Exhibit PTX-0238, # 14 Exhibit PTX-0239, # 15 Exhibit PTX-0255 Excerpts, # 16 Exhibit PTX-0381, # 17 Exhibit PTX-0383, # 18 Exhibit PTX-0719 Excerpts, # 19 Exhibit PTX-0749, # 20 Exhibit PTX-0917, # 21 Exhibit PTX-1140 Excerpts, # 22 Exhibit PTX-1141, # 23 Exhibit PTX-1221, # 24 Exhibit PTX-1229, # 25 Exhibit PTX-1231, # 26 Exhibit PTX-1232, # 27 Exhibit PTX-1233, # 28 Exhibit PTX-1271, # 29 Exhibit PTX-1294, # 30 Exhibit PTX-1301, # 31 Exhibit PTX-1334, # 32 Exhibit PTX-1480, # 33 Exhibit DTX-0908)(Ding, Frederick) (Entered: 10/05/2022) (Affidavit Declaration of Frederick J. Ding) (4)
Oct 5, 2022	232	MOTION for Enhanced Damages Pursuant to 35 U.S.C. � 284 by Ravgen, Inc.. (Attachments: # 1 Affidavit Declaration of Frederick J. Ding, # 2 Exhibit 1 - 9/19/22 Trial Transcript Excerpts, # 3 Exhibit 2 - 9/20/22 Trial Transcript Excerpts, # 4 Exhibit 2A - Redacted in Entirety, # 5 Exhibit 3 - 9/21/22 Trial Transcript Excerpts, # 6 Exhibit 3A - Redacted in Entirety, # 7 Exhibit 4 - 9/22/22 Trial Transcript Excerpts, # 8 Exhibit 5 - 9/23/22 Trial Transcript Excerpts, # 9 Exhibit PTX-0002, # 10 Exhibit PTX-0175, # 11 Exhibit PTX-0176 Excerpts, # 12 Exhibit PTX-0234, # 13 Exhibit PTX-0238, # 14 Exhibit PTX-0239, # 15 Exhibit PTX-0255 Excerpts, # 16 Exhibit PTX-0381, # 17 Exhibit PTX-0383, # 18 Exhibit PTX-0719 Excerpts, # 19 Exhibit PTX-0749, # 20 Exhibit PTX-0917, # 21 Exhibit PTX-1140 Excerpts, # 22 Exhibit PTX-1141, # 23 Exhibit PTX-1221, # 24 Exhibit PTX-1229, # 25 Exhibit PTX-1231, # 26 Exhibit PTX-1232, # 27 Exhibit PTX-1233, # 28 Exhibit PTX-1271, # 29 Exhibit PTX-1294, # 30 Exhibit PTX-1301, # 31 Exhibit PTX-1334, # 32 Exhibit PTX-1480, # 33 Exhibit DTX-0908)(Ding, Frederick) (Entered: 10/05/2022) (Exhibit 1 - 9/19/22 Trial Transcript Excerpts) (30)
Oct 5, 2022	232	MOTION for Enhanced Damages Pursuant to 35 U.S.C. � 284 by Ravgen, Inc.. (Attachments: # 1 Affidavit Declaration of Frederick J. Ding, # 2 Exhibit 1 - 9/19/22 Trial Transcript Excerpts, # 3 Exhibit 2 - 9/20/22 Trial Transcript Excerpts, # 4 Exhibit 2A - Redacted in Entirety, # 5 Exhibit 3 - 9/21/22 Trial Transcript Excerpts, # 6 Exhibit 3A - Redacted in Entirety, # 7 Exhibit 4 - 9/22/22 Trial Transcript Excerpts, # 8 Exhibit 5 - 9/23/22 Trial Transcript Excerpts, # 9 Exhibit PTX-0002, # 10 Exhibit PTX-0175, # 11 Exhibit PTX-0176 Excerpts, # 12 Exhibit PTX-0234, # 13 Exhibit PTX-0238, # 14 Exhibit PTX-0239, # 15 Exhibit PTX-0255 Excerpts, # 16 Exhibit PTX-0381, # 17 Exhibit PTX-0383, # 18 Exhibit PTX-0719 Excerpts, # 19 Exhibit PTX-0749, # 20 Exhibit PTX-0917, # 21 Exhibit PTX-1140 Excerpts, # 22 Exhibit PTX-1141, # 23 Exhibit PTX-1221, # 24 Exhibit PTX-1229, # 25 Exhibit PTX-1231, # 26 Exhibit PTX-1232, # 27 Exhibit PTX-1233, # 28 Exhibit PTX-1271, # 29 Exhibit PTX-1294, # 30 Exhibit PTX-1301, # 31 Exhibit PTX-1334, # 32 Exhibit PTX-1480, # 33 Exhibit DTX-0908)(Ding, Frederick) (Entered: 10/05/2022) (Exhibit 2 - 9/20/22 Trial Transcript Excerpts) (30)
Oct 5, 2022	232	MOTION for Enhanced Damages Pursuant to 35 U.S.C. � 284 by Ravgen, Inc.. (Attachments: # 1 Affidavit Declaration of Frederick J. Ding, # 2 Exhibit 1 - 9/19/22 Trial Transcript Excerpts, # 3 Exhibit 2 - 9/20/22 Trial Transcript Excerpts, # 4 Exhibit 2A - Redacted in Entirety, # 5 Exhibit 3 - 9/21/22 Trial Transcript Excerpts, # 6 Exhibit 3A - Redacted in Entirety, # 7 Exhibit 4 - 9/22/22 Trial Transcript Excerpts, # 8 Exhibit 5 - 9/23/22 Trial Transcript Excerpts, # 9 Exhibit PTX-0002, # 10 Exhibit PTX-0175, # 11 Exhibit PTX-0176 Excerpts, # 12 Exhibit PTX-0234, # 13 Exhibit PTX-0238, # 14 Exhibit PTX-0239, # 15 Exhibit PTX-0255 Excerpts, # 16 Exhibit PTX-0381, # 17 Exhibit PTX-0383, # 18 Exhibit PTX-0719 Excerpts, # 19 Exhibit PTX-0749, # 20 Exhibit PTX-0917, # 21 Exhibit PTX-1140 Excerpts, # 22 Exhibit PTX-1141, # 23 Exhibit PTX-1221, # 24 Exhibit PTX-1229, # 25 Exhibit PTX-1231, # 26 Exhibit PTX-1232, # 27 Exhibit PTX-1233, # 28 Exhibit PTX-1271, # 29 Exhibit PTX-1294, # 30 Exhibit PTX-1301, # 31 Exhibit PTX-1334, # 32 Exhibit PTX-1480, # 33 Exhibit DTX-0908)(Ding, Frederick) (Entered: 10/05/2022) (Exhibit 2A - Redacted in Entirety) (1)
Oct 5, 2022	232	MOTION for Enhanced Damages Pursuant to 35 U.S.C. � 284 by Ravgen, Inc.. (Attachments: # 1 Affidavit Declaration of Frederick J. Ding, # 2 Exhibit 1 - 9/19/22 Trial Transcript Excerpts, # 3 Exhibit 2 - 9/20/22 Trial Transcript Excerpts, # 4 Exhibit 2A - Redacted in Entirety, # 5 Exhibit 3 - 9/21/22 Trial Transcript Excerpts, # 6 Exhibit 3A - Redacted in Entirety, # 7 Exhibit 4 - 9/22/22 Trial Transcript Excerpts, # 8 Exhibit 5 - 9/23/22 Trial Transcript Excerpts, # 9 Exhibit PTX-0002, # 10 Exhibit PTX-0175, # 11 Exhibit PTX-0176 Excerpts, # 12 Exhibit PTX-0234, # 13 Exhibit PTX-0238, # 14 Exhibit PTX-0239, # 15 Exhibit PTX-0255 Excerpts, # 16 Exhibit PTX-0381, # 17 Exhibit PTX-0383, # 18 Exhibit PTX-0719 Excerpts, # 19 Exhibit PTX-0749, # 20 Exhibit PTX-0917, # 21 Exhibit PTX-1140 Excerpts, # 22 Exhibit PTX-1141, # 23 Exhibit PTX-1221, # 24 Exhibit PTX-1229, # 25 Exhibit PTX-1231, # 26 Exhibit PTX-1232, # 27 Exhibit PTX-1233, # 28 Exhibit PTX-1271, # 29 Exhibit PTX-1294, # 30 Exhibit PTX-1301, # 31 Exhibit PTX-1334, # 32 Exhibit PTX-1480, # 33 Exhibit DTX-0908)(Ding, Frederick) (Entered: 10/05/2022) (Exhibit 3 - 9/21/22 Trial Transcript Excerpts) (30)
Oct 5, 2022	232	MOTION for Enhanced Damages Pursuant to 35 U.S.C. � 284 by Ravgen, Inc.. (Attachments: # 1 Affidavit Declaration of Frederick J. Ding, # 2 Exhibit 1 - 9/19/22 Trial Transcript Excerpts, # 3 Exhibit 2 - 9/20/22 Trial Transcript Excerpts, # 4 Exhibit 2A - Redacted in Entirety, # 5 Exhibit 3 - 9/21/22 Trial Transcript Excerpts, # 6 Exhibit 3A - Redacted in Entirety, # 7 Exhibit 4 - 9/22/22 Trial Transcript Excerpts, # 8 Exhibit 5 - 9/23/22 Trial Transcript Excerpts, # 9 Exhibit PTX-0002, # 10 Exhibit PTX-0175, # 11 Exhibit PTX-0176 Excerpts, # 12 Exhibit PTX-0234, # 13 Exhibit PTX-0238, # 14 Exhibit PTX-0239, # 15 Exhibit PTX-0255 Excerpts, # 16 Exhibit PTX-0381, # 17 Exhibit PTX-0383, # 18 Exhibit PTX-0719 Excerpts, # 19 Exhibit PTX-0749, # 20 Exhibit PTX-0917, # 21 Exhibit PTX-1140 Excerpts, # 22 Exhibit PTX-1141, # 23 Exhibit PTX-1221, # 24 Exhibit PTX-1229, # 25 Exhibit PTX-1231, # 26 Exhibit PTX-1232, # 27 Exhibit PTX-1233, # 28 Exhibit PTX-1271, # 29 Exhibit PTX-1294, # 30 Exhibit PTX-1301, # 31 Exhibit PTX-1334, # 32 Exhibit PTX-1480, # 33 Exhibit DTX-0908)(Ding, Frederick) (Entered: 10/05/2022) (Exhibit 3A - Redacted in Entirety) (1)
Oct 5, 2022	232	MOTION for Enhanced Damages Pursuant to 35 U.S.C. � 284 by Ravgen, Inc.. (Attachments: # 1 Affidavit Declaration of Frederick J. Ding, # 2 Exhibit 1 - 9/19/22 Trial Transcript Excerpts, # 3 Exhibit 2 - 9/20/22 Trial Transcript Excerpts, # 4 Exhibit 2A - Redacted in Entirety, # 5 Exhibit 3 - 9/21/22 Trial Transcript Excerpts, # 6 Exhibit 3A - Redacted in Entirety, # 7 Exhibit 4 - 9/22/22 Trial Transcript Excerpts, # 8 Exhibit 5 - 9/23/22 Trial Transcript Excerpts, # 9 Exhibit PTX-0002, # 10 Exhibit PTX-0175, # 11 Exhibit PTX-0176 Excerpts, # 12 Exhibit PTX-0234, # 13 Exhibit PTX-0238, # 14 Exhibit PTX-0239, # 15 Exhibit PTX-0255 Excerpts, # 16 Exhibit PTX-0381, # 17 Exhibit PTX-0383, # 18 Exhibit PTX-0719 Excerpts, # 19 Exhibit PTX-0749, # 20 Exhibit PTX-0917, # 21 Exhibit PTX-1140 Excerpts, # 22 Exhibit PTX-1141, # 23 Exhibit PTX-1221, # 24 Exhibit PTX-1229, # 25 Exhibit PTX-1231, # 26 Exhibit PTX-1232, # 27 Exhibit PTX-1233, # 28 Exhibit PTX-1271, # 29 Exhibit PTX-1294, # 30 Exhibit PTX-1301, # 31 Exhibit PTX-1334, # 32 Exhibit PTX-1480, # 33 Exhibit DTX-0908)(Ding, Frederick) (Entered: 10/05/2022) (Exhibit 4 - 9/22/22 Trial Transcript Excerpts) (27)
Oct 5, 2022	232	MOTION for Enhanced Damages Pursuant to 35 U.S.C. � 284 by Ravgen, Inc.. (Attachments: # 1 Affidavit Declaration of Frederick J. Ding, # 2 Exhibit 1 - 9/19/22 Trial Transcript Excerpts, # 3 Exhibit 2 - 9/20/22 Trial Transcript Excerpts, # 4 Exhibit 2A - Redacted in Entirety, # 5 Exhibit 3 - 9/21/22 Trial Transcript Excerpts, # 6 Exhibit 3A - Redacted in Entirety, # 7 Exhibit 4 - 9/22/22 Trial Transcript Excerpts, # 8 Exhibit 5 - 9/23/22 Trial Transcript Excerpts, # 9 Exhibit PTX-0002, # 10 Exhibit PTX-0175, # 11 Exhibit PTX-0176 Excerpts, # 12 Exhibit PTX-0234, # 13 Exhibit PTX-0238, # 14 Exhibit PTX-0239, # 15 Exhibit PTX-0255 Excerpts, # 16 Exhibit PTX-0381, # 17 Exhibit PTX-0383, # 18 Exhibit PTX-0719 Excerpts, # 19 Exhibit PTX-0749, # 20 Exhibit PTX-0917, # 21 Exhibit PTX-1140 Excerpts, # 22 Exhibit PTX-1141, # 23 Exhibit PTX-1221, # 24 Exhibit PTX-1229, # 25 Exhibit PTX-1231, # 26 Exhibit PTX-1232, # 27 Exhibit PTX-1233, # 28 Exhibit PTX-1271, # 29 Exhibit PTX-1294, # 30 Exhibit PTX-1301, # 31 Exhibit PTX-1334, # 32 Exhibit PTX-1480, # 33 Exhibit DTX-0908)(Ding, Frederick) (Entered: 10/05/2022) (Exhibit 5 - 9/23/22 Trial Transcript Excerpts) (10)
Oct 5, 2022	232	MOTION for Enhanced Damages Pursuant to 35 U.S.C. � 284 by Ravgen, Inc.. (Attachments: # 1 Affidavit Declaration of Frederick J. Ding, # 2 Exhibit 1 - 9/19/22 Trial Transcript Excerpts, # 3 Exhibit 2 - 9/20/22 Trial Transcript Excerpts, # 4 Exhibit 2A - Redacted in Entirety, # 5 Exhibit 3 - 9/21/22 Trial Transcript Excerpts, # 6 Exhibit 3A - Redacted in Entirety, # 7 Exhibit 4 - 9/22/22 Trial Transcript Excerpts, # 8 Exhibit 5 - 9/23/22 Trial Transcript Excerpts, # 9 Exhibit PTX-0002, # 10 Exhibit PTX-0175, # 11 Exhibit PTX-0176 Excerpts, # 12 Exhibit PTX-0234, # 13 Exhibit PTX-0238, # 14 Exhibit PTX-0239, # 15 Exhibit PTX-0255 Excerpts, # 16 Exhibit PTX-0381, # 17 Exhibit PTX-0383, # 18 Exhibit PTX-0719 Excerpts, # 19 Exhibit PTX-0749, # 20 Exhibit PTX-0917, # 21 Exhibit PTX-1140 Excerpts, # 22 Exhibit PTX-1141, # 23 Exhibit PTX-1221, # 24 Exhibit PTX-1229, # 25 Exhibit PTX-1231, # 26 Exhibit PTX-1232, # 27 Exhibit PTX-1233, # 28 Exhibit PTX-1271, # 29 Exhibit PTX-1294, # 30 Exhibit PTX-1301, # 31 Exhibit PTX-1334, # 32 Exhibit PTX-1480, # 33 Exhibit DTX-0908)(Ding, Frederick) (Entered: 10/05/2022) (Exhibit PTX-0002) (30)
Oct 5, 2022	232	MOTION for Enhanced Damages Pursuant to 35 U.S.C. � 284 by Ravgen, Inc.. (Attachments: # 1 Affidavit Declaration of Frederick J. Ding, # 2 Exhibit 1 - 9/19/22 Trial Transcript Excerpts, # 3 Exhibit 2 - 9/20/22 Trial Transcript Excerpts, # 4 Exhibit 2A - Redacted in Entirety, # 5 Exhibit 3 - 9/21/22 Trial Transcript Excerpts, # 6 Exhibit 3A - Redacted in Entirety, # 7 Exhibit 4 - 9/22/22 Trial Transcript Excerpts, # 8 Exhibit 5 - 9/23/22 Trial Transcript Excerpts, # 9 Exhibit PTX-0002, # 10 Exhibit PTX-0175, # 11 Exhibit PTX-0176 Excerpts, # 12 Exhibit PTX-0234, # 13 Exhibit PTX-0238, # 14 Exhibit PTX-0239, # 15 Exhibit PTX-0255 Excerpts, # 16 Exhibit PTX-0381, # 17 Exhibit PTX-0383, # 18 Exhibit PTX-0719 Excerpts, # 19 Exhibit PTX-0749, # 20 Exhibit PTX-0917, # 21 Exhibit PTX-1140 Excerpts, # 22 Exhibit PTX-1141, # 23 Exhibit PTX-1221, # 24 Exhibit PTX-1229, # 25 Exhibit PTX-1231, # 26 Exhibit PTX-1232, # 27 Exhibit PTX-1233, # 28 Exhibit PTX-1271, # 29 Exhibit PTX-1294, # 30 Exhibit PTX-1301, # 31 Exhibit PTX-1334, # 32 Exhibit PTX-1480, # 33 Exhibit DTX-0908)(Ding, Frederick) (Entered: 10/05/2022) (Exhibit PTX-0175) (18)
Oct 5, 2022	232	MOTION for Enhanced Damages Pursuant to 35 U.S.C. � 284 by Ravgen, Inc.. (Attachments: # 1 Affidavit Declaration of Frederick J. Ding, # 2 Exhibit 1 - 9/19/22 Trial Transcript Excerpts, # 3 Exhibit 2 - 9/20/22 Trial Transcript Excerpts, # 4 Exhibit 2A - Redacted in Entirety, # 5 Exhibit 3 - 9/21/22 Trial Transcript Excerpts, # 6 Exhibit 3A - Redacted in Entirety, # 7 Exhibit 4 - 9/22/22 Trial Transcript Excerpts, # 8 Exhibit 5 - 9/23/22 Trial Transcript Excerpts, # 9 Exhibit PTX-0002, # 10 Exhibit PTX-0175, # 11 Exhibit PTX-0176 Excerpts, # 12 Exhibit PTX-0234, # 13 Exhibit PTX-0238, # 14 Exhibit PTX-0239, # 15 Exhibit PTX-0255 Excerpts, # 16 Exhibit PTX-0381, # 17 Exhibit PTX-0383, # 18 Exhibit PTX-0719 Excerpts, # 19 Exhibit PTX-0749, # 20 Exhibit PTX-0917, # 21 Exhibit PTX-1140 Excerpts, # 22 Exhibit PTX-1141, # 23 Exhibit PTX-1221, # 24 Exhibit PTX-1229, # 25 Exhibit PTX-1231, # 26 Exhibit PTX-1232, # 27 Exhibit PTX-1233, # 28 Exhibit PTX-1271, # 29 Exhibit PTX-1294, # 30 Exhibit PTX-1301, # 31 Exhibit PTX-1334, # 32 Exhibit PTX-1480, # 33 Exhibit DTX-0908)(Ding, Frederick) (Entered: 10/05/2022) (Exhibit PTX-0176 Excerpts) (4)
Oct 5, 2022	232	MOTION for Enhanced Damages Pursuant to 35 U.S.C. � 284 by Ravgen, Inc.. (Attachments: # 1 Affidavit Declaration of Frederick J. Ding, # 2 Exhibit 1 - 9/19/22 Trial Transcript Excerpts, # 3 Exhibit 2 - 9/20/22 Trial Transcript Excerpts, # 4 Exhibit 2A - Redacted in Entirety, # 5 Exhibit 3 - 9/21/22 Trial Transcript Excerpts, # 6 Exhibit 3A - Redacted in Entirety, # 7 Exhibit 4 - 9/22/22 Trial Transcript Excerpts, # 8 Exhibit 5 - 9/23/22 Trial Transcript Excerpts, # 9 Exhibit PTX-0002, # 10 Exhibit PTX-0175, # 11 Exhibit PTX-0176 Excerpts, # 12 Exhibit PTX-0234, # 13 Exhibit PTX-0238, # 14 Exhibit PTX-0239, # 15 Exhibit PTX-0255 Excerpts, # 16 Exhibit PTX-0381, # 17 Exhibit PTX-0383, # 18 Exhibit PTX-0719 Excerpts, # 19 Exhibit PTX-0749, # 20 Exhibit PTX-0917, # 21 Exhibit PTX-1140 Excerpts, # 22 Exhibit PTX-1141, # 23 Exhibit PTX-1221, # 24 Exhibit PTX-1229, # 25 Exhibit PTX-1231, # 26 Exhibit PTX-1232, # 27 Exhibit PTX-1233, # 28 Exhibit PTX-1271, # 29 Exhibit PTX-1294, # 30 Exhibit PTX-1301, # 31 Exhibit PTX-1334, # 32 Exhibit PTX-1480, # 33 Exhibit DTX-0908)(Ding, Frederick) (Entered: 10/05/2022) (Exhibit PTX-0234) (1)
Oct 5, 2022	232	MOTION for Enhanced Damages Pursuant to 35 U.S.C. � 284 by Ravgen, Inc.. (Attachments: # 1 Affidavit Declaration of Frederick J. Ding, # 2 Exhibit 1 - 9/19/22 Trial Transcript Excerpts, # 3 Exhibit 2 - 9/20/22 Trial Transcript Excerpts, # 4 Exhibit 2A - Redacted in Entirety, # 5 Exhibit 3 - 9/21/22 Trial Transcript Excerpts, # 6 Exhibit 3A - Redacted in Entirety, # 7 Exhibit 4 - 9/22/22 Trial Transcript Excerpts, # 8 Exhibit 5 - 9/23/22 Trial Transcript Excerpts, # 9 Exhibit PTX-0002, # 10 Exhibit PTX-0175, # 11 Exhibit PTX-0176 Excerpts, # 12 Exhibit PTX-0234, # 13 Exhibit PTX-0238, # 14 Exhibit PTX-0239, # 15 Exhibit PTX-0255 Excerpts, # 16 Exhibit PTX-0381, # 17 Exhibit PTX-0383, # 18 Exhibit PTX-0719 Excerpts, # 19 Exhibit PTX-0749, # 20 Exhibit PTX-0917, # 21 Exhibit PTX-1140 Excerpts, # 22 Exhibit PTX-1141, # 23 Exhibit PTX-1221, # 24 Exhibit PTX-1229, # 25 Exhibit PTX-1231, # 26 Exhibit PTX-1232, # 27 Exhibit PTX-1233, # 28 Exhibit PTX-1271, # 29 Exhibit PTX-1294, # 30 Exhibit PTX-1301, # 31 Exhibit PTX-1334, # 32 Exhibit PTX-1480, # 33 Exhibit DTX-0908)(Ding, Frederick) (Entered: 10/05/2022) (Exhibit PTX-0238) (6)
Oct 5, 2022	232	MOTION for Enhanced Damages Pursuant to 35 U.S.C. � 284 by Ravgen, Inc.. (Attachments: # 1 Affidavit Declaration of Frederick J. Ding, # 2 Exhibit 1 - 9/19/22 Trial Transcript Excerpts, # 3 Exhibit 2 - 9/20/22 Trial Transcript Excerpts, # 4 Exhibit 2A - Redacted in Entirety, # 5 Exhibit 3 - 9/21/22 Trial Transcript Excerpts, # 6 Exhibit 3A - Redacted in Entirety, # 7 Exhibit 4 - 9/22/22 Trial Transcript Excerpts, # 8 Exhibit 5 - 9/23/22 Trial Transcript Excerpts, # 9 Exhibit PTX-0002, # 10 Exhibit PTX-0175, # 11 Exhibit PTX-0176 Excerpts, # 12 Exhibit PTX-0234, # 13 Exhibit PTX-0238, # 14 Exhibit PTX-0239, # 15 Exhibit PTX-0255 Excerpts, # 16 Exhibit PTX-0381, # 17 Exhibit PTX-0383, # 18 Exhibit PTX-0719 Excerpts, # 19 Exhibit PTX-0749, # 20 Exhibit PTX-0917, # 21 Exhibit PTX-1140 Excerpts, # 22 Exhibit PTX-1141, # 23 Exhibit PTX-1221, # 24 Exhibit PTX-1229, # 25 Exhibit PTX-1231, # 26 Exhibit PTX-1232, # 27 Exhibit PTX-1233, # 28 Exhibit PTX-1271, # 29 Exhibit PTX-1294, # 30 Exhibit PTX-1301, # 31 Exhibit PTX-1334, # 32 Exhibit PTX-1480, # 33 Exhibit DTX-0908)(Ding, Frederick) (Entered: 10/05/2022) (Exhibit PTX-0239) (8)
Oct 5, 2022	232	MOTION for Enhanced Damages Pursuant to 35 U.S.C. � 284 by Ravgen, Inc.. (Attachments: # 1 Affidavit Declaration of Frederick J. Ding, # 2 Exhibit 1 - 9/19/22 Trial Transcript Excerpts, # 3 Exhibit 2 - 9/20/22 Trial Transcript Excerpts, # 4 Exhibit 2A - Redacted in Entirety, # 5 Exhibit 3 - 9/21/22 Trial Transcript Excerpts, # 6 Exhibit 3A - Redacted in Entirety, # 7 Exhibit 4 - 9/22/22 Trial Transcript Excerpts, # 8 Exhibit 5 - 9/23/22 Trial Transcript Excerpts, # 9 Exhibit PTX-0002, # 10 Exhibit PTX-0175, # 11 Exhibit PTX-0176 Excerpts, # 12 Exhibit PTX-0234, # 13 Exhibit PTX-0238, # 14 Exhibit PTX-0239, # 15 Exhibit PTX-0255 Excerpts, # 16 Exhibit PTX-0381, # 17 Exhibit PTX-0383, # 18 Exhibit PTX-0719 Excerpts, # 19 Exhibit PTX-0749, # 20 Exhibit PTX-0917, # 21 Exhibit PTX-1140 Excerpts, # 22 Exhibit PTX-1141, # 23 Exhibit PTX-1221, # 24 Exhibit PTX-1229, # 25 Exhibit PTX-1231, # 26 Exhibit PTX-1232, # 27 Exhibit PTX-1233, # 28 Exhibit PTX-1271, # 29 Exhibit PTX-1294, # 30 Exhibit PTX-1301, # 31 Exhibit PTX-1334, # 32 Exhibit PTX-1480, # 33 Exhibit DTX-0908)(Ding, Frederick) (Entered: 10/05/2022) (Exhibit PTX-0255 Excerpts) (3)
Oct 5, 2022	232	MOTION for Enhanced Damages Pursuant to 35 U.S.C. � 284 by Ravgen, Inc.. (Attachments: # 1 Affidavit Declaration of Frederick J. Ding, # 2 Exhibit 1 - 9/19/22 Trial Transcript Excerpts, # 3 Exhibit 2 - 9/20/22 Trial Transcript Excerpts, # 4 Exhibit 2A - Redacted in Entirety, # 5 Exhibit 3 - 9/21/22 Trial Transcript Excerpts, # 6 Exhibit 3A - Redacted in Entirety, # 7 Exhibit 4 - 9/22/22 Trial Transcript Excerpts, # 8 Exhibit 5 - 9/23/22 Trial Transcript Excerpts, # 9 Exhibit PTX-0002, # 10 Exhibit PTX-0175, # 11 Exhibit PTX-0176 Excerpts, # 12 Exhibit PTX-0234, # 13 Exhibit PTX-0238, # 14 Exhibit PTX-0239, # 15 Exhibit PTX-0255 Excerpts, # 16 Exhibit PTX-0381, # 17 Exhibit PTX-0383, # 18 Exhibit PTX-0719 Excerpts, # 19 Exhibit PTX-0749, # 20 Exhibit PTX-0917, # 21 Exhibit PTX-1140 Excerpts, # 22 Exhibit PTX-1141, # 23 Exhibit PTX-1221, # 24 Exhibit PTX-1229, # 25 Exhibit PTX-1231, # 26 Exhibit PTX-1232, # 27 Exhibit PTX-1233, # 28 Exhibit PTX-1271, # 29 Exhibit PTX-1294, # 30 Exhibit PTX-1301, # 31 Exhibit PTX-1334, # 32 Exhibit PTX-1480, # 33 Exhibit DTX-0908)(Ding, Frederick) (Entered: 10/05/2022) (Exhibit PTX-0381) (5)
Oct 5, 2022	232	MOTION for Enhanced Damages Pursuant to 35 U.S.C. � 284 by Ravgen, Inc.. (Attachments: # 1 Affidavit Declaration of Frederick J. Ding, # 2 Exhibit 1 - 9/19/22 Trial Transcript Excerpts, # 3 Exhibit 2 - 9/20/22 Trial Transcript Excerpts, # 4 Exhibit 2A - Redacted in Entirety, # 5 Exhibit 3 - 9/21/22 Trial Transcript Excerpts, # 6 Exhibit 3A - Redacted in Entirety, # 7 Exhibit 4 - 9/22/22 Trial Transcript Excerpts, # 8 Exhibit 5 - 9/23/22 Trial Transcript Excerpts, # 9 Exhibit PTX-0002, # 10 Exhibit PTX-0175, # 11 Exhibit PTX-0176 Excerpts, # 12 Exhibit PTX-0234, # 13 Exhibit PTX-0238, # 14 Exhibit PTX-0239, # 15 Exhibit PTX-0255 Excerpts, # 16 Exhibit PTX-0381, # 17 Exhibit PTX-0383, # 18 Exhibit PTX-0719 Excerpts, # 19 Exhibit PTX-0749, # 20 Exhibit PTX-0917, # 21 Exhibit PTX-1140 Excerpts, # 22 Exhibit PTX-1141, # 23 Exhibit PTX-1221, # 24 Exhibit PTX-1229, # 25 Exhibit PTX-1231, # 26 Exhibit PTX-1232, # 27 Exhibit PTX-1233, # 28 Exhibit PTX-1271, # 29 Exhibit PTX-1294, # 30 Exhibit PTX-1301, # 31 Exhibit PTX-1334, # 32 Exhibit PTX-1480, # 33 Exhibit DTX-0908)(Ding, Frederick) (Entered: 10/05/2022) (Exhibit PTX-0383) (3)
Oct 5, 2022	232	MOTION for Enhanced Damages Pursuant to 35 U.S.C. � 284 by Ravgen, Inc.. (Attachments: # 1 Affidavit Declaration of Frederick J. Ding, # 2 Exhibit 1 - 9/19/22 Trial Transcript Excerpts, # 3 Exhibit 2 - 9/20/22 Trial Transcript Excerpts, # 4 Exhibit 2A - Redacted in Entirety, # 5 Exhibit 3 - 9/21/22 Trial Transcript Excerpts, # 6 Exhibit 3A - Redacted in Entirety, # 7 Exhibit 4 - 9/22/22 Trial Transcript Excerpts, # 8 Exhibit 5 - 9/23/22 Trial Transcript Excerpts, # 9 Exhibit PTX-0002, # 10 Exhibit PTX-0175, # 11 Exhibit PTX-0176 Excerpts, # 12 Exhibit PTX-0234, # 13 Exhibit PTX-0238, # 14 Exhibit PTX-0239, # 15 Exhibit PTX-0255 Excerpts, # 16 Exhibit PTX-0381, # 17 Exhibit PTX-0383, # 18 Exhibit PTX-0719 Excerpts, # 19 Exhibit PTX-0749, # 20 Exhibit PTX-0917, # 21 Exhibit PTX-1140 Excerpts, # 22 Exhibit PTX-1141, # 23 Exhibit PTX-1221, # 24 Exhibit PTX-1229, # 25 Exhibit PTX-1231, # 26 Exhibit PTX-1232, # 27 Exhibit PTX-1233, # 28 Exhibit PTX-1271, # 29 Exhibit PTX-1294, # 30 Exhibit PTX-1301, # 31 Exhibit PTX-1334, # 32 Exhibit PTX-1480, # 33 Exhibit DTX-0908)(Ding, Frederick) (Entered: 10/05/2022) (Exhibit PTX-0719 Excerpts) (3)
Oct 5, 2022	232	MOTION for Enhanced Damages Pursuant to 35 U.S.C. � 284 by Ravgen, Inc.. (Attachments: # 1 Affidavit Declaration of Frederick J. Ding, # 2 Exhibit 1 - 9/19/22 Trial Transcript Excerpts, # 3 Exhibit 2 - 9/20/22 Trial Transcript Excerpts, # 4 Exhibit 2A - Redacted in Entirety, # 5 Exhibit 3 - 9/21/22 Trial Transcript Excerpts, # 6 Exhibit 3A - Redacted in Entirety, # 7 Exhibit 4 - 9/22/22 Trial Transcript Excerpts, # 8 Exhibit 5 - 9/23/22 Trial Transcript Excerpts, # 9 Exhibit PTX-0002, # 10 Exhibit PTX-0175, # 11 Exhibit PTX-0176 Excerpts, # 12 Exhibit PTX-0234, # 13 Exhibit PTX-0238, # 14 Exhibit PTX-0239, # 15 Exhibit PTX-0255 Excerpts, # 16 Exhibit PTX-0381, # 17 Exhibit PTX-0383, # 18 Exhibit PTX-0719 Excerpts, # 19 Exhibit PTX-0749, # 20 Exhibit PTX-0917, # 21 Exhibit PTX-1140 Excerpts, # 22 Exhibit PTX-1141, # 23 Exhibit PTX-1221, # 24 Exhibit PTX-1229, # 25 Exhibit PTX-1231, # 26 Exhibit PTX-1232, # 27 Exhibit PTX-1233, # 28 Exhibit PTX-1271, # 29 Exhibit PTX-1294, # 30 Exhibit PTX-1301, # 31 Exhibit PTX-1334, # 32 Exhibit PTX-1480, # 33 Exhibit DTX-0908)(Ding, Frederick) (Entered: 10/05/2022) (Exhibit PTX-0749) (16)
Oct 5, 2022	232	MOTION for Enhanced Damages Pursuant to 35 U.S.C. � 284 by Ravgen, Inc.. (Attachments: # 1 Affidavit Declaration of Frederick J. Ding, # 2 Exhibit 1 - 9/19/22 Trial Transcript Excerpts, # 3 Exhibit 2 - 9/20/22 Trial Transcript Excerpts, # 4 Exhibit 2A - Redacted in Entirety, # 5 Exhibit 3 - 9/21/22 Trial Transcript Excerpts, # 6 Exhibit 3A - Redacted in Entirety, # 7 Exhibit 4 - 9/22/22 Trial Transcript Excerpts, # 8 Exhibit 5 - 9/23/22 Trial Transcript Excerpts, # 9 Exhibit PTX-0002, # 10 Exhibit PTX-0175, # 11 Exhibit PTX-0176 Excerpts, # 12 Exhibit PTX-0234, # 13 Exhibit PTX-0238, # 14 Exhibit PTX-0239, # 15 Exhibit PTX-0255 Excerpts, # 16 Exhibit PTX-0381, # 17 Exhibit PTX-0383, # 18 Exhibit PTX-0719 Excerpts, # 19 Exhibit PTX-0749, # 20 Exhibit PTX-0917, # 21 Exhibit PTX-1140 Excerpts, # 22 Exhibit PTX-1141, # 23 Exhibit PTX-1221, # 24 Exhibit PTX-1229, # 25 Exhibit PTX-1231, # 26 Exhibit PTX-1232, # 27 Exhibit PTX-1233, # 28 Exhibit PTX-1271, # 29 Exhibit PTX-1294, # 30 Exhibit PTX-1301, # 31 Exhibit PTX-1334, # 32 Exhibit PTX-1480, # 33 Exhibit DTX-0908)(Ding, Frederick) (Entered: 10/05/2022) (Exhibit PTX-0917) (3)
Oct 5, 2022	232	MOTION for Enhanced Damages Pursuant to 35 U.S.C. � 284 by Ravgen, Inc.. (Attachments: # 1 Affidavit Declaration of Frederick J. Ding, # 2 Exhibit 1 - 9/19/22 Trial Transcript Excerpts, # 3 Exhibit 2 - 9/20/22 Trial Transcript Excerpts, # 4 Exhibit 2A - Redacted in Entirety, # 5 Exhibit 3 - 9/21/22 Trial Transcript Excerpts, # 6 Exhibit 3A - Redacted in Entirety, # 7 Exhibit 4 - 9/22/22 Trial Transcript Excerpts, # 8 Exhibit 5 - 9/23/22 Trial Transcript Excerpts, # 9 Exhibit PTX-0002, # 10 Exhibit PTX-0175, # 11 Exhibit PTX-0176 Excerpts, # 12 Exhibit PTX-0234, # 13 Exhibit PTX-0238, # 14 Exhibit PTX-0239, # 15 Exhibit PTX-0255 Excerpts, # 16 Exhibit PTX-0381, # 17 Exhibit PTX-0383, # 18 Exhibit PTX-0719 Excerpts, # 19 Exhibit PTX-0749, # 20 Exhibit PTX-0917, # 21 Exhibit PTX-1140 Excerpts, # 22 Exhibit PTX-1141, # 23 Exhibit PTX-1221, # 24 Exhibit PTX-1229, # 25 Exhibit PTX-1231, # 26 Exhibit PTX-1232, # 27 Exhibit PTX-1233, # 28 Exhibit PTX-1271, # 29 Exhibit PTX-1294, # 30 Exhibit PTX-1301, # 31 Exhibit PTX-1334, # 32 Exhibit PTX-1480, # 33 Exhibit DTX-0908)(Ding, Frederick) (Entered: 10/05/2022) (Exhibit PTX-1140 Excerpts) (2)
Oct 5, 2022	232	MOTION for Enhanced Damages Pursuant to 35 U.S.C. � 284 by Ravgen, Inc.. (Attachments: # 1 Affidavit Declaration of Frederick J. Ding, # 2 Exhibit 1 - 9/19/22 Trial Transcript Excerpts, # 3 Exhibit 2 - 9/20/22 Trial Transcript Excerpts, # 4 Exhibit 2A - Redacted in Entirety, # 5 Exhibit 3 - 9/21/22 Trial Transcript Excerpts, # 6 Exhibit 3A - Redacted in Entirety, # 7 Exhibit 4 - 9/22/22 Trial Transcript Excerpts, # 8 Exhibit 5 - 9/23/22 Trial Transcript Excerpts, # 9 Exhibit PTX-0002, # 10 Exhibit PTX-0175, # 11 Exhibit PTX-0176 Excerpts, # 12 Exhibit PTX-0234, # 13 Exhibit PTX-0238, # 14 Exhibit PTX-0239, # 15 Exhibit PTX-0255 Excerpts, # 16 Exhibit PTX-0381, # 17 Exhibit PTX-0383, # 18 Exhibit PTX-0719 Excerpts, # 19 Exhibit PTX-0749, # 20 Exhibit PTX-0917, # 21 Exhibit PTX-1140 Excerpts, # 22 Exhibit PTX-1141, # 23 Exhibit PTX-1221, # 24 Exhibit PTX-1229, # 25 Exhibit PTX-1231, # 26 Exhibit PTX-1232, # 27 Exhibit PTX-1233, # 28 Exhibit PTX-1271, # 29 Exhibit PTX-1294, # 30 Exhibit PTX-1301, # 31 Exhibit PTX-1334, # 32 Exhibit PTX-1480, # 33 Exhibit DTX-0908)(Ding, Frederick) (Entered: 10/05/2022) (Exhibit PTX-1141) (6)
Oct 5, 2022	232	MOTION for Enhanced Damages Pursuant to 35 U.S.C. � 284 by Ravgen, Inc.. (Attachments: # 1 Affidavit Declaration of Frederick J. Ding, # 2 Exhibit 1 - 9/19/22 Trial Transcript Excerpts, # 3 Exhibit 2 - 9/20/22 Trial Transcript Excerpts, # 4 Exhibit 2A - Redacted in Entirety, # 5 Exhibit 3 - 9/21/22 Trial Transcript Excerpts, # 6 Exhibit 3A - Redacted in Entirety, # 7 Exhibit 4 - 9/22/22 Trial Transcript Excerpts, # 8 Exhibit 5 - 9/23/22 Trial Transcript Excerpts, # 9 Exhibit PTX-0002, # 10 Exhibit PTX-0175, # 11 Exhibit PTX-0176 Excerpts, # 12 Exhibit PTX-0234, # 13 Exhibit PTX-0238, # 14 Exhibit PTX-0239, # 15 Exhibit PTX-0255 Excerpts, # 16 Exhibit PTX-0381, # 17 Exhibit PTX-0383, # 18 Exhibit PTX-0719 Excerpts, # 19 Exhibit PTX-0749, # 20 Exhibit PTX-0917, # 21 Exhibit PTX-1140 Excerpts, # 22 Exhibit PTX-1141, # 23 Exhibit PTX-1221, # 24 Exhibit PTX-1229, # 25 Exhibit PTX-1231, # 26 Exhibit PTX-1232, # 27 Exhibit PTX-1233, # 28 Exhibit PTX-1271, # 29 Exhibit PTX-1294, # 30 Exhibit PTX-1301, # 31 Exhibit PTX-1334, # 32 Exhibit PTX-1480, # 33 Exhibit DTX-0908)(Ding, Frederick) (Entered: 10/05/2022) (Exhibit PTX-1221) (2)
Oct 5, 2022	232	MOTION for Enhanced Damages Pursuant to 35 U.S.C. � 284 by Ravgen, Inc.. (Attachments: # 1 Affidavit Declaration of Frederick J. Ding, # 2 Exhibit 1 - 9/19/22 Trial Transcript Excerpts, # 3 Exhibit 2 - 9/20/22 Trial Transcript Excerpts, # 4 Exhibit 2A - Redacted in Entirety, # 5 Exhibit 3 - 9/21/22 Trial Transcript Excerpts, # 6 Exhibit 3A - Redacted in Entirety, # 7 Exhibit 4 - 9/22/22 Trial Transcript Excerpts, # 8 Exhibit 5 - 9/23/22 Trial Transcript Excerpts, # 9 Exhibit PTX-0002, # 10 Exhibit PTX-0175, # 11 Exhibit PTX-0176 Excerpts, # 12 Exhibit PTX-0234, # 13 Exhibit PTX-0238, # 14 Exhibit PTX-0239, # 15 Exhibit PTX-0255 Excerpts, # 16 Exhibit PTX-0381, # 17 Exhibit PTX-0383, # 18 Exhibit PTX-0719 Excerpts, # 19 Exhibit PTX-0749, # 20 Exhibit PTX-0917, # 21 Exhibit PTX-1140 Excerpts, # 22 Exhibit PTX-1141, # 23 Exhibit PTX-1221, # 24 Exhibit PTX-1229, # 25 Exhibit PTX-1231, # 26 Exhibit PTX-1232, # 27 Exhibit PTX-1233, # 28 Exhibit PTX-1271, # 29 Exhibit PTX-1294, # 30 Exhibit PTX-1301, # 31 Exhibit PTX-1334, # 32 Exhibit PTX-1480, # 33 Exhibit DTX-0908)(Ding, Frederick) (Entered: 10/05/2022) (Exhibit PTX-1229) (1)
Oct 5, 2022	232	MOTION for Enhanced Damages Pursuant to 35 U.S.C. � 284 by Ravgen, Inc.. (Attachments: # 1 Affidavit Declaration of Frederick J. Ding, # 2 Exhibit 1 - 9/19/22 Trial Transcript Excerpts, # 3 Exhibit 2 - 9/20/22 Trial Transcript Excerpts, # 4 Exhibit 2A - Redacted in Entirety, # 5 Exhibit 3 - 9/21/22 Trial Transcript Excerpts, # 6 Exhibit 3A - Redacted in Entirety, # 7 Exhibit 4 - 9/22/22 Trial Transcript Excerpts, # 8 Exhibit 5 - 9/23/22 Trial Transcript Excerpts, # 9 Exhibit PTX-0002, # 10 Exhibit PTX-0175, # 11 Exhibit PTX-0176 Excerpts, # 12 Exhibit PTX-0234, # 13 Exhibit PTX-0238, # 14 Exhibit PTX-0239, # 15 Exhibit PTX-0255 Excerpts, # 16 Exhibit PTX-0381, # 17 Exhibit PTX-0383, # 18 Exhibit PTX-0719 Excerpts, # 19 Exhibit PTX-0749, # 20 Exhibit PTX-0917, # 21 Exhibit PTX-1140 Excerpts, # 22 Exhibit PTX-1141, # 23 Exhibit PTX-1221, # 24 Exhibit PTX-1229, # 25 Exhibit PTX-1231, # 26 Exhibit PTX-1232, # 27 Exhibit PTX-1233, # 28 Exhibit PTX-1271, # 29 Exhibit PTX-1294, # 30 Exhibit PTX-1301, # 31 Exhibit PTX-1334, # 32 Exhibit PTX-1480, # 33 Exhibit DTX-0908)(Ding, Frederick) (Entered: 10/05/2022) (Exhibit PTX-1231) (2)
Oct 5, 2022	232	MOTION for Enhanced Damages Pursuant to 35 U.S.C. � 284 by Ravgen, Inc.. (Attachments: # 1 Affidavit Declaration of Frederick J. Ding, # 2 Exhibit 1 - 9/19/22 Trial Transcript Excerpts, # 3 Exhibit 2 - 9/20/22 Trial Transcript Excerpts, # 4 Exhibit 2A - Redacted in Entirety, # 5 Exhibit 3 - 9/21/22 Trial Transcript Excerpts, # 6 Exhibit 3A - Redacted in Entirety, # 7 Exhibit 4 - 9/22/22 Trial Transcript Excerpts, # 8 Exhibit 5 - 9/23/22 Trial Transcript Excerpts, # 9 Exhibit PTX-0002, # 10 Exhibit PTX-0175, # 11 Exhibit PTX-0176 Excerpts, # 12 Exhibit PTX-0234, # 13 Exhibit PTX-0238, # 14 Exhibit PTX-0239, # 15 Exhibit PTX-0255 Excerpts, # 16 Exhibit PTX-0381, # 17 Exhibit PTX-0383, # 18 Exhibit PTX-0719 Excerpts, # 19 Exhibit PTX-0749, # 20 Exhibit PTX-0917, # 21 Exhibit PTX-1140 Excerpts, # 22 Exhibit PTX-1141, # 23 Exhibit PTX-1221, # 24 Exhibit PTX-1229, # 25 Exhibit PTX-1231, # 26 Exhibit PTX-1232, # 27 Exhibit PTX-1233, # 28 Exhibit PTX-1271, # 29 Exhibit PTX-1294, # 30 Exhibit PTX-1301, # 31 Exhibit PTX-1334, # 32 Exhibit PTX-1480, # 33 Exhibit DTX-0908)(Ding, Frederick) (Entered: 10/05/2022) (Exhibit PTX-1232) (2)
Oct 5, 2022	232	MOTION for Enhanced Damages Pursuant to 35 U.S.C. � 284 by Ravgen, Inc.. (Attachments: # 1 Affidavit Declaration of Frederick J. Ding, # 2 Exhibit 1 - 9/19/22 Trial Transcript Excerpts, # 3 Exhibit 2 - 9/20/22 Trial Transcript Excerpts, # 4 Exhibit 2A - Redacted in Entirety, # 5 Exhibit 3 - 9/21/22 Trial Transcript Excerpts, # 6 Exhibit 3A - Redacted in Entirety, # 7 Exhibit 4 - 9/22/22 Trial Transcript Excerpts, # 8 Exhibit 5 - 9/23/22 Trial Transcript Excerpts, # 9 Exhibit PTX-0002, # 10 Exhibit PTX-0175, # 11 Exhibit PTX-0176 Excerpts, # 12 Exhibit PTX-0234, # 13 Exhibit PTX-0238, # 14 Exhibit PTX-0239, # 15 Exhibit PTX-0255 Excerpts, # 16 Exhibit PTX-0381, # 17 Exhibit PTX-0383, # 18 Exhibit PTX-0719 Excerpts, # 19 Exhibit PTX-0749, # 20 Exhibit PTX-0917, # 21 Exhibit PTX-1140 Excerpts, # 22 Exhibit PTX-1141, # 23 Exhibit PTX-1221, # 24 Exhibit PTX-1229, # 25 Exhibit PTX-1231, # 26 Exhibit PTX-1232, # 27 Exhibit PTX-1233, # 28 Exhibit PTX-1271, # 29 Exhibit PTX-1294, # 30 Exhibit PTX-1301, # 31 Exhibit PTX-1334, # 32 Exhibit PTX-1480, # 33 Exhibit DTX-0908)(Ding, Frederick) (Entered: 10/05/2022) (Exhibit PTX-1233) (2)
Oct 5, 2022	232	MOTION for Enhanced Damages Pursuant to 35 U.S.C. � 284 by Ravgen, Inc.. (Attachments: # 1 Affidavit Declaration of Frederick J. Ding, # 2 Exhibit 1 - 9/19/22 Trial Transcript Excerpts, # 3 Exhibit 2 - 9/20/22 Trial Transcript Excerpts, # 4 Exhibit 2A - Redacted in Entirety, # 5 Exhibit 3 - 9/21/22 Trial Transcript Excerpts, # 6 Exhibit 3A - Redacted in Entirety, # 7 Exhibit 4 - 9/22/22 Trial Transcript Excerpts, # 8 Exhibit 5 - 9/23/22 Trial Transcript Excerpts, # 9 Exhibit PTX-0002, # 10 Exhibit PTX-0175, # 11 Exhibit PTX-0176 Excerpts, # 12 Exhibit PTX-0234, # 13 Exhibit PTX-0238, # 14 Exhibit PTX-0239, # 15 Exhibit PTX-0255 Excerpts, # 16 Exhibit PTX-0381, # 17 Exhibit PTX-0383, # 18 Exhibit PTX-0719 Excerpts, # 19 Exhibit PTX-0749, # 20 Exhibit PTX-0917, # 21 Exhibit PTX-1140 Excerpts, # 22 Exhibit PTX-1141, # 23 Exhibit PTX-1221, # 24 Exhibit PTX-1229, # 25 Exhibit PTX-1231, # 26 Exhibit PTX-1232, # 27 Exhibit PTX-1233, # 28 Exhibit PTX-1271, # 29 Exhibit PTX-1294, # 30 Exhibit PTX-1301, # 31 Exhibit PTX-1334, # 32 Exhibit PTX-1480, # 33 Exhibit DTX-0908)(Ding, Frederick) (Entered: 10/05/2022) (Exhibit PTX-1271) (1)
Oct 5, 2022	232	MOTION for Enhanced Damages Pursuant to 35 U.S.C. � 284 by Ravgen, Inc.. (Attachments: # 1 Affidavit Declaration of Frederick J. Ding, # 2 Exhibit 1 - 9/19/22 Trial Transcript Excerpts, # 3 Exhibit 2 - 9/20/22 Trial Transcript Excerpts, # 4 Exhibit 2A - Redacted in Entirety, # 5 Exhibit 3 - 9/21/22 Trial Transcript Excerpts, # 6 Exhibit 3A - Redacted in Entirety, # 7 Exhibit 4 - 9/22/22 Trial Transcript Excerpts, # 8 Exhibit 5 - 9/23/22 Trial Transcript Excerpts, # 9 Exhibit PTX-0002, # 10 Exhibit PTX-0175, # 11 Exhibit PTX-0176 Excerpts, # 12 Exhibit PTX-0234, # 13 Exhibit PTX-0238, # 14 Exhibit PTX-0239, # 15 Exhibit PTX-0255 Excerpts, # 16 Exhibit PTX-0381, # 17 Exhibit PTX-0383, # 18 Exhibit PTX-0719 Excerpts, # 19 Exhibit PTX-0749, # 20 Exhibit PTX-0917, # 21 Exhibit PTX-1140 Excerpts, # 22 Exhibit PTX-1141, # 23 Exhibit PTX-1221, # 24 Exhibit PTX-1229, # 25 Exhibit PTX-1231, # 26 Exhibit PTX-1232, # 27 Exhibit PTX-1233, # 28 Exhibit PTX-1271, # 29 Exhibit PTX-1294, # 30 Exhibit PTX-1301, # 31 Exhibit PTX-1334, # 32 Exhibit PTX-1480, # 33 Exhibit DTX-0908)(Ding, Frederick) (Entered: 10/05/2022) (Exhibit PTX-1294) (1)
Oct 5, 2022	232	MOTION for Enhanced Damages Pursuant to 35 U.S.C. � 284 by Ravgen, Inc.. (Attachments: # 1 Affidavit Declaration of Frederick J. Ding, # 2 Exhibit 1 - 9/19/22 Trial Transcript Excerpts, # 3 Exhibit 2 - 9/20/22 Trial Transcript Excerpts, # 4 Exhibit 2A - Redacted in Entirety, # 5 Exhibit 3 - 9/21/22 Trial Transcript Excerpts, # 6 Exhibit 3A - Redacted in Entirety, # 7 Exhibit 4 - 9/22/22 Trial Transcript Excerpts, # 8 Exhibit 5 - 9/23/22 Trial Transcript Excerpts, # 9 Exhibit PTX-0002, # 10 Exhibit PTX-0175, # 11 Exhibit PTX-0176 Excerpts, # 12 Exhibit PTX-0234, # 13 Exhibit PTX-0238, # 14 Exhibit PTX-0239, # 15 Exhibit PTX-0255 Excerpts, # 16 Exhibit PTX-0381, # 17 Exhibit PTX-0383, # 18 Exhibit PTX-0719 Excerpts, # 19 Exhibit PTX-0749, # 20 Exhibit PTX-0917, # 21 Exhibit PTX-1140 Excerpts, # 22 Exhibit PTX-1141, # 23 Exhibit PTX-1221, # 24 Exhibit PTX-1229, # 25 Exhibit PTX-1231, # 26 Exhibit PTX-1232, # 27 Exhibit PTX-1233, # 28 Exhibit PTX-1271, # 29 Exhibit PTX-1294, # 30 Exhibit PTX-1301, # 31 Exhibit PTX-1334, # 32 Exhibit PTX-1480, # 33 Exhibit DTX-0908)(Ding, Frederick) (Entered: 10/05/2022) (Exhibit PTX-1301) (1)
Oct 5, 2022	232	MOTION for Enhanced Damages Pursuant to 35 U.S.C. � 284 by Ravgen, Inc.. (Attachments: # 1 Affidavit Declaration of Frederick J. Ding, # 2 Exhibit 1 - 9/19/22 Trial Transcript Excerpts, # 3 Exhibit 2 - 9/20/22 Trial Transcript Excerpts, # 4 Exhibit 2A - Redacted in Entirety, # 5 Exhibit 3 - 9/21/22 Trial Transcript Excerpts, # 6 Exhibit 3A - Redacted in Entirety, # 7 Exhibit 4 - 9/22/22 Trial Transcript Excerpts, # 8 Exhibit 5 - 9/23/22 Trial Transcript Excerpts, # 9 Exhibit PTX-0002, # 10 Exhibit PTX-0175, # 11 Exhibit PTX-0176 Excerpts, # 12 Exhibit PTX-0234, # 13 Exhibit PTX-0238, # 14 Exhibit PTX-0239, # 15 Exhibit PTX-0255 Excerpts, # 16 Exhibit PTX-0381, # 17 Exhibit PTX-0383, # 18 Exhibit PTX-0719 Excerpts, # 19 Exhibit PTX-0749, # 20 Exhibit PTX-0917, # 21 Exhibit PTX-1140 Excerpts, # 22 Exhibit PTX-1141, # 23 Exhibit PTX-1221, # 24 Exhibit PTX-1229, # 25 Exhibit PTX-1231, # 26 Exhibit PTX-1232, # 27 Exhibit PTX-1233, # 28 Exhibit PTX-1271, # 29 Exhibit PTX-1294, # 30 Exhibit PTX-1301, # 31 Exhibit PTX-1334, # 32 Exhibit PTX-1480, # 33 Exhibit DTX-0908)(Ding, Frederick) (Entered: 10/05/2022) (Exhibit PTX-1334) (1)
Oct 5, 2022	232	MOTION for Enhanced Damages Pursuant to 35 U.S.C. � 284 by Ravgen, Inc.. (Attachments: # 1 Affidavit Declaration of Frederick J. Ding, # 2 Exhibit 1 - 9/19/22 Trial Transcript Excerpts, # 3 Exhibit 2 - 9/20/22 Trial Transcript Excerpts, # 4 Exhibit 2A - Redacted in Entirety, # 5 Exhibit 3 - 9/21/22 Trial Transcript Excerpts, # 6 Exhibit 3A - Redacted in Entirety, # 7 Exhibit 4 - 9/22/22 Trial Transcript Excerpts, # 8 Exhibit 5 - 9/23/22 Trial Transcript Excerpts, # 9 Exhibit PTX-0002, # 10 Exhibit PTX-0175, # 11 Exhibit PTX-0176 Excerpts, # 12 Exhibit PTX-0234, # 13 Exhibit PTX-0238, # 14 Exhibit PTX-0239, # 15 Exhibit PTX-0255 Excerpts, # 16 Exhibit PTX-0381, # 17 Exhibit PTX-0383, # 18 Exhibit PTX-0719 Excerpts, # 19 Exhibit PTX-0749, # 20 Exhibit PTX-0917, # 21 Exhibit PTX-1140 Excerpts, # 22 Exhibit PTX-1141, # 23 Exhibit PTX-1221, # 24 Exhibit PTX-1229, # 25 Exhibit PTX-1231, # 26 Exhibit PTX-1232, # 27 Exhibit PTX-1233, # 28 Exhibit PTX-1271, # 29 Exhibit PTX-1294, # 30 Exhibit PTX-1301, # 31 Exhibit PTX-1334, # 32 Exhibit PTX-1480, # 33 Exhibit DTX-0908)(Ding, Frederick) (Entered: 10/05/2022) (Exhibit PTX-1480) (5)
Oct 5, 2022	232	MOTION for Enhanced Damages Pursuant to 35 U.S.C. � 284 by Ravgen, Inc.. (Attachments: # 1 Affidavit Declaration of Frederick J. Ding, # 2 Exhibit 1 - 9/19/22 Trial Transcript Excerpts, # 3 Exhibit 2 - 9/20/22 Trial Transcript Excerpts, # 4 Exhibit 2A - Redacted in Entirety, # 5 Exhibit 3 - 9/21/22 Trial Transcript Excerpts, # 6 Exhibit 3A - Redacted in Entirety, # 7 Exhibit 4 - 9/22/22 Trial Transcript Excerpts, # 8 Exhibit 5 - 9/23/22 Trial Transcript Excerpts, # 9 Exhibit PTX-0002, # 10 Exhibit PTX-0175, # 11 Exhibit PTX-0176 Excerpts, # 12 Exhibit PTX-0234, # 13 Exhibit PTX-0238, # 14 Exhibit PTX-0239, # 15 Exhibit PTX-0255 Excerpts, # 16 Exhibit PTX-0381, # 17 Exhibit PTX-0383, # 18 Exhibit PTX-0719 Excerpts, # 19 Exhibit PTX-0749, # 20 Exhibit PTX-0917, # 21 Exhibit PTX-1140 Excerpts, # 22 Exhibit PTX-1141, # 23 Exhibit PTX-1221, # 24 Exhibit PTX-1229, # 25 Exhibit PTX-1231, # 26 Exhibit PTX-1232, # 27 Exhibit PTX-1233, # 28 Exhibit PTX-1271, # 29 Exhibit PTX-1294, # 30 Exhibit PTX-1301, # 31 Exhibit PTX-1334, # 32 Exhibit PTX-1480, # 33 Exhibit DTX-0908)(Ding, Frederick) (Entered: 10/05/2022) (Exhibit DTX-0908) (2)
Oct 4, 2022	227	Sealed Order GRANTING PLAINTIFF RAVGEN, INC.S MOTION TO STRIKE AND EXCLUDE DEFENDANT LABCORPS FED. R. CIV. P. 26(A)(2)(C) DISCLOSURE [ECF NO. 122 ]. Signed by Judge Alan D Albright. (zv) (Entered: 10/04/2022) (0)
Oct 4, 2022	228	MEMORANDUM OPINION AND ORDER GRANTING PLAINTIFFS MOTION TO EXCLUDE, IN PART, THE EXPERT OPINON OF DR. STEPHEN D. PROWSE [ECF NO. 123 ]. Signed by Judge Alan D Albright. (zv) Modified on 10/12/2022 to unseal document per RJlc (zv). (Entered: 10/04/2022) (15)
Oct 4, 2022	229	Sealed Order DENYING DEFENDANT LABCORPS MOTION TO EXCLUDE OPINIONS OF PAUL K. MEYER [ECF NO. 113 ]. Signed by Judge Alan D Albright. (zv) (Entered: 10/04/2022) (0)
Oct 4, 2022	230	Order GRANTING PLAINTIFFS MOTION TO EXCLUDE AND PRECLUDE CERTAIN EXPERT TESTIMONY OF DRS. PAUL T. SPELLMAN AND LARRY J. DUMONT [ECF NO. 120 ]. Signed by Judge Alan D Albright. (zv) Modified on 10/12/2022 to unseal document per RJlc (zv). (Entered: 10/04/2022) (9)
Oct 3, 2022	226	Order: OPINION GRANTING-IN-PART DEFENDANTS MOTION TO EXCLUDE CERTAIN OPINIONS OF DR. BRIAN VAN NESS (ECF NO. 111 ). Signed by Judge Alan D Albright. (zv) Modified on 10/12/2022 to unseal document per RJlc (zv). (Entered: 10/03/2022) (4)
Sep 29, 2022	223	Redacted Transcript filed re: 197 Transcript. (kd) (Entered: 09/29/2022) (135)
Sep 29, 2022	224	Unopposed MOTION for Entry of Judgment by Ravgen, Inc.. (Attachments: # 1 Proposed Order (Proposed Judgment))(Ding, Frederick) Modified on 9/29/2022. Contacted Plaintiff's counsel in regard to Proposed Order omitting the word "Proposed." Directed to refile corrected Proposed Order as an Attachment (zv). (Entered: 09/29/2022) (Main Document) (3)
Sep 29, 2022	225	Unopposed MOTION for Entry of Judgment (refiled 224 ) by Ravgen, Inc.. (Attachments: # 1 Proposed Order)(Ding, Frederick) (Entered: 09/29/2022) (Main Document) (3)
Sep 29, 2022	225	Unopposed MOTION for Entry of Judgment (refiled 224 ) by Ravgen, Inc.. (Attachments: # 1 Proposed Order)(Ding, Frederick) (Entered: 09/29/2022) (Proposed Order) (2)
Sep 29, 2022	224	Unopposed MOTION for Entry of Judgment by Ravgen, Inc.. (Attachments: # 1 Proposed Order (Proposed Judgment))(Ding, Frederick) Modified on 9/29/2022. Contacted Plaintiff's counsel in regard to Proposed Order omitting the word "Proposed." Directed to refile corrected Proposed Order as an Attachment (zv). (Entered: 09/29/2022) (Proposed Order (Proposed Judgment)) (2)
Sep 23, 2022	213	TRIAL Witness List. (sv) (Entered: 09/23/2022) (1)
Sep 23, 2022	214	JURY NOTE 1 SEALED pursuant to E-Government Act of 2002. (sv) (Entered: 09/23/2022) (0)
Sep 23, 2022	215	Final Instructions to Jury. (sv) (Entered: 09/23/2022) (30)
Sep 23, 2022	216	Jury Note #1 (Redacted Version) filed. (sv) (Entered: 09/23/2022) (1)
Sep 23, 2022	217	JURY NOTE 2 SEALED pursuant to E-Government Act of 2002. (sv) (Entered: 09/23/2022) (0)
Sep 23, 2022	218	JURY NOTE 2 (Redacted Version) filed. (sv) (Entered: 09/23/2022) (1)
Sep 23, 2022	220	Minute Entry for proceedings held before Judge Alan D Albright: Jury Trial held on 9/23/2022. RULE INVOKED, CLOSING ARGUMENTS OF COUNSEL FOR PLAINTIFF AND DEFENDANT, COURT CHARGES JURY, JURY RETIRES TO DELIBERATE, JURY POLLED/DISCHARGED, TRIAL CONCLUDED. (Minute entry documents are not available electronically). (Court Reporter Kristie Davis)(sv) (Entered: 09/23/2022) (0)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Main Document) (3)
Sep 23, 2022	222	JURY VERDICT (Redacted Version) filed. Unredacted Jury Verdict Sealed pursuant to E-Government Act of 2002.(sv) (Entered: 09/27/2022) (6)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Pla-2) (30)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Pla-3-A1) (30)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Pla-3-A2) (30)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Pla-3-A3) (30)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Pla-3-A4) (30)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Pla-3-A5) (30)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Pla-3-A6) (30)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Pla-3-A7) (30)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Pla-3-A8) (30)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Pla-3-A9) (30)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Pla-14) (30)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Pla-113) (1)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Pla-145) (15)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Pla-175) (18)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Pla-176) (30)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Pla-177) (6)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Pla-226) (3)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Pla-228) (30)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Pla-234) (1)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Pla-236) (19)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Pla-238) (6)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Pla-239) (8)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Pla-254) (8)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Pla-255) (30)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Pla-335) (3)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Pla-381) (5)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Pla-383) (3)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Pla-563) (26)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Pla-716) (30)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Pla-719) (30)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Pla-721) (30)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Pla-742) (17)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Pla-748) (3)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Pla-749) (16)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Pla-751) (11)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Pla-758) (19)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Pla-766) (30)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Pla-785) (10)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Pla-789) (15)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Pla-802) (30)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Pla-911) (30)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Pla-913) (30)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Pla-917) (3)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Pla-929) (1)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Pla-957-A1) (30)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Pla-957-A2) (30)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Pla-957-A3) (30)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Pla-957-A4) (30)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Pla_1085) (8)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Pla-1106) (5)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Pla_1130) (20)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Pla_1140) (10)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Pla_1141) (6)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Pla_1221) (2)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Pla_1229) (1)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Pla_1231) (2)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Pla_1232) (2)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Pla_1233) (2)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Pla_1266) (1)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Pla_1270) (1)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Pla_1271) (1)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Pla_1280) (2)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Errata Pla_1294) (1)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Pla_1301) (1)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Pla_1334) (1)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Pla_1372) (12)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Pla_1374) (12)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Pla_1381) (14)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Pla_1382) (19)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Pla_1386) (12)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Pla_1387) (12)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Pla_1413) (12)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Pla_1455) (2)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Pla_1457) (1)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Pla_1469) (2)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Pla_1480) (5)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Pla_1500) (1)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Pla_1526) (3)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Pla_1549) (1)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Pla_1583) (1)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Pla_1626) (1)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Def_12) (2)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Def_15) (3)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Def_19) (3)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Def_20) (4)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Def_54) (28)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Def_57) (12)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Def_58) (20)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Errata Def_64) (1)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Def_72) (6)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Def_112) (3)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Def_212) (2)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Def_215) (19)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Def_218) (6)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Def_219) (1)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Def_220) (1)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Def_312) (14)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Def_338) (10)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Def_612) (3)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Def_614) (2)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Def_618) (6)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Def_638) (6)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Def_751) (3)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Def_857) (4)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Def_860) (8)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Def_908) (2)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Def_919) (11)
Sep 23, 2022	221	TRIAL Exhibit List (sv) (Additional attachment(s) added on 10/12/2022: # 1 Exhibit Pla-2, # 2 Exhibit Pla-3-A1, # 3 Exhibit Pla-3-A2, # 4 Exhibit Pla-3-A3, # 5 Exhibit Pla-3-A4, # 6 Exhibit Pla-3-A5, # 7 Exhibit Pla-3-A6, # 8 Exhibit Pla-3-A7, # 9 Exhibit Pla-3-A8) (zv). (Additional attachment(s) added on 10/12/2022: # 10 Exhibit Pla-3-A9, # 11 Exhibit Pla-14, # 12 Exhibit Pla-113, # 13 Exhibit Pla-145, # 14 Exhibit Pla-175, # 15 Exhibit Pla-176, # 16 Exhibit Pla-177, # 17 Exhibit Pla-226, # 18 Exhibit Pla-228) (zv). (Additional attachment(s) added on 10/12/2022: # 19 Exhibit Pla-234, # 20 Exhibit Pla-236, # 21 Exhibit Pla-238, # 22 Exhibit Pla-239, # 23 Exhibit Pla-254, # 24 Exhibit Pla-255, # 25 Exhibit Pla-335, # 26 Exhibit Pla-381, # 27 Exhibit Pla-383, # 28 Exhibit Pla-563, # 29 Exhibit Pla-716, # 30 Exhibit Pla-719) (zv). (Additional attachment(s) added on 10/12/2022: # 31 Exhibit Pla-721, # 32 Exhibit Pla-742, # 33 Exhibit Pla-748, # 34 Exhibit Pla-749, # 35 Exhibit Pla-751, # 36 Exhibit Pla-758, # 37 Exhibit Pla-766, # 38 Exhibit Pla-785, # 39 Exhibit Pla-789, # 40 Exhibit Pla-802, # 41 Exhibit Pla-911, # 42 Exhibit Pla-913) (zv). (Additional attachment(s) added on 10/12/2022: # 43 Exhibit Pla-917, # 44 Exhibit Pla-929, # 45 Exhibit Pla-957-A1, # 46 Exhibit Pla-957-A2, # 47 Exhibit Pla-957-A3, # 48 Exhibit Pla-957-A4) (zv). (Additional attachment(s) added on 10/14/2022: # 49 Exhibit Pla_1085, # 50 Exhibit Pla-1106, # 51 Exhibit Pla_1130, # 52 Exhibit Pla_1140, # 53 Exhibit Pla_1141, # 54 Exhibit Pla_1221, # 55 Exhibit Pla_1229, # 56 Exhibit Pla_1231, # 57 Exhibit Pla_1232) (zv). (Additional attachment(s) added on 10/14/2022: # 58 Exhibit Pla_1233, # 59 Exhibit Pla_1266, # 60 Exhibit Pla_1270, # 61 Exhibit Pla_1271, # 62 Exhibit Pla_1280, # 63 Errata Pla_1294, # 64 Exhibit Pla_1301, # 65 Exhibit Pla_1334) (zv). (Additional attachment(s) added on 10/14/2022: # 66 Exhibit Pla_1372, # 67 Exhibit Pla_1374, # 68 Exhibit Pla_1381, # 69 Exhibit Pla_1382, # 70 Exhibit Pla_1386, # 71 Exhibit Pla_1387, # 72 Exhibit Pla_1413, # 73 Exhibit Pla_1455, # 74 Exhibit Pla_1457, # 75 Exhibit Pla_1469, # 76 Exhibit Pla_1480) (zv). (Additional attachment(s) added on 10/14/2022: # 77 Exhibit Pla_1500, # 78 Exhibit Pla_1526, # 79 Exhibit Pla_1549, # 80 Exhibit Pla_1583, # 81 Exhibit Pla_1626, # 82 Exhibit Def_12, # 83 Exhibit Def_15, # 84 Exhibit Def_19, # 85 Exhibit Def_20, # 86 Exhibit Def_54, # 87 Exhibit Def_57) (zv). (Additional attachment(s) added on 10/14/2022: # 88 Exhibit Def_58, # 89 Errata Def_64, # 90 Exhibit Def_72, # 91 Exhibit Def_112, # 92 Exhibit Def_212, # 93 Exhibit Def_215, # 94 Exhibit Def_218, # 95 Exhibit Def_219, # 96 Exhibit Def_220) (zv). (Additional attachment(s) added on 10/14/2022: # 97 Exhibit Def_312, # 98 Exhibit Def_338, # 99 Exhibit Def_612, # 100 Exhibit Def_614, # 101 Exhibit Def_618, # 102 Exhibit Def_638, # 103 Exhibit Def_751, # 104 Exhibit Def_857, # 105 Exhibit Def_860, # 106 Exhibit Def_908, # 107 Exhibit Def_919, # 108 Exhibit Def_988) (zv). (Entered: 09/23/2022) (Exhibit Def_988) (17)
Sep 22, 2022	212	Minute Entry for proceedings held before Judge Alan D Albright: Jury Trial held on 9/22/2022. RULE INVOKED, EVIDENCE PRESENTED ON BEHALF OF PLAINTIFF AND DEFENDANT, DEFENDANT REST (Minute entry documents are not available electronically). ( Jury Trial set for 9/23/2022 08:30 AM before Judge Alan D Albright). (Court Reporter Kritie Davis)(sv) (Entered: 09/23/2022) (0)
Sep 21, 2022	210	Transcript Redaction Request re 197 Transcript by attorney Naoya Son. (Attachments: # 1 Motion to Redact Hearing Transcript, # 2 Exhibit 1, # 3 Proposed Order)(Son, Naoya) (Entered: 09/21/2022) (0)
Sep 21, 2022	211	Minute Entry for proceedings held before Judge Alan D Albright: Jury Trial held on 9/21/2022. TRIAL HELD, RULE INVOKED, EVIDENCE PRESENTED ON BEHALF OF PLAINTIFF AND DEFENDANT. (Minute entry documents are not available electronically) Jury Trial set for 9/22/2022 08:30 AM before Judge Alan D Albright. (Court Reporter Kristie Davis)(sv) (Entered: 09/22/2022) (0)
Sep 20, 2022	209	Minute Entry for proceedings held before Judge Alan D Albright: Jury Trial held on 9/20/2022. RULE INVOKED, EVIDENCE PRESENTED ON BEHALF OF PLAINTIFF AND DEFENDANT, PLAINTIFF REST, TRIAL CONTINUED AND RECESSED TO: September 21, 2022 8:45am. (Minute entry documents are not available electronically). (Jury Trial set for 9/21/2022 08:45 AM before Judge Alan D Albright). (Court Reporter Kristie Davis)(sv) (Entered: 09/21/2022) (0)
Sep 19, 2022	207	Minute Entry for proceedings held before Judge Alan D Albright: Hearing Out of Jury Presence held on 9/19/2022 (Minute entry documents are not available electronically). (Court Reporter Kristie Davis)(sv) (Entered: 09/19/2022) (0)
Sep 19, 2022	208	Minute Entry for proceedings held before Judge Alan D Albright: Jury Selection held on 9/19/2022 (Minute entry documents are not available electronically), Jury Trial begun on 9/19/2022, TRIAL HELD, RULE INVOKED, OPENING STATEMENTS OF COUNSEL FOR PLAINTIFF AND DEFENDANT HEARD, EVIDENCE PRESENTED ON BEHALF OF PLAINTIFF AND DEFENDANT, TRIAL CONTINUED AND RECESSED TO: September 20, 2022 at 8:30 am. (Minute entry documents are not available electronically), Jury Trial set for 9/20/2022 08:30 AM before Judge Alan D Albright. (Court Reporter Kristie Davis.)(sv) (Main Document 208 replaced on 9/27/2022) (jc5). (Entered: 09/20/2022) (0)
Sep 16, 2022	205	Unopposed MOTION to Withdraw as Attorney by Laboratory Corporation of America Holdings. (Attachments: # 1 Proposed Order)(Chassman, Peter) (Entered: 09/16/2022) (Main Document) (5)
Sep 16, 2022	206	NOTICE Regarding Third-Party Streck's Confidential Information by Laboratory Corporation of America Holdings (Attachments: # 1 Attachment A)(Son, Naoya) (Entered: 09/16/2022) (Main Document) (3)
Sep 16, 2022	205	Unopposed MOTION to Withdraw as Attorney by Laboratory Corporation of America Holdings. (Attachments: # 1 Proposed Order)(Chassman, Peter) (Entered: 09/16/2022) (Proposed Order) (2)
Sep 16, 2022	206	NOTICE Regarding Third-Party Streck's Confidential Information by Laboratory Corporation of America Holdings (Attachments: # 1 Attachment A)(Son, Naoya) (Entered: 09/16/2022) (Attachment A) (3)
Sep 14, 2022	203	JURY PARTIAL SEQUESTRATION ORDER. Signed by Judge Alan D Albright. (sv) (Entered: 09/14/2022) (1)
Sep 14, 2022	204	Minute Entry for proceedings held before Judge Derek T. Gilliland: Jury Selection held on 9/14/2022. VOIR DIRE BEGINS, JURY SELECTION HELD, JURORS SWORN, TRIAL TO BEGIN WITH JUDGE ALBRIGHT: Monday, September 19, 2022 at 9:00am. (Minute entry documents are not available electronically). (Court Reporter Judy Werlinger)(sv) (Entered: 09/15/2022) (0)
Sep 13, 2022	199	Order CONCERNING FINAL PRETRIAL CONFERENCE MOTIONS. Signed by Judge Alan D Albright. (sv) (Entered: 09/13/2022) (5)
Sep 13, 2022	201	Minute Entry for proceedings held before Judge Derek T. Gilliland: Pre-Voir Dire Conference held on 9/13/2022. Case called for a Pre Voir Dire Conference via Zoom. Counsel for the parties entered appearances. The Court outlined procedures for Voir Dire to be held on Thursday, September 15, 2022 at 9:00am in Courtroom #2. (Minute entry documents are not available electronically). (Court Reporter FTR.)(sv) (Entered: 09/13/2022) (0)
Sep 13, 2022	202	STIPULATION (Joint Notice and Stipulation to Dismiss Certain Claims and Counterclaims) by Ravgen, Inc.. (Limbeek, Kerri-Ann) (Entered: 09/13/2022) (5)
Sep 12, 2022	200	Sealed Order GRANTING-IN-PART AND DENYING-IN-PARTRELIEF REQUESTED IN DISCOVERY DISPUTES. Signed by Judge Alan D Albright. (sv) (Entered: 09/13/2022) (0)
Sep 9, 2022	198	NOTICE OF TRIAL PROCEDURES. Signed by Judge Alan D Albright. (sv) (Entered: 09/09/2022) (4)
Sep 1, 2022	197	Transcript filed of Proceedings held on 8-31-22, Proceedings Transcribed: Pretrial Conference. Court Reporter/Transcriber: Kristie Davis (kmdaviscsr@yahoo.com), Telephone number: 2546660904. Parties are notified of their duty to review the transcript to ensure compliance with the FRCP 5.2(a)/FRCrP 49.1(a). A copy may be purchased from the court reporter or viewed at the clerk's office public terminal. If redaction is necessary, a Notice of Redaction Request must be filed within 21 days. If no such Notice is filed, the transcript will be made available via PACER without redaction after 90 calendar days. The clerk will mail a copy of this notice to parties not electronically noticed Redaction Request due 9/22/2022, Redacted Transcript Deadline set for 10/3/2022, Release of Transcript Restriction set for 11/30/2022, (kd) (Entered: 09/01/2022) (0)
Aug 31, 2022	195	Minute Entry for proceedings held before Judge Alan D Albright: Pretrial Conference held on 8/31/2022. PARTIES ANNOUNCE READY, STATEMENTS AND ARGUMENTS OF COUNSEL HEARD, WRITTEN ORDER FORTHCOMING. (Minute entry documents are not available electronically). (Court Reporter Kristie Davis)(sv) (Entered: 08/31/2022) (0)
Aug 31, 2022	196	ORDER SETTING VOIR DIRE AND PRE-VOIR DIRE CONFERENCE. Pre Voir Dire Conference set for 9/13/2022 02:00 PM before Judge Derek T. Gilliland. Jury Selection set for 9/15/2022 09:00AM before Judge Derek T. Gilliland. Signed by Judge Derek T. Gilliland. (sv) (Entered: 08/31/2022) (1)
Aug 29, 2022	193	NOTICE to Attorneys regarding Jury Evidence Recording System (JERS) Instructions (sv) (Entered: 08/29/2022) (3)
Aug 29, 2022	194	ORDER SETTING VOIR DIRE AND PRE-VOIR DIRE CONFERENCE. Pre Voir Dire Conference set for 9/13/2022 09:00 AM before Judge Derek T. Gilliland, Jury Selection set for 9/15/2022 09:00AM before Judge Derek T. Gilliland. Signed by Judge Derek T. Gilliland. (sv) (Entered: 08/30/2022) (1)
Aug 23, 2022	192	ORDER GRANTING 189 Motion to Appear Pro Hac Vice for Attorney Savannah Carnes. Attorney added for Ravgen, Inc. Pursuant to our Administrative Policies and Procedures for Electronic Filing, the attorney hereby granted to practice pro hac vice in this case must register for electronic filing with our court within 10 days of this order, if he/she has not previously done so for a prior case in this District. Registration is managed by the PACER Service Center. Signed by Judge Alan D Albright. (bot1) (Entered: 08/23/2022) (1)
Aug 22, 2022	188	ORDER GRANTING 89 Motion PLAINTIFF RAVGEN INC.S MOTION TO ADOPT THE COURTS PREVIOUS SUPPLEMENTAL CLAIM CONSTRUCTION ORDER Signed by Judge Alan D Albright. (sv) (Entered: 08/22/2022) (1)
Aug 22, 2022	189	MOTION to Appear Pro Hac Vice by Deron R Dacus (on behalf of Savannah Carnes) ( Filing fee $ 100 receipt number ATXWDC-16432119) by on behalf of Ravgen, Inc.. (Attachments: # 1 Proposed Order)(Dacus, Deron) (Entered: 08/22/2022) (Main Document) (3)
Aug 22, 2022	190	NOTICE (Joint Notice Identifying Remaining Objections to Pretrial Disclosures and Disputes On Motions in Limine) by Ravgen, Inc. (Luehrs, Benjamin) (Entered: 08/22/2022) (5)
Aug 22, 2022	191	ORDER RESETTING PRETRIAL CONFERENCE. Pretrial Conference set for 8/31/2022 09:00 AM before Judge Alan D Albright. Signed by Judge Alan D Albright. (sv) (Entered: 08/22/2022) (1)
Aug 22, 2022	189	MOTION to Appear Pro Hac Vice by Deron R Dacus (on behalf of Savannah Carnes) ( Filing fee $ 100 receipt number ATXWDC-16432119) by on behalf of Ravgen, Inc.. (Attachments: # 1 Proposed Order)(Dacus, Deron) (Entered: 08/22/2022) (Proposed Order) (1)
Aug 19, 2022	187	ORDER GRANTING 186 Motion to Appear Pro Hac Vice for Attorney Maria A. Tartakovsky. Attorney added for Ravgen, Inc. Pursuant to our Administrative Policies and Procedures for Electronic Filing, the attorney hereby granted to practice pro hac vice in this case must register for electronic filing with our court within 10 days of this order, if he/she has not previously done so for a prior case in this District. Registration is managed by the PACER Service Center. Signed by Judge Alan D Albright. (bot2) (Entered: 08/19/2022) (1)
Aug 18, 2022	186	MOTION to Appear Pro Hac Vice by Deron R Dacus (on behalf of Maria A. Tartakovsky) ( Filing fee $ 100 receipt number ATXWDC-16420924) by on behalf of Ravgen, Inc.. (Attachments: # 1 Proposed Order)(Dacus, Deron) (Entered: 08/18/2022) (Main Document) (3)
Aug 18, 2022	186	MOTION to Appear Pro Hac Vice by Deron R Dacus (on behalf of Maria A. Tartakovsky) ( Filing fee $ 100 receipt number ATXWDC-16420924) by on behalf of Ravgen, Inc.. (Attachments: # 1 Proposed Order)(Dacus, Deron) (Entered: 08/18/2022) (Proposed Order) (1)
Aug 16, 2022	185	ORDER DENYING 162 Motion to Extend Scheduling Order Deadlines Signed by Judge Alan D Albright. (sv) (Entered: 08/16/2022) (9)
Aug 11, 2022	181	NOTICE of Request for Daily Transcript and Real Time Reporting of Trial Proceedings by Ravgen, Inc. (Limbeek, Kerri-Ann) (Entered: 08/11/2022) (3)
Aug 11, 2022	182	Redacted Public Version of Ravgen's Opposition to LabCorp's Motions In Limine Nos. 1-6 of 177 Sealed Document, by Ravgen, Inc.. (Limbeek, Kerri-Ann) (Entered: 08/11/2022) (21)
Aug 11, 2022	183	NOTICE of Request for Daily Transcript and Real Time Reporting of Trial Proceedings by Laboratory Corporation of America Holdings (Kim, Olivia) (Entered: 08/11/2022) (4)
Aug 11, 2022	184	Redacted Copy Defendant's Opposition to Ravgen, Inc.'s Motions in Limine of 175 Sealed Document, by Laboratory Corporation of America Holdings. (Kim, Olivia) (Entered: 08/11/2022) (27)
Aug 5, 2022	175	Sealed Document: Defendant's Opposition to Ravgen, Inc.'s Motions in Limine of 169 Sealed Motion (Motions In Limine) by Ravgen, Inc. by Laboratory Corporation of America Holdings (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D) (Kim, Olivia) (Entered: 08/05/2022) (0)
Aug 5, 2022	176	SUPPLEMENT to 175 Sealed Document, Defendant's Opposition to Ravgen, Inc.'s Motions in Limine by Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit E)(Kim, Olivia) (Entered: 08/05/2022) (Main Document) (4)
Aug 5, 2022	177	Sealed Document: Ravgen Opposition to LabCorp's Motions in Limine of 170 Sealed Document, by Ravgen, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 4, # 4 Exhibit 5, # 5 Exhibit 6, # 6 Exhibit 7, # 7 Exhibit 9, # 8 Exhibit 10, # 9 Exhibit 11, # 10 Exhibit 12, # 11 Exhibit 13) (Limbeek, Kerri-Ann) (Entered: 08/05/2022) (0)
Aug 5, 2022	178	Redacted Public Version (Declaration of Benjamin N. Luehrs, Exhibits 3, 8, and 14) of 177 Sealed Document, by Ravgen, Inc.. (Attachments: # 1 Exhibit 3, # 2 Exhibit 8, # 3 Exhibit 14)(Limbeek, Kerri-Ann) (Entered: 08/05/2022) (Main Document) (3)
Aug 5, 2022	179	Pretrial Disclosures by Ravgen, Inc.. (Attachments: # 1 Exhibit 1 (Joint Statement of Uncontested Facts), # 2 Exhibit 2 (Ravgen Disputed Issues of Fact and Law), # 3 Exhibit 3 (Labcorp Disputed Issues of Fact and Law), # 4 Exhibit 4 (Filed Under Seal), # 5 Exhibit 5 (Filed Under Seal), # 6 Exhibit 6 (Ravgen Initial Witness List), # 7 Exhibit 7 (Labcorp First Amended Witness List), # 8 Exhibit 8 (Ravgen Depo Designations), # 9 Exhibit 9 (LabCorp Depo Designations), # 10 Exhibit 10 (Ravgen Discovery Designations), # 11 Exhibit 11 (Joint Jury Instructions), # 12 Exhibit 12 (Ravgen Proposed Verdict Form), # 13 Exhibit 13 (Labcorp Proposed Verdict Form), # 14 Exhibit 14 (Joint Proposed Voir Dire), # 15 Exhibit 15 (Filed Under Seal), # 16 Exhibit 16 (Filed Under Seal))(Limbeek, Kerri-Ann) (Entered: 08/05/2022) (Main Document) (30)
Aug 5, 2022	180	Sealed Document: (Exhibits 4, 5, 15, and 16 to Joint Pretrial Order) of 179 Pretrial Disclosures,,, by Ravgen, Inc. (Attachments: # 1 Exhibit 4 (Ravgen First Amended Exhibit List), # 2 Exhibit 5 ( Labcorp Exhibit List), # 3 Exhibit 15 (Ravgen Motions in Limine), # 4 Exhibit 16 (LabCorp Motions in Limine)) (Limbeek, Kerri-Ann) (Entered: 08/05/2022) (0)
Aug 5, 2022	176	SUPPLEMENT to 175 Sealed Document, Defendant's Opposition to Ravgen, Inc.'s Motions in Limine by Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit E)(Kim, Olivia) (Entered: 08/05/2022) (Exhibit E) (30)
Aug 5, 2022	178	Redacted Public Version (Declaration of Benjamin N. Luehrs, Exhibits 3, 8, and 14) of 177 Sealed Document, by Ravgen, Inc.. (Attachments: # 1 Exhibit 3, # 2 Exhibit 8, # 3 Exhibit 14)(Limbeek, Kerri-Ann) (Entered: 08/05/2022) (Exhibit 3) (6)
Aug 5, 2022	178	Redacted Public Version (Declaration of Benjamin N. Luehrs, Exhibits 3, 8, and 14) of 177 Sealed Document, by Ravgen, Inc.. (Attachments: # 1 Exhibit 3, # 2 Exhibit 8, # 3 Exhibit 14)(Limbeek, Kerri-Ann) (Entered: 08/05/2022) (Exhibit 8) (30)
Aug 5, 2022	178	Redacted Public Version (Declaration of Benjamin N. Luehrs, Exhibits 3, 8, and 14) of 177 Sealed Document, by Ravgen, Inc.. (Attachments: # 1 Exhibit 3, # 2 Exhibit 8, # 3 Exhibit 14)(Limbeek, Kerri-Ann) (Entered: 08/05/2022) (Exhibit 14) (3)
Aug 5, 2022	179	Pretrial Disclosures by Ravgen, Inc.. (Attachments: # 1 Exhibit 1 (Joint Statement of Uncontested Facts), # 2 Exhibit 2 (Ravgen Disputed Issues of Fact and Law), # 3 Exhibit 3 (Labcorp Disputed Issues of Fact and Law), # 4 Exhibit 4 (Filed Under Seal), # 5 Exhibit 5 (Filed Under Seal), # 6 Exhibit 6 (Ravgen Initial Witness List), # 7 Exhibit 7 (Labcorp First Amended Witness List), # 8 Exhibit 8 (Ravgen Depo Designations), # 9 Exhibit 9 (LabCorp Depo Designations), # 10 Exhibit 10 (Ravgen Discovery Designations), # 11 Exhibit 11 (Joint Jury Instructions), # 12 Exhibit 12 (Ravgen Proposed Verdict Form), # 13 Exhibit 13 (Labcorp Proposed Verdict Form), # 14 Exhibit 14 (Joint Proposed Voir Dire), # 15 Exhibit 15 (Filed Under Seal), # 16 Exhibit 16 (Filed Under Seal))(Limbeek, Kerri-Ann) (Entered: 08/05/2022) (Exhibit 1 (Joint Statement of Uncontested Facts)) (3)
Aug 5, 2022	179	Pretrial Disclosures by Ravgen, Inc.. (Attachments: # 1 Exhibit 1 (Joint Statement of Uncontested Facts), # 2 Exhibit 2 (Ravgen Disputed Issues of Fact and Law), # 3 Exhibit 3 (Labcorp Disputed Issues of Fact and Law), # 4 Exhibit 4 (Filed Under Seal), # 5 Exhibit 5 (Filed Under Seal), # 6 Exhibit 6 (Ravgen Initial Witness List), # 7 Exhibit 7 (Labcorp First Amended Witness List), # 8 Exhibit 8 (Ravgen Depo Designations), # 9 Exhibit 9 (LabCorp Depo Designations), # 10 Exhibit 10 (Ravgen Discovery Designations), # 11 Exhibit 11 (Joint Jury Instructions), # 12 Exhibit 12 (Ravgen Proposed Verdict Form), # 13 Exhibit 13 (Labcorp Proposed Verdict Form), # 14 Exhibit 14 (Joint Proposed Voir Dire), # 15 Exhibit 15 (Filed Under Seal), # 16 Exhibit 16 (Filed Under Seal))(Limbeek, Kerri-Ann) (Entered: 08/05/2022) (Exhibit 2 (Ravgen Disputed Issues of Fact and Law)) (7)
Aug 5, 2022	179	Pretrial Disclosures by Ravgen, Inc.. (Attachments: # 1 Exhibit 1 (Joint Statement of Uncontested Facts), # 2 Exhibit 2 (Ravgen Disputed Issues of Fact and Law), # 3 Exhibit 3 (Labcorp Disputed Issues of Fact and Law), # 4 Exhibit 4 (Filed Under Seal), # 5 Exhibit 5 (Filed Under Seal), # 6 Exhibit 6 (Ravgen Initial Witness List), # 7 Exhibit 7 (Labcorp First Amended Witness List), # 8 Exhibit 8 (Ravgen Depo Designations), # 9 Exhibit 9 (LabCorp Depo Designations), # 10 Exhibit 10 (Ravgen Discovery Designations), # 11 Exhibit 11 (Joint Jury Instructions), # 12 Exhibit 12 (Ravgen Proposed Verdict Form), # 13 Exhibit 13 (Labcorp Proposed Verdict Form), # 14 Exhibit 14 (Joint Proposed Voir Dire), # 15 Exhibit 15 (Filed Under Seal), # 16 Exhibit 16 (Filed Under Seal))(Limbeek, Kerri-Ann) (Entered: 08/05/2022) (Exhibit 3 (Labcorp Disputed Issues of Fact and Law)) (7)
Aug 5, 2022	179	Pretrial Disclosures by Ravgen, Inc.. (Attachments: # 1 Exhibit 1 (Joint Statement of Uncontested Facts), # 2 Exhibit 2 (Ravgen Disputed Issues of Fact and Law), # 3 Exhibit 3 (Labcorp Disputed Issues of Fact and Law), # 4 Exhibit 4 (Filed Under Seal), # 5 Exhibit 5 (Filed Under Seal), # 6 Exhibit 6 (Ravgen Initial Witness List), # 7 Exhibit 7 (Labcorp First Amended Witness List), # 8 Exhibit 8 (Ravgen Depo Designations), # 9 Exhibit 9 (LabCorp Depo Designations), # 10 Exhibit 10 (Ravgen Discovery Designations), # 11 Exhibit 11 (Joint Jury Instructions), # 12 Exhibit 12 (Ravgen Proposed Verdict Form), # 13 Exhibit 13 (Labcorp Proposed Verdict Form), # 14 Exhibit 14 (Joint Proposed Voir Dire), # 15 Exhibit 15 (Filed Under Seal), # 16 Exhibit 16 (Filed Under Seal))(Limbeek, Kerri-Ann) (Entered: 08/05/2022) (Exhibit 4 (Filed Under Seal)) (1)
Aug 5, 2022	179	Pretrial Disclosures by Ravgen, Inc.. (Attachments: # 1 Exhibit 1 (Joint Statement of Uncontested Facts), # 2 Exhibit 2 (Ravgen Disputed Issues of Fact and Law), # 3 Exhibit 3 (Labcorp Disputed Issues of Fact and Law), # 4 Exhibit 4 (Filed Under Seal), # 5 Exhibit 5 (Filed Under Seal), # 6 Exhibit 6 (Ravgen Initial Witness List), # 7 Exhibit 7 (Labcorp First Amended Witness List), # 8 Exhibit 8 (Ravgen Depo Designations), # 9 Exhibit 9 (LabCorp Depo Designations), # 10 Exhibit 10 (Ravgen Discovery Designations), # 11 Exhibit 11 (Joint Jury Instructions), # 12 Exhibit 12 (Ravgen Proposed Verdict Form), # 13 Exhibit 13 (Labcorp Proposed Verdict Form), # 14 Exhibit 14 (Joint Proposed Voir Dire), # 15 Exhibit 15 (Filed Under Seal), # 16 Exhibit 16 (Filed Under Seal))(Limbeek, Kerri-Ann) (Entered: 08/05/2022) (Exhibit 5 (Filed Under Seal)) (1)
Aug 5, 2022	179	Pretrial Disclosures by Ravgen, Inc.. (Attachments: # 1 Exhibit 1 (Joint Statement of Uncontested Facts), # 2 Exhibit 2 (Ravgen Disputed Issues of Fact and Law), # 3 Exhibit 3 (Labcorp Disputed Issues of Fact and Law), # 4 Exhibit 4 (Filed Under Seal), # 5 Exhibit 5 (Filed Under Seal), # 6 Exhibit 6 (Ravgen Initial Witness List), # 7 Exhibit 7 (Labcorp First Amended Witness List), # 8 Exhibit 8 (Ravgen Depo Designations), # 9 Exhibit 9 (LabCorp Depo Designations), # 10 Exhibit 10 (Ravgen Discovery Designations), # 11 Exhibit 11 (Joint Jury Instructions), # 12 Exhibit 12 (Ravgen Proposed Verdict Form), # 13 Exhibit 13 (Labcorp Proposed Verdict Form), # 14 Exhibit 14 (Joint Proposed Voir Dire), # 15 Exhibit 15 (Filed Under Seal), # 16 Exhibit 16 (Filed Under Seal))(Limbeek, Kerri-Ann) (Entered: 08/05/2022) (Exhibit 6 (Ravgen Initial Witness List)) (6)
Aug 5, 2022	179	Pretrial Disclosures by Ravgen, Inc.. (Attachments: # 1 Exhibit 1 (Joint Statement of Uncontested Facts), # 2 Exhibit 2 (Ravgen Disputed Issues of Fact and Law), # 3 Exhibit 3 (Labcorp Disputed Issues of Fact and Law), # 4 Exhibit 4 (Filed Under Seal), # 5 Exhibit 5 (Filed Under Seal), # 6 Exhibit 6 (Ravgen Initial Witness List), # 7 Exhibit 7 (Labcorp First Amended Witness List), # 8 Exhibit 8 (Ravgen Depo Designations), # 9 Exhibit 9 (LabCorp Depo Designations), # 10 Exhibit 10 (Ravgen Discovery Designations), # 11 Exhibit 11 (Joint Jury Instructions), # 12 Exhibit 12 (Ravgen Proposed Verdict Form), # 13 Exhibit 13 (Labcorp Proposed Verdict Form), # 14 Exhibit 14 (Joint Proposed Voir Dire), # 15 Exhibit 15 (Filed Under Seal), # 16 Exhibit 16 (Filed Under Seal))(Limbeek, Kerri-Ann) (Entered: 08/05/2022) (Exhibit 7 (Labcorp First Amended Witness List)) (6)
Aug 5, 2022	179	Pretrial Disclosures by Ravgen, Inc.. (Attachments: # 1 Exhibit 1 (Joint Statement of Uncontested Facts), # 2 Exhibit 2 (Ravgen Disputed Issues of Fact and Law), # 3 Exhibit 3 (Labcorp Disputed Issues of Fact and Law), # 4 Exhibit 4 (Filed Under Seal), # 5 Exhibit 5 (Filed Under Seal), # 6 Exhibit 6 (Ravgen Initial Witness List), # 7 Exhibit 7 (Labcorp First Amended Witness List), # 8 Exhibit 8 (Ravgen Depo Designations), # 9 Exhibit 9 (LabCorp Depo Designations), # 10 Exhibit 10 (Ravgen Discovery Designations), # 11 Exhibit 11 (Joint Jury Instructions), # 12 Exhibit 12 (Ravgen Proposed Verdict Form), # 13 Exhibit 13 (Labcorp Proposed Verdict Form), # 14 Exhibit 14 (Joint Proposed Voir Dire), # 15 Exhibit 15 (Filed Under Seal), # 16 Exhibit 16 (Filed Under Seal))(Limbeek, Kerri-Ann) (Entered: 08/05/2022) (Exhibit 8 (Ravgen Depo Designations)) (30)
Aug 5, 2022	179	Pretrial Disclosures by Ravgen, Inc.. (Attachments: # 1 Exhibit 1 (Joint Statement of Uncontested Facts), # 2 Exhibit 2 (Ravgen Disputed Issues of Fact and Law), # 3 Exhibit 3 (Labcorp Disputed Issues of Fact and Law), # 4 Exhibit 4 (Filed Under Seal), # 5 Exhibit 5 (Filed Under Seal), # 6 Exhibit 6 (Ravgen Initial Witness List), # 7 Exhibit 7 (Labcorp First Amended Witness List), # 8 Exhibit 8 (Ravgen Depo Designations), # 9 Exhibit 9 (LabCorp Depo Designations), # 10 Exhibit 10 (Ravgen Discovery Designations), # 11 Exhibit 11 (Joint Jury Instructions), # 12 Exhibit 12 (Ravgen Proposed Verdict Form), # 13 Exhibit 13 (Labcorp Proposed Verdict Form), # 14 Exhibit 14 (Joint Proposed Voir Dire), # 15 Exhibit 15 (Filed Under Seal), # 16 Exhibit 16 (Filed Under Seal))(Limbeek, Kerri-Ann) (Entered: 08/05/2022) (Exhibit 9 (LabCorp Depo Designations)) (30)
Aug 5, 2022	179	Pretrial Disclosures by Ravgen, Inc.. (Attachments: # 1 Exhibit 1 (Joint Statement of Uncontested Facts), # 2 Exhibit 2 (Ravgen Disputed Issues of Fact and Law), # 3 Exhibit 3 (Labcorp Disputed Issues of Fact and Law), # 4 Exhibit 4 (Filed Under Seal), # 5 Exhibit 5 (Filed Under Seal), # 6 Exhibit 6 (Ravgen Initial Witness List), # 7 Exhibit 7 (Labcorp First Amended Witness List), # 8 Exhibit 8 (Ravgen Depo Designations), # 9 Exhibit 9 (LabCorp Depo Designations), # 10 Exhibit 10 (Ravgen Discovery Designations), # 11 Exhibit 11 (Joint Jury Instructions), # 12 Exhibit 12 (Ravgen Proposed Verdict Form), # 13 Exhibit 13 (Labcorp Proposed Verdict Form), # 14 Exhibit 14 (Joint Proposed Voir Dire), # 15 Exhibit 15 (Filed Under Seal), # 16 Exhibit 16 (Filed Under Seal))(Limbeek, Kerri-Ann) (Entered: 08/05/2022) (Exhibit 10 (Ravgen Discovery Designations)) (7)
Aug 5, 2022	179	Pretrial Disclosures by Ravgen, Inc.. (Attachments: # 1 Exhibit 1 (Joint Statement of Uncontested Facts), # 2 Exhibit 2 (Ravgen Disputed Issues of Fact and Law), # 3 Exhibit 3 (Labcorp Disputed Issues of Fact and Law), # 4 Exhibit 4 (Filed Under Seal), # 5 Exhibit 5 (Filed Under Seal), # 6 Exhibit 6 (Ravgen Initial Witness List), # 7 Exhibit 7 (Labcorp First Amended Witness List), # 8 Exhibit 8 (Ravgen Depo Designations), # 9 Exhibit 9 (LabCorp Depo Designations), # 10 Exhibit 10 (Ravgen Discovery Designations), # 11 Exhibit 11 (Joint Jury Instructions), # 12 Exhibit 12 (Ravgen Proposed Verdict Form), # 13 Exhibit 13 (Labcorp Proposed Verdict Form), # 14 Exhibit 14 (Joint Proposed Voir Dire), # 15 Exhibit 15 (Filed Under Seal), # 16 Exhibit 16 (Filed Under Seal))(Limbeek, Kerri-Ann) (Entered: 08/05/2022) (Exhibit 11 (Joint Jury Instructions)) (30)
Aug 5, 2022	179	Pretrial Disclosures by Ravgen, Inc.. (Attachments: # 1 Exhibit 1 (Joint Statement of Uncontested Facts), # 2 Exhibit 2 (Ravgen Disputed Issues of Fact and Law), # 3 Exhibit 3 (Labcorp Disputed Issues of Fact and Law), # 4 Exhibit 4 (Filed Under Seal), # 5 Exhibit 5 (Filed Under Seal), # 6 Exhibit 6 (Ravgen Initial Witness List), # 7 Exhibit 7 (Labcorp First Amended Witness List), # 8 Exhibit 8 (Ravgen Depo Designations), # 9 Exhibit 9 (LabCorp Depo Designations), # 10 Exhibit 10 (Ravgen Discovery Designations), # 11 Exhibit 11 (Joint Jury Instructions), # 12 Exhibit 12 (Ravgen Proposed Verdict Form), # 13 Exhibit 13 (Labcorp Proposed Verdict Form), # 14 Exhibit 14 (Joint Proposed Voir Dire), # 15 Exhibit 15 (Filed Under Seal), # 16 Exhibit 16 (Filed Under Seal))(Limbeek, Kerri-Ann) (Entered: 08/05/2022) (Exhibit 12 (Ravgen Proposed Verdict Form)) (8)
Aug 5, 2022	179	Pretrial Disclosures by Ravgen, Inc.. (Attachments: # 1 Exhibit 1 (Joint Statement of Uncontested Facts), # 2 Exhibit 2 (Ravgen Disputed Issues of Fact and Law), # 3 Exhibit 3 (Labcorp Disputed Issues of Fact and Law), # 4 Exhibit 4 (Filed Under Seal), # 5 Exhibit 5 (Filed Under Seal), # 6 Exhibit 6 (Ravgen Initial Witness List), # 7 Exhibit 7 (Labcorp First Amended Witness List), # 8 Exhibit 8 (Ravgen Depo Designations), # 9 Exhibit 9 (LabCorp Depo Designations), # 10 Exhibit 10 (Ravgen Discovery Designations), # 11 Exhibit 11 (Joint Jury Instructions), # 12 Exhibit 12 (Ravgen Proposed Verdict Form), # 13 Exhibit 13 (Labcorp Proposed Verdict Form), # 14 Exhibit 14 (Joint Proposed Voir Dire), # 15 Exhibit 15 (Filed Under Seal), # 16 Exhibit 16 (Filed Under Seal))(Limbeek, Kerri-Ann) (Entered: 08/05/2022) (Exhibit 13 (Labcorp Proposed Verdict Form)) (11)
Aug 5, 2022	179	Pretrial Disclosures by Ravgen, Inc.. (Attachments: # 1 Exhibit 1 (Joint Statement of Uncontested Facts), # 2 Exhibit 2 (Ravgen Disputed Issues of Fact and Law), # 3 Exhibit 3 (Labcorp Disputed Issues of Fact and Law), # 4 Exhibit 4 (Filed Under Seal), # 5 Exhibit 5 (Filed Under Seal), # 6 Exhibit 6 (Ravgen Initial Witness List), # 7 Exhibit 7 (Labcorp First Amended Witness List), # 8 Exhibit 8 (Ravgen Depo Designations), # 9 Exhibit 9 (LabCorp Depo Designations), # 10 Exhibit 10 (Ravgen Discovery Designations), # 11 Exhibit 11 (Joint Jury Instructions), # 12 Exhibit 12 (Ravgen Proposed Verdict Form), # 13 Exhibit 13 (Labcorp Proposed Verdict Form), # 14 Exhibit 14 (Joint Proposed Voir Dire), # 15 Exhibit 15 (Filed Under Seal), # 16 Exhibit 16 (Filed Under Seal))(Limbeek, Kerri-Ann) (Entered: 08/05/2022) (Exhibit 14 (Joint Proposed Voir Dire)) (8)
Aug 5, 2022	179	Pretrial Disclosures by Ravgen, Inc.. (Attachments: # 1 Exhibit 1 (Joint Statement of Uncontested Facts), # 2 Exhibit 2 (Ravgen Disputed Issues of Fact and Law), # 3 Exhibit 3 (Labcorp Disputed Issues of Fact and Law), # 4 Exhibit 4 (Filed Under Seal), # 5 Exhibit 5 (Filed Under Seal), # 6 Exhibit 6 (Ravgen Initial Witness List), # 7 Exhibit 7 (Labcorp First Amended Witness List), # 8 Exhibit 8 (Ravgen Depo Designations), # 9 Exhibit 9 (LabCorp Depo Designations), # 10 Exhibit 10 (Ravgen Discovery Designations), # 11 Exhibit 11 (Joint Jury Instructions), # 12 Exhibit 12 (Ravgen Proposed Verdict Form), # 13 Exhibit 13 (Labcorp Proposed Verdict Form), # 14 Exhibit 14 (Joint Proposed Voir Dire), # 15 Exhibit 15 (Filed Under Seal), # 16 Exhibit 16 (Filed Under Seal))(Limbeek, Kerri-Ann) (Entered: 08/05/2022) (Exhibit 15 (Filed Under Seal)) (1)
Aug 5, 2022	179	Pretrial Disclosures by Ravgen, Inc.. (Attachments: # 1 Exhibit 1 (Joint Statement of Uncontested Facts), # 2 Exhibit 2 (Ravgen Disputed Issues of Fact and Law), # 3 Exhibit 3 (Labcorp Disputed Issues of Fact and Law), # 4 Exhibit 4 (Filed Under Seal), # 5 Exhibit 5 (Filed Under Seal), # 6 Exhibit 6 (Ravgen Initial Witness List), # 7 Exhibit 7 (Labcorp First Amended Witness List), # 8 Exhibit 8 (Ravgen Depo Designations), # 9 Exhibit 9 (LabCorp Depo Designations), # 10 Exhibit 10 (Ravgen Discovery Designations), # 11 Exhibit 11 (Joint Jury Instructions), # 12 Exhibit 12 (Ravgen Proposed Verdict Form), # 13 Exhibit 13 (Labcorp Proposed Verdict Form), # 14 Exhibit 14 (Joint Proposed Voir Dire), # 15 Exhibit 15 (Filed Under Seal), # 16 Exhibit 16 (Filed Under Seal))(Limbeek, Kerri-Ann) (Entered: 08/05/2022) (Exhibit 16 (Filed Under Seal)) (1)
Aug 4, 2022	173	Redacted Public Version Defendant's Motions in Limine of 170 Sealed Document, by Laboratory Corporation of America Holdings. (Kim, Olivia) (Entered: 08/04/2022) (21)
Aug 4, 2022	174	Redacted Public Version of 169 Sealed Motion (Motions In Limine) by Ravgen, Inc. by Ravgen, Inc.. (Limbeek, Kerri-Ann) (Entered: 08/04/2022) (27)
Jul 28, 2022	164	MOTION to Appear Pro Hac Vice by Deron R Dacus (On behalf of Julianne M. Thomsen) ( Filing fee $ 100 receipt number 0542-16314409) by on behalf of Ravgen, Inc.. (Attachments: # 1 Proposed Order)(Dacus, Deron) (Entered: 07/28/2022) (Main Document) (3)
Jul 28, 2022	165	ORDER GRANTING 164 Motion to Appear Pro Hac Vice for Attorney Julianne M. Thomsen. Attorney added for Ravgen, Inc. Pursuant to our Administrative Policies and Procedures for Electronic Filing, the attorney hereby granted to practice pro hac vice in this case must register for electronic filing with our court within 10 days of this order, if he/she has not previously done so for a prior case in this District. Signed by Judge Alan D Albright. (bot2) (Entered: 07/28/2022) (1)
Jul 28, 2022	166	Redacted Public Version (Ravgen's Reply Brief In Support of Its Motion to Strike and Exclude LabCorp's Fed. R. Civ. P. 26(a)(2)(C) Disclosure) of 158 Sealed Document by Ravgen, Inc.. (Limbeek, Kerri-Ann) (Entered: 07/28/2022) (16)
Jul 28, 2022	167	Redacted Public Version (Ravgen's Reply In Support of Its Motion to Exclude, In Part, the Expert Opinion of Dr. Stephen D. Prowse) of 161 Sealed Document by Ravgen, Inc.. (Limbeek, Kerri-Ann) (Entered: 07/28/2022) (17)
Jul 28, 2022	168	Redacted Public Version Reply in Support of 110 Motion for Summary Judgment of Invalidity Under Indefiniteness, or in the Alternative, Non-Infringement of 155 Sealed Document by Laboratory Corporation of America Holdings. (Kim, Olivia) (Entered: 07/28/2022) (16)
Jul 28, 2022	169	Sealed Motion (Motions In Limine) by Ravgen, Inc. (Attachments: # 1 Proposed Order, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 11, # 10 Exhibit 12, # 11 Exhibit 13, # 12 Exhibit 14, # 13 Exhibit 15, # 14 Exhibit 18, # 15 Exhibit 19, # 16 Exhibit 20, # 17 Exhibit 21, # 18 Exhibit 22, # 19 Exhibit 23, # 20 Exhibit 24) (Limbeek, Kerri-Ann) (Entered: 07/28/2022) (0)
Jul 28, 2022	170	Sealed Document: Defendant's Motions in Limine by Laboratory Corporation of America Holdings (Attachments: # 1 Exhibit D, # 2 Exhibit E, # 3 Exhibit F, # 4 Exhibit G, # 5 Exhibit H, # 6 Exhibit I, # 7 Exhibit J) (Kim, Olivia) (Entered: 07/28/2022) (0)
Jul 28, 2022	171	Redacted Public Version (Declaration of Benjamin N. Luehrs, Exhibits 3, 9-10, 16, 17, 25-27) of 169 Sealed Motion (Motions In Limine) by Ravgen, Inc. by Ravgen, Inc.. (Attachments: # 1 Exhibit 3, # 2 Exhibit 9, # 3 Exhibit 10, # 4 Exhibit 16, # 5 Exhibit 17, # 6 Exhibit 25, # 7 Exhibit 26, # 8 Exhibit 27)(Limbeek, Kerri-Ann) (Entered: 07/28/2022) (Main Document) (5)
Jul 28, 2022	172	SUPPLEMENT to 170 Sealed Document, Defendant's Motions in Limine by Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Proposed Order)(Kim, Olivia) (Entered: 07/28/2022) (Main Document) (4)
Jul 28, 2022	171	Redacted Public Version (Declaration of Benjamin N. Luehrs, Exhibits 3, 9-10, 16, 17, 25-27) of 169 Sealed Motion (Motions In Limine) by Ravgen, Inc. by Ravgen, Inc.. (Attachments: # 1 Exhibit 3, # 2 Exhibit 9, # 3 Exhibit 10, # 4 Exhibit 16, # 5 Exhibit 17, # 6 Exhibit 25, # 7 Exhibit 26, # 8 Exhibit 27)(Limbeek, Kerri-Ann) (Entered: 07/28/2022) (Exhibit 3) (18)
Jul 28, 2022	171	Redacted Public Version (Declaration of Benjamin N. Luehrs, Exhibits 3, 9-10, 16, 17, 25-27) of 169 Sealed Motion (Motions In Limine) by Ravgen, Inc. by Ravgen, Inc.. (Attachments: # 1 Exhibit 3, # 2 Exhibit 9, # 3 Exhibit 10, # 4 Exhibit 16, # 5 Exhibit 17, # 6 Exhibit 25, # 7 Exhibit 26, # 8 Exhibit 27)(Limbeek, Kerri-Ann) (Entered: 07/28/2022) (Exhibit 9) (21)
Jul 28, 2022	171	Redacted Public Version (Declaration of Benjamin N. Luehrs, Exhibits 3, 9-10, 16, 17, 25-27) of 169 Sealed Motion (Motions In Limine) by Ravgen, Inc. by Ravgen, Inc.. (Attachments: # 1 Exhibit 3, # 2 Exhibit 9, # 3 Exhibit 10, # 4 Exhibit 16, # 5 Exhibit 17, # 6 Exhibit 25, # 7 Exhibit 26, # 8 Exhibit 27)(Limbeek, Kerri-Ann) (Entered: 07/28/2022) (Exhibit 10) (30)
Jul 28, 2022	171	Redacted Public Version (Declaration of Benjamin N. Luehrs, Exhibits 3, 9-10, 16, 17, 25-27) of 169 Sealed Motion (Motions In Limine) by Ravgen, Inc. by Ravgen, Inc.. (Attachments: # 1 Exhibit 3, # 2 Exhibit 9, # 3 Exhibit 10, # 4 Exhibit 16, # 5 Exhibit 17, # 6 Exhibit 25, # 7 Exhibit 26, # 8 Exhibit 27)(Limbeek, Kerri-Ann) (Entered: 07/28/2022) (Exhibit 16) (2)
Jul 28, 2022	171	Redacted Public Version (Declaration of Benjamin N. Luehrs, Exhibits 3, 9-10, 16, 17, 25-27) of 169 Sealed Motion (Motions In Limine) by Ravgen, Inc. by Ravgen, Inc.. (Attachments: # 1 Exhibit 3, # 2 Exhibit 9, # 3 Exhibit 10, # 4 Exhibit 16, # 5 Exhibit 17, # 6 Exhibit 25, # 7 Exhibit 26, # 8 Exhibit 27)(Limbeek, Kerri-Ann) (Entered: 07/28/2022) (Exhibit 17) (4)
Jul 28, 2022	171	Redacted Public Version (Declaration of Benjamin N. Luehrs, Exhibits 3, 9-10, 16, 17, 25-27) of 169 Sealed Motion (Motions In Limine) by Ravgen, Inc. by Ravgen, Inc.. (Attachments: # 1 Exhibit 3, # 2 Exhibit 9, # 3 Exhibit 10, # 4 Exhibit 16, # 5 Exhibit 17, # 6 Exhibit 25, # 7 Exhibit 26, # 8 Exhibit 27)(Limbeek, Kerri-Ann) (Entered: 07/28/2022) (Exhibit 25) (6)
Jul 28, 2022	171	Redacted Public Version (Declaration of Benjamin N. Luehrs, Exhibits 3, 9-10, 16, 17, 25-27) of 169 Sealed Motion (Motions In Limine) by Ravgen, Inc. by Ravgen, Inc.. (Attachments: # 1 Exhibit 3, # 2 Exhibit 9, # 3 Exhibit 10, # 4 Exhibit 16, # 5 Exhibit 17, # 6 Exhibit 25, # 7 Exhibit 26, # 8 Exhibit 27)(Limbeek, Kerri-Ann) (Entered: 07/28/2022) (Exhibit 26) (30)
Jul 28, 2022	171	Redacted Public Version (Declaration of Benjamin N. Luehrs, Exhibits 3, 9-10, 16, 17, 25-27) of 169 Sealed Motion (Motions In Limine) by Ravgen, Inc. by Ravgen, Inc.. (Attachments: # 1 Exhibit 3, # 2 Exhibit 9, # 3 Exhibit 10, # 4 Exhibit 16, # 5 Exhibit 17, # 6 Exhibit 25, # 7 Exhibit 26, # 8 Exhibit 27)(Limbeek, Kerri-Ann) (Entered: 07/28/2022) (Exhibit 27) (30)
Jul 28, 2022	164	MOTION to Appear Pro Hac Vice by Deron R Dacus (On behalf of Julianne M. Thomsen) ( Filing fee $ 100 receipt number 0542-16314409) by on behalf of Ravgen, Inc.. (Attachments: # 1 Proposed Order)(Dacus, Deron) (Entered: 07/28/2022) (Proposed Order) (1)
Jul 28, 2022	172	SUPPLEMENT to 170 Sealed Document, Defendant's Motions in Limine by Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Proposed Order)(Kim, Olivia) (Entered: 07/28/2022) (Exhibit A) (6)
Jul 28, 2022	172	SUPPLEMENT to 170 Sealed Document, Defendant's Motions in Limine by Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Proposed Order)(Kim, Olivia) (Entered: 07/28/2022) (Exhibit B) (4)
Jul 28, 2022	172	SUPPLEMENT to 170 Sealed Document, Defendant's Motions in Limine by Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Proposed Order)(Kim, Olivia) (Entered: 07/28/2022) (Exhibit C) (6)
Jul 28, 2022	172	SUPPLEMENT to 170 Sealed Document, Defendant's Motions in Limine by Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Proposed Order)(Kim, Olivia) (Entered: 07/28/2022) (Proposed Order) (2)
Jul 27, 2022	163	Response in Opposition to Motion, filed by Ravgen, Inc., re 162 MOTION to Extend Scheduling Order Deadlines Opposed Motion to Extend the Trial Date filed by Defendant Laboratory Corporation of America Holdings (Attachments: # 1 Declaration of Benjamin N. Luehrs, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10)(Limbeek, Kerri-Ann) (Entered: 07/27/2022) (Main Document) (16)
Jul 27, 2022	163	Response in Opposition to Motion, filed by Ravgen, Inc., re 162 MOTION to Extend Scheduling Order Deadlines Opposed Motion to Extend the Trial Date filed by Defendant Laboratory Corporation of America Holdings (Attachments: # 1 Declaration of Benjamin N. Luehrs, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10)(Limbeek, Kerri-Ann) (Entered: 07/27/2022) (Declaration of Benjamin N. Luehrs) (3)
Jul 27, 2022	163	Response in Opposition to Motion, filed by Ravgen, Inc., re 162 MOTION to Extend Scheduling Order Deadlines Opposed Motion to Extend the Trial Date filed by Defendant Laboratory Corporation of America Holdings (Attachments: # 1 Declaration of Benjamin N. Luehrs, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10)(Limbeek, Kerri-Ann) (Entered: 07/27/2022) (Exhibit 1) (2)
Jul 27, 2022	163	Response in Opposition to Motion, filed by Ravgen, Inc., re 162 MOTION to Extend Scheduling Order Deadlines Opposed Motion to Extend the Trial Date filed by Defendant Laboratory Corporation of America Holdings (Attachments: # 1 Declaration of Benjamin N. Luehrs, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10)(Limbeek, Kerri-Ann) (Entered: 07/27/2022) (Exhibit 2) (2)
Jul 27, 2022	163	Response in Opposition to Motion, filed by Ravgen, Inc., re 162 MOTION to Extend Scheduling Order Deadlines Opposed Motion to Extend the Trial Date filed by Defendant Laboratory Corporation of America Holdings (Attachments: # 1 Declaration of Benjamin N. Luehrs, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10)(Limbeek, Kerri-Ann) (Entered: 07/27/2022) (Exhibit 3) (5)
Jul 27, 2022	163	Response in Opposition to Motion, filed by Ravgen, Inc., re 162 MOTION to Extend Scheduling Order Deadlines Opposed Motion to Extend the Trial Date filed by Defendant Laboratory Corporation of America Holdings (Attachments: # 1 Declaration of Benjamin N. Luehrs, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10)(Limbeek, Kerri-Ann) (Entered: 07/27/2022) (Exhibit 4) (19)
Jul 27, 2022	163	Response in Opposition to Motion, filed by Ravgen, Inc., re 162 MOTION to Extend Scheduling Order Deadlines Opposed Motion to Extend the Trial Date filed by Defendant Laboratory Corporation of America Holdings (Attachments: # 1 Declaration of Benjamin N. Luehrs, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10)(Limbeek, Kerri-Ann) (Entered: 07/27/2022) (Exhibit 5) (30)
Jul 27, 2022	163	Response in Opposition to Motion, filed by Ravgen, Inc., re 162 MOTION to Extend Scheduling Order Deadlines Opposed Motion to Extend the Trial Date filed by Defendant Laboratory Corporation of America Holdings (Attachments: # 1 Declaration of Benjamin N. Luehrs, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10)(Limbeek, Kerri-Ann) (Entered: 07/27/2022) (Exhibit 6) (30)
Jul 27, 2022	163	Response in Opposition to Motion, filed by Ravgen, Inc., re 162 MOTION to Extend Scheduling Order Deadlines Opposed Motion to Extend the Trial Date filed by Defendant Laboratory Corporation of America Holdings (Attachments: # 1 Declaration of Benjamin N. Luehrs, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10)(Limbeek, Kerri-Ann) (Entered: 07/27/2022) (Exhibit 7) (8)
Jul 27, 2022	163	Response in Opposition to Motion, filed by Ravgen, Inc., re 162 MOTION to Extend Scheduling Order Deadlines Opposed Motion to Extend the Trial Date filed by Defendant Laboratory Corporation of America Holdings (Attachments: # 1 Declaration of Benjamin N. Luehrs, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10)(Limbeek, Kerri-Ann) (Entered: 07/27/2022) (Exhibit 8) (5)
Jul 27, 2022	163	Response in Opposition to Motion, filed by Ravgen, Inc., re 162 MOTION to Extend Scheduling Order Deadlines Opposed Motion to Extend the Trial Date filed by Defendant Laboratory Corporation of America Holdings (Attachments: # 1 Declaration of Benjamin N. Luehrs, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10)(Limbeek, Kerri-Ann) (Entered: 07/27/2022) (Exhibit 9) (30)
Jul 27, 2022	163	Response in Opposition to Motion, filed by Ravgen, Inc., re 162 MOTION to Extend Scheduling Order Deadlines Opposed Motion to Extend the Trial Date filed by Defendant Laboratory Corporation of America Holdings (Attachments: # 1 Declaration of Benjamin N. Luehrs, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10)(Limbeek, Kerri-Ann) (Entered: 07/27/2022) (Exhibit 10) (6)
Jul 22, 2022	162	MOTION to Extend Scheduling Order Deadlines Opposed Motion to Extend the Trial Date by Laboratory Corporation of America Holdings. (Attachments: # 1 Proposed Order)(Kim, Olivia) (Entered: 07/22/2022) (Main Document) (6)
Jul 22, 2022	162	MOTION to Extend Scheduling Order Deadlines Opposed Motion to Extend the Trial Date by Laboratory Corporation of America Holdings. (Attachments: # 1 Proposed Order)(Kim, Olivia) (Entered: 07/22/2022) (Proposed Order) (1)
Jul 21, 2022	148	Redacted Public Version Plaintiff's Opposition to Defendant's Motion for Summary Judgement of Invalidity Under Indefiniteness, Or in the Alternative, Non-Infringement of 145 Sealed Document,, by Ravgen, Inc.. (Limbeek, Kerri-Ann) (Entered: 07/21/2022) (29)
Jul 21, 2022	149	Redacted Public Version Opposition of Motion for Summary Judgment of No Anticipation By Lee, Holodniy, and Landes of 138 Sealed Document, by Laboratory Corporation of America Holdings. (Kim, Olivia) (Entered: 07/21/2022) (28)
Jul 21, 2022	150	Redacted Public Version Opposition of Motion to Exclude and Preclude Certain Expert Testimony of Drs. Paul T. Spellman and Larry J. Dumont of 140 Sealed Document, by Laboratory Corporation of America Holdings. (Kim, Olivia) (Entered: 07/21/2022) (21)
Jul 21, 2022	151	Redacted Public Version Opposition of Motion to Strike and Exclude LabCorp's Fed. R. Civ. P. 26(A)(2)(C) Disclosure of 141 Sealed Document, by Laboratory Corporation of America Holdings. (Kim, Olivia) (Entered: 07/21/2022) (18)
Jul 21, 2022	152	Redacted Public Version Opposition of Motion to Exclude, In Part, the Expert Opinion of Dr. Stephen D. Prowse of 142 Sealed Document by Laboratory Corporation of America Holdings. (Kim, Olivia) (Entered: 07/21/2022) (20)
Jul 21, 2022	153	Redacted Public Version Reply in Support of 111 MOTION to Exclude Certain infringement Opinions of Dr. Brian Van Ness of 143 Sealed Document by Laboratory Corporation of America Holdings. (Kim, Olivia) (Entered: 07/21/2022) (16)
Jul 21, 2022	154	Redacted Public Version Reply in Support of 113 MOTION to Exclude Opinions of Paul K. Meyer of 144 Sealed Document by Laboratory Corporation of America Holdings. (Kim, Olivia) (Entered: 07/21/2022) (17)
Jul 21, 2022	155	Sealed Document: Reply in Support of 110 Motion for Summary Judgment of Invalidity Under Indefiniteness, or in the Alternative, Non-Infringement by Laboratory Corporation of America Holdings (Kim, Olivia) (Entered: 07/21/2022) (0)
Jul 21, 2022	156	Sealed Document: Reply In Support of 117 Sealed Motion for Summary Judgment of No Anticipation By Lee, Holodniy, and Landes by Ravgen, Inc. by Ravgen, Inc. (Attachments: # 1 Exhibit 27, # 2 Exhibit 28, # 3 Exhibit 29) (Limbeek, Kerri-Ann) (Entered: 07/21/2022) (0)
Jul 21, 2022	157	Redacted Public Version (Declaration of Benjamin N. Luehrs and Exhibit 30) of 156 Sealed Document, by Ravgen, Inc.. (Attachments: # 1 Exhibit 30)(Limbeek, Kerri-Ann) (Entered: 07/21/2022) (Main Document) (2)
Jul 21, 2022	158	Sealed Document: Reply In Support of 122 Sealed Motion to Strike and Exclude LabCorp's Fed. R. Civ. P. 26(A)(2)(C) Disclosure by Ravgen, Inc. by Ravgen, Inc. (Attachments: # 1 Exhibit 11) (Limbeek, Kerri-Ann) (Entered: 07/21/2022) (0)
Jul 21, 2022	159	Sealed Document: Reply In Support of 120 Sealed Motion to Exclude and Preclude Certain Expert Testimony of Drs. Paul T. Spellman and Larry J. Dumont by Ravgen, Inc. by Ravgen, Inc. (Attachments: # 1 Exhibit 12, # 2 Exhibit 13, # 3 Exhibit 14, # 4 Exhibit 15) (Limbeek, Kerri-Ann) (Entered: 07/21/2022) (0)
Jul 21, 2022	160	Redacted Public Version (Exhibits 16 and 17) of 159 Sealed Document, by Ravgen, Inc.. (Attachments: # 1 Exhibit 16, # 2 Exhibit 17)(Limbeek, Kerri-Ann) (Entered: 07/21/2022) (Main Document) (1)
Jul 21, 2022	161	Sealed Document: Reply In Support of 123 Sealed Motion to Exclude, In Part, the Expert Opinion of Dr. Stephen D. Prowse by Ravgen, Inc. by Ravgen, Inc. (Limbeek, Kerri-Ann) (Entered: 07/21/2022) (0)
Jul 21, 2022	160	Redacted Public Version (Exhibits 16 and 17) of 159 Sealed Document, by Ravgen, Inc.. (Attachments: # 1 Exhibit 16, # 2 Exhibit 17)(Limbeek, Kerri-Ann) (Entered: 07/21/2022) (Exhibit 16) (11)
Jul 21, 2022	160	Redacted Public Version (Exhibits 16 and 17) of 159 Sealed Document, by Ravgen, Inc.. (Attachments: # 1 Exhibit 16, # 2 Exhibit 17)(Limbeek, Kerri-Ann) (Entered: 07/21/2022) (Exhibit 17) (10)
Jul 21, 2022	157	Redacted Public Version (Declaration of Benjamin N. Luehrs and Exhibit 30) of 156 Sealed Document, by Ravgen, Inc.. (Attachments: # 1 Exhibit 30)(Limbeek, Kerri-Ann) (Entered: 07/21/2022) (Exhibit 30) (2)
Jul 18, 2022	147	Transcript filed of Proceedings held on 6-21-22, Proceedings Transcribed: Discovery Hearing (Zoom). Court Reporter/Transcriber: Kristie Davis (kmdaviscsr@yahoo.com), Telephone number: 254-340-6114. (kd) (Entered: 07/18/2022) (12)
Jul 14, 2022	136	Redacted Public Version Response to Defendant's Motion to Exclude Certain Infringement Opinions of Dr. Brian Van Ness of 132 Sealed Document, by Ravgen, Inc.. (Luehrs, Benjamin) (Entered: 07/14/2022) (17)
Jul 14, 2022	137	Redacted Public Version Opposition of Motion to Exclude Opinions of Paul K. Meyer of 133 Sealed Document by Ravgen, Inc.. (Limbeek, Kerri-Ann) (Entered: 07/14/2022) (23)
Jul 14, 2022	138	Sealed Document: Defendant's Labcorp's Opposition of 117 Sealed Motion for Summary Judgment of No Anticipation By Lee, Holodniy, and Landes by Ravgen, Inc. by Laboratory Corporation of America Holdings (Kim, Olivia) (Entered: 07/14/2022) (0)
Jul 14, 2022	139	SUPPLEMENT to 138 Sealed Document, Exhibits A-B to Labcorp's Opposition of 117 Sealed Motion for Summary Judgment of No Anticipation By Lee, Holodniy, and Landes by Ravgen, Inc. by Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Kim, Olivia) (Entered: 07/14/2022) (Main Document) (4)
Jul 14, 2022	140	Sealed Document: Defendant's Labcorp's Opposition of 120 Sealed Motion to Exclude and Preclude Certain Expert Testimony of Drs. Paul T. Spellman and Larry J. Dumont by Ravgen, Inc. by Laboratory Corporation of America Holdings (Attachments: # 1 Exhibit A, # 2 Exhibit B) (Kim, Olivia) (Entered: 07/14/2022) (0)
Jul 14, 2022	141	Sealed Document: Defendant Labcorp's Opposition of 122 Sealed Motion to Strike and Exclude LabCorp's Fed. R. Civ. P. 26(A)(2)(C) Disclosure by Ravgen, Inc. by Laboratory Corporation of America Holdings (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C) (Kim, Olivia) (Entered: 07/14/2022) (0)
Jul 14, 2022	142	Sealed Document: Defendant Labcorp's Opposition of 123 Sealed Motion to Exclude, In Part, the Expert Opinion of Dr. Stephen D. Prowse by Ravgen, Inc. by Laboratory Corporation of America Holdings (Kim, Olivia) (Entered: 07/14/2022) (0)
Jul 14, 2022	143	Sealed Document: Defendant Labcorp's Reply in Support of 111 MOTION to Exclude Certain infringement Opinions of Dr. Brian Van Ness by Laboratory Corporation of America Holdings (Kim, Olivia) (Entered: 07/14/2022) (0)
Jul 14, 2022	144	Sealed Document: Defendant Labcorp's Reply in Support of 113 MOTION to Exclude Opinions of Paul K. Meyer by Laboratory Corporation of America Holdings (Attachments: # 1 Exhibit A) (Kim, Olivia) (Entered: 07/14/2022) (0)
Jul 14, 2022	145	Sealed Document: Opposition to Defendant's Motion for Summary Judgement of Invalidity Under Indefiniteness, Or in the Alternative, Non-Infringement of 110 Sealed Document by Ravgen, Inc. (Attachments: # 1 Declaration of Glenn D. Prestwich, Ph.D., # 2 Declaration of Brian G. Van Ness, Ph.D., # 3 Exhibit 17, # 4 Exhibit 18, # 5 Exhibit 20, # 6 Exhibit 21, # 7 Exhibit 22, # 8 Exhibit 23, # 9 Exhibit 24, # 10 Exhibit 25, # 11 Exhibit 26, # 12 Exhibit 28) (Limbeek, Kerri-Ann) (Entered: 07/14/2022) (0)
Jul 14, 2022	146	Redacted Public Version (Declaration of Benjamin N. Luehrs, Exhibits 1-16, 19, 27, 29-31 of 145 Sealed Document,, by Ravgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 19, # 18 Exhibit 27, # 19 Exhibit 29, # 20 Exhibit 30, # 21 Exhibit 31)(Limbeek, Kerri-Ann) (Entered: 07/14/2022) (Main Document) (5)
Jul 14, 2022	139	SUPPLEMENT to 138 Sealed Document, Exhibits A-B to Labcorp's Opposition of 117 Sealed Motion for Summary Judgment of No Anticipation By Lee, Holodniy, and Landes by Ravgen, Inc. by Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Kim, Olivia) (Entered: 07/14/2022) (Exhibit A) (7)
Jul 14, 2022	139	SUPPLEMENT to 138 Sealed Document, Exhibits A-B to Labcorp's Opposition of 117 Sealed Motion for Summary Judgment of No Anticipation By Lee, Holodniy, and Landes by Ravgen, Inc. by Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Kim, Olivia) (Entered: 07/14/2022) (Exhibit B) (30)
Jul 14, 2022	146	Redacted Public Version (Declaration of Benjamin N. Luehrs, Exhibits 1-16, 19, 27, 29-31 of 145 Sealed Document,, by Ravgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 19, # 18 Exhibit 27, # 19 Exhibit 29, # 20 Exhibit 30, # 21 Exhibit 31)(Limbeek, Kerri-Ann) (Entered: 07/14/2022) (Exhibit 1) (30)
Jul 14, 2022	146	Redacted Public Version (Declaration of Benjamin N. Luehrs, Exhibits 1-16, 19, 27, 29-31 of 145 Sealed Document,, by Ravgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 19, # 18 Exhibit 27, # 19 Exhibit 29, # 20 Exhibit 30, # 21 Exhibit 31)(Limbeek, Kerri-Ann) (Entered: 07/14/2022) (Exhibit 2) (30)
Jul 14, 2022	146	Redacted Public Version (Declaration of Benjamin N. Luehrs, Exhibits 1-16, 19, 27, 29-31 of 145 Sealed Document,, by Ravgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 19, # 18 Exhibit 27, # 19 Exhibit 29, # 20 Exhibit 30, # 21 Exhibit 31)(Limbeek, Kerri-Ann) (Entered: 07/14/2022) (Exhibit 3) (26)
Jul 14, 2022	146	Redacted Public Version (Declaration of Benjamin N. Luehrs, Exhibits 1-16, 19, 27, 29-31 of 145 Sealed Document,, by Ravgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 19, # 18 Exhibit 27, # 19 Exhibit 29, # 20 Exhibit 30, # 21 Exhibit 31)(Limbeek, Kerri-Ann) (Entered: 07/14/2022) (Exhibit 4) (26)
Jul 14, 2022	146	Redacted Public Version (Declaration of Benjamin N. Luehrs, Exhibits 1-16, 19, 27, 29-31 of 145 Sealed Document,, by Ravgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 19, # 18 Exhibit 27, # 19 Exhibit 29, # 20 Exhibit 30, # 21 Exhibit 31)(Limbeek, Kerri-Ann) (Entered: 07/14/2022) (Exhibit 5) (3)
Jul 14, 2022	146	Redacted Public Version (Declaration of Benjamin N. Luehrs, Exhibits 1-16, 19, 27, 29-31 of 145 Sealed Document,, by Ravgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 19, # 18 Exhibit 27, # 19 Exhibit 29, # 20 Exhibit 30, # 21 Exhibit 31)(Limbeek, Kerri-Ann) (Entered: 07/14/2022) (Exhibit 6) (4)
Jul 14, 2022	146	Redacted Public Version (Declaration of Benjamin N. Luehrs, Exhibits 1-16, 19, 27, 29-31 of 145 Sealed Document,, by Ravgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 19, # 18 Exhibit 27, # 19 Exhibit 29, # 20 Exhibit 30, # 21 Exhibit 31)(Limbeek, Kerri-Ann) (Entered: 07/14/2022) (Exhibit 7) (27)
Jul 14, 2022	146	Redacted Public Version (Declaration of Benjamin N. Luehrs, Exhibits 1-16, 19, 27, 29-31 of 145 Sealed Document,, by Ravgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 19, # 18 Exhibit 27, # 19 Exhibit 29, # 20 Exhibit 30, # 21 Exhibit 31)(Limbeek, Kerri-Ann) (Entered: 07/14/2022) (Exhibit 8) (5)
Jul 14, 2022	146	Redacted Public Version (Declaration of Benjamin N. Luehrs, Exhibits 1-16, 19, 27, 29-31 of 145 Sealed Document,, by Ravgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 19, # 18 Exhibit 27, # 19 Exhibit 29, # 20 Exhibit 30, # 21 Exhibit 31)(Limbeek, Kerri-Ann) (Entered: 07/14/2022) (Exhibit 9) (16)
Jul 14, 2022	146	Redacted Public Version (Declaration of Benjamin N. Luehrs, Exhibits 1-16, 19, 27, 29-31 of 145 Sealed Document,, by Ravgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 19, # 18 Exhibit 27, # 19 Exhibit 29, # 20 Exhibit 30, # 21 Exhibit 31)(Limbeek, Kerri-Ann) (Entered: 07/14/2022) (Exhibit 10) (13)
Jul 14, 2022	146	Redacted Public Version (Declaration of Benjamin N. Luehrs, Exhibits 1-16, 19, 27, 29-31 of 145 Sealed Document,, by Ravgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 19, # 18 Exhibit 27, # 19 Exhibit 29, # 20 Exhibit 30, # 21 Exhibit 31)(Limbeek, Kerri-Ann) (Entered: 07/14/2022) (Exhibit 11) (13)
Jul 14, 2022	146	Redacted Public Version (Declaration of Benjamin N. Luehrs, Exhibits 1-16, 19, 27, 29-31 of 145 Sealed Document,, by Ravgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 19, # 18 Exhibit 27, # 19 Exhibit 29, # 20 Exhibit 30, # 21 Exhibit 31)(Limbeek, Kerri-Ann) (Entered: 07/14/2022) (Exhibit 12) (11)
Jul 14, 2022	146	Redacted Public Version (Declaration of Benjamin N. Luehrs, Exhibits 1-16, 19, 27, 29-31 of 145 Sealed Document,, by Ravgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 19, # 18 Exhibit 27, # 19 Exhibit 29, # 20 Exhibit 30, # 21 Exhibit 31)(Limbeek, Kerri-Ann) (Entered: 07/14/2022) (Exhibit 13) (30)
Jul 14, 2022	146	Redacted Public Version (Declaration of Benjamin N. Luehrs, Exhibits 1-16, 19, 27, 29-31 of 145 Sealed Document,, by Ravgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 19, # 18 Exhibit 27, # 19 Exhibit 29, # 20 Exhibit 30, # 21 Exhibit 31)(Limbeek, Kerri-Ann) (Entered: 07/14/2022) (Exhibit 14) (11)
Jul 14, 2022	146	Redacted Public Version (Declaration of Benjamin N. Luehrs, Exhibits 1-16, 19, 27, 29-31 of 145 Sealed Document,, by Ravgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 19, # 18 Exhibit 27, # 19 Exhibit 29, # 20 Exhibit 30, # 21 Exhibit 31)(Limbeek, Kerri-Ann) (Entered: 07/14/2022) (Exhibit 15) (5)
Jul 14, 2022	146	Redacted Public Version (Declaration of Benjamin N. Luehrs, Exhibits 1-16, 19, 27, 29-31 of 145 Sealed Document,, by Ravgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 19, # 18 Exhibit 27, # 19 Exhibit 29, # 20 Exhibit 30, # 21 Exhibit 31)(Limbeek, Kerri-Ann) (Entered: 07/14/2022) (Exhibit 16) (8)
Jul 14, 2022	146	Redacted Public Version (Declaration of Benjamin N. Luehrs, Exhibits 1-16, 19, 27, 29-31 of 145 Sealed Document,, by Ravgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 19, # 18 Exhibit 27, # 19 Exhibit 29, # 20 Exhibit 30, # 21 Exhibit 31)(Limbeek, Kerri-Ann) (Entered: 07/14/2022) (Exhibit 19) (7)
Jul 14, 2022	146	Redacted Public Version (Declaration of Benjamin N. Luehrs, Exhibits 1-16, 19, 27, 29-31 of 145 Sealed Document,, by Ravgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 19, # 18 Exhibit 27, # 19 Exhibit 29, # 20 Exhibit 30, # 21 Exhibit 31)(Limbeek, Kerri-Ann) (Entered: 07/14/2022) (Exhibit 27) (30)
Jul 14, 2022	146	Redacted Public Version (Declaration of Benjamin N. Luehrs, Exhibits 1-16, 19, 27, 29-31 of 145 Sealed Document,, by Ravgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 19, # 18 Exhibit 27, # 19 Exhibit 29, # 20 Exhibit 30, # 21 Exhibit 31)(Limbeek, Kerri-Ann) (Entered: 07/14/2022) (Exhibit 29) (30)
Jul 14, 2022	146	Redacted Public Version (Declaration of Benjamin N. Luehrs, Exhibits 1-16, 19, 27, 29-31 of 145 Sealed Document,, by Ravgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 19, # 18 Exhibit 27, # 19 Exhibit 29, # 20 Exhibit 30, # 21 Exhibit 31)(Limbeek, Kerri-Ann) (Entered: 07/14/2022) (Exhibit 30) (30)
Jul 14, 2022	146	Redacted Public Version (Declaration of Benjamin N. Luehrs, Exhibits 1-16, 19, 27, 29-31 of 145 Sealed Document,, by Ravgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 19, # 18 Exhibit 27, # 19 Exhibit 29, # 20 Exhibit 30, # 21 Exhibit 31)(Limbeek, Kerri-Ann) (Entered: 07/14/2022) (Exhibit 31) (24)
Jul 8, 2022	135	Redacted Public Version Exhibits 5, 6, and 7 of 133 Sealed Document by Ravgen, Inc.. (Attachments: # 1 Exhibit 5, # 2 Exhibit 6, # 3 Exhibit 7)(Limbeek, Kerri-Ann) (Entered: 07/08/2022) (Main Document) (3)
Jul 8, 2022	135	Redacted Public Version Exhibits 5, 6, and 7 of 133 Sealed Document by Ravgen, Inc.. (Attachments: # 1 Exhibit 5, # 2 Exhibit 6, # 3 Exhibit 7)(Limbeek, Kerri-Ann) (Entered: 07/08/2022) (Exhibit 5) (6)
Jul 8, 2022	135	Redacted Public Version Exhibits 5, 6, and 7 of 133 Sealed Document by Ravgen, Inc.. (Attachments: # 1 Exhibit 5, # 2 Exhibit 6, # 3 Exhibit 7)(Limbeek, Kerri-Ann) (Entered: 07/08/2022) (Exhibit 6) (4)
Jul 8, 2022	135	Redacted Public Version Exhibits 5, 6, and 7 of 133 Sealed Document by Ravgen, Inc.. (Attachments: # 1 Exhibit 5, # 2 Exhibit 6, # 3 Exhibit 7)(Limbeek, Kerri-Ann) (Entered: 07/08/2022) (Exhibit 7) (7)
Jul 7, 2022	125	Redacted Public Version of 117 Sealed Motion for Summary Judgment of No Anticipation By Lee, Holodniy, and Landes by Ravgen, Inc. by Ravgen, Inc.. (Limbeek, Kerri-Ann) (Entered: 07/07/2022) (27)
Jul 7, 2022	126	Redacted Public Version of 123 Sealed Motion to Exclude, In Part, the Expert Opinion of Dr. Stephen D. Prowse by Ravgen, Inc. by Ravgen, Inc.. (Limbeek, Kerri-Ann) (Entered: 07/07/2022) (23)
Jul 7, 2022	127	Redacted Public Version of 120 Sealed Motion to Exclude and Preclude Certain Expert Testimony of Drs. Paul T. Spellman and Larry J. Dumont by Ravgen, Inc. by Ravgen, Inc.. (Limbeek, Kerri-Ann) (Entered: 07/07/2022) (16)
Jul 7, 2022	128	Redacted Public Version of 122 Sealed Motion to Strike and Exclude LabCorp's Fed. R. Civ. P. 26(A)(2)(C) Disclosure by Ravgen, Inc. by Ravgen, Inc.. (Limbeek, Kerri-Ann) (Entered: 07/07/2022) (20)
Jul 7, 2022	129	Redacted Public Version Motion for Summary Judgment of Invalidity Under Indefiniteness, or in the Alternative, Non-Infringement of 110 Sealed Document by Laboratory Corporation of America Holdings. (Kim, Olivia) (Entered: 07/07/2022) (27)
Jul 7, 2022	130	Redacted Public Version Opening Brief in Support of 111 MOTION to Exclude Certain infringement Opinions of Dr. Brian Van Ness of 112 Sealed Document by Laboratory Corporation of America Holdings. (Kim, Olivia) (Entered: 07/07/2022) (17)
Jul 7, 2022	131	Redacted Public Version Opening Brief in Support of 113 MOTION to Exclude Opinions of Paul K. Meyer of 114 Sealed Document by Laboratory Corporation of America Holdings. (Kim, Olivia) (Entered: 07/07/2022) (28)
Jul 7, 2022	132	Sealed Document: Response to Defendant's Motion to Exclude Certain Infringement Opinions of Dr. Brian Van Ness of 112 Sealed Document, 111 MOTION to Exclude Certain infringement Opinions of Dr. Brian Van Ness by Ravgen, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2) (Limbeek, Kerri-Ann) (Entered: 07/07/2022) (0)
Jul 7, 2022	133	Sealed Document: Opposition of 113 MOTION to Exclude Opinions of Paul K. Meyer, 114 Sealed Document by Ravgen, Inc. (Limbeek, Kerri-Ann) (Entered: 07/07/2022) (0)
Jul 7, 2022	134	Sealed Document: Declaration in Support of 133 Sealed Document by Ravgen, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 8, # 6 Exhibit 9, # 7 Exhibit 10) (Limbeek, Kerri-Ann) (Entered: 07/08/2022) (0)
Jul 1, 2022	123	Sealed Motion to Exclude, In Part, the Expert Opinion of Dr. Stephen D. Prowse by Ravgen, Inc. (Attachments: # 1 Proposed Order, # 2 Exhibit 3, # 3 Exhibit 4, # 4 Exhibit 5, # 5 Exhibit 6, # 6 Exhibit 7, # 7 Exhibit 8) (Limbeek, Kerri-Ann) (Entered: 07/01/2022) (0)
Jul 1, 2022	124	SUPPLEMENT to 123 Sealed Motion to Exclude, In Part, the Expert Opinion of Dr. Stephen D. Prowse by Ravgen, Inc. by Ravgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 9)(Limbeek, Kerri-Ann) (Entered: 07/01/2022) (Main Document) (1)
Jul 1, 2022	124	SUPPLEMENT to 123 Sealed Motion to Exclude, In Part, the Expert Opinion of Dr. Stephen D. Prowse by Ravgen, Inc. by Ravgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 9)(Limbeek, Kerri-Ann) (Entered: 07/01/2022) (Exhibit 1) (30)
Jul 1, 2022	124	SUPPLEMENT to 123 Sealed Motion to Exclude, In Part, the Expert Opinion of Dr. Stephen D. Prowse by Ravgen, Inc. by Ravgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 9)(Limbeek, Kerri-Ann) (Entered: 07/01/2022) (Exhibit 2) (30)
Jul 1, 2022	124	SUPPLEMENT to 123 Sealed Motion to Exclude, In Part, the Expert Opinion of Dr. Stephen D. Prowse by Ravgen, Inc. by Ravgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 9)(Limbeek, Kerri-Ann) (Entered: 07/01/2022) (Exhibit 9) (30)
Jun 30, 2022	110	Sealed Document: Motion for Summary Judgment of Invalidity Under Indefiniteness, or in the Alternative, Non-Infringement by Laboratory Corporation of America Holdings (Kim, Olivia) (Entered: 06/30/2022) (0)
Jun 30, 2022	111	MOTION to Exclude Certain infringement Opinions of Dr. Brian Van Ness by Laboratory Corporation of America Holdings. (Attachments: # 1 Proposed Order)(Kim, Olivia) (Entered: 06/30/2022) (Main Document) (3)
Jun 30, 2022	112	Sealed Document: Opening Brief in Support of 111 MOTION to Exclude Certain infringement Opinions of Dr. Brian Van Ness by Laboratory Corporation of America Holdings (Kim, Olivia) (Entered: 06/30/2022) (0)
Jun 30, 2022	113	MOTION to Exclude Opinions of Paul K. Meyer by Laboratory Corporation of America Holdings. (Attachments: # 1 Proposed Order)(Kim, Olivia) (Entered: 06/30/2022) (Main Document) (3)
Jun 30, 2022	114	Sealed Document: Opening Brief in Support of 113 MOTION to Exclude Opinions of Paul K. Meyer by Laboratory Corporation of America Holdings (Kim, Olivia) (Entered: 06/30/2022) (0)
Jun 30, 2022	115	AFFIDAVIT in Support of 113 MOTION to Exclude Opinions of Paul K. Meyer, 111 MOTION to Exclude Certain infringement Opinions of Dr. Brian Van Ness, 110 Sealed Document Motion for Summary Judgment of Invalidity Under Indefiniteness, or in the Alternative, Non-Infringement by Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit A to Kim Declaration, # 2 Exhibit B to Kim Declaration, # 3 Exhibit C to Kim Declaration, # 4 Exhibit I to Kim Declaration, # 5 Exhibit J to Kim Declaration, # 6 Exhibit K to Kim Declaration, # 7 Exhibit L to Kim Declaration, # 8 Exhibit LL to Kim Declaration)(Kim, Olivia) (Entered: 06/30/2022) (Main Document) (7)
Jun 30, 2022	116	Sealed Document: Sealed Exhibits D-H, M-KK, AND MM-PP of 115 Affidavit in Support,, by Laboratory Corporation of America Holdings (Attachments: # 1 Exhibit D to Kim Declaration, # 2 Exhibit E to Kim Declaration, # 3 Exhibit F to Kim Declaration, # 4 Exhibit G to Kim Declaration, # 5 Exhibit H to Kim Declaration, # 6 Exhibit M to Kim Declaration, # 7 Exhibit N to Kim Declaration, # 8 Exhibit O to Kim Declaration, # 9 Exhibit P to Kim Declaration, # 10 Exhibit Q to Kim Declaration, # 11 Exhibit R to Kim Declaration, # 12 Exhibit S to Kim Declaration, # 13 Exhibit T to Kim Declaration, # 14 Exhibit U to Kim Declaration, # 15 Exhibit V to Kim Declaration, # 16 Exhibit W to Kim Declaration, # 17 Exhibit X to Kim Declaration, # 18 Exhibit Y to Kim Declaration, # 19 Exhibit Z to Kim Declaration, # 20 Exhibit AA to Kim Declaration, # 21 Exhibit BB to Kim Declaration, # 22 Exhibit CC to Kim Declaration, # 23 Exhibit DD to Kim Declaration, # 24 Exhibit EE to Kim Declaration, # 25 Exhibit FF to Kim Declaration, # 26 Exhibit GG to Kim Declaration, # 27 Exhibit HH to Kim Declaration, # 28 Exhibit II to Kim Declaration, # 29 Exhibit JJ to Kim Declaration, # 30 Exhibit KK to Kim Declaration, # 31 Exhibit MM to Kim Declaration, # 32 Exhibit NN to Kim Declaration, # 33 Exhibit OO to Kim Declaration, # 34 Exhibit PP to Kim Declaration) (Kim, Olivia) (Entered: 06/30/2022) (0)
Jun 30, 2022	117	Sealed Motion for Summary Judgment of No Anticipation By Lee, Holodniy, and Landes by Ravgen, Inc. (Attachments: # 1 Declaration of Glenn D. Prestwich, Ph.D., # 2 Declaration of Brian G. Van Ness, Ph.D.) (Limbeek, Kerri-Ann) (Entered: 06/30/2022) (0)
Jun 30, 2022	118	Sealed Document: Sealed Exhibits to Declaration of Benjamin N. Luehrs of 117 Sealed Motion for Summary Judgment of No Anticipation By Lee, Holodniy, and Landes by Ravgen, Inc. by Ravgen, Inc. (Attachments: # 1 Exhibit 14 of Luehrs Declaration, # 2 Exhibit 18 of Luehrs Declaration, # 3 Exhibit 19 of Luehrs Declaration, # 4 Exhibit 20 of Luehrs Declaration, # 5 Exhibit 21 of Luehrs Declaration, # 6 Exhibit 22 of Luehrs Declaration, # 7 Exhibit 23 of Luehrs Declaration, # 8 Exhibit 24 of Luehrs Declaration, # 9 Exhibit 25 of Luehrs Declaration, # 10 Exhibit 26 of Luehrs Declaration) (Limbeek, Kerri-Ann) (Entered: 06/30/2022) (0)
Jun 30, 2022	119	AFFIDAVIT in Support of 117 Sealed Motion for Summary Judgment of No Anticipation By Lee, Holodniy, and Landes by Ravgen, Inc. by Ravgen, Inc.. (Attachments: # 1 Exhibit 1 of Luehrs Declaration, # 2 Exhibit 2 of Luehrs Declaration, # 3 Exhibit 3 of Luehrs Declaration, # 4 Exhibit 4 of Luehrs Declaration, # 5 Exhibit 5 of Luehrs Declaration, # 6 Exhibit 6 of Luehrs Declaration, # 7 Exhibit 7 of Luehrs Declaration, # 8 Exhibit 8 of Luehrs Declaration, # 9 Exhibit 9 of Luehrs Declaration, # 10 Exhibit 10 of Luehrs Declaration, # 11 Exhibit 11 of Luehrs Declaration, # 12 Exhibit 12 of Luehrs Declaration, # 13 Exhibit 13 of Luehrs Declaration, # 14 Exhibit 15 of Luehrs Declaration, # 15 Exhibit 16 of Luehrs Declaration, # 16 Exhibit 17 of Luehrs Declaration)(Limbeek, Kerri-Ann) (Entered: 06/30/2022) (Main Document) (5)
Jun 30, 2022	120	Sealed Motion to Exclude and Preclude Certain Expert Testimony of Drs. Paul T. Spellman and Larry J. Dumont by Ravgen, Inc. (Attachments: # 1 Proposed Order, # 2 Exhibit 1, # 3 Exhibit 4, # 4 Exhibit 5, # 5 Exhibit 6, # 6 Exhibit 7, # 7 Exhibit 8, # 8 Exhibit 9, # 9 Exhibit 10, # 10 Exhibit 11) (Limbeek, Kerri-Ann) (Entered: 06/30/2022) (0)
Jun 30, 2022	121	SUPPLEMENT to 120 Sealed Motion to Exclude and Preclude Certain Expert Testimony of Drs. Paul T. Spellman and Larry J. Dumont by Ravgen, Inc. by Ravgen, Inc.. (Attachments: # 1 Exhibit 2, # 2 Exhibit 3)(Limbeek, Kerri-Ann) (Entered: 06/30/2022) (Main Document) (1)
Jun 30, 2022	122	Sealed Motion to Strike and Exclude LabCorp's Fed. R. Civ. P. 26(A)(2)(C) Disclosure by Ravgen, Inc. (Attachments: # 1 Proposed Order, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10) (Limbeek, Kerri-Ann) (Entered: 07/01/2022) (0)
Jun 30, 2022	119	AFFIDAVIT in Support of 117 Sealed Motion for Summary Judgment of No Anticipation By Lee, Holodniy, and Landes by Ravgen, Inc. by Ravgen, Inc.. (Attachments: # 1 Exhibit 1 of Luehrs Declaration, # 2 Exhibit 2 of Luehrs Declaration, # 3 Exhibit 3 of Luehrs Declaration, # 4 Exhibit 4 of Luehrs Declaration, # 5 Exhibit 5 of Luehrs Declaration, # 6 Exhibit 6 of Luehrs Declaration, # 7 Exhibit 7 of Luehrs Declaration, # 8 Exhibit 8 of Luehrs Declaration, # 9 Exhibit 9 of Luehrs Declaration, # 10 Exhibit 10 of Luehrs Declaration, # 11 Exhibit 11 of Luehrs Declaration, # 12 Exhibit 12 of Luehrs Declaration, # 13 Exhibit 13 of Luehrs Declaration, # 14 Exhibit 15 of Luehrs Declaration, # 15 Exhibit 16 of Luehrs Declaration, # 16 Exhibit 17 of Luehrs Declaration)(Limbeek, Kerri-Ann) (Entered: 06/30/2022) (Exhibit 1 of Luehrs Declaration) (30)
Jun 30, 2022	119	AFFIDAVIT in Support of 117 Sealed Motion for Summary Judgment of No Anticipation By Lee, Holodniy, and Landes by Ravgen, Inc. by Ravgen, Inc.. (Attachments: # 1 Exhibit 1 of Luehrs Declaration, # 2 Exhibit 2 of Luehrs Declaration, # 3 Exhibit 3 of Luehrs Declaration, # 4 Exhibit 4 of Luehrs Declaration, # 5 Exhibit 5 of Luehrs Declaration, # 6 Exhibit 6 of Luehrs Declaration, # 7 Exhibit 7 of Luehrs Declaration, # 8 Exhibit 8 of Luehrs Declaration, # 9 Exhibit 9 of Luehrs Declaration, # 10 Exhibit 10 of Luehrs Declaration, # 11 Exhibit 11 of Luehrs Declaration, # 12 Exhibit 12 of Luehrs Declaration, # 13 Exhibit 13 of Luehrs Declaration, # 14 Exhibit 15 of Luehrs Declaration, # 15 Exhibit 16 of Luehrs Declaration, # 16 Exhibit 17 of Luehrs Declaration)(Limbeek, Kerri-Ann) (Entered: 06/30/2022) (Exhibit 2 of Luehrs Declaration) (30)
Jun 30, 2022	119	AFFIDAVIT in Support of 117 Sealed Motion for Summary Judgment of No Anticipation By Lee, Holodniy, and Landes by Ravgen, Inc. by Ravgen, Inc.. (Attachments: # 1 Exhibit 1 of Luehrs Declaration, # 2 Exhibit 2 of Luehrs Declaration, # 3 Exhibit 3 of Luehrs Declaration, # 4 Exhibit 4 of Luehrs Declaration, # 5 Exhibit 5 of Luehrs Declaration, # 6 Exhibit 6 of Luehrs Declaration, # 7 Exhibit 7 of Luehrs Declaration, # 8 Exhibit 8 of Luehrs Declaration, # 9 Exhibit 9 of Luehrs Declaration, # 10 Exhibit 10 of Luehrs Declaration, # 11 Exhibit 11 of Luehrs Declaration, # 12 Exhibit 12 of Luehrs Declaration, # 13 Exhibit 13 of Luehrs Declaration, # 14 Exhibit 15 of Luehrs Declaration, # 15 Exhibit 16 of Luehrs Declaration, # 16 Exhibit 17 of Luehrs Declaration)(Limbeek, Kerri-Ann) (Entered: 06/30/2022) (Exhibit 3 of Luehrs Declaration) (8)
Jun 30, 2022	119	AFFIDAVIT in Support of 117 Sealed Motion for Summary Judgment of No Anticipation By Lee, Holodniy, and Landes by Ravgen, Inc. by Ravgen, Inc.. (Attachments: # 1 Exhibit 1 of Luehrs Declaration, # 2 Exhibit 2 of Luehrs Declaration, # 3 Exhibit 3 of Luehrs Declaration, # 4 Exhibit 4 of Luehrs Declaration, # 5 Exhibit 5 of Luehrs Declaration, # 6 Exhibit 6 of Luehrs Declaration, # 7 Exhibit 7 of Luehrs Declaration, # 8 Exhibit 8 of Luehrs Declaration, # 9 Exhibit 9 of Luehrs Declaration, # 10 Exhibit 10 of Luehrs Declaration, # 11 Exhibit 11 of Luehrs Declaration, # 12 Exhibit 12 of Luehrs Declaration, # 13 Exhibit 13 of Luehrs Declaration, # 14 Exhibit 15 of Luehrs Declaration, # 15 Exhibit 16 of Luehrs Declaration, # 16 Exhibit 17 of Luehrs Declaration)(Limbeek, Kerri-Ann) (Entered: 06/30/2022) (Exhibit 4 of Luehrs Declaration) (8)
Jun 30, 2022	119	AFFIDAVIT in Support of 117 Sealed Motion for Summary Judgment of No Anticipation By Lee, Holodniy, and Landes by Ravgen, Inc. by Ravgen, Inc.. (Attachments: # 1 Exhibit 1 of Luehrs Declaration, # 2 Exhibit 2 of Luehrs Declaration, # 3 Exhibit 3 of Luehrs Declaration, # 4 Exhibit 4 of Luehrs Declaration, # 5 Exhibit 5 of Luehrs Declaration, # 6 Exhibit 6 of Luehrs Declaration, # 7 Exhibit 7 of Luehrs Declaration, # 8 Exhibit 8 of Luehrs Declaration, # 9 Exhibit 9 of Luehrs Declaration, # 10 Exhibit 10 of Luehrs Declaration, # 11 Exhibit 11 of Luehrs Declaration, # 12 Exhibit 12 of Luehrs Declaration, # 13 Exhibit 13 of Luehrs Declaration, # 14 Exhibit 15 of Luehrs Declaration, # 15 Exhibit 16 of Luehrs Declaration, # 16 Exhibit 17 of Luehrs Declaration)(Limbeek, Kerri-Ann) (Entered: 06/30/2022) (Exhibit 5 of Luehrs Declaration) (30)
Jun 30, 2022	119	AFFIDAVIT in Support of 117 Sealed Motion for Summary Judgment of No Anticipation By Lee, Holodniy, and Landes by Ravgen, Inc. by Ravgen, Inc.. (Attachments: # 1 Exhibit 1 of Luehrs Declaration, # 2 Exhibit 2 of Luehrs Declaration, # 3 Exhibit 3 of Luehrs Declaration, # 4 Exhibit 4 of Luehrs Declaration, # 5 Exhibit 5 of Luehrs Declaration, # 6 Exhibit 6 of Luehrs Declaration, # 7 Exhibit 7 of Luehrs Declaration, # 8 Exhibit 8 of Luehrs Declaration, # 9 Exhibit 9 of Luehrs Declaration, # 10 Exhibit 10 of Luehrs Declaration, # 11 Exhibit 11 of Luehrs Declaration, # 12 Exhibit 12 of Luehrs Declaration, # 13 Exhibit 13 of Luehrs Declaration, # 14 Exhibit 15 of Luehrs Declaration, # 15 Exhibit 16 of Luehrs Declaration, # 16 Exhibit 17 of Luehrs Declaration)(Limbeek, Kerri-Ann) (Entered: 06/30/2022) (Exhibit 6 of Luehrs Declaration) (11)
Jun 30, 2022	119	AFFIDAVIT in Support of 117 Sealed Motion for Summary Judgment of No Anticipation By Lee, Holodniy, and Landes by Ravgen, Inc. by Ravgen, Inc.. (Attachments: # 1 Exhibit 1 of Luehrs Declaration, # 2 Exhibit 2 of Luehrs Declaration, # 3 Exhibit 3 of Luehrs Declaration, # 4 Exhibit 4 of Luehrs Declaration, # 5 Exhibit 5 of Luehrs Declaration, # 6 Exhibit 6 of Luehrs Declaration, # 7 Exhibit 7 of Luehrs Declaration, # 8 Exhibit 8 of Luehrs Declaration, # 9 Exhibit 9 of Luehrs Declaration, # 10 Exhibit 10 of Luehrs Declaration, # 11 Exhibit 11 of Luehrs Declaration, # 12 Exhibit 12 of Luehrs Declaration, # 13 Exhibit 13 of Luehrs Declaration, # 14 Exhibit 15 of Luehrs Declaration, # 15 Exhibit 16 of Luehrs Declaration, # 16 Exhibit 17 of Luehrs Declaration)(Limbeek, Kerri-Ann) (Entered: 06/30/2022) (Exhibit 7 of Luehrs Declaration) (30)
Jun 30, 2022	119	AFFIDAVIT in Support of 117 Sealed Motion for Summary Judgment of No Anticipation By Lee, Holodniy, and Landes by Ravgen, Inc. by Ravgen, Inc.. (Attachments: # 1 Exhibit 1 of Luehrs Declaration, # 2 Exhibit 2 of Luehrs Declaration, # 3 Exhibit 3 of Luehrs Declaration, # 4 Exhibit 4 of Luehrs Declaration, # 5 Exhibit 5 of Luehrs Declaration, # 6 Exhibit 6 of Luehrs Declaration, # 7 Exhibit 7 of Luehrs Declaration, # 8 Exhibit 8 of Luehrs Declaration, # 9 Exhibit 9 of Luehrs Declaration, # 10 Exhibit 10 of Luehrs Declaration, # 11 Exhibit 11 of Luehrs Declaration, # 12 Exhibit 12 of Luehrs Declaration, # 13 Exhibit 13 of Luehrs Declaration, # 14 Exhibit 15 of Luehrs Declaration, # 15 Exhibit 16 of Luehrs Declaration, # 16 Exhibit 17 of Luehrs Declaration)(Limbeek, Kerri-Ann) (Entered: 06/30/2022) (Exhibit 8 of Luehrs Declaration) (18)
Jun 30, 2022	119	AFFIDAVIT in Support of 117 Sealed Motion for Summary Judgment of No Anticipation By Lee, Holodniy, and Landes by Ravgen, Inc. by Ravgen, Inc.. (Attachments: # 1 Exhibit 1 of Luehrs Declaration, # 2 Exhibit 2 of Luehrs Declaration, # 3 Exhibit 3 of Luehrs Declaration, # 4 Exhibit 4 of Luehrs Declaration, # 5 Exhibit 5 of Luehrs Declaration, # 6 Exhibit 6 of Luehrs Declaration, # 7 Exhibit 7 of Luehrs Declaration, # 8 Exhibit 8 of Luehrs Declaration, # 9 Exhibit 9 of Luehrs Declaration, # 10 Exhibit 10 of Luehrs Declaration, # 11 Exhibit 11 of Luehrs Declaration, # 12 Exhibit 12 of Luehrs Declaration, # 13 Exhibit 13 of Luehrs Declaration, # 14 Exhibit 15 of Luehrs Declaration, # 15 Exhibit 16 of Luehrs Declaration, # 16 Exhibit 17 of Luehrs Declaration)(Limbeek, Kerri-Ann) (Entered: 06/30/2022) (Exhibit 9 of Luehrs Declaration) (30)
Jun 30, 2022	119	AFFIDAVIT in Support of 117 Sealed Motion for Summary Judgment of No Anticipation By Lee, Holodniy, and Landes by Ravgen, Inc. by Ravgen, Inc.. (Attachments: # 1 Exhibit 1 of Luehrs Declaration, # 2 Exhibit 2 of Luehrs Declaration, # 3 Exhibit 3 of Luehrs Declaration, # 4 Exhibit 4 of Luehrs Declaration, # 5 Exhibit 5 of Luehrs Declaration, # 6 Exhibit 6 of Luehrs Declaration, # 7 Exhibit 7 of Luehrs Declaration, # 8 Exhibit 8 of Luehrs Declaration, # 9 Exhibit 9 of Luehrs Declaration, # 10 Exhibit 10 of Luehrs Declaration, # 11 Exhibit 11 of Luehrs Declaration, # 12 Exhibit 12 of Luehrs Declaration, # 13 Exhibit 13 of Luehrs Declaration, # 14 Exhibit 15 of Luehrs Declaration, # 15 Exhibit 16 of Luehrs Declaration, # 16 Exhibit 17 of Luehrs Declaration)(Limbeek, Kerri-Ann) (Entered: 06/30/2022) (Exhibit 10 of Luehrs Declaration) (19)
Jun 30, 2022	119	AFFIDAVIT in Support of 117 Sealed Motion for Summary Judgment of No Anticipation By Lee, Holodniy, and Landes by Ravgen, Inc. by Ravgen, Inc.. (Attachments: # 1 Exhibit 1 of Luehrs Declaration, # 2 Exhibit 2 of Luehrs Declaration, # 3 Exhibit 3 of Luehrs Declaration, # 4 Exhibit 4 of Luehrs Declaration, # 5 Exhibit 5 of Luehrs Declaration, # 6 Exhibit 6 of Luehrs Declaration, # 7 Exhibit 7 of Luehrs Declaration, # 8 Exhibit 8 of Luehrs Declaration, # 9 Exhibit 9 of Luehrs Declaration, # 10 Exhibit 10 of Luehrs Declaration, # 11 Exhibit 11 of Luehrs Declaration, # 12 Exhibit 12 of Luehrs Declaration, # 13 Exhibit 13 of Luehrs Declaration, # 14 Exhibit 15 of Luehrs Declaration, # 15 Exhibit 16 of Luehrs Declaration, # 16 Exhibit 17 of Luehrs Declaration)(Limbeek, Kerri-Ann) (Entered: 06/30/2022) (Exhibit 11 of Luehrs Declaration) (9)
Jun 30, 2022	119	AFFIDAVIT in Support of 117 Sealed Motion for Summary Judgment of No Anticipation By Lee, Holodniy, and Landes by Ravgen, Inc. by Ravgen, Inc.. (Attachments: # 1 Exhibit 1 of Luehrs Declaration, # 2 Exhibit 2 of Luehrs Declaration, # 3 Exhibit 3 of Luehrs Declaration, # 4 Exhibit 4 of Luehrs Declaration, # 5 Exhibit 5 of Luehrs Declaration, # 6 Exhibit 6 of Luehrs Declaration, # 7 Exhibit 7 of Luehrs Declaration, # 8 Exhibit 8 of Luehrs Declaration, # 9 Exhibit 9 of Luehrs Declaration, # 10 Exhibit 10 of Luehrs Declaration, # 11 Exhibit 11 of Luehrs Declaration, # 12 Exhibit 12 of Luehrs Declaration, # 13 Exhibit 13 of Luehrs Declaration, # 14 Exhibit 15 of Luehrs Declaration, # 15 Exhibit 16 of Luehrs Declaration, # 16 Exhibit 17 of Luehrs Declaration)(Limbeek, Kerri-Ann) (Entered: 06/30/2022) (Exhibit 12 of Luehrs Declaration) (30)
Jun 30, 2022	119	AFFIDAVIT in Support of 117 Sealed Motion for Summary Judgment of No Anticipation By Lee, Holodniy, and Landes by Ravgen, Inc. by Ravgen, Inc.. (Attachments: # 1 Exhibit 1 of Luehrs Declaration, # 2 Exhibit 2 of Luehrs Declaration, # 3 Exhibit 3 of Luehrs Declaration, # 4 Exhibit 4 of Luehrs Declaration, # 5 Exhibit 5 of Luehrs Declaration, # 6 Exhibit 6 of Luehrs Declaration, # 7 Exhibit 7 of Luehrs Declaration, # 8 Exhibit 8 of Luehrs Declaration, # 9 Exhibit 9 of Luehrs Declaration, # 10 Exhibit 10 of Luehrs Declaration, # 11 Exhibit 11 of Luehrs Declaration, # 12 Exhibit 12 of Luehrs Declaration, # 13 Exhibit 13 of Luehrs Declaration, # 14 Exhibit 15 of Luehrs Declaration, # 15 Exhibit 16 of Luehrs Declaration, # 16 Exhibit 17 of Luehrs Declaration)(Limbeek, Kerri-Ann) (Entered: 06/30/2022) (Exhibit 13 of Luehrs Declaration) (30)
Jun 30, 2022	119	AFFIDAVIT in Support of 117 Sealed Motion for Summary Judgment of No Anticipation By Lee, Holodniy, and Landes by Ravgen, Inc. by Ravgen, Inc.. (Attachments: # 1 Exhibit 1 of Luehrs Declaration, # 2 Exhibit 2 of Luehrs Declaration, # 3 Exhibit 3 of Luehrs Declaration, # 4 Exhibit 4 of Luehrs Declaration, # 5 Exhibit 5 of Luehrs Declaration, # 6 Exhibit 6 of Luehrs Declaration, # 7 Exhibit 7 of Luehrs Declaration, # 8 Exhibit 8 of Luehrs Declaration, # 9 Exhibit 9 of Luehrs Declaration, # 10 Exhibit 10 of Luehrs Declaration, # 11 Exhibit 11 of Luehrs Declaration, # 12 Exhibit 12 of Luehrs Declaration, # 13 Exhibit 13 of Luehrs Declaration, # 14 Exhibit 15 of Luehrs Declaration, # 15 Exhibit 16 of Luehrs Declaration, # 16 Exhibit 17 of Luehrs Declaration)(Limbeek, Kerri-Ann) (Entered: 06/30/2022) (Exhibit 15 of Luehrs Declaration) (13)
Jun 30, 2022	119	AFFIDAVIT in Support of 117 Sealed Motion for Summary Judgment of No Anticipation By Lee, Holodniy, and Landes by Ravgen, Inc. by Ravgen, Inc.. (Attachments: # 1 Exhibit 1 of Luehrs Declaration, # 2 Exhibit 2 of Luehrs Declaration, # 3 Exhibit 3 of Luehrs Declaration, # 4 Exhibit 4 of Luehrs Declaration, # 5 Exhibit 5 of Luehrs Declaration, # 6 Exhibit 6 of Luehrs Declaration, # 7 Exhibit 7 of Luehrs Declaration, # 8 Exhibit 8 of Luehrs Declaration, # 9 Exhibit 9 of Luehrs Declaration, # 10 Exhibit 10 of Luehrs Declaration, # 11 Exhibit 11 of Luehrs Declaration, # 12 Exhibit 12 of Luehrs Declaration, # 13 Exhibit 13 of Luehrs Declaration, # 14 Exhibit 15 of Luehrs Declaration, # 15 Exhibit 16 of Luehrs Declaration, # 16 Exhibit 17 of Luehrs Declaration)(Limbeek, Kerri-Ann) (Entered: 06/30/2022) (Exhibit 16 of Luehrs Declaration) (26)
Jun 30, 2022	119	AFFIDAVIT in Support of 117 Sealed Motion for Summary Judgment of No Anticipation By Lee, Holodniy, and Landes by Ravgen, Inc. by Ravgen, Inc.. (Attachments: # 1 Exhibit 1 of Luehrs Declaration, # 2 Exhibit 2 of Luehrs Declaration, # 3 Exhibit 3 of Luehrs Declaration, # 4 Exhibit 4 of Luehrs Declaration, # 5 Exhibit 5 of Luehrs Declaration, # 6 Exhibit 6 of Luehrs Declaration, # 7 Exhibit 7 of Luehrs Declaration, # 8 Exhibit 8 of Luehrs Declaration, # 9 Exhibit 9 of Luehrs Declaration, # 10 Exhibit 10 of Luehrs Declaration, # 11 Exhibit 11 of Luehrs Declaration, # 12 Exhibit 12 of Luehrs Declaration, # 13 Exhibit 13 of Luehrs Declaration, # 14 Exhibit 15 of Luehrs Declaration, # 15 Exhibit 16 of Luehrs Declaration, # 16 Exhibit 17 of Luehrs Declaration)(Limbeek, Kerri-Ann) (Entered: 06/30/2022) (Exhibit 17 of Luehrs Declaration) (30)
Jun 30, 2022	115	AFFIDAVIT in Support of 113 MOTION to Exclude Opinions of Paul K. Meyer, 111 MOTION to Exclude Certain infringement Opinions of Dr. Brian Van Ness, 110 Sealed Document Motion for Summary Judgment of Invalidity Under Indefiniteness, or in the Alternative, Non-Infringement by Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit A to Kim Declaration, # 2 Exhibit B to Kim Declaration, # 3 Exhibit C to Kim Declaration, # 4 Exhibit I to Kim Declaration, # 5 Exhibit J to Kim Declaration, # 6 Exhibit K to Kim Declaration, # 7 Exhibit L to Kim Declaration, # 8 Exhibit LL to Kim Declaration)(Kim, Olivia) (Entered: 06/30/2022) (Exhibit A to Kim Declaration) (30)
Jun 30, 2022	115	AFFIDAVIT in Support of 113 MOTION to Exclude Opinions of Paul K. Meyer, 111 MOTION to Exclude Certain infringement Opinions of Dr. Brian Van Ness, 110 Sealed Document Motion for Summary Judgment of Invalidity Under Indefiniteness, or in the Alternative, Non-Infringement by Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit A to Kim Declaration, # 2 Exhibit B to Kim Declaration, # 3 Exhibit C to Kim Declaration, # 4 Exhibit I to Kim Declaration, # 5 Exhibit J to Kim Declaration, # 6 Exhibit K to Kim Declaration, # 7 Exhibit L to Kim Declaration, # 8 Exhibit LL to Kim Declaration)(Kim, Olivia) (Entered: 06/30/2022) (Exhibit B to Kim Declaration) (30)
Jun 30, 2022	115	AFFIDAVIT in Support of 113 MOTION to Exclude Opinions of Paul K. Meyer, 111 MOTION to Exclude Certain infringement Opinions of Dr. Brian Van Ness, 110 Sealed Document Motion for Summary Judgment of Invalidity Under Indefiniteness, or in the Alternative, Non-Infringement by Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit A to Kim Declaration, # 2 Exhibit B to Kim Declaration, # 3 Exhibit C to Kim Declaration, # 4 Exhibit I to Kim Declaration, # 5 Exhibit J to Kim Declaration, # 6 Exhibit K to Kim Declaration, # 7 Exhibit L to Kim Declaration, # 8 Exhibit LL to Kim Declaration)(Kim, Olivia) (Entered: 06/30/2022) (Exhibit C to Kim Declaration) (5)
Jun 30, 2022	115	AFFIDAVIT in Support of 113 MOTION to Exclude Opinions of Paul K. Meyer, 111 MOTION to Exclude Certain infringement Opinions of Dr. Brian Van Ness, 110 Sealed Document Motion for Summary Judgment of Invalidity Under Indefiniteness, or in the Alternative, Non-Infringement by Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit A to Kim Declaration, # 2 Exhibit B to Kim Declaration, # 3 Exhibit C to Kim Declaration, # 4 Exhibit I to Kim Declaration, # 5 Exhibit J to Kim Declaration, # 6 Exhibit K to Kim Declaration, # 7 Exhibit L to Kim Declaration, # 8 Exhibit LL to Kim Declaration)(Kim, Olivia) (Entered: 06/30/2022) (Exhibit I to Kim Declaration) (30)
Jun 30, 2022	115	AFFIDAVIT in Support of 113 MOTION to Exclude Opinions of Paul K. Meyer, 111 MOTION to Exclude Certain infringement Opinions of Dr. Brian Van Ness, 110 Sealed Document Motion for Summary Judgment of Invalidity Under Indefiniteness, or in the Alternative, Non-Infringement by Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit A to Kim Declaration, # 2 Exhibit B to Kim Declaration, # 3 Exhibit C to Kim Declaration, # 4 Exhibit I to Kim Declaration, # 5 Exhibit J to Kim Declaration, # 6 Exhibit K to Kim Declaration, # 7 Exhibit L to Kim Declaration, # 8 Exhibit LL to Kim Declaration)(Kim, Olivia) (Entered: 06/30/2022) (Exhibit J to Kim Declaration) (30)
Jun 30, 2022	115	AFFIDAVIT in Support of 113 MOTION to Exclude Opinions of Paul K. Meyer, 111 MOTION to Exclude Certain infringement Opinions of Dr. Brian Van Ness, 110 Sealed Document Motion for Summary Judgment of Invalidity Under Indefiniteness, or in the Alternative, Non-Infringement by Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit A to Kim Declaration, # 2 Exhibit B to Kim Declaration, # 3 Exhibit C to Kim Declaration, # 4 Exhibit I to Kim Declaration, # 5 Exhibit J to Kim Declaration, # 6 Exhibit K to Kim Declaration, # 7 Exhibit L to Kim Declaration, # 8 Exhibit LL to Kim Declaration)(Kim, Olivia) (Entered: 06/30/2022) (Exhibit K to Kim Declaration) (30)
Jun 30, 2022	115	AFFIDAVIT in Support of 113 MOTION to Exclude Opinions of Paul K. Meyer, 111 MOTION to Exclude Certain infringement Opinions of Dr. Brian Van Ness, 110 Sealed Document Motion for Summary Judgment of Invalidity Under Indefiniteness, or in the Alternative, Non-Infringement by Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit A to Kim Declaration, # 2 Exhibit B to Kim Declaration, # 3 Exhibit C to Kim Declaration, # 4 Exhibit I to Kim Declaration, # 5 Exhibit J to Kim Declaration, # 6 Exhibit K to Kim Declaration, # 7 Exhibit L to Kim Declaration, # 8 Exhibit LL to Kim Declaration)(Kim, Olivia) (Entered: 06/30/2022) (Exhibit L to Kim Declaration) (24)
Jun 30, 2022	115	AFFIDAVIT in Support of 113 MOTION to Exclude Opinions of Paul K. Meyer, 111 MOTION to Exclude Certain infringement Opinions of Dr. Brian Van Ness, 110 Sealed Document Motion for Summary Judgment of Invalidity Under Indefiniteness, or in the Alternative, Non-Infringement by Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit A to Kim Declaration, # 2 Exhibit B to Kim Declaration, # 3 Exhibit C to Kim Declaration, # 4 Exhibit I to Kim Declaration, # 5 Exhibit J to Kim Declaration, # 6 Exhibit K to Kim Declaration, # 7 Exhibit L to Kim Declaration, # 8 Exhibit LL to Kim Declaration)(Kim, Olivia) (Entered: 06/30/2022) (Exhibit LL to Kim Declaration) (9)
Jun 30, 2022	121	SUPPLEMENT to 120 Sealed Motion to Exclude and Preclude Certain Expert Testimony of Drs. Paul T. Spellman and Larry J. Dumont by Ravgen, Inc. by Ravgen, Inc.. (Attachments: # 1 Exhibit 2, # 2 Exhibit 3)(Limbeek, Kerri-Ann) (Entered: 06/30/2022) (Exhibit 2) (17)
Jun 30, 2022	121	SUPPLEMENT to 120 Sealed Motion to Exclude and Preclude Certain Expert Testimony of Drs. Paul T. Spellman and Larry J. Dumont by Ravgen, Inc. by Ravgen, Inc.. (Attachments: # 1 Exhibit 2, # 2 Exhibit 3)(Limbeek, Kerri-Ann) (Entered: 06/30/2022) (Exhibit 3) (13)
Jun 30, 2022	113	MOTION to Exclude Opinions of Paul K. Meyer by Laboratory Corporation of America Holdings. (Attachments: # 1 Proposed Order)(Kim, Olivia) (Entered: 06/30/2022) (Proposed Order) (1)
Jun 30, 2022	111	MOTION to Exclude Certain infringement Opinions of Dr. Brian Van Ness by Laboratory Corporation of America Holdings. (Attachments: # 1 Proposed Order)(Kim, Olivia) (Entered: 06/30/2022) (Proposed Order) (1)
Jun 29, 2022	108	STATUS REPORT (Joint Report Regarding Narrowing of Asserted Claims and Prior Art) by Ravgen, Inc.. (Limbeek, Kerri-Ann) (Entered: 06/29/2022) (4)
Jun 29, 2022	109	ORDER DENYING RELIEF REQUESTED IN DISCOVERY DISPUTE re 106 Order, Set Hearings. Signed by Judge Alan D Albright. (sv) (Entered: 06/29/2022) (1)
Jun 21, 2022	106	ORDER Setting Zoom Discovery for 6/21/2022 11:00 AM before Judge Alan D Albright. Signed by Judge Alan D Albright. (bot1) (Entered: 06/21/2022) (1)
Jun 21, 2022	107	Minute Entry for proceedings held before Judge Alan D Albright: Discovery Hearing held on 6/21/2022. PARTIES ANNOUNCE READY, STATEMENTS AND ARGUMENTS OF COUNSEL HEARD, COURT DENIES DISCOVERY REQUEST. (Minute entry documents are not available electronically). (Court Reporter Kristie Davis)(sv) (Entered: 06/21/2022) (0)
May 26, 2022	105	STIPULATION - Joint Stipulation Modifying Certain Deadlines by Laboratory Corporation of America Holdings. (Son, Naoya) (Entered: 05/26/2022) (5)
May 12, 2022	104	Federal Circuit ORDER denying Petition for Writ of Mandamus in #22-127. (zv) (Entered: 05/12/2022) (4)
May 9, 2022	103	ORDER GRANTING 102 Motion to Appear Pro Hac Vice for Attorney Brian D. Matty. Attorney added for Ravgen, Inc. Pursuant to our Administrative Policies and Procedures for Electronic Filing, the attorney hereby granted to practice pro hac vice in this case must register for electronic filing with our court within 10 days of this order, if he/she has not previously done so for a prior case in this District. Signed by Judge Alan D Albright. (bot1) (Entered: 05/09/2022) (1)
May 6, 2022	102	MOTION to Appear Pro Hac Vice by Deron R Dacus (on behalf of Brian D. Matty) ( Filing fee $ 100 receipt number 0542-16005373) by on behalf of Ravgen, Inc.. (Attachments: # 1 Proposed Order)(Dacus, Deron) (Entered: 05/06/2022) (Main Document) (3)
May 6, 2022	102	MOTION to Appear Pro Hac Vice by Deron R Dacus (on behalf of Brian D. Matty) ( Filing fee $ 100 receipt number 0542-16005373) by on behalf of Ravgen, Inc.. (Attachments: # 1 Proposed Order)(Dacus, Deron) (Entered: 05/06/2022) (Proposed Order) (1)
Apr 20, 2022	101	ORDER ORDER GRANTING-IN-PART AND DENYING-IN-PART RELIEF REQUESTED IN DISCOVERY DISPUTE re 93 Order of Limited Referral. Signed by Judge Derek T. Gilliland. (sv) (Entered: 04/20/2022) (2)
Apr 18, 2022	99	TRANSCRIPT REQUEST by Laboratory Corporation of America Holdings for proceedings held on 4/12/2022. Proceedings Transcribed: Discovery Hearing. Court Reporter: FTR. (Kim, Olivia) (Entered: 04/18/2022) (1)
Apr 18, 2022	100	TRANSCRIPT REQUEST by Ravgen, Inc. for proceedings held on 4/12/2022. Proceedings Transcribed: Discovery Hearing. Court Reporter: FTR. (Luehrs, Benjamin) (Entered: 04/18/2022) (1)
Apr 14, 2022	97	Standing Order Regarding Order Governing Proceedings Patent Cases. Signed by Judge Alan D Albright. (Entered: 04/14/2022) (18)
Apr 14, 2022	98	ORDER GRANTING 96 Motion to Appear Pro Hac Vice for Attorney Aarti Shah. Attorney added for Laboratory Corporation of America Holdings. Pursuant to our Administrative Policies and Procedures for Electronic Filing, the attorney hereby granted to practice pro hac vice in this case must register for electronic filing with our court within 10 days of this order, if he/she has not previously done so for a prior case in this District. Signed by Judge Alan D Albright. (bot2) (Entered: 04/14/2022) (1)
Apr 13, 2022	96	MOTION to Appear Pro Hac Vice by Aden M. Allen on behalf of Aarti Shah ( Filing fee $ 100 receipt number 0542-15923802) by on behalf of Laboratory Corporation of America Holdings. (Attachments: # 1 Proposed Order)(Allen, Aden) (Entered: 04/13/2022) (Main Document) (3)
Apr 13, 2022	96	MOTION to Appear Pro Hac Vice by Aden M. Allen on behalf of Aarti Shah ( Filing fee $ 100 receipt number 0542-15923802) by on behalf of Laboratory Corporation of America Holdings. (Attachments: # 1 Proposed Order)(Allen, Aden) (Entered: 04/13/2022) (Proposed Order) (1)
Apr 12, 2022	95	Minute Entry for proceedings held before Judge Derek T. Gilliland: Discovery Hearing held on 4/12/2022. Case called for Discovery Hearing via Zoom. Parties announced ready. Statements and arguments of counsel heard. Pursuant to the Standing Order Governing Proceedings (OGP) 4.0 - Patent Cases, the parties are to email a jointly proposed order to the Court's Law Clerks at TXWDml_LawClerks_WA_JudgeAlbright&Gilliland@txwd.uscourts.gov within seven (7) days of the date of this hearing. (Minute entry documents are not available electronically). (Court Reporter FTR.)(sv) (Entered: 04/12/2022) (0)
Apr 8, 2022	93	ORDER of Limited Referral: The discovery dispute listed in the attached Appendix A is referred to United States Magistrate Judge Derek T. Gilliland. Signed by Judge Alan D Albright. (sv) (Entered: 04/08/2022) (8)
Apr 8, 2022	94	ORDER SETTING DISCOVERY HEARING VIA ZOOM set for 4/12/2022 01:30 PM before Judge Derek T. Gilliland. Signed by Judge Derek T. Gilliland. (sv) (Entered: 04/08/2022) (1)
Mar 31, 2022	92	Response in Opposition to Motion, filed by Laboratory Corporation of America Holdings, re 89 MOTION to Adopt the Courts Previous Supplemental Claim Construction Order filed by Plaintiff Ravgen, Inc. (Kim, Olivia) (Entered: 03/31/2022) (4)
Mar 25, 2022	91	ORDER GRANTING 90 Motion to Appear Pro Hac Vice for Attorney Nicole Regna. Attorney added for Laboratory Corporation of America Holdings. Pursuant to our Administrative Policies and Procedures for Electronic Filing, the attorney hereby granted to practice pro hac vice in this case must register for electronic filing with our court within 10 days of this order, if he/she has not previously done so for a prior case in this District. Signed by Judge Alan D Albright. (bot1) (Entered: 03/25/2022) (1)
Mar 24, 2022	90	MOTION to Appear Pro Hac Vice by Aden M. Allen on behalf of Nicole Regna ( Filing fee $ 100 receipt number 0542-15853119) by on behalf of Laboratory Corporation of America Holdings. (Attachments: # 1 Proposed Order)(Allen, Aden) (Entered: 03/24/2022) (Main Document) (3)
Mar 24, 2022	90	MOTION to Appear Pro Hac Vice by Aden M. Allen on behalf of Nicole Regna ( Filing fee $ 100 receipt number 0542-15853119) by on behalf of Laboratory Corporation of America Holdings. (Attachments: # 1 Proposed Order)(Allen, Aden) (Entered: 03/24/2022) (Proposed Order) (1)
Mar 17, 2022	89	MOTION to Adopt the Courts Previous Supplemental Claim Construction Order by Ravgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Proposed Order)(Petrie, Kyle) (Entered: 03/17/2022) (Main Document) (8)
Mar 17, 2022	89	MOTION to Adopt the Courts Previous Supplemental Claim Construction Order by Ravgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Proposed Order)(Petrie, Kyle) (Entered: 03/17/2022) (Exhibit 1) (11)
Mar 17, 2022	89	MOTION to Adopt the Courts Previous Supplemental Claim Construction Order by Ravgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Proposed Order)(Petrie, Kyle) (Entered: 03/17/2022) (Exhibit 2) (5)
Mar 17, 2022	89	MOTION to Adopt the Courts Previous Supplemental Claim Construction Order by Ravgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Proposed Order)(Petrie, Kyle) (Entered: 03/17/2022) (Exhibit 3) (4)
Mar 17, 2022	89	MOTION to Adopt the Courts Previous Supplemental Claim Construction Order by Ravgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Proposed Order)(Petrie, Kyle) (Entered: 03/17/2022) (Proposed Order) (1)
Mar 1, 2022	87	NOTICE of Filing and Service of Petition for Writ of Mandamus by Laboratory Corporation of America Holdings (Attachments: # 1 Brief Petition for Writ of Mandamus, # 2 Appendix Non-Confidential Appendix)(Allen, Aden) (Entered: 03/01/2022) (Main Document) (3)
Mar 1, 2022	88	Sealed Document: Notice of Filing and Service of Appendix to Petition for Writ of Mandamus (Confidential Version) by Laboratory Corporation of America Holdings (Attachments: # 1 Appendix Confidential Appendix) (Allen, Aden) (Entered: 03/01/2022) (0)
Mar 1, 2022	87	NOTICE of Filing and Service of Petition for Writ of Mandamus by Laboratory Corporation of America Holdings (Attachments: # 1 Brief Petition for Writ of Mandamus, # 2 Appendix Non-Confidential Appendix)(Allen, Aden) (Entered: 03/01/2022) (Brief Petition for Writ of Mandamus) (30)
Mar 1, 2022	87	NOTICE of Filing and Service of Petition for Writ of Mandamus by Laboratory Corporation of America Holdings (Attachments: # 1 Brief Petition for Writ of Mandamus, # 2 Appendix Non-Confidential Appendix)(Allen, Aden) (Entered: 03/01/2022) (Appendix Non-Confidential Appendix) (30)
Feb 25, 2022	86	ORDER GRANTING 85 Motion to Appear Pro Hac Vice for Attorney Naoya Son. Attorney added for Laboratory Corporation of America Holdings. Pursuant to our Administrative Policies and Procedures for Electronic Filing, the attorney hereby granted to practice pro hac vice in this case must register for electronic filing with our court within 10 days of this order, if he/she has not previously done so for a prior case in this District. Signed by Judge Alan D Albright. (bot1) (Entered: 02/25/2022) (1)
Feb 24, 2022	85	MOTION to Appear Pro Hac Vice by Aden M. Allen on behalf of Naoya Son ( Filing fee $ 100 receipt number 0542-15749932) by on behalf of Laboratory Corporation of America Holdings. (Attachments: # 1 Proposed Order)(Allen, Aden) (Entered: 02/24/2022) (Main Document) (3)
Feb 24, 2022	85	MOTION to Appear Pro Hac Vice by Aden M. Allen on behalf of Naoya Son ( Filing fee $ 100 receipt number 0542-15749932) by on behalf of Laboratory Corporation of America Holdings. (Attachments: # 1 Proposed Order)(Allen, Aden) (Entered: 02/24/2022) (Proposed Order) (1)
Jan 28, 2022	81	ORDER DENYING 72 Motion for Leave to File. Signed by Judge Alan D Albright. (jc5) (Entered: 01/28/2022) (7)
Jan 28, 2022	82	SCHEDULING ORDER: Dispositive Motions due by 6/23/2022. Pretrial Conference reset for 8/25/2022 before Judge Alan D Albright. Jury Selection reset for 9/19/2022 before Judge Jeffrey C. Manske. Jury Trial reset for 9/19/2022 before Judge Alan D Albright. Signed by Judge Alan D Albright. (jc5) Modified on 1/28/2022 (jc5). (Entered: 01/28/2022) (4)
Jan 28, 2022	83	ORDER DENYING DEFENDANTS OPPOSED MOTION TO STAY PENDINGRESOLUTION OF INTER PARTES REVIEWS 69 Motion to Stay Case. Signed by Judge Alan D Albright. (jc5) (Entered: 01/28/2022) (1)
Dec 16, 2021	80	RESPONSE Ravgen, Inc.'s Objection to Laboratory Corporation of America Holdings Notice of Supplemental Authority in Support of its Motion to Stay Pending Resolution of Inter Partes Review to 79 Notice (Other) by Ravgen, Inc.. (Luehrs, Benjamin) (Entered: 12/16/2021) (4)
Dec 15, 2021	79	NOTICE of Supplemental Authority by Laboratory Corporation of America Holdings re 69 Opposed MOTION to Stay Case Pending Resolution of Inter Partes Reviews (Attachments: # 1 Exhibit J)(Kim, Olivia) (Entered: 12/15/2021) (Main Document) (4)
Dec 15, 2021	79	NOTICE of Supplemental Authority by Laboratory Corporation of America Holdings re 69 Opposed MOTION to Stay Case Pending Resolution of Inter Partes Reviews (Attachments: # 1 Exhibit J)(Kim, Olivia) (Entered: 12/15/2021) (Exhibit J) (30)
Dec 14, 2021	78	REPLY to Response to Motion, filed by Laboratory Corporation of America Holdings, re 72 MOTION for Leave to File filed by Defendant Laboratory Corporation of America Holdings Motion to Transfer (Kim, Olivia) (Entered: 12/14/2021) (9)
Dec 7, 2021	77	Response in Opposition to Motion, filed by Ravgen, Inc., re 72 MOTION for Leave to File filed by Defendant Laboratory Corporation of America Holdings (Attachments: # 1 Declaration of Benjamin N. Luehrs, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Proposed Order)(Luehrs, Benjamin) (Entered: 12/07/2021) (Main Document) (17)
Dec 7, 2021	77	Response in Opposition to Motion, filed by Ravgen, Inc., re 72 MOTION for Leave to File filed by Defendant Laboratory Corporation of America Holdings (Attachments: # 1 Declaration of Benjamin N. Luehrs, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Proposed Order)(Luehrs, Benjamin) (Entered: 12/07/2021) (Declaration of Benjamin N. Luehrs) (2)
Dec 7, 2021	77	Response in Opposition to Motion, filed by Ravgen, Inc., re 72 MOTION for Leave to File filed by Defendant Laboratory Corporation of America Holdings (Attachments: # 1 Declaration of Benjamin N. Luehrs, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Proposed Order)(Luehrs, Benjamin) (Entered: 12/07/2021) (Exhibit 1) (4)
Dec 7, 2021	77	Response in Opposition to Motion, filed by Ravgen, Inc., re 72 MOTION for Leave to File filed by Defendant Laboratory Corporation of America Holdings (Attachments: # 1 Declaration of Benjamin N. Luehrs, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Proposed Order)(Luehrs, Benjamin) (Entered: 12/07/2021) (Exhibit 2) (3)
Dec 7, 2021	77	Response in Opposition to Motion, filed by Ravgen, Inc., re 72 MOTION for Leave to File filed by Defendant Laboratory Corporation of America Holdings (Attachments: # 1 Declaration of Benjamin N. Luehrs, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Proposed Order)(Luehrs, Benjamin) (Entered: 12/07/2021) (Exhibit 3) (2)
Dec 7, 2021	77	Response in Opposition to Motion, filed by Ravgen, Inc., re 72 MOTION for Leave to File filed by Defendant Laboratory Corporation of America Holdings (Attachments: # 1 Declaration of Benjamin N. Luehrs, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Proposed Order)(Luehrs, Benjamin) (Entered: 12/07/2021) (Proposed Order) (1)
Nov 30, 2021	75	Proposed Scheduling Order Joint Proposed Scheduling Order and Proposed Amended Order Governing Proceedings - Patent Cases by Ravgen, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Luehrs, Benjamin) (Entered: 11/30/2021) (Main Document) (7)
Nov 30, 2021	76	REPLY to Response to Motion, filed by Laboratory Corporation of America Holdings, re 69 Opposed MOTION to Stay Case Pending Resolution of Inter Partes Reviews filed by Defendant Laboratory Corporation of America Holdings (Kim, Olivia) (Entered: 11/30/2021) (9)
Nov 30, 2021	75	Proposed Scheduling Order Joint Proposed Scheduling Order and Proposed Amended Order Governing Proceedings - Patent Cases by Ravgen, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Luehrs, Benjamin) (Entered: 11/30/2021) (Exhibit A) (5)
Nov 30, 2021	75	Proposed Scheduling Order Joint Proposed Scheduling Order and Proposed Amended Order Governing Proceedings - Patent Cases by Ravgen, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Luehrs, Benjamin) (Entered: 11/30/2021) (Exhibit B) (12)
Nov 23, 2021	72	Opposed Motion for Leave to file Opposed MOTION to Transfer Case by Laboratory Corporation of America Holdings. (Attachments: # 1 Appendix 1 (Motion to Transfer), # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D, # 6 Exhibit E, # 7 Exhibit F, # 8 Exhibit G, # 9 Exhibit H, # 10 Exhibit I [FILED UNDER SEAL], # 11 Exhibit J, # 12 Exhibit K, # 13 Exhibit L, # 14 Exhibit M, # 15 Exhibit N, # 16 Exhibit O, # 17 Exhibit P, # 18 Exhibit Q, # 19 Exhibit R, # 20 Exhibit S, # 21 Exhibit T, # 22 Exhibit U, # 23 Exhibit V, # 24 Exhibit W, # 25 Proposed Order Granting Motion to Transfer, # 26 Proposed Order Granting Motion for Leave)(Kim, Olivia) Modified on 11/24/2021: Attachments 2-24 are exhibits for the Motion to Transfer. (ir) (Entered: 11/23/2021) (Main Document) (5)
Nov 23, 2021	73	Response in Opposition to Motion, filed by Ravgen, Inc., re 69 Opposed MOTION to Stay Case Pending Resolution of Inter Partes Reviews filed by Defendant Laboratory Corporation of America Holdings (Attachments: # 1 Declaration of Benjamin N. Luehrs, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19, # 21 Exhibit 20, # 22 Exhibit 21, # 23 Proposed Order)(Luehrs, Benjamin) (Entered: 11/23/2021) (Main Document) (16)
Nov 23, 2021	74	Sealed Document: Exhibit I to Motion to Transfer of 72 Opposed MOTION to Transfer Case by Laboratory Corporation of America Holdings (Kim, Olivia) (Entered: 11/23/2021) (0)
Nov 23, 2021	73	Response in Opposition to Motion, filed by Ravgen, Inc., re 69 Opposed MOTION to Stay Case Pending Resolution of Inter Partes Reviews filed by Defendant Laboratory Corporation of America Holdings (Attachments: # 1 Declaration of Benjamin N. Luehrs, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19, # 21 Exhibit 20, # 22 Exhibit 21, # 23 Proposed Order)(Luehrs, Benjamin) (Entered: 11/23/2021) (Declaration of Benjamin N. Luehrs) (3)
Nov 23, 2021	73	Response in Opposition to Motion, filed by Ravgen, Inc., re 69 Opposed MOTION to Stay Case Pending Resolution of Inter Partes Reviews filed by Defendant Laboratory Corporation of America Holdings (Attachments: # 1 Declaration of Benjamin N. Luehrs, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19, # 21 Exhibit 20, # 22 Exhibit 21, # 23 Proposed Order)(Luehrs, Benjamin) (Entered: 11/23/2021) (Exhibit 1) (9)
Nov 23, 2021	73	Response in Opposition to Motion, filed by Ravgen, Inc., re 69 Opposed MOTION to Stay Case Pending Resolution of Inter Partes Reviews filed by Defendant Laboratory Corporation of America Holdings (Attachments: # 1 Declaration of Benjamin N. Luehrs, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19, # 21 Exhibit 20, # 22 Exhibit 21, # 23 Proposed Order)(Luehrs, Benjamin) (Entered: 11/23/2021) (Exhibit 2) (30)
Nov 23, 2021	73	Response in Opposition to Motion, filed by Ravgen, Inc., re 69 Opposed MOTION to Stay Case Pending Resolution of Inter Partes Reviews filed by Defendant Laboratory Corporation of America Holdings (Attachments: # 1 Declaration of Benjamin N. Luehrs, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19, # 21 Exhibit 20, # 22 Exhibit 21, # 23 Proposed Order)(Luehrs, Benjamin) (Entered: 11/23/2021) (Exhibit 3) (30)
Nov 23, 2021	73	Response in Opposition to Motion, filed by Ravgen, Inc., re 69 Opposed MOTION to Stay Case Pending Resolution of Inter Partes Reviews filed by Defendant Laboratory Corporation of America Holdings (Attachments: # 1 Declaration of Benjamin N. Luehrs, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19, # 21 Exhibit 20, # 22 Exhibit 21, # 23 Proposed Order)(Luehrs, Benjamin) (Entered: 11/23/2021) (Exhibit 4) (30)
Nov 23, 2021	73	Response in Opposition to Motion, filed by Ravgen, Inc., re 69 Opposed MOTION to Stay Case Pending Resolution of Inter Partes Reviews filed by Defendant Laboratory Corporation of America Holdings (Attachments: # 1 Declaration of Benjamin N. Luehrs, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19, # 21 Exhibit 20, # 22 Exhibit 21, # 23 Proposed Order)(Luehrs, Benjamin) (Entered: 11/23/2021) (Exhibit 5) (30)
Nov 23, 2021	73	Response in Opposition to Motion, filed by Ravgen, Inc., re 69 Opposed MOTION to Stay Case Pending Resolution of Inter Partes Reviews filed by Defendant Laboratory Corporation of America Holdings (Attachments: # 1 Declaration of Benjamin N. Luehrs, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19, # 21 Exhibit 20, # 22 Exhibit 21, # 23 Proposed Order)(Luehrs, Benjamin) (Entered: 11/23/2021) (Exhibit 6) (10)
Nov 23, 2021	73	Response in Opposition to Motion, filed by Ravgen, Inc., re 69 Opposed MOTION to Stay Case Pending Resolution of Inter Partes Reviews filed by Defendant Laboratory Corporation of America Holdings (Attachments: # 1 Declaration of Benjamin N. Luehrs, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19, # 21 Exhibit 20, # 22 Exhibit 21, # 23 Proposed Order)(Luehrs, Benjamin) (Entered: 11/23/2021) (Exhibit 7) (11)
Nov 23, 2021	73	Response in Opposition to Motion, filed by Ravgen, Inc., re 69 Opposed MOTION to Stay Case Pending Resolution of Inter Partes Reviews filed by Defendant Laboratory Corporation of America Holdings (Attachments: # 1 Declaration of Benjamin N. Luehrs, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19, # 21 Exhibit 20, # 22 Exhibit 21, # 23 Proposed Order)(Luehrs, Benjamin) (Entered: 11/23/2021) (Exhibit 8) (16)
Nov 23, 2021	73	Response in Opposition to Motion, filed by Ravgen, Inc., re 69 Opposed MOTION to Stay Case Pending Resolution of Inter Partes Reviews filed by Defendant Laboratory Corporation of America Holdings (Attachments: # 1 Declaration of Benjamin N. Luehrs, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19, # 21 Exhibit 20, # 22 Exhibit 21, # 23 Proposed Order)(Luehrs, Benjamin) (Entered: 11/23/2021) (Exhibit 9) (18)
Nov 23, 2021	73	Response in Opposition to Motion, filed by Ravgen, Inc., re 69 Opposed MOTION to Stay Case Pending Resolution of Inter Partes Reviews filed by Defendant Laboratory Corporation of America Holdings (Attachments: # 1 Declaration of Benjamin N. Luehrs, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19, # 21 Exhibit 20, # 22 Exhibit 21, # 23 Proposed Order)(Luehrs, Benjamin) (Entered: 11/23/2021) (Exhibit 10) (20)
Nov 23, 2021	73	Response in Opposition to Motion, filed by Ravgen, Inc., re 69 Opposed MOTION to Stay Case Pending Resolution of Inter Partes Reviews filed by Defendant Laboratory Corporation of America Holdings (Attachments: # 1 Declaration of Benjamin N. Luehrs, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19, # 21 Exhibit 20, # 22 Exhibit 21, # 23 Proposed Order)(Luehrs, Benjamin) (Entered: 11/23/2021) (Exhibit 11) (22)
Nov 23, 2021	73	Response in Opposition to Motion, filed by Ravgen, Inc., re 69 Opposed MOTION to Stay Case Pending Resolution of Inter Partes Reviews filed by Defendant Laboratory Corporation of America Holdings (Attachments: # 1 Declaration of Benjamin N. Luehrs, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19, # 21 Exhibit 20, # 22 Exhibit 21, # 23 Proposed Order)(Luehrs, Benjamin) (Entered: 11/23/2021) (Exhibit 12) (2)
Nov 23, 2021	73	Response in Opposition to Motion, filed by Ravgen, Inc., re 69 Opposed MOTION to Stay Case Pending Resolution of Inter Partes Reviews filed by Defendant Laboratory Corporation of America Holdings (Attachments: # 1 Declaration of Benjamin N. Luehrs, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19, # 21 Exhibit 20, # 22 Exhibit 21, # 23 Proposed Order)(Luehrs, Benjamin) (Entered: 11/23/2021) (Exhibit 13) (2)
Nov 23, 2021	73	Response in Opposition to Motion, filed by Ravgen, Inc., re 69 Opposed MOTION to Stay Case Pending Resolution of Inter Partes Reviews filed by Defendant Laboratory Corporation of America Holdings (Attachments: # 1 Declaration of Benjamin N. Luehrs, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19, # 21 Exhibit 20, # 22 Exhibit 21, # 23 Proposed Order)(Luehrs, Benjamin) (Entered: 11/23/2021) (Exhibit 14) (2)
Nov 23, 2021	73	Response in Opposition to Motion, filed by Ravgen, Inc., re 69 Opposed MOTION to Stay Case Pending Resolution of Inter Partes Reviews filed by Defendant Laboratory Corporation of America Holdings (Attachments: # 1 Declaration of Benjamin N. Luehrs, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19, # 21 Exhibit 20, # 22 Exhibit 21, # 23 Proposed Order)(Luehrs, Benjamin) (Entered: 11/23/2021) (Exhibit 15) (3)
Nov 23, 2021	73	Response in Opposition to Motion, filed by Ravgen, Inc., re 69 Opposed MOTION to Stay Case Pending Resolution of Inter Partes Reviews filed by Defendant Laboratory Corporation of America Holdings (Attachments: # 1 Declaration of Benjamin N. Luehrs, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19, # 21 Exhibit 20, # 22 Exhibit 21, # 23 Proposed Order)(Luehrs, Benjamin) (Entered: 11/23/2021) (Exhibit 16) (3)
Nov 23, 2021	73	Response in Opposition to Motion, filed by Ravgen, Inc., re 69 Opposed MOTION to Stay Case Pending Resolution of Inter Partes Reviews filed by Defendant Laboratory Corporation of America Holdings (Attachments: # 1 Declaration of Benjamin N. Luehrs, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19, # 21 Exhibit 20, # 22 Exhibit 21, # 23 Proposed Order)(Luehrs, Benjamin) (Entered: 11/23/2021) (Exhibit 17) (3)
Nov 23, 2021	73	Response in Opposition to Motion, filed by Ravgen, Inc., re 69 Opposed MOTION to Stay Case Pending Resolution of Inter Partes Reviews filed by Defendant Laboratory Corporation of America Holdings (Attachments: # 1 Declaration of Benjamin N. Luehrs, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19, # 21 Exhibit 20, # 22 Exhibit 21, # 23 Proposed Order)(Luehrs, Benjamin) (Entered: 11/23/2021) (Exhibit 18) (5)
Nov 23, 2021	73	Response in Opposition to Motion, filed by Ravgen, Inc., re 69 Opposed MOTION to Stay Case Pending Resolution of Inter Partes Reviews filed by Defendant Laboratory Corporation of America Holdings (Attachments: # 1 Declaration of Benjamin N. Luehrs, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19, # 21 Exhibit 20, # 22 Exhibit 21, # 23 Proposed Order)(Luehrs, Benjamin) (Entered: 11/23/2021) (Exhibit 19) (3)
Nov 23, 2021	73	Response in Opposition to Motion, filed by Ravgen, Inc., re 69 Opposed MOTION to Stay Case Pending Resolution of Inter Partes Reviews filed by Defendant Laboratory Corporation of America Holdings (Attachments: # 1 Declaration of Benjamin N. Luehrs, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19, # 21 Exhibit 20, # 22 Exhibit 21, # 23 Proposed Order)(Luehrs, Benjamin) (Entered: 11/23/2021) (Exhibit 20) (3)
Nov 23, 2021	73	Response in Opposition to Motion, filed by Ravgen, Inc., re 69 Opposed MOTION to Stay Case Pending Resolution of Inter Partes Reviews filed by Defendant Laboratory Corporation of America Holdings (Attachments: # 1 Declaration of Benjamin N. Luehrs, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19, # 21 Exhibit 20, # 22 Exhibit 21, # 23 Proposed Order)(Luehrs, Benjamin) (Entered: 11/23/2021) (Exhibit 21) (3)
Nov 23, 2021	73	Response in Opposition to Motion, filed by Ravgen, Inc., re 69 Opposed MOTION to Stay Case Pending Resolution of Inter Partes Reviews filed by Defendant Laboratory Corporation of America Holdings (Attachments: # 1 Declaration of Benjamin N. Luehrs, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19, # 21 Exhibit 20, # 22 Exhibit 21, # 23 Proposed Order)(Luehrs, Benjamin) (Entered: 11/23/2021) (Proposed Order) (1)
Nov 23, 2021	72	Opposed Motion for Leave to file Opposed MOTION to Transfer Case by Laboratory Corporation of America Holdings. (Attachments: # 1 Appendix 1 (Motion to Transfer), # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D, # 6 Exhibit E, # 7 Exhibit F, # 8 Exhibit G, # 9 Exhibit H, # 10 Exhibit I [FILED UNDER SEAL], # 11 Exhibit J, # 12 Exhibit K, # 13 Exhibit L, # 14 Exhibit M, # 15 Exhibit N, # 16 Exhibit O, # 17 Exhibit P, # 18 Exhibit Q, # 19 Exhibit R, # 20 Exhibit S, # 21 Exhibit T, # 22 Exhibit U, # 23 Exhibit V, # 24 Exhibit W, # 25 Proposed Order Granting Motion to Transfer, # 26 Proposed Order Granting Motion for Leave)(Kim, Olivia) Modified on 11/24/2021: Attachments 2-24 are exhibits for the Motion to Transfer. (ir) (Entered: 11/23/2021) (Appendix 1) (25)
Nov 23, 2021	72	Opposed Motion for Leave to file Opposed MOTION to Transfer Case by Laboratory Corporation of America Holdings. (Attachments: # 1 Appendix 1 (Motion to Transfer), # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D, # 6 Exhibit E, # 7 Exhibit F, # 8 Exhibit G, # 9 Exhibit H, # 10 Exhibit I [FILED UNDER SEAL], # 11 Exhibit J, # 12 Exhibit K, # 13 Exhibit L, # 14 Exhibit M, # 15 Exhibit N, # 16 Exhibit O, # 17 Exhibit P, # 18 Exhibit Q, # 19 Exhibit R, # 20 Exhibit S, # 21 Exhibit T, # 22 Exhibit U, # 23 Exhibit V, # 24 Exhibit W, # 25 Proposed Order Granting Motion to Transfer, # 26 Proposed Order Granting Motion for Leave)(Kim, Olivia) Modified on 11/24/2021: Attachments 2-24 are exhibits for the Motion to Transfer. (ir) (Entered: 11/23/2021) (Exhibit A) (4)
Nov 23, 2021	72	Opposed Motion for Leave to file Opposed MOTION to Transfer Case by Laboratory Corporation of America Holdings. (Attachments: # 1 Appendix 1 (Motion to Transfer), # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D, # 6 Exhibit E, # 7 Exhibit F, # 8 Exhibit G, # 9 Exhibit H, # 10 Exhibit I [FILED UNDER SEAL], # 11 Exhibit J, # 12 Exhibit K, # 13 Exhibit L, # 14 Exhibit M, # 15 Exhibit N, # 16 Exhibit O, # 17 Exhibit P, # 18 Exhibit Q, # 19 Exhibit R, # 20 Exhibit S, # 21 Exhibit T, # 22 Exhibit U, # 23 Exhibit V, # 24 Exhibit W, # 25 Proposed Order Granting Motion to Transfer, # 26 Proposed Order Granting Motion for Leave)(Kim, Olivia) Modified on 11/24/2021: Attachments 2-24 are exhibits for the Motion to Transfer. (ir) (Entered: 11/23/2021) (Exhibit B) (30)
Nov 23, 2021	72	Opposed Motion for Leave to file Opposed MOTION to Transfer Case by Laboratory Corporation of America Holdings. (Attachments: # 1 Appendix 1 (Motion to Transfer), # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D, # 6 Exhibit E, # 7 Exhibit F, # 8 Exhibit G, # 9 Exhibit H, # 10 Exhibit I [FILED UNDER SEAL], # 11 Exhibit J, # 12 Exhibit K, # 13 Exhibit L, # 14 Exhibit M, # 15 Exhibit N, # 16 Exhibit O, # 17 Exhibit P, # 18 Exhibit Q, # 19 Exhibit R, # 20 Exhibit S, # 21 Exhibit T, # 22 Exhibit U, # 23 Exhibit V, # 24 Exhibit W, # 25 Proposed Order Granting Motion to Transfer, # 26 Proposed Order Granting Motion for Leave)(Kim, Olivia) Modified on 11/24/2021: Attachments 2-24 are exhibits for the Motion to Transfer. (ir) (Entered: 11/23/2021) (Exhibit C) (3)
Nov 23, 2021	72	Opposed Motion for Leave to file Opposed MOTION to Transfer Case by Laboratory Corporation of America Holdings. (Attachments: # 1 Appendix 1 (Motion to Transfer), # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D, # 6 Exhibit E, # 7 Exhibit F, # 8 Exhibit G, # 9 Exhibit H, # 10 Exhibit I [FILED UNDER SEAL], # 11 Exhibit J, # 12 Exhibit K, # 13 Exhibit L, # 14 Exhibit M, # 15 Exhibit N, # 16 Exhibit O, # 17 Exhibit P, # 18 Exhibit Q, # 19 Exhibit R, # 20 Exhibit S, # 21 Exhibit T, # 22 Exhibit U, # 23 Exhibit V, # 24 Exhibit W, # 25 Proposed Order Granting Motion to Transfer, # 26 Proposed Order Granting Motion for Leave)(Kim, Olivia) Modified on 11/24/2021: Attachments 2-24 are exhibits for the Motion to Transfer. (ir) (Entered: 11/23/2021) (Exhibit D) (10)
Nov 23, 2021	72	Opposed Motion for Leave to file Opposed MOTION to Transfer Case by Laboratory Corporation of America Holdings. (Attachments: # 1 Appendix 1 (Motion to Transfer), # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D, # 6 Exhibit E, # 7 Exhibit F, # 8 Exhibit G, # 9 Exhibit H, # 10 Exhibit I [FILED UNDER SEAL], # 11 Exhibit J, # 12 Exhibit K, # 13 Exhibit L, # 14 Exhibit M, # 15 Exhibit N, # 16 Exhibit O, # 17 Exhibit P, # 18 Exhibit Q, # 19 Exhibit R, # 20 Exhibit S, # 21 Exhibit T, # 22 Exhibit U, # 23 Exhibit V, # 24 Exhibit W, # 25 Proposed Order Granting Motion to Transfer, # 26 Proposed Order Granting Motion for Leave)(Kim, Olivia) Modified on 11/24/2021: Attachments 2-24 are exhibits for the Motion to Transfer. (ir) (Entered: 11/23/2021) (Exhibit E) (30)
Nov 23, 2021	72	Opposed Motion for Leave to file Opposed MOTION to Transfer Case by Laboratory Corporation of America Holdings. (Attachments: # 1 Appendix 1 (Motion to Transfer), # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D, # 6 Exhibit E, # 7 Exhibit F, # 8 Exhibit G, # 9 Exhibit H, # 10 Exhibit I [FILED UNDER SEAL], # 11 Exhibit J, # 12 Exhibit K, # 13 Exhibit L, # 14 Exhibit M, # 15 Exhibit N, # 16 Exhibit O, # 17 Exhibit P, # 18 Exhibit Q, # 19 Exhibit R, # 20 Exhibit S, # 21 Exhibit T, # 22 Exhibit U, # 23 Exhibit V, # 24 Exhibit W, # 25 Proposed Order Granting Motion to Transfer, # 26 Proposed Order Granting Motion for Leave)(Kim, Olivia) Modified on 11/24/2021: Attachments 2-24 are exhibits for the Motion to Transfer. (ir) (Entered: 11/23/2021) (Exhibit F) (11)
Nov 23, 2021	72	Opposed Motion for Leave to file Opposed MOTION to Transfer Case by Laboratory Corporation of America Holdings. (Attachments: # 1 Appendix 1 (Motion to Transfer), # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D, # 6 Exhibit E, # 7 Exhibit F, # 8 Exhibit G, # 9 Exhibit H, # 10 Exhibit I [FILED UNDER SEAL], # 11 Exhibit J, # 12 Exhibit K, # 13 Exhibit L, # 14 Exhibit M, # 15 Exhibit N, # 16 Exhibit O, # 17 Exhibit P, # 18 Exhibit Q, # 19 Exhibit R, # 20 Exhibit S, # 21 Exhibit T, # 22 Exhibit U, # 23 Exhibit V, # 24 Exhibit W, # 25 Proposed Order Granting Motion to Transfer, # 26 Proposed Order Granting Motion for Leave)(Kim, Olivia) Modified on 11/24/2021: Attachments 2-24 are exhibits for the Motion to Transfer. (ir) (Entered: 11/23/2021) (Exhibit G) (26)
Nov 23, 2021	72	Opposed Motion for Leave to file Opposed MOTION to Transfer Case by Laboratory Corporation of America Holdings. (Attachments: # 1 Appendix 1 (Motion to Transfer), # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D, # 6 Exhibit E, # 7 Exhibit F, # 8 Exhibit G, # 9 Exhibit H, # 10 Exhibit I [FILED UNDER SEAL], # 11 Exhibit J, # 12 Exhibit K, # 13 Exhibit L, # 14 Exhibit M, # 15 Exhibit N, # 16 Exhibit O, # 17 Exhibit P, # 18 Exhibit Q, # 19 Exhibit R, # 20 Exhibit S, # 21 Exhibit T, # 22 Exhibit U, # 23 Exhibit V, # 24 Exhibit W, # 25 Proposed Order Granting Motion to Transfer, # 26 Proposed Order Granting Motion for Leave)(Kim, Olivia) Modified on 11/24/2021: Attachments 2-24 are exhibits for the Motion to Transfer. (ir) (Entered: 11/23/2021) (Exhibit H) (25)
Nov 23, 2021	72	Opposed Motion for Leave to file Opposed MOTION to Transfer Case by Laboratory Corporation of America Holdings. (Attachments: # 1 Appendix 1 (Motion to Transfer), # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D, # 6 Exhibit E, # 7 Exhibit F, # 8 Exhibit G, # 9 Exhibit H, # 10 Exhibit I [FILED UNDER SEAL], # 11 Exhibit J, # 12 Exhibit K, # 13 Exhibit L, # 14 Exhibit M, # 15 Exhibit N, # 16 Exhibit O, # 17 Exhibit P, # 18 Exhibit Q, # 19 Exhibit R, # 20 Exhibit S, # 21 Exhibit T, # 22 Exhibit U, # 23 Exhibit V, # 24 Exhibit W, # 25 Proposed Order Granting Motion to Transfer, # 26 Proposed Order Granting Motion for Leave)(Kim, Olivia) Modified on 11/24/2021: Attachments 2-24 are exhibits for the Motion to Transfer. (ir) (Entered: 11/23/2021) (Exhibit I [FILED UNDER SEAL]) (2)
Nov 23, 2021	72	Opposed Motion for Leave to file Opposed MOTION to Transfer Case by Laboratory Corporation of America Holdings. (Attachments: # 1 Appendix 1 (Motion to Transfer), # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D, # 6 Exhibit E, # 7 Exhibit F, # 8 Exhibit G, # 9 Exhibit H, # 10 Exhibit I [FILED UNDER SEAL], # 11 Exhibit J, # 12 Exhibit K, # 13 Exhibit L, # 14 Exhibit M, # 15 Exhibit N, # 16 Exhibit O, # 17 Exhibit P, # 18 Exhibit Q, # 19 Exhibit R, # 20 Exhibit S, # 21 Exhibit T, # 22 Exhibit U, # 23 Exhibit V, # 24 Exhibit W, # 25 Proposed Order Granting Motion to Transfer, # 26 Proposed Order Granting Motion for Leave)(Kim, Olivia) Modified on 11/24/2021: Attachments 2-24 are exhibits for the Motion to Transfer. (ir) (Entered: 11/23/2021) (Exhibit J) (18)
Nov 23, 2021	72	Opposed Motion for Leave to file Opposed MOTION to Transfer Case by Laboratory Corporation of America Holdings. (Attachments: # 1 Appendix 1 (Motion to Transfer), # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D, # 6 Exhibit E, # 7 Exhibit F, # 8 Exhibit G, # 9 Exhibit H, # 10 Exhibit I [FILED UNDER SEAL], # 11 Exhibit J, # 12 Exhibit K, # 13 Exhibit L, # 14 Exhibit M, # 15 Exhibit N, # 16 Exhibit O, # 17 Exhibit P, # 18 Exhibit Q, # 19 Exhibit R, # 20 Exhibit S, # 21 Exhibit T, # 22 Exhibit U, # 23 Exhibit V, # 24 Exhibit W, # 25 Proposed Order Granting Motion to Transfer, # 26 Proposed Order Granting Motion for Leave)(Kim, Olivia) Modified on 11/24/2021: Attachments 2-24 are exhibits for the Motion to Transfer. (ir) (Entered: 11/23/2021) (Exhibit K) (30)
Nov 23, 2021	72	Opposed Motion for Leave to file Opposed MOTION to Transfer Case by Laboratory Corporation of America Holdings. (Attachments: # 1 Appendix 1 (Motion to Transfer), # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D, # 6 Exhibit E, # 7 Exhibit F, # 8 Exhibit G, # 9 Exhibit H, # 10 Exhibit I [FILED UNDER SEAL], # 11 Exhibit J, # 12 Exhibit K, # 13 Exhibit L, # 14 Exhibit M, # 15 Exhibit N, # 16 Exhibit O, # 17 Exhibit P, # 18 Exhibit Q, # 19 Exhibit R, # 20 Exhibit S, # 21 Exhibit T, # 22 Exhibit U, # 23 Exhibit V, # 24 Exhibit W, # 25 Proposed Order Granting Motion to Transfer, # 26 Proposed Order Granting Motion for Leave)(Kim, Olivia) Modified on 11/24/2021: Attachments 2-24 are exhibits for the Motion to Transfer. (ir) (Entered: 11/23/2021) (Exhibit L) (10)
Nov 23, 2021	72	Opposed Motion for Leave to file Opposed MOTION to Transfer Case by Laboratory Corporation of America Holdings. (Attachments: # 1 Appendix 1 (Motion to Transfer), # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D, # 6 Exhibit E, # 7 Exhibit F, # 8 Exhibit G, # 9 Exhibit H, # 10 Exhibit I [FILED UNDER SEAL], # 11 Exhibit J, # 12 Exhibit K, # 13 Exhibit L, # 14 Exhibit M, # 15 Exhibit N, # 16 Exhibit O, # 17 Exhibit P, # 18 Exhibit Q, # 19 Exhibit R, # 20 Exhibit S, # 21 Exhibit T, # 22 Exhibit U, # 23 Exhibit V, # 24 Exhibit W, # 25 Proposed Order Granting Motion to Transfer, # 26 Proposed Order Granting Motion for Leave)(Kim, Olivia) Modified on 11/24/2021: Attachments 2-24 are exhibits for the Motion to Transfer. (ir) (Entered: 11/23/2021) (Exhibit M) (30)
Nov 23, 2021	72	Opposed Motion for Leave to file Opposed MOTION to Transfer Case by Laboratory Corporation of America Holdings. (Attachments: # 1 Appendix 1 (Motion to Transfer), # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D, # 6 Exhibit E, # 7 Exhibit F, # 8 Exhibit G, # 9 Exhibit H, # 10 Exhibit I [FILED UNDER SEAL], # 11 Exhibit J, # 12 Exhibit K, # 13 Exhibit L, # 14 Exhibit M, # 15 Exhibit N, # 16 Exhibit O, # 17 Exhibit P, # 18 Exhibit Q, # 19 Exhibit R, # 20 Exhibit S, # 21 Exhibit T, # 22 Exhibit U, # 23 Exhibit V, # 24 Exhibit W, # 25 Proposed Order Granting Motion to Transfer, # 26 Proposed Order Granting Motion for Leave)(Kim, Olivia) Modified on 11/24/2021: Attachments 2-24 are exhibits for the Motion to Transfer. (ir) (Entered: 11/23/2021) (Exhibit N) (3)
Nov 23, 2021	72	Opposed Motion for Leave to file Opposed MOTION to Transfer Case by Laboratory Corporation of America Holdings. (Attachments: # 1 Appendix 1 (Motion to Transfer), # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D, # 6 Exhibit E, # 7 Exhibit F, # 8 Exhibit G, # 9 Exhibit H, # 10 Exhibit I [FILED UNDER SEAL], # 11 Exhibit J, # 12 Exhibit K, # 13 Exhibit L, # 14 Exhibit M, # 15 Exhibit N, # 16 Exhibit O, # 17 Exhibit P, # 18 Exhibit Q, # 19 Exhibit R, # 20 Exhibit S, # 21 Exhibit T, # 22 Exhibit U, # 23 Exhibit V, # 24 Exhibit W, # 25 Proposed Order Granting Motion to Transfer, # 26 Proposed Order Granting Motion for Leave)(Kim, Olivia) Modified on 11/24/2021: Attachments 2-24 are exhibits for the Motion to Transfer. (ir) (Entered: 11/23/2021) (Exhibit O) (2)
Nov 23, 2021	72	Opposed Motion for Leave to file Opposed MOTION to Transfer Case by Laboratory Corporation of America Holdings. (Attachments: # 1 Appendix 1 (Motion to Transfer), # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D, # 6 Exhibit E, # 7 Exhibit F, # 8 Exhibit G, # 9 Exhibit H, # 10 Exhibit I [FILED UNDER SEAL], # 11 Exhibit J, # 12 Exhibit K, # 13 Exhibit L, # 14 Exhibit M, # 15 Exhibit N, # 16 Exhibit O, # 17 Exhibit P, # 18 Exhibit Q, # 19 Exhibit R, # 20 Exhibit S, # 21 Exhibit T, # 22 Exhibit U, # 23 Exhibit V, # 24 Exhibit W, # 25 Proposed Order Granting Motion to Transfer, # 26 Proposed Order Granting Motion for Leave)(Kim, Olivia) Modified on 11/24/2021: Attachments 2-24 are exhibits for the Motion to Transfer. (ir) (Entered: 11/23/2021) (Exhibit P) (2)
Nov 23, 2021	72	Opposed Motion for Leave to file Opposed MOTION to Transfer Case by Laboratory Corporation of America Holdings. (Attachments: # 1 Appendix 1 (Motion to Transfer), # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D, # 6 Exhibit E, # 7 Exhibit F, # 8 Exhibit G, # 9 Exhibit H, # 10 Exhibit I [FILED UNDER SEAL], # 11 Exhibit J, # 12 Exhibit K, # 13 Exhibit L, # 14 Exhibit M, # 15 Exhibit N, # 16 Exhibit O, # 17 Exhibit P, # 18 Exhibit Q, # 19 Exhibit R, # 20 Exhibit S, # 21 Exhibit T, # 22 Exhibit U, # 23 Exhibit V, # 24 Exhibit W, # 25 Proposed Order Granting Motion to Transfer, # 26 Proposed Order Granting Motion for Leave)(Kim, Olivia) Modified on 11/24/2021: Attachments 2-24 are exhibits for the Motion to Transfer. (ir) (Entered: 11/23/2021) (Exhibit Q) (2)
Nov 23, 2021	72	Opposed Motion for Leave to file Opposed MOTION to Transfer Case by Laboratory Corporation of America Holdings. (Attachments: # 1 Appendix 1 (Motion to Transfer), # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D, # 6 Exhibit E, # 7 Exhibit F, # 8 Exhibit G, # 9 Exhibit H, # 10 Exhibit I [FILED UNDER SEAL], # 11 Exhibit J, # 12 Exhibit K, # 13 Exhibit L, # 14 Exhibit M, # 15 Exhibit N, # 16 Exhibit O, # 17 Exhibit P, # 18 Exhibit Q, # 19 Exhibit R, # 20 Exhibit S, # 21 Exhibit T, # 22 Exhibit U, # 23 Exhibit V, # 24 Exhibit W, # 25 Proposed Order Granting Motion to Transfer, # 26 Proposed Order Granting Motion for Leave)(Kim, Olivia) Modified on 11/24/2021: Attachments 2-24 are exhibits for the Motion to Transfer. (ir) (Entered: 11/23/2021) (Exhibit R) (2)
Nov 23, 2021	72	Opposed Motion for Leave to file Opposed MOTION to Transfer Case by Laboratory Corporation of America Holdings. (Attachments: # 1 Appendix 1 (Motion to Transfer), # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D, # 6 Exhibit E, # 7 Exhibit F, # 8 Exhibit G, # 9 Exhibit H, # 10 Exhibit I [FILED UNDER SEAL], # 11 Exhibit J, # 12 Exhibit K, # 13 Exhibit L, # 14 Exhibit M, # 15 Exhibit N, # 16 Exhibit O, # 17 Exhibit P, # 18 Exhibit Q, # 19 Exhibit R, # 20 Exhibit S, # 21 Exhibit T, # 22 Exhibit U, # 23 Exhibit V, # 24 Exhibit W, # 25 Proposed Order Granting Motion to Transfer, # 26 Proposed Order Granting Motion for Leave)(Kim, Olivia) Modified on 11/24/2021: Attachments 2-24 are exhibits for the Motion to Transfer. (ir) (Entered: 11/23/2021) (Exhibit S) (2)
Nov 23, 2021	72	Opposed Motion for Leave to file Opposed MOTION to Transfer Case by Laboratory Corporation of America Holdings. (Attachments: # 1 Appendix 1 (Motion to Transfer), # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D, # 6 Exhibit E, # 7 Exhibit F, # 8 Exhibit G, # 9 Exhibit H, # 10 Exhibit I [FILED UNDER SEAL], # 11 Exhibit J, # 12 Exhibit K, # 13 Exhibit L, # 14 Exhibit M, # 15 Exhibit N, # 16 Exhibit O, # 17 Exhibit P, # 18 Exhibit Q, # 19 Exhibit R, # 20 Exhibit S, # 21 Exhibit T, # 22 Exhibit U, # 23 Exhibit V, # 24 Exhibit W, # 25 Proposed Order Granting Motion to Transfer, # 26 Proposed Order Granting Motion for Leave)(Kim, Olivia) Modified on 11/24/2021: Attachments 2-24 are exhibits for the Motion to Transfer. (ir) (Entered: 11/23/2021) (Exhibit T) (2)
Nov 23, 2021	72	Opposed Motion for Leave to file Opposed MOTION to Transfer Case by Laboratory Corporation of America Holdings. (Attachments: # 1 Appendix 1 (Motion to Transfer), # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D, # 6 Exhibit E, # 7 Exhibit F, # 8 Exhibit G, # 9 Exhibit H, # 10 Exhibit I [FILED UNDER SEAL], # 11 Exhibit J, # 12 Exhibit K, # 13 Exhibit L, # 14 Exhibit M, # 15 Exhibit N, # 16 Exhibit O, # 17 Exhibit P, # 18 Exhibit Q, # 19 Exhibit R, # 20 Exhibit S, # 21 Exhibit T, # 22 Exhibit U, # 23 Exhibit V, # 24 Exhibit W, # 25 Proposed Order Granting Motion to Transfer, # 26 Proposed Order Granting Motion for Leave)(Kim, Olivia) Modified on 11/24/2021: Attachments 2-24 are exhibits for the Motion to Transfer. (ir) (Entered: 11/23/2021) (Exhibit U) (2)
Nov 23, 2021	72	Opposed Motion for Leave to file Opposed MOTION to Transfer Case by Laboratory Corporation of America Holdings. (Attachments: # 1 Appendix 1 (Motion to Transfer), # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D, # 6 Exhibit E, # 7 Exhibit F, # 8 Exhibit G, # 9 Exhibit H, # 10 Exhibit I [FILED UNDER SEAL], # 11 Exhibit J, # 12 Exhibit K, # 13 Exhibit L, # 14 Exhibit M, # 15 Exhibit N, # 16 Exhibit O, # 17 Exhibit P, # 18 Exhibit Q, # 19 Exhibit R, # 20 Exhibit S, # 21 Exhibit T, # 22 Exhibit U, # 23 Exhibit V, # 24 Exhibit W, # 25 Proposed Order Granting Motion to Transfer, # 26 Proposed Order Granting Motion for Leave)(Kim, Olivia) Modified on 11/24/2021: Attachments 2-24 are exhibits for the Motion to Transfer. (ir) (Entered: 11/23/2021) (Exhibit V) (2)
Nov 23, 2021	72	Opposed Motion for Leave to file Opposed MOTION to Transfer Case by Laboratory Corporation of America Holdings. (Attachments: # 1 Appendix 1 (Motion to Transfer), # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D, # 6 Exhibit E, # 7 Exhibit F, # 8 Exhibit G, # 9 Exhibit H, # 10 Exhibit I [FILED UNDER SEAL], # 11 Exhibit J, # 12 Exhibit K, # 13 Exhibit L, # 14 Exhibit M, # 15 Exhibit N, # 16 Exhibit O, # 17 Exhibit P, # 18 Exhibit Q, # 19 Exhibit R, # 20 Exhibit S, # 21 Exhibit T, # 22 Exhibit U, # 23 Exhibit V, # 24 Exhibit W, # 25 Proposed Order Granting Motion to Transfer, # 26 Proposed Order Granting Motion for Leave)(Kim, Olivia) Modified on 11/24/2021: Attachments 2-24 are exhibits for the Motion to Transfer. (ir) (Entered: 11/23/2021) (Exhibit W) (4)
Nov 23, 2021	72	Opposed Motion for Leave to file Opposed MOTION to Transfer Case by Laboratory Corporation of America Holdings. (Attachments: # 1 Appendix 1 (Motion to Transfer), # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D, # 6 Exhibit E, # 7 Exhibit F, # 8 Exhibit G, # 9 Exhibit H, # 10 Exhibit I [FILED UNDER SEAL], # 11 Exhibit J, # 12 Exhibit K, # 13 Exhibit L, # 14 Exhibit M, # 15 Exhibit N, # 16 Exhibit O, # 17 Exhibit P, # 18 Exhibit Q, # 19 Exhibit R, # 20 Exhibit S, # 21 Exhibit T, # 22 Exhibit U, # 23 Exhibit V, # 24 Exhibit W, # 25 Proposed Order Granting Motion to Transfer, # 26 Proposed Order Granting Motion for Leave)(Kim, Olivia) Modified on 11/24/2021: Attachments 2-24 are exhibits for the Motion to Transfer. (ir) (Entered: 11/23/2021) (Proposed Order Granting Motion to Transfer) (1)
Nov 23, 2021	72	Opposed Motion for Leave to file Opposed MOTION to Transfer Case by Laboratory Corporation of America Holdings. (Attachments: # 1 Appendix 1 (Motion to Transfer), # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D, # 6 Exhibit E, # 7 Exhibit F, # 8 Exhibit G, # 9 Exhibit H, # 10 Exhibit I [FILED UNDER SEAL], # 11 Exhibit J, # 12 Exhibit K, # 13 Exhibit L, # 14 Exhibit M, # 15 Exhibit N, # 16 Exhibit O, # 17 Exhibit P, # 18 Exhibit Q, # 19 Exhibit R, # 20 Exhibit S, # 21 Exhibit T, # 22 Exhibit U, # 23 Exhibit V, # 24 Exhibit W, # 25 Proposed Order Granting Motion to Transfer, # 26 Proposed Order Granting Motion for Leave)(Kim, Olivia) Modified on 11/24/2021: Attachments 2-24 are exhibits for the Motion to Transfer. (ir) (Entered: 11/23/2021) (Proposed Order Granting Motion for Leave) (1)
Nov 17, 2021	70	DEFICIENCY NOTICE: re 69 Opposed MOTION to Stay Case Pending Resolution of Inter Partes Reviews. Pursuant to the Standing Order Governing Proceedings Dated 10/8/2021. The proposed Order shall omit the word Proposed from the title. (ir) (Entered: 11/17/2021) (1)
Nov 17, 2021	71	ATTACHMENT Corrected Proposed Order to 69 Opposed MOTION to Stay Case Pending Resolution of Inter Partes Reviews by Laboratory Corporation of America Holdings. (Kim, Olivia) (Entered: 11/17/2021) (1)
Nov 16, 2021	69	Opposed MOTION to Stay Case Pending Resolution of Inter Partes Reviews by Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Proposed Order)(Kim, Olivia) (Entered: 11/16/2021) (Main Document) (18)
Nov 16, 2021	69	Opposed MOTION to Stay Case Pending Resolution of Inter Partes Reviews by Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Proposed Order)(Kim, Olivia) (Entered: 11/16/2021) (Exhibit A) (30)
Nov 16, 2021	69	Opposed MOTION to Stay Case Pending Resolution of Inter Partes Reviews by Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Proposed Order)(Kim, Olivia) (Entered: 11/16/2021) (Exhibit B) (30)
Nov 16, 2021	69	Opposed MOTION to Stay Case Pending Resolution of Inter Partes Reviews by Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Proposed Order)(Kim, Olivia) (Entered: 11/16/2021) (Exhibit C) (6)
Nov 16, 2021	69	Opposed MOTION to Stay Case Pending Resolution of Inter Partes Reviews by Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Proposed Order)(Kim, Olivia) (Entered: 11/16/2021) (Exhibit D) (30)
Nov 16, 2021	69	Opposed MOTION to Stay Case Pending Resolution of Inter Partes Reviews by Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Proposed Order)(Kim, Olivia) (Entered: 11/16/2021) (Exhibit E) (30)
Nov 16, 2021	69	Opposed MOTION to Stay Case Pending Resolution of Inter Partes Reviews by Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Proposed Order)(Kim, Olivia) (Entered: 11/16/2021) (Exhibit F) (11)
Nov 16, 2021	69	Opposed MOTION to Stay Case Pending Resolution of Inter Partes Reviews by Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Proposed Order)(Kim, Olivia) (Entered: 11/16/2021) (Exhibit G) (10)
Nov 16, 2021	69	Opposed MOTION to Stay Case Pending Resolution of Inter Partes Reviews by Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Proposed Order)(Kim, Olivia) (Entered: 11/16/2021) (Exhibit H) (13)
Nov 16, 2021	69	Opposed MOTION to Stay Case Pending Resolution of Inter Partes Reviews by Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Proposed Order)(Kim, Olivia) (Entered: 11/16/2021) (Exhibit I) (30)
Nov 16, 2021	69	Opposed MOTION to Stay Case Pending Resolution of Inter Partes Reviews by Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Proposed Order)(Kim, Olivia) (Entered: 11/16/2021) (Proposed Order) (1)
Oct 25, 2021	68	PROTECTIVE ORDER. Signed by Judge Alan D Albright. (ir) (Entered: 10/25/2021) (19)
Oct 22, 2021	67	Joint MOTION for Protective Order JOINT MOTION FOR ENTRY OF STIPULATED PROTECTIVE ORDER by Ravgen, Inc.. (Attachments: # 1 Proposed Order - Stipulated Protective Order)(Luehrs, Benjamin) (Entered: 10/22/2021) (Main Document) (3)
Oct 22, 2021	67	Joint MOTION for Protective Order JOINT MOTION FOR ENTRY OF STIPULATED PROTECTIVE ORDER by Ravgen, Inc.. (Attachments: # 1 Proposed Order - Stipulated Protective Order)(Luehrs, Benjamin) (Entered: 10/22/2021) (Proposed Order - Stipulated Protective Order) (19)
Oct 12, 2021	65	NOTICE of Filing Petitions for Inter Partes Review by Ravgen, Inc. (Limbeek, Kerri-Ann) (Entered: 10/12/2021) (3)
Oct 11, 2021	64	ORDER TO PAY TECHNICAL ADVISOR. Signed by Judge Alan D Albright. (lad) (Entered: 10/12/2021) (1)
Oct 8, 2021	66	Standing Order Regarding Order Governing Proceedings Patent Cases. Signed by Judge Alan D Albright. (Entered: 10/13/2021) (11)
Oct 6, 2021	63	ORDER GRANTING 61 Motion to Appear Pro Hac Vice for Attorney Gabrielle E. Higgins for Ravgen, Inc. Pursuant to our Administrative Policies and Procedures for Electronic Filing, the attorney hereby granted to practice pro hac vice in this case must register for electronic filing with our court within 10 days of this order. Signed by Judge Alan D Albright. (ir) (Entered: 10/06/2021) (1)
Oct 5, 2021	62	CLAIM CONSTRUCTION ORDER. Signed by Judge Alan D Albright. (Attachments: # 1 Memo in Support)(lad) (Main Document 62 replaced on 10/6/2021) (lad). (Attachment 1 replaced on 10/6/2021) (lad). (Entered: 10/05/2021) (Main Document) (2)
Oct 5, 2021	84	MEMORANDUM in support of 62 Claim Construction Order. Signed by Judge Alan D Albright. (lad) (Entered: 02/23/2022) (10)
Oct 5, 2021	62	CLAIM CONSTRUCTION ORDER. Signed by Judge Alan D Albright. (Attachments: # 1 Memo in Support)(lad) (Main Document 62 replaced on 10/6/2021) (lad). (Attachment 1 replaced on 10/6/2021) (lad). (Entered: 10/05/2021) (Memo in Support) (10)
Sep 30, 2021	61	MOTION to Appear Pro Hac Vice by Deron R Dacus (on behalf of Gabrielle E. Higgins) ( Filing fee $ 100 receipt number 0542-15283762) by on behalf of Ravgen, Inc.. (Attachments: # 1 Proposed Order)(Dacus, Deron) (Entered: 09/30/2021) (Main Document) (4)
Sep 30, 2021	61	MOTION to Appear Pro Hac Vice by Deron R Dacus (on behalf of Gabrielle E. Higgins) ( Filing fee $ 100 receipt number 0542-15283762) by on behalf of Ravgen, Inc.. (Attachments: # 1 Proposed Order)(Dacus, Deron) (Entered: 09/30/2021) (Proposed Order) (1)
Sep 28, 2021	60	NOTICE of Attorney Appearance by Benjamin Norenberg Luehrs on behalf of Ravgen, Inc.. Attorney Benjamin Norenberg Luehrs added to party Ravgen, Inc.(pty:pla) (Luehrs, Benjamin) (Entered: 09/28/2021) (2)
Sep 27, 2021	59	ORDER GRANTING 58 Motion to Appear Pro Hac Vice for Attorney Vi T. Tran. Attorney added for Ravgen, Inc. Pursuant to our Administrative Policies and Procedures for Electronic Filing, the attorney hereby granted to practice pro hac vice in this case must register for electronic filing with our court within 10 days of this order, if he/she has not previously done so for a prior case in this District. Signed by Judge Alan D Albright. (jkda) (Entered: 09/27/2021) (1)
Sep 22, 2021	58	MOTION to Appear Pro Hac Vice by Deron R Dacus (on behalf of Vi T. Tran) ( Filing fee $ 100 receipt number 0542-15253813) by on behalf of Ravgen, Inc.. (Attachments: # 1 Proposed Order)(Dacus, Deron) (Entered: 09/22/2021) (Main Document) (3)
Sep 22, 2021	58	MOTION to Appear Pro Hac Vice by Deron R Dacus (on behalf of Vi T. Tran) ( Filing fee $ 100 receipt number 0542-15253813) by on behalf of Ravgen, Inc.. (Attachments: # 1 Proposed Order)(Dacus, Deron) (Entered: 09/22/2021) (Proposed Order) (1)
Sep 21, 2021	57	Transcript filed of Proceedings held on 9-20-21, Proceedings Transcribed: Markman hearing. Court Reporter/Transcriber: Kristie Davis, Telephone number: 254-340-6114. Parties are notified of their duty to review the transcript to ensure compliance with the FRCP 5.2(a)/FRCrP 49.1(a). A copy may be purchased from the court reporter or viewed at the clerk's office public terminal. If redaction is necessary, a Notice of Redaction Request must be filed within 21 days. If no such Notice is filed, the transcript will be made available via PACER without redaction after 90 calendar days. The clerk will mail a copy of this notice to parties not electronically noticed Redaction Request due 10/12/2021, Redacted Transcript Deadline set for 10/22/2021, Release of Transcript Restriction set for 12/20/2021, (kd) (Entered: 09/21/2021) (68)
Sep 20, 2021	56	Minute Entry for proceedings held before Judge Alan D Albright: Markman Hearing held on 9/20/2021. Case called for Markman Hearing for this and companion case. The Court heard argument regarding disputed claim terms. The Court determined that he was going to keep his original preliminary hearing except for one term which the Court asked for both parties to provide more information on. There will be an Order issued with claim term definitions.(Minute entry documents are not available electronically.) (Court Reporter Kristie Davis.)(ir) (Entered: 09/20/2021) (0)
Sep 10, 2021	55	ORDER, (Markman Hearing set for 9/20/2021 02:30 PM before Judge Alan D Albright). Signed by Judge Alan D Albright. (bot1) (Entered: 09/10/2021) (1)
Sep 8, 2021	53	Reply Claim Construction Brief regarding 52 Claim Construction Brief,, by Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit J)(Allen, Aden) (Entered: 09/08/2021) (Main Document) (17)
Sep 8, 2021	54	Joint Claim Construction Brief or Statement by Ravgen, Inc.. (Limbeek, Kerri-Ann) (Entered: 09/08/2021) (6)
Sep 8, 2021	53	Reply Claim Construction Brief regarding 52 Claim Construction Brief,, by Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit J)(Allen, Aden) (Entered: 09/08/2021) (Exhibit J) (30)
Aug 25, 2021	52	Reply Claim Construction Brief by Ravgen, Inc.. (Attachments: # 1 Declaration of Dr. Brian Van Ness in support of Ravgen's Reply Claim Construction Brief, # 2 Exhibit 5 - Excerpt of Ravgen's Preliminary Infringement Contentions, # 3 Exhibit 6 - Excerpts from Aug. 20, 2021 Dep Trans of Dr. Gary D. Fletcher, # 4 Exhibit 7 - Excerpts from Petition for IPR (IPR2021-00902), # 5 Exhibit 8 - Excerpts from Ex. 1002 (IPR2021-01026), # 6 Exhibit 9 - Excerpts from Petition for IPR (IPR2021-01026), # 7 Exhibit 10 - Excerpts from Ex. 1002 (IPR2021-00902), # 8 Exhibit 11 - Excerpts from US Patent No. 10,194,851 (Fletcher Dep Ex. 5))(Limbeek, Kerri-Ann) (Entered: 08/25/2021) (Main Document) (16)
Aug 25, 2021	52	Reply Claim Construction Brief by Ravgen, Inc.. (Attachments: # 1 Declaration of Dr. Brian Van Ness in support of Ravgen's Reply Claim Construction Brief, # 2 Exhibit 5 - Excerpt of Ravgen's Preliminary Infringement Contentions, # 3 Exhibit 6 - Excerpts from Aug. 20, 2021 Dep Trans of Dr. Gary D. Fletcher, # 4 Exhibit 7 - Excerpts from Petition for IPR (IPR2021-00902), # 5 Exhibit 8 - Excerpts from Ex. 1002 (IPR2021-01026), # 6 Exhibit 9 - Excerpts from Petition for IPR (IPR2021-01026), # 7 Exhibit 10 - Excerpts from Ex. 1002 (IPR2021-00902), # 8 Exhibit 11 - Excerpts from US Patent No. 10,194,851 (Fletcher Dep Ex. 5))(Limbeek, Kerri-Ann) (Entered: 08/25/2021) (Declaration of Dr. Brian Van Ness in support of Ravgen's Reply Claim Const) (11)
Aug 25, 2021	52	Reply Claim Construction Brief by Ravgen, Inc.. (Attachments: # 1 Declaration of Dr. Brian Van Ness in support of Ravgen's Reply Claim Construction Brief, # 2 Exhibit 5 - Excerpt of Ravgen's Preliminary Infringement Contentions, # 3 Exhibit 6 - Excerpts from Aug. 20, 2021 Dep Trans of Dr. Gary D. Fletcher, # 4 Exhibit 7 - Excerpts from Petition for IPR (IPR2021-00902), # 5 Exhibit 8 - Excerpts from Ex. 1002 (IPR2021-01026), # 6 Exhibit 9 - Excerpts from Petition for IPR (IPR2021-01026), # 7 Exhibit 10 - Excerpts from Ex. 1002 (IPR2021-00902), # 8 Exhibit 11 - Excerpts from US Patent No. 10,194,851 (Fletcher Dep Ex. 5))(Limbeek, Kerri-Ann) (Entered: 08/25/2021) (Exhibit 5 - Excerpt of Ravgen's Preliminary Infringement Contentions) (6)
Aug 25, 2021	52	Reply Claim Construction Brief by Ravgen, Inc.. (Attachments: # 1 Declaration of Dr. Brian Van Ness in support of Ravgen's Reply Claim Construction Brief, # 2 Exhibit 5 - Excerpt of Ravgen's Preliminary Infringement Contentions, # 3 Exhibit 6 - Excerpts from Aug. 20, 2021 Dep Trans of Dr. Gary D. Fletcher, # 4 Exhibit 7 - Excerpts from Petition for IPR (IPR2021-00902), # 5 Exhibit 8 - Excerpts from Ex. 1002 (IPR2021-01026), # 6 Exhibit 9 - Excerpts from Petition for IPR (IPR2021-01026), # 7 Exhibit 10 - Excerpts from Ex. 1002 (IPR2021-00902), # 8 Exhibit 11 - Excerpts from US Patent No. 10,194,851 (Fletcher Dep Ex. 5))(Limbeek, Kerri-Ann) (Entered: 08/25/2021) (Exhibit 6 - Excerpts from Aug. 20, 2021 Dep Trans of Dr. Gary D. Fletcher) (18)
Aug 25, 2021	52	Reply Claim Construction Brief by Ravgen, Inc.. (Attachments: # 1 Declaration of Dr. Brian Van Ness in support of Ravgen's Reply Claim Construction Brief, # 2 Exhibit 5 - Excerpt of Ravgen's Preliminary Infringement Contentions, # 3 Exhibit 6 - Excerpts from Aug. 20, 2021 Dep Trans of Dr. Gary D. Fletcher, # 4 Exhibit 7 - Excerpts from Petition for IPR (IPR2021-00902), # 5 Exhibit 8 - Excerpts from Ex. 1002 (IPR2021-01026), # 6 Exhibit 9 - Excerpts from Petition for IPR (IPR2021-01026), # 7 Exhibit 10 - Excerpts from Ex. 1002 (IPR2021-00902), # 8 Exhibit 11 - Excerpts from US Patent No. 10,194,851 (Fletcher Dep Ex. 5))(Limbeek, Kerri-Ann) (Entered: 08/25/2021) (Exhibit 7 - Excerpts from Petition for IPR (IPR2021-00902)) (16)
Aug 25, 2021	52	Reply Claim Construction Brief by Ravgen, Inc.. (Attachments: # 1 Declaration of Dr. Brian Van Ness in support of Ravgen's Reply Claim Construction Brief, # 2 Exhibit 5 - Excerpt of Ravgen's Preliminary Infringement Contentions, # 3 Exhibit 6 - Excerpts from Aug. 20, 2021 Dep Trans of Dr. Gary D. Fletcher, # 4 Exhibit 7 - Excerpts from Petition for IPR (IPR2021-00902), # 5 Exhibit 8 - Excerpts from Ex. 1002 (IPR2021-01026), # 6 Exhibit 9 - Excerpts from Petition for IPR (IPR2021-01026), # 7 Exhibit 10 - Excerpts from Ex. 1002 (IPR2021-00902), # 8 Exhibit 11 - Excerpts from US Patent No. 10,194,851 (Fletcher Dep Ex. 5))(Limbeek, Kerri-Ann) (Entered: 08/25/2021) (Exhibit 8 - Excerpts from Ex. 1002 (IPR2021-01026)) (21)
Aug 25, 2021	52	Reply Claim Construction Brief by Ravgen, Inc.. (Attachments: # 1 Declaration of Dr. Brian Van Ness in support of Ravgen's Reply Claim Construction Brief, # 2 Exhibit 5 - Excerpt of Ravgen's Preliminary Infringement Contentions, # 3 Exhibit 6 - Excerpts from Aug. 20, 2021 Dep Trans of Dr. Gary D. Fletcher, # 4 Exhibit 7 - Excerpts from Petition for IPR (IPR2021-00902), # 5 Exhibit 8 - Excerpts from Ex. 1002 (IPR2021-01026), # 6 Exhibit 9 - Excerpts from Petition for IPR (IPR2021-01026), # 7 Exhibit 10 - Excerpts from Ex. 1002 (IPR2021-00902), # 8 Exhibit 11 - Excerpts from US Patent No. 10,194,851 (Fletcher Dep Ex. 5))(Limbeek, Kerri-Ann) (Entered: 08/25/2021) (Exhibit 9 - Excerpts from Petition for IPR (IPR2021-01026)) (13)
Aug 25, 2021	52	Reply Claim Construction Brief by Ravgen, Inc.. (Attachments: # 1 Declaration of Dr. Brian Van Ness in support of Ravgen's Reply Claim Construction Brief, # 2 Exhibit 5 - Excerpt of Ravgen's Preliminary Infringement Contentions, # 3 Exhibit 6 - Excerpts from Aug. 20, 2021 Dep Trans of Dr. Gary D. Fletcher, # 4 Exhibit 7 - Excerpts from Petition for IPR (IPR2021-00902), # 5 Exhibit 8 - Excerpts from Ex. 1002 (IPR2021-01026), # 6 Exhibit 9 - Excerpts from Petition for IPR (IPR2021-01026), # 7 Exhibit 10 - Excerpts from Ex. 1002 (IPR2021-00902), # 8 Exhibit 11 - Excerpts from US Patent No. 10,194,851 (Fletcher Dep Ex. 5))(Limbeek, Kerri-Ann) (Entered: 08/25/2021) (Exhibit 10 - Excerpts from Ex. 1002 (IPR2021-00902)) (13)
Aug 25, 2021	52	Reply Claim Construction Brief by Ravgen, Inc.. (Attachments: # 1 Declaration of Dr. Brian Van Ness in support of Ravgen's Reply Claim Construction Brief, # 2 Exhibit 5 - Excerpt of Ravgen's Preliminary Infringement Contentions, # 3 Exhibit 6 - Excerpts from Aug. 20, 2021 Dep Trans of Dr. Gary D. Fletcher, # 4 Exhibit 7 - Excerpts from Petition for IPR (IPR2021-00902), # 5 Exhibit 8 - Excerpts from Ex. 1002 (IPR2021-01026), # 6 Exhibit 9 - Excerpts from Petition for IPR (IPR2021-01026), # 7 Exhibit 10 - Excerpts from Ex. 1002 (IPR2021-00902), # 8 Exhibit 11 - Excerpts from US Patent No. 10,194,851 (Fletcher Dep Ex. 5))(Limbeek, Kerri-Ann) (Entered: 08/25/2021) (Exhibit 11 - Excerpts from US Patent No. 10,194,851 (Fletcher Dep Ex. 5)) (2)
Aug 11, 2021	50	BRIEF regarding 48 Claim Construction Brief,, by Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I)(Allen, Aden) (Entered: 08/11/2021) (Main Document) (28)
Aug 11, 2021	50	BRIEF regarding 48 Claim Construction Brief,, by Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I)(Allen, Aden) (Entered: 08/11/2021) (Exhibit A) (17)
Aug 11, 2021	50	BRIEF regarding 48 Claim Construction Brief,, by Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I)(Allen, Aden) (Entered: 08/11/2021) (Exhibit B) (10)
Aug 11, 2021	50	BRIEF regarding 48 Claim Construction Brief,, by Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I)(Allen, Aden) (Entered: 08/11/2021) (Exhibit C) (30)
Aug 11, 2021	50	BRIEF regarding 48 Claim Construction Brief,, by Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I)(Allen, Aden) (Entered: 08/11/2021) (Exhibit D) (8)
Aug 11, 2021	50	BRIEF regarding 48 Claim Construction Brief,, by Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I)(Allen, Aden) (Entered: 08/11/2021) (Exhibit E) (27)
Aug 11, 2021	50	BRIEF regarding 48 Claim Construction Brief,, by Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I)(Allen, Aden) (Entered: 08/11/2021) (Exhibit F) (4)
Aug 11, 2021	50	BRIEF regarding 48 Claim Construction Brief,, by Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I)(Allen, Aden) (Entered: 08/11/2021) (Exhibit G) (4)
Aug 11, 2021	50	BRIEF regarding 48 Claim Construction Brief,, by Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I)(Allen, Aden) (Entered: 08/11/2021) (Exhibit H) (4)
Aug 11, 2021	50	BRIEF regarding 48 Claim Construction Brief,, by Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I)(Allen, Aden) (Entered: 08/11/2021) (Exhibit I) (12)
Aug 10, 2021	51	ORDER APPOINTING TECHNICAL ADVISOR. Signed by Judge Alan D Albright. (ir) (Entered: 08/12/2021) (2)
Aug 3, 2021	49	NOTICE of Filing Petitions for Inter Partes Review PLAINTIFF'S NOTICE OF FILING OF PETITIONS FOR INTER PARTES REVIEW by Ravgen, Inc. (Limbeek, Kerri-Ann) (Entered: 08/03/2021) (3)
Jul 21, 2021	48	Opening Claim Construction Brief by Ravgen, Inc.. (Attachments: # 1 Exhibit 1 (Part 1 of 2) - '277 Patent, # 2 Exhibit 1 (Part 2 of 2) - '277 Patent, # 3 Exhibit 2 (Part 1 of 2) - '720 Patent, # 4 Exhibit 2 (Part 2 of 2) - '720 Patent, # 5 Exhibit 3 - '277 File History Excerpt 2007-05-30 Amendment, # 6 Exhibit 4 - LabCorp Preliminary Invalidity Contentions, # 7 Declaration of Dr. Van Ness in Support of Plaintiff's Claim Construction Brief, # 8 Exhibit A to Van Ness Declaration)(Limbeek, Kerri-Ann) (Entered: 07/21/2021) (Main Document) (21)
Jul 21, 2021	48	Opening Claim Construction Brief by Ravgen, Inc.. (Attachments: # 1 Exhibit 1 (Part 1 of 2) - '277 Patent, # 2 Exhibit 1 (Part 2 of 2) - '277 Patent, # 3 Exhibit 2 (Part 1 of 2) - '720 Patent, # 4 Exhibit 2 (Part 2 of 2) - '720 Patent, # 5 Exhibit 3 - '277 File History Excerpt 2007-05-30 Amendment, # 6 Exhibit 4 - LabCorp Preliminary Invalidity Contentions, # 7 Declaration of Dr. Van Ness in Support of Plaintiff's Claim Construction Brief, # 8 Exhibit A to Van Ness Declaration)(Limbeek, Kerri-Ann) (Entered: 07/21/2021) (Exhibit 1 (Part 1 of 2) - '277 Patent) (30)
Jul 21, 2021	48	Opening Claim Construction Brief by Ravgen, Inc.. (Attachments: # 1 Exhibit 1 (Part 1 of 2) - '277 Patent, # 2 Exhibit 1 (Part 2 of 2) - '277 Patent, # 3 Exhibit 2 (Part 1 of 2) - '720 Patent, # 4 Exhibit 2 (Part 2 of 2) - '720 Patent, # 5 Exhibit 3 - '277 File History Excerpt 2007-05-30 Amendment, # 6 Exhibit 4 - LabCorp Preliminary Invalidity Contentions, # 7 Declaration of Dr. Van Ness in Support of Plaintiff's Claim Construction Brief, # 8 Exhibit A to Van Ness Declaration)(Limbeek, Kerri-Ann) (Entered: 07/21/2021) (Exhibit 1 (Part 2 of 2) - '277 Patent) (30)
Jul 21, 2021	48	Opening Claim Construction Brief by Ravgen, Inc.. (Attachments: # 1 Exhibit 1 (Part 1 of 2) - '277 Patent, # 2 Exhibit 1 (Part 2 of 2) - '277 Patent, # 3 Exhibit 2 (Part 1 of 2) - '720 Patent, # 4 Exhibit 2 (Part 2 of 2) - '720 Patent, # 5 Exhibit 3 - '277 File History Excerpt 2007-05-30 Amendment, # 6 Exhibit 4 - LabCorp Preliminary Invalidity Contentions, # 7 Declaration of Dr. Van Ness in Support of Plaintiff's Claim Construction Brief, # 8 Exhibit A to Van Ness Declaration)(Limbeek, Kerri-Ann) (Entered: 07/21/2021) (Exhibit 2 (Part 1 of 2) - '720 Patent) (30)
Jul 21, 2021	48	Opening Claim Construction Brief by Ravgen, Inc.. (Attachments: # 1 Exhibit 1 (Part 1 of 2) - '277 Patent, # 2 Exhibit 1 (Part 2 of 2) - '277 Patent, # 3 Exhibit 2 (Part 1 of 2) - '720 Patent, # 4 Exhibit 2 (Part 2 of 2) - '720 Patent, # 5 Exhibit 3 - '277 File History Excerpt 2007-05-30 Amendment, # 6 Exhibit 4 - LabCorp Preliminary Invalidity Contentions, # 7 Declaration of Dr. Van Ness in Support of Plaintiff's Claim Construction Brief, # 8 Exhibit A to Van Ness Declaration)(Limbeek, Kerri-Ann) (Entered: 07/21/2021) (Exhibit 2 (Part 2 of 2) - '720 Patent) (30)
Jul 21, 2021	48	Opening Claim Construction Brief by Ravgen, Inc.. (Attachments: # 1 Exhibit 1 (Part 1 of 2) - '277 Patent, # 2 Exhibit 1 (Part 2 of 2) - '277 Patent, # 3 Exhibit 2 (Part 1 of 2) - '720 Patent, # 4 Exhibit 2 (Part 2 of 2) - '720 Patent, # 5 Exhibit 3 - '277 File History Excerpt 2007-05-30 Amendment, # 6 Exhibit 4 - LabCorp Preliminary Invalidity Contentions, # 7 Declaration of Dr. Van Ness in Support of Plaintiff's Claim Construction Brief, # 8 Exhibit A to Van Ness Declaration)(Limbeek, Kerri-Ann) (Entered: 07/21/2021) (Exhibit 3 - '277 File History Excerpt 2007-05-30 Amendment) (30)
Jul 21, 2021	48	Opening Claim Construction Brief by Ravgen, Inc.. (Attachments: # 1 Exhibit 1 (Part 1 of 2) - '277 Patent, # 2 Exhibit 1 (Part 2 of 2) - '277 Patent, # 3 Exhibit 2 (Part 1 of 2) - '720 Patent, # 4 Exhibit 2 (Part 2 of 2) - '720 Patent, # 5 Exhibit 3 - '277 File History Excerpt 2007-05-30 Amendment, # 6 Exhibit 4 - LabCorp Preliminary Invalidity Contentions, # 7 Declaration of Dr. Van Ness in Support of Plaintiff's Claim Construction Brief, # 8 Exhibit A to Van Ness Declaration)(Limbeek, Kerri-Ann) (Entered: 07/21/2021) (Exhibit 4 - LabCorp Preliminary Invalidity Contentions) (30)
Jul 21, 2021	48	Opening Claim Construction Brief by Ravgen, Inc.. (Attachments: # 1 Exhibit 1 (Part 1 of 2) - '277 Patent, # 2 Exhibit 1 (Part 2 of 2) - '277 Patent, # 3 Exhibit 2 (Part 1 of 2) - '720 Patent, # 4 Exhibit 2 (Part 2 of 2) - '720 Patent, # 5 Exhibit 3 - '277 File History Excerpt 2007-05-30 Amendment, # 6 Exhibit 4 - LabCorp Preliminary Invalidity Contentions, # 7 Declaration of Dr. Van Ness in Support of Plaintiff's Claim Construction Brief, # 8 Exhibit A to Van Ness Declaration)(Limbeek, Kerri-Ann) (Entered: 07/21/2021) (Declaration of Dr. Van Ness in Support of Plaintiff's Claim Construction B) (17)
Jul 21, 2021	48	Opening Claim Construction Brief by Ravgen, Inc.. (Attachments: # 1 Exhibit 1 (Part 1 of 2) - '277 Patent, # 2 Exhibit 1 (Part 2 of 2) - '277 Patent, # 3 Exhibit 2 (Part 1 of 2) - '720 Patent, # 4 Exhibit 2 (Part 2 of 2) - '720 Patent, # 5 Exhibit 3 - '277 File History Excerpt 2007-05-30 Amendment, # 6 Exhibit 4 - LabCorp Preliminary Invalidity Contentions, # 7 Declaration of Dr. Van Ness in Support of Plaintiff's Claim Construction Brief, # 8 Exhibit A to Van Ness Declaration)(Limbeek, Kerri-Ann) (Entered: 07/21/2021) (Exhibit A to Van Ness Declaration) (27)
Jun 16, 2021	47	Standing Order regarding Scheduling Order. Signed by Judge Alan D Albright. (Entered: 06/17/2021) (5)
Jun 11, 2021	46	NOTICE of Filing Petition for Inter Partes Review PLAINTIFF'S NOTICE OF FILING OF PETITION FOR INTER PARTES REVIEW by Ravgen, Inc. (Limbeek, Kerri-Ann) (Entered: 06/11/2021) (3)
Jun 4, 2021	45	NOTICE Third Contingent Election of Defenses by Laboratory Corporation of America Holdings (Allen, Aden) (Entered: 06/04/2021) (5)
Jun 1, 2021	N/A	Text Order GRANTING 37 , 38 , and 39 Motions to Withdraw as Attorney and GRANTING 41 , 42 , and 43 Motions to Appear Pro Hac Vice. The Court having considered the motions to withdraw as counsel of record for the Defendant is of the opinion that the motions should be granted. IT IS THEREFORE ORDERED that the motions to withdraw are GRANTED and attorneysare withdrawn as counsel of record for the Defendant effective immediately. Before the Court are the Motions for Admission Pro Hac Vice. The Court, having reviewed the Motions, finds they should be GRANTED and therefore orders as follows: IT IS ORDERED the Motions for Admission Pro Hac Vice are GRANTED. IT IS FURTHER ORDERED that Applicant, if he/she has not already done so, shall immediately tender the amount of $100.00, made payable to: Clerk, U.S. District Court, in compliance with Local Rule AT-I (f)(2). Pursuant to our Administrative Policies and Procedures for Electronic Filing, the attorney hereby granted to practice pro hac vice in this case must register for electronic filing with our court within 10 days of this order entered by Judge Alan D Albright. Entered by Judge Alan D Albright. (This is a text-only entry generated by the court. There is no document associated with this entry.) (ep4) (Entered: 06/01/2021) (0)
May 28, 2021	44	NOTICE Second Contingent Election of Defenses by Laboratory Corporation of America Holdings (Allen, Aden) (Entered: 05/28/2021) (5)
May 25, 2021	41	MOTION to Appear Pro Hac Vice by Deron R Dacus (on behalf of Deborah Mariottini) ( Filing fee $ 100 receipt number 0542-14843589) by on behalf of Ravgen, Inc.. (Attachments: # 1 Proposed Order)(Dacus, Deron) (Entered: 05/25/2021) (Main Document) (3)
May 25, 2021	42	MOTION to Appear Pro Hac Vice by Deron R Dacus (on behalf of Peter Zhu) ( Filing fee $ 100 receipt number 0542-14843626) by on behalf of Ravgen, Inc.. (Attachments: # 1 Proposed Order)(Dacus, Deron) (Entered: 05/25/2021) (Main Document) (3)
May 25, 2021	43	MOTION to Appear Pro Hac Vice by Deron R Dacus (on behalf of Joze Welsh) ( Filing fee $ 100 receipt number 0542-14843654) by on behalf of Ravgen, Inc.. (Attachments: # 1 Proposed Order)(Dacus, Deron) (Entered: 05/25/2021) (Main Document) (3)
May 25, 2021	43	MOTION to Appear Pro Hac Vice by Deron R Dacus (on behalf of Joze Welsh) ( Filing fee $ 100 receipt number 0542-14843654) by on behalf of Ravgen, Inc.. (Attachments: # 1 Proposed Order)(Dacus, Deron) (Entered: 05/25/2021) (Proposed Order) (1)
May 25, 2021	42	MOTION to Appear Pro Hac Vice by Deron R Dacus (on behalf of Peter Zhu) ( Filing fee $ 100 receipt number 0542-14843626) by on behalf of Ravgen, Inc.. (Attachments: # 1 Proposed Order)(Dacus, Deron) (Entered: 05/25/2021) (Proposed Order) (1)
May 25, 2021	41	MOTION to Appear Pro Hac Vice by Deron R Dacus (on behalf of Deborah Mariottini) ( Filing fee $ 100 receipt number 0542-14843589) by on behalf of Ravgen, Inc.. (Attachments: # 1 Proposed Order)(Dacus, Deron) (Entered: 05/25/2021) (Proposed Order) (1)
May 21, 2021	40	Proposed Scheduling Order JOINT PROPOSED SCHEDULING ORDER AND PROPOSED ORDER GOVERNING PROCEEDINGS FOR PATENT CASES by Ravgen, Inc.. (Attachments: # 1 Exhibit A - Proposed Scheduling Order, # 2 Exhibit B - Proposed Order Governing Proceedings)(Limbeek, Kerri-Ann) (Entered: 05/21/2021) (Main Document) (8)
May 21, 2021	40	Proposed Scheduling Order JOINT PROPOSED SCHEDULING ORDER AND PROPOSED ORDER GOVERNING PROCEEDINGS FOR PATENT CASES by Ravgen, Inc.. (Attachments: # 1 Exhibit A - Proposed Scheduling Order, # 2 Exhibit B - Proposed Order Governing Proceedings)(Limbeek, Kerri-Ann) (Entered: 05/21/2021) (Exhibit A - Proposed Scheduling Order) (6)
May 21, 2021	40	Proposed Scheduling Order JOINT PROPOSED SCHEDULING ORDER AND PROPOSED ORDER GOVERNING PROCEEDINGS FOR PATENT CASES by Ravgen, Inc.. (Attachments: # 1 Exhibit A - Proposed Scheduling Order, # 2 Exhibit B - Proposed Order Governing Proceedings)(Limbeek, Kerri-Ann) (Entered: 05/21/2021) (Exhibit B - Proposed Order Governing Proceedings) (7)
May 20, 2021	37	MOTION to Withdraw as Attorney of Alexandra Leeper by Laboratory Corporation of America Holdings. (Attachments: # 1 Proposed Order Proposed Order)(Allen, Aden) (Entered: 05/20/2021) (Main Document) (3)
May 20, 2021	38	MOTION to Withdraw as Attorney of Michelle Rhyu by Laboratory Corporation of America Holdings. (Attachments: # 1 Proposed Order)(Allen, Aden) (Entered: 05/20/2021) (Main Document) (3)
May 20, 2021	39	MOTION to Withdraw as Attorney of Cameron Vanderwall by Laboratory Corporation of America Holdings. (Attachments: # 1 Proposed Order)(Allen, Aden) (Entered: 05/20/2021) (Main Document) (3)
May 20, 2021	37	MOTION to Withdraw as Attorney of Alexandra Leeper by Laboratory Corporation of America Holdings. (Attachments: # 1 Proposed Order Proposed Order)(Allen, Aden) (Entered: 05/20/2021) (Proposed Order Proposed Order) (1)
May 20, 2021	38	MOTION to Withdraw as Attorney of Michelle Rhyu by Laboratory Corporation of America Holdings. (Attachments: # 1 Proposed Order)(Allen, Aden) (Entered: 05/20/2021) (Proposed Order) (1)
May 20, 2021	39	MOTION to Withdraw as Attorney of Cameron Vanderwall by Laboratory Corporation of America Holdings. (Attachments: # 1 Proposed Order)(Allen, Aden) (Entered: 05/20/2021) (Proposed Order) (1)
May 17, 2021	36	NOTICE of Filing Petition for Inter Partes Review by Ravgen, Inc. (Limbeek, Kerri-Ann) (Entered: 05/17/2021) (3)
May 14, 2021	N/A	Text Order GRANTING 34 & 35 Motions to Appear Pro Hac Vice. Before the Court are the Motions for Admission Pro Hac Vice. The Court, having reviewed the Motions, finds they should be GRANTED and therefore orders as follows: IT IS ORDERED the Motions for Admission Pro Hac Vice are GRANTED. IT IS FURTHER ORDERED that Applicant, if he/she has not already done so, shall immediately tender the amount of $100.00, made payable to: Clerk, U.S. District Court, in compliance with Local Rule AT-I (f)(2). Pursuant to our Administrative Policies and Procedures for Electronic Filing, the attorney hereby granted to practice pro hac vice in this case must register for electronic filing with our court within 10 days of this order entered by Judge Alan D Albright. Entered by Judge Alan D Albright. (This is a text-only entry generated by the court. There is no document associated with this entry.) (ep4) (Entered: 05/14/2021) (0)
May 13, 2021	33	NOTICE of Attorney Appearance by R. Jeffrey Layne on behalf of Laboratory Corporation of America Holdings. Attorney R. Jeffrey Layne added to party Laboratory Corporation of America Holdings(pty:cc), Attorney R. Jeffrey Layne added to party Laboratory Corporation of America Holdings(pty:dft) (Layne, R.) (Entered: 05/13/2021) (2)
May 13, 2021	34	MOTION to Appear Pro Hac Vice by R. Jeffrey Layne Motion to Appear Pro Hac Vice of Peter J. Chassman ( Filing fee $ 100 receipt number 0542-14804198) by on behalf of Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit Exhibit A, # 2 Exhibit Exhibit B, # 3 Proposed Order)(Layne, R.) (Entered: 05/13/2021) (Main Document) (3)
May 13, 2021	35	MOTION to Appear Pro Hac Vice by R. Jeffrey Layne Motion for Admission Pro Hac Vice Hallie H. Wimberly ( Filing fee $ 100 receipt number 0542-14804282) by on behalf of Laboratory Corporation of America Holdings. (Attachments: # 1 Proposed Order)(Layne, R.) (Entered: 05/13/2021) (Main Document) (3)
May 13, 2021	35	MOTION to Appear Pro Hac Vice by R. Jeffrey Layne Motion for Admission Pro Hac Vice Hallie H. Wimberly ( Filing fee $ 100 receipt number 0542-14804282) by on behalf of Laboratory Corporation of America Holdings. (Attachments: # 1 Proposed Order)(Layne, R.) (Entered: 05/13/2021) (Proposed Order) (1)
May 13, 2021	34	MOTION to Appear Pro Hac Vice by R. Jeffrey Layne Motion to Appear Pro Hac Vice of Peter J. Chassman ( Filing fee $ 100 receipt number 0542-14804198) by on behalf of Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit Exhibit A, # 2 Exhibit Exhibit B, # 3 Proposed Order)(Layne, R.) (Entered: 05/13/2021) (Exhibit Exhibit A) (1)
May 13, 2021	34	MOTION to Appear Pro Hac Vice by R. Jeffrey Layne Motion to Appear Pro Hac Vice of Peter J. Chassman ( Filing fee $ 100 receipt number 0542-14804198) by on behalf of Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit Exhibit A, # 2 Exhibit Exhibit B, # 3 Proposed Order)(Layne, R.) (Entered: 05/13/2021) (Exhibit Exhibit B) (1)
May 13, 2021	34	MOTION to Appear Pro Hac Vice by R. Jeffrey Layne Motion to Appear Pro Hac Vice of Peter J. Chassman ( Filing fee $ 100 receipt number 0542-14804198) by on behalf of Laboratory Corporation of America Holdings. (Attachments: # 1 Exhibit Exhibit A, # 2 Exhibit Exhibit B, # 3 Proposed Order)(Layne, R.) (Entered: 05/13/2021) (Proposed Order) (1)
May 7, 2021	32	NOTICE of Filing Petitions for Inter Partes Review UPDATED NOTICE OF PETITIONS by Ravgen, Inc. (Limbeek, Kerri-Ann) (Entered: 05/07/2021) (3)
May 3, 2021	31	NOTICE Contingent Election of Defenses by Laboratory Corporation of America Holdings (Allen, Aden) (Entered: 05/03/2021) (4)
Apr 29, 2021	30	NOTICE of Filing Petitions for Inter Partes Review by Ravgen, Inc. (Limbeek, Kerri-Ann) (Entered: 04/29/2021) (3)
Apr 19, 2021	N/A	Text Order GRANTING 27 Motion to Appear Pro Hac Vice for Attorney Alexandra Leeper for Laboratory Corporation of America Holdings. Before the Court is the Motion for Admission Pro Hac Vice. The Court, having reviewed the Motion, finds it should be GRANTED and therefore orders as follows: IT IS ORDERED the Motion for Admission Pro Hac Vice is GRANTED. IT IS FURTHER ORDERED that Applicant, if he/she has not already done so, shall immediately tender the amount of $100.00, made payable to: Clerk, U.S. District Court, in compliance with Local Rule AT-I (f)(2). Pursuant to our Administrative Policies and Procedures for Electronic Filing, the attorney hereby granted to practice pro hac vice in this case must register for electronic filing with our court within 10 days of this order entered by Judge Alan D Albright. (This is a text-only entry generated by the court. There is no document associated with this entry.) (mm6) (Entered: 04/19/2021) (0)
Apr 19, 2021	N/A	Text Order GRANTING 28 Motion to Appear Pro Hac Vice for Attorney Michelle S. Rhyu for Laboratory Corporation of America Holdings. Before the Court is the Motion for Admission Pro Hac Vice. The Court, having reviewed the Motion, finds it should be GRANTED and therefore orders as follows: IT IS ORDERED the Motion for Admission Pro Hac Vice is GRANTED. IT IS FURTHER ORDERED that Applicant, if he/she has not already done so, shall immediately tender the amount of $100.00, made payable to: Clerk, U.S. District Court, in compliance with Local Rule AT-I (f)(2). Pursuant to our Administrative Policies and Procedures for Electronic Filing, the attorney hereby granted to practice pro hac vice in this case must register for electronic filing with our court within 10 days of this order entered by Judge Alan D Albright. (This is a text-only entry generated by the court. There is no document associated with this entry.) (mm6) (Entered: 04/19/2021) (0)
Apr 19, 2021	N/A	Text Order GRANTING 29 Motion to Appear Pro Hac Vice for Attorney Cameron C. Vanderwall for Laboratory Corporation of America Holdings. Before the Court is the Motion for Admission Pro Hac Vice. The Court, having reviewed the Motion, finds it should be GRANTED and therefore orders as follows: IT IS ORDERED the Motion for Admission Pro Hac Vice is GRANTED. IT IS FURTHER ORDERED that Applicant, if he/she has not already done so, shall immediately tender the amount of $100.00, made payable to: Clerk, U.S. District Court, in compliance with Local Rule AT-I (f)(2). Pursuant to our Administrative Policies and Procedures for Electronic Filing, the attorney hereby granted to practice pro hac vice in this case must register for electronic filing with our court within 10 days of this order entered by Judge Alan D Albright. (This is a text-only entry generated by the court. There is no document associated with this entry.) (mm6) (Entered: 04/19/2021) (0)
Apr 6, 2021	27	MOTION to Appear Pro Hac Vice by Aden M. Allen on behalf of Alexandra Leeper ( Filing fee $ 100 receipt number 0542-14665468) by on behalf of Laboratory Corporation of America Holdings. (Allen, Aden) (Entered: 04/06/2021) (6)
Apr 6, 2021	28	MOTION to Appear Pro Hac Vice by Aden M. Allen on behalf of Michelle S.. Rhyu ( Filing fee $ 100 receipt number 0542-14665503) by on behalf of Laboratory Corporation of America Holdings. (Allen, Aden) (Entered: 04/06/2021) (9)
Apr 6, 2021	29	MOTION to Appear Pro Hac Vice by Aden M. Allen on behalf of Cameron C. Vanderwall ( Filing fee $ 100 receipt number 0542-14665533) by on behalf of Laboratory Corporation of America Holdings. (Allen, Aden) (Entered: 04/06/2021) (4)
Feb 12, 2021	26	Standing Order Regarding Filing Documents Under Seal and Redacted Pleadings in Patent Cases. Signed by Judge Alan D Albright. as of 2/12/2021. (bot1) (Entered: 02/24/2021) (1)
Feb 1, 2021	25	ANSWER to 19 Answer to Complaint, Counterclaim by Ravgen, Inc..(Dacus, Deron) (Entered: 02/01/2021) (6)
Jan 21, 2021	N/A	Text Order GRANTING 20 Motion to Appear Pro Hac Vice for Attorney Edward G. Poplawski for Laboratory Corporation of America Holdings. Before the Court is the Motion for Admission Pro Hac Vice. The Court, having reviewed the Motion, finds it should be GRANTED and therefore orders as follows: IT IS ORDERED the Motion for Admission Pro Hac Vice is GRANTED. IT IS FURTHER ORDERED that Applicant, if he/she has not already done so, shall immediately tender the amount of $100.00, made payable to: Clerk, U.S. District Court, in compliance with Local Rule AT-I (f)(2). Pursuant to our Administrative Policies and Procedures for Electronic Filing, the attorney hereby granted to practice pro hac vice in this case must register for electronic filing with our court within 10 days of this order entered by Judge Alan D Albright. (This is a text-only entry generated by the court. There is no document associated with this entry.) (mm6) (Entered: 01/21/2021) (0)
Jan 21, 2021	N/A	Text Order GRANTING 21 Motion to Appear Pro Hac Vice for Attorney Olivia M. Kim for Laboratory Corporation of America Holdings. Before the Court is the Motion for Admission Pro Hac Vice. The Court, having reviewed the Motion, finds it should be GRANTED and therefore orders as follows: IT IS ORDERED the Motion for Admission Pro Hac Vice is GRANTED. IT IS FURTHER ORDERED that Applicant, if he/she has not already done so, shall immediately tender the amount of $100.00, made payable to: Clerk, U.S. District Court, in compliance with Local Rule AT-I (f)(2). Pursuant to our Administrative Policies and Procedures for Electronic Filing, the attorney hereby granted to practice pro hac vice in this case must register for electronic filing with our court within 10 days of this order entered by Judge Alan D Albright. (This is a text-only entry generated by the court. There is no document associated with this entry.) (mm6) (Entered: 01/21/2021) (0)
Jan 21, 2021	N/A	Text Order GRANTING 22 Motion to Appear Pro Hac Vice for Attorney Erik J. Carlson for Laboratory Corporation of America Holdings. Before the Court is the Motion for Admission Pro Hac Vice. The Court, having reviewed the Motion, finds it should be GRANTED and therefore orders as follows: IT IS ORDERED the Motion for Admission Pro Hac Vice is GRANTED. IT IS FURTHER ORDERED that Applicant, if he/she has not already done so, shall immediately tender the amount of $100.00, made payable to: Clerk, U.S. District Court, in compliance with Local Rule AT-I (f)(2). Pursuant to our Administrative Policies and Procedures for Electronic Filing, the attorney hereby granted to practice pro hac vice in this case must register for electronic filing with our court within 10 days of this order entered by Judge Alan D Albright. (This is a text-only entry generated by the court. There is no document associated with this entry.) (mm6) (Entered: 01/21/2021) (0)
Jan 21, 2021	N/A	Text Order GRANTING 23 Motion to Appear Pro Hac Vice for Attorney Matias Ferrario for Laboratory Corporation of America Holdings. Before the Court is the Motion for Admission Pro Hac Vice. The Court, having reviewed the Motion, finds it should be GRANTED and therefore orders as follows: IT IS ORDERED the Motion for Admission Pro Hac Vice is GRANTED. IT IS FURTHER ORDERED that Applicant, if he/she has not already done so, shall immediately tender the amount of $100.00, made payable to: Clerk, U.S. District Court, in compliance with Local Rule AT-I (f)(2). Pursuant to our Administrative Policies and Procedures for Electronic Filing, the attorney hereby granted to practice pro hac vice in this case must register for electronic filing with our court within 10 days of this order entered by Judge Alan D Albright. (This is a text-only entry generated by the court. There is no document associated with this entry.) (mm6) (Entered: 01/21/2021) (0)
Jan 18, 2021	24	STATUS REPORT REGARDING CASE READINESS by Ravgen, Inc.. (Limbeek, Kerri-Ann) (Entered: 01/18/2021) (4)
Jan 11, 2021	19	Laboratory Corporation of America Holdings ANSWER to 1 Complaint with Jury Demand , COUNTERCLAIM against Ravgen, Inc. by Laboratory Corporation of America Holdings.(Allen, Aden) (Entered: 01/11/2021) (26)
Jan 11, 2021	20	MOTION to Appear Pro Hac Vice by Aden M. Allen on behalf of Edward Poplawski ( Filing fee $ 100 receipt number 0542-14359684) by on behalf of Laboratory Corporation of America Holdings. (Attachments: # 1 Proposed Order)(Allen, Aden) (Entered: 01/11/2021) (Main Document) (3)
Jan 11, 2021	21	MOTION to Appear Pro Hac Vice by Aden M. Allen on behalf of Olivia M. Kim ( Filing fee $ 100 receipt number 0542-14359705) by on behalf of Laboratory Corporation of America Holdings. (Attachments: # 1 Proposed Order)(Allen, Aden) (Entered: 01/11/2021) (Main Document) (3)
Jan 11, 2021	22	MOTION to Appear Pro Hac Vice by Aden M. Allen on behalf of Erik J. Carlson ( Filing fee $ 100 receipt number 0542-14359730) by on behalf of Laboratory Corporation of America Holdings. (Attachments: # 1 Proposed Order)(Allen, Aden) (Entered: 01/11/2021) (Main Document) (3)
Jan 11, 2021	23	MOTION to Appear Pro Hac Vice by Aden M. Allen on behalf of Matias Ferrario ( Filing fee $ 100 receipt number 0542-14359745) by on behalf of Laboratory Corporation of America Holdings. (Attachments: # 1 Proposed Order)(Allen, Aden) (Entered: 01/11/2021) (Main Document) (3)
Jan 11, 2021	20	MOTION to Appear Pro Hac Vice by Aden M. Allen on behalf of Edward Poplawski ( Filing fee $ 100 receipt number 0542-14359684) by on behalf of Laboratory Corporation of America Holdings. (Attachments: # 1 Proposed Order)(Allen, Aden) (Entered: 01/11/2021) (Proposed Order) (1)
Jan 11, 2021	21	MOTION to Appear Pro Hac Vice by Aden M. Allen on behalf of Olivia M. Kim ( Filing fee $ 100 receipt number 0542-14359705) by on behalf of Laboratory Corporation of America Holdings. (Attachments: # 1 Proposed Order)(Allen, Aden) (Entered: 01/11/2021) (Proposed Order) (1)
Jan 11, 2021	23	MOTION to Appear Pro Hac Vice by Aden M. Allen on behalf of Matias Ferrario ( Filing fee $ 100 receipt number 0542-14359745) by on behalf of Laboratory Corporation of America Holdings. (Attachments: # 1 Proposed Order)(Allen, Aden) (Entered: 01/11/2021) (Proposed Order) (1)
Jan 11, 2021	22	MOTION to Appear Pro Hac Vice by Aden M. Allen on behalf of Erik J. Carlson ( Filing fee $ 100 receipt number 0542-14359730) by on behalf of Laboratory Corporation of America Holdings. (Attachments: # 1 Proposed Order)(Allen, Aden) (Entered: 01/11/2021) (Proposed Order) (1)
Nov 8, 2020	N/A	Text Order GRANTING 17 Motion for Extension of Time to Answer entered by Judge Alan D Albright. Before the Court is Defendant Laboratory Corporation of America Holdings (LabCorp) Motion for Extension of Time to respond to Plaintiff Ravgen, Inc.s (Ravgen) Complaint. After consideration, the Court finds that the Motion should be GRANTED. It is therefore ORDERED that the deadline for LabCorp to answer, move, or otherwise respond to Ravgens Complaint is extended to January 11, 2021. (This is a text-only entry generated by the court. There is no document associated with this entry.) (ep4) (Entered: 11/08/2020) (0)
Nov 8, 2020	N/A	Reset Deadlines: Laboratory Corporation of America Holdings answer due 1/11/2021. (lad) (Entered: 11/09/2020) (0)
Nov 5, 2020	17	Unopposed MOTION for Extension of Time to File Answer , Move, or Otherwise Respond to Complaint by Laboratory Corporation of America Holdings. (Attachments: # 1 Proposed Order)(Allen, Aden) (Entered: 11/05/2020) (Main Document) (2)
Nov 5, 2020	18	RULE 7 DISCLOSURE STATEMENT filed by Laboratory Corporation of America Holdings. (Allen, Aden) (Entered: 11/05/2020) (2)
Nov 5, 2020	17	Unopposed MOTION for Extension of Time to File Answer , Move, or Otherwise Respond to Complaint by Laboratory Corporation of America Holdings. (Attachments: # 1 Proposed Order)(Allen, Aden) (Entered: 11/05/2020) (Proposed Order) (1)
Nov 4, 2020	N/A	Text Order GRANTING 16 Motion to Appear Pro Hac Vice for Attorney Jamie L. Kringstein for Ravgen, Inc. Before the Court is the Motion for Admission Pro Hac Vice. The Court, having reviewed the Motion, finds it should be GRANTED and therefore orders as follows: IT IS ORDERED the Motion for Admission Pro Hac Vice is GRANTED. IT IS FURTHER ORDERED that Applicant, if he/she has not already done so, shall immediately tender the amount of $100.00, made payable to: Clerk, U.S. District Court, in compliance with Local Rule AT-I (f)(2). Pursuant to our Administrative Policies and Procedures for Electronic Filing, the attorney hereby granted to practice pro hac vice in this case must register for electronic filing with our court within 10 days of this order entered by Judge Alan D Albright. (This is a text-only entry generated by the court. There is no document associated with this entry.) (mm6) (Entered: 11/04/2020) (0)
Nov 3, 2020	16	MOTION to Appear Pro Hac Vice by Deron R Dacus (on behalf of Jamie L. Kringstein) ( Filing fee $ 100 receipt number 0542-14142323) by on behalf of Ravgen, Inc.. (Attachments: # 1 Proposed Order)(Dacus, Deron) (Entered: 11/03/2020) (Main Document) (3)
Nov 3, 2020	16	MOTION to Appear Pro Hac Vice by Deron R Dacus (on behalf of Jamie L. Kringstein) ( Filing fee $ 100 receipt number 0542-14142323) by on behalf of Ravgen, Inc.. (Attachments: # 1 Proposed Order)(Dacus, Deron) (Entered: 11/03/2020) (Proposed Order) (1)
Oct 26, 2020	10	MOTION to Appear Pro Hac Vice by Deron R Dacus (on behalf of John M. Desmarais) ( Filing fee $ 100 receipt number 0542-14110915) by on behalf of Ravgen, Inc.. (Attachments: # 1 Proposed Order)(Dacus, Deron) (Entered: 10/26/2020) (Main Document) (5)
Oct 26, 2020	11	MOTION to Appear Pro Hac Vice by Deron R Dacus (on behalf of Frederick J. Ding) ( Filing fee $ 100 receipt number 0542-14110932) by on behalf of Ravgen, Inc.. (Attachments: # 1 Proposed Order)(Dacus, Deron) (Entered: 10/26/2020) (Main Document) (4)
Oct 26, 2020	N/A	Text Order GRANTING 10 Motion to Appear Pro Hac Vice for Attorney John M. Desmarais for Ravgen, Inc. Before the Court is the Motion for Admission Pro Hac Vice. The Court, having reviewed the Motion, finds it should be GRANTED and therefore orders as follows: IT IS ORDERED the Motion for Admission Pro Hac Vice is GRANTED. IT IS FURTHER ORDERED that Applicant, if he/she has not already done so, shall immediately tender the amount of $100.00, made payable to: Clerk, U.S. District Court, in compliance with Local Rule AT-I (f)(2). Pursuant to our Administrative Policies and Procedures for Electronic Filing, the attorney hereby granted to practice pro hac vice in this case must register for electronic filing with our court within 10 days of this order entered by Judge Alan D Albright. (This is a text-only entry generated by the court. There is no document associated with this entry.) (mm6) (Entered: 10/26/2020) (0)
Oct 26, 2020	N/A	Text Order GRANTING 11 Motion to Appear Pro Hac Vice for Attorney Frederick J. Ding for Ravgen, Inc. Before the Court is the Motion for Admission Pro Hac Vice. The Court, having reviewed the Motion, finds it should be GRANTED and therefore orders as follows: IT IS ORDERED the Motion for Admission Pro Hac Vice is GRANTED. IT IS FURTHER ORDERED that Applicant, if he/she has not already done so, shall immediately tender the amount of $100.00, made payable to: Clerk, U.S. District Court, in compliance with Local Rule AT-I (f)(2). Pursuant to our Administrative Policies and Procedures for Electronic Filing, the attorney hereby granted to practice pro hac vice in this case must register for electronic filing with our court within 10 days of this order entered by Judge Alan D Albright. (This is a text-only entry generated by the court. There is no document associated with this entry.) (mm6) (Entered: 10/26/2020) (0)
Oct 26, 2020	12	MOTION to Appear Pro Hac Vice by Deron R Dacus (on behalf of Kyle G. Petrie) ( Filing fee $ 100 receipt number 0542-14110949) by on behalf of Ravgen, Inc.. (Attachments: # 1 Proposed Order)(Dacus, Deron) (Entered: 10/26/2020) (Main Document) (3)
Oct 26, 2020	N/A	Text Order GRANTING 12 Motion to Appear Pro Hac Vice for Attorney Kyle G. Petrie for Ravgen, Inc. Before the Court is the Motion for Admission Pro Hac Vice. The Court, having reviewed the Motion, finds it should be GRANTED and therefore orders as follows: IT IS ORDERED the Motion for Admission Pro Hac Vice is GRANTED. IT IS FURTHER ORDERED that Applicant, if he/she has not already done so, shall immediately tender the amount of $100.00, made payable to: Clerk, U.S. District Court, in compliance with Local Rule AT-I (f)(2). Pursuant to our Administrative Policies and Procedures for Electronic Filing, the attorney hereby granted to practice pro hac vice in this case must register for electronic filing with our court within 10 days of this order entered by Judge Alan D Albright. (This is a text-only entry generated by the court. There is no document associated with this entry.) (mm6) (Entered: 10/26/2020) (0)
Oct 26, 2020	13	MOTION to Appear Pro Hac Vice by Deron R Dacus (on behalf of Jun Tong) ( Filing fee $ 100 receipt number 0542-14110971) by on behalf of Ravgen, Inc.. (Attachments: # 1 Proposed Order)(Dacus, Deron) (Entered: 10/26/2020) (Main Document) (3)
Oct 26, 2020	14	MOTION to Appear Pro Hac Vice by Deron R Dacus (on behalf of Kerri-Ann Limbeck) ( Filing fee $ 100 receipt number 0542-14111002) by on behalf of Ravgen, Inc.. (Attachments: # 1 Proposed Order)(Dacus, Deron) (Entered: 10/26/2020) (Main Document) (5)
Oct 26, 2020	N/A	Text Order GRANTING 13 Motion to Appear Pro Hac Vice for Attorney Jun Tong for Ravgen, Inc. Before the Court is the Motion for Admission Pro Hac Vice. The Court, having reviewed the Motion, finds it should be GRANTED and therefore orders as follows: IT IS ORDERED the Motion for Admission Pro Hac Vice is GRANTED. IT IS FURTHER ORDERED that Applicant, if he/she has not already done so, shall immediately tender the amount of $100.00, made payable to: Clerk, U.S. District Court, in compliance with Local Rule AT-I (f)(2). Pursuant to our Administrative Policies and Procedures for Electronic Filing, the attorney hereby granted to practice pro hac vice in this case must register for electronic filing with our court within 10 days of this order entered by Judge Alan D Albright. (This is a text-only entry generated by the court. There is no document associated with this entry.) (mm6) (Entered: 10/26/2020) (0)
Oct 26, 2020	N/A	Text Order GRANTING 14 Motion to Appear Pro Hac Vice for Attorney Kerri-Ann Limbeek for Ravgen, Inc. Before the Court is the Motion for Admission Pro Hac Vice. The Court, having reviewed the Motion, finds it should be GRANTED and therefore orders as follows: IT IS ORDERED the Motion for Admission Pro Hac Vice is GRANTED. IT IS FURTHER ORDERED that Applicant, if he/she has not already done so, shall immediately tender the amount of $100.00, made payable to: Clerk, U.S. District Court, in compliance with Local Rule AT-I (f)(2). Pursuant to our Administrative Policies and Procedures for Electronic Filing, the attorney hereby granted to practice pro hac vice in this case must register for electronic filing with our court within 10 days of this order entered by Judge Alan D Albright. (This is a text-only entry generated by the court. There is no document associated with this entry.) (mm6) (Entered: 10/26/2020) (0)
Oct 26, 2020	15	SUMMONS Returned Executed by Ravgen, Inc.. Laboratory Corporation of America Holdings served on 10/21/2020, answer due 11/11/2020. (Dacus, Deron) (Entered: 10/26/2020) (1)
Oct 26, 2020	11	MOTION to Appear Pro Hac Vice by Deron R Dacus (on behalf of Frederick J. Ding) ( Filing fee $ 100 receipt number 0542-14110932) by on behalf of Ravgen, Inc.. (Attachments: # 1 Proposed Order)(Dacus, Deron) (Entered: 10/26/2020) (Proposed Order) (1)
Oct 26, 2020	13	MOTION to Appear Pro Hac Vice by Deron R Dacus (on behalf of Jun Tong) ( Filing fee $ 100 receipt number 0542-14110971) by on behalf of Ravgen, Inc.. (Attachments: # 1 Proposed Order)(Dacus, Deron) (Entered: 10/26/2020) (Proposed Order) (1)
Oct 26, 2020	12	MOTION to Appear Pro Hac Vice by Deron R Dacus (on behalf of Kyle G. Petrie) ( Filing fee $ 100 receipt number 0542-14110949) by on behalf of Ravgen, Inc.. (Attachments: # 1 Proposed Order)(Dacus, Deron) (Entered: 10/26/2020) (Proposed Order) (1)
Oct 26, 2020	14	MOTION to Appear Pro Hac Vice by Deron R Dacus (on behalf of Kerri-Ann Limbeck) ( Filing fee $ 100 receipt number 0542-14111002) by on behalf of Ravgen, Inc.. (Attachments: # 1 Proposed Order)(Dacus, Deron) (Entered: 10/26/2020) (Proposed Order) (1)
Oct 26, 2020	10	MOTION to Appear Pro Hac Vice by Deron R Dacus (on behalf of John M. Desmarais) ( Filing fee $ 100 receipt number 0542-14110915) by on behalf of Ravgen, Inc.. (Attachments: # 1 Proposed Order)(Dacus, Deron) (Entered: 10/26/2020) (Proposed Order) (1)
Oct 16, 2020	2	Notice of Filing of Patent/Trademark Form (AO 120). AO 120 forwarded to the Director of the U.S. Patent and Trademark Office. (Dacus, Deron) (Main Document 2 replaced on 10/16/2020) (lad). (Entered: 10/16/2020) (1)
Oct 16, 2020	3	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Exhibit 40, # 41 Exhibit 41, # 42 Exhibit 42, # 43 Exhibit 43, # 44 Exhibit 44, # 45 Exhibit 45, # 46 Exhibit 46, # 47 Exhibit 47, # 48 Exhibit 48, # 49 Exhibit 49, # 50 Exhibit 50)(Dacus, Deron) (Entered: 10/16/2020) (Main Document) (1)
Oct 16, 2020	4	Pro Hac Vice Letter to DESMARAIS LLP attorneys. (lad) (Entered: 10/16/2020) (1)
Oct 16, 2020	N/A	Case assigned to Judge Alan D Albright. CM WILL NOW REFLECT THE JUDGE INITIALS AS PART OF THE CASE NUMBER. PLEASE APPEND THESE JUDGE INITIALS TO THE CASE NUMBER ON EACH DOCUMENT THAT YOU FILE IN THIS CASE. (lad) (Entered: 10/16/2020) (0)
Oct 16, 2020	6	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 51, # 2 Exhibit 52, # 3 Exhibit 53, # 4 Exhibit 54, # 5 Exhibit 55, # 6 Exhibit 56, # 7 Exhibit 57, # 8 Exhibit 58, # 9 Exhibit 59, # 10 Exhibit 60, # 11 Exhibit 61, # 12 Exhibit 62, # 13 Exhibit 63, # 14 Exhibit 64, # 15 Exhibit 65, # 16 Exhibit 66, # 17 Exhibit 67, # 18 Exhibit 68, # 19 Exhibit 69, # 20 Exhibit 70, # 21 Exhibit 71, # 22 Exhibit 72, # 23 Exhibit 73, # 24 Exhibit 74, # 25 Exhibit 75, # 26 Exhibit 76, # 27 Exhibit 77, # 28 Exhibit 78, # 29 Exhibit 79, # 30 Exhibit 80, # 31 Exhibit 81, # 32 Exhibit 82, # 33 Exhibit 83, # 34 Exhibit 84, # 35 Exhibit 85, # 36 Exhibit 86, # 37 Exhibit 87, # 38 Exhibit 88 part 1, # 39 Exhibit 88 part 2, # 40 Exhibit 89, # 41 Exhibit 90 part 1, # 42 Exhibit 90 part 2, # 43 Exhibit 91 part 1, # 44 Exhibit 91 part 2, # 45 Exhibit 92 part 1, # 46 Exhibit 92 part 2, # 47 Exhibit 93 part 1, # 48 Exhibit 93 part 2, # 49 Exhibit 93 part 3, # 50 Exhibit 93 part 4, # 51 Exhibit 94 part 1, # 52 Exhibit 94 part 2, # 53 Exhibit 94 part 3, # 54 Exhibit 94 part 4, # 55 Exhibit 95 part 1, # 56 Exhibit 95 part 2, # 57 Exhibit 96 part 1, # 58 Exhibit 96 part 2, # 59 Exhibit 97 part 1, # 60 Exhibit 97 part 2)(Dacus, Deron) (Entered: 10/16/2020) (Main Document) (1)
Oct 16, 2020	7	REQUEST FOR ISSUANCE OF SUMMONS by Ravgen, Inc.. (Dacus, Deron) (Main Document 7 replaced on 10/16/2020) (lad). (Entered: 10/16/2020) (2)
Oct 16, 2020	8	RULE 7 DISCLOSURE STATEMENT filed by Ravgen, Inc.. (Dacus, Deron) (Entered: 10/16/2020) (2)
Oct 16, 2020	9	Summons Issued as to Laboratory Corporation of America Holdings. (lad) (Entered: 10/16/2020) (2)
Oct 16, 2020	1	Complaint* (1)
Oct 16, 2020	6	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 51, # 2 Exhibit 52, # 3 Exhibit 53, # 4 Exhibit 54, # 5 Exhibit 55, # 6 Exhibit 56, # 7 Exhibit 57, # 8 Exhibit 58, # 9 Exhibit 59, # 10 Exhibit 60, # 11 Exhibit 61, # 12 Exhibit 62, # 13 Exhibit 63, # 14 Exhibit 64, # 15 Exhibit 65, # 16 Exhibit 66, # 17 Exhibit 67, # 18 Exhibit 68, # 19 Exhibit 69, # 20 Exhibit 70, # 21 Exhibit 71, # 22 Exhibit 72, # 23 Exhibit 73, # 24 Exhibit 74, # 25 Exhibit 75, # 26 Exhibit 76, # 27 Exhibit 77, # 28 Exhibit 78, # 29 Exhibit 79, # 30 Exhibit 80, # 31 Exhibit 81, # 32 Exhibit 82, # 33 Exhibit 83, # 34 Exhibit 84, # 35 Exhibit 85, # 36 Exhibit 86, # 37 Exhibit 87, # 38 Exhibit 88 part 1, # 39 Exhibit 88 part 2, # 40 Exhibit 89, # 41 Exhibit 90 part 1, # 42 Exhibit 90 part 2, # 43 Exhibit 91 part 1, # 44 Exhibit 91 part 2, # 45 Exhibit 92 part 1, # 46 Exhibit 92 part 2, # 47 Exhibit 93 part 1, # 48 Exhibit 93 part 2, # 49 Exhibit 93 part 3, # 50 Exhibit 93 part 4, # 51 Exhibit 94 part 1, # 52 Exhibit 94 part 2, # 53 Exhibit 94 part 3, # 54 Exhibit 94 part 4, # 55 Exhibit 95 part 1, # 56 Exhibit 95 part 2, # 57 Exhibit 96 part 1, # 58 Exhibit 96 part 2, # 59 Exhibit 97 part 1, # 60 Exhibit 97 part 2)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 51) (6)
Oct 16, 2020	6	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 51, # 2 Exhibit 52, # 3 Exhibit 53, # 4 Exhibit 54, # 5 Exhibit 55, # 6 Exhibit 56, # 7 Exhibit 57, # 8 Exhibit 58, # 9 Exhibit 59, # 10 Exhibit 60, # 11 Exhibit 61, # 12 Exhibit 62, # 13 Exhibit 63, # 14 Exhibit 64, # 15 Exhibit 65, # 16 Exhibit 66, # 17 Exhibit 67, # 18 Exhibit 68, # 19 Exhibit 69, # 20 Exhibit 70, # 21 Exhibit 71, # 22 Exhibit 72, # 23 Exhibit 73, # 24 Exhibit 74, # 25 Exhibit 75, # 26 Exhibit 76, # 27 Exhibit 77, # 28 Exhibit 78, # 29 Exhibit 79, # 30 Exhibit 80, # 31 Exhibit 81, # 32 Exhibit 82, # 33 Exhibit 83, # 34 Exhibit 84, # 35 Exhibit 85, # 36 Exhibit 86, # 37 Exhibit 87, # 38 Exhibit 88 part 1, # 39 Exhibit 88 part 2, # 40 Exhibit 89, # 41 Exhibit 90 part 1, # 42 Exhibit 90 part 2, # 43 Exhibit 91 part 1, # 44 Exhibit 91 part 2, # 45 Exhibit 92 part 1, # 46 Exhibit 92 part 2, # 47 Exhibit 93 part 1, # 48 Exhibit 93 part 2, # 49 Exhibit 93 part 3, # 50 Exhibit 93 part 4, # 51 Exhibit 94 part 1, # 52 Exhibit 94 part 2, # 53 Exhibit 94 part 3, # 54 Exhibit 94 part 4, # 55 Exhibit 95 part 1, # 56 Exhibit 95 part 2, # 57 Exhibit 96 part 1, # 58 Exhibit 96 part 2, # 59 Exhibit 97 part 1, # 60 Exhibit 97 part 2)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 52) (3)
Oct 16, 2020	6	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 51, # 2 Exhibit 52, # 3 Exhibit 53, # 4 Exhibit 54, # 5 Exhibit 55, # 6 Exhibit 56, # 7 Exhibit 57, # 8 Exhibit 58, # 9 Exhibit 59, # 10 Exhibit 60, # 11 Exhibit 61, # 12 Exhibit 62, # 13 Exhibit 63, # 14 Exhibit 64, # 15 Exhibit 65, # 16 Exhibit 66, # 17 Exhibit 67, # 18 Exhibit 68, # 19 Exhibit 69, # 20 Exhibit 70, # 21 Exhibit 71, # 22 Exhibit 72, # 23 Exhibit 73, # 24 Exhibit 74, # 25 Exhibit 75, # 26 Exhibit 76, # 27 Exhibit 77, # 28 Exhibit 78, # 29 Exhibit 79, # 30 Exhibit 80, # 31 Exhibit 81, # 32 Exhibit 82, # 33 Exhibit 83, # 34 Exhibit 84, # 35 Exhibit 85, # 36 Exhibit 86, # 37 Exhibit 87, # 38 Exhibit 88 part 1, # 39 Exhibit 88 part 2, # 40 Exhibit 89, # 41 Exhibit 90 part 1, # 42 Exhibit 90 part 2, # 43 Exhibit 91 part 1, # 44 Exhibit 91 part 2, # 45 Exhibit 92 part 1, # 46 Exhibit 92 part 2, # 47 Exhibit 93 part 1, # 48 Exhibit 93 part 2, # 49 Exhibit 93 part 3, # 50 Exhibit 93 part 4, # 51 Exhibit 94 part 1, # 52 Exhibit 94 part 2, # 53 Exhibit 94 part 3, # 54 Exhibit 94 part 4, # 55 Exhibit 95 part 1, # 56 Exhibit 95 part 2, # 57 Exhibit 96 part 1, # 58 Exhibit 96 part 2, # 59 Exhibit 97 part 1, # 60 Exhibit 97 part 2)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 53) (30)
Oct 16, 2020	6	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 51, # 2 Exhibit 52, # 3 Exhibit 53, # 4 Exhibit 54, # 5 Exhibit 55, # 6 Exhibit 56, # 7 Exhibit 57, # 8 Exhibit 58, # 9 Exhibit 59, # 10 Exhibit 60, # 11 Exhibit 61, # 12 Exhibit 62, # 13 Exhibit 63, # 14 Exhibit 64, # 15 Exhibit 65, # 16 Exhibit 66, # 17 Exhibit 67, # 18 Exhibit 68, # 19 Exhibit 69, # 20 Exhibit 70, # 21 Exhibit 71, # 22 Exhibit 72, # 23 Exhibit 73, # 24 Exhibit 74, # 25 Exhibit 75, # 26 Exhibit 76, # 27 Exhibit 77, # 28 Exhibit 78, # 29 Exhibit 79, # 30 Exhibit 80, # 31 Exhibit 81, # 32 Exhibit 82, # 33 Exhibit 83, # 34 Exhibit 84, # 35 Exhibit 85, # 36 Exhibit 86, # 37 Exhibit 87, # 38 Exhibit 88 part 1, # 39 Exhibit 88 part 2, # 40 Exhibit 89, # 41 Exhibit 90 part 1, # 42 Exhibit 90 part 2, # 43 Exhibit 91 part 1, # 44 Exhibit 91 part 2, # 45 Exhibit 92 part 1, # 46 Exhibit 92 part 2, # 47 Exhibit 93 part 1, # 48 Exhibit 93 part 2, # 49 Exhibit 93 part 3, # 50 Exhibit 93 part 4, # 51 Exhibit 94 part 1, # 52 Exhibit 94 part 2, # 53 Exhibit 94 part 3, # 54 Exhibit 94 part 4, # 55 Exhibit 95 part 1, # 56 Exhibit 95 part 2, # 57 Exhibit 96 part 1, # 58 Exhibit 96 part 2, # 59 Exhibit 97 part 1, # 60 Exhibit 97 part 2)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 54) (24)
Oct 16, 2020	6	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 51, # 2 Exhibit 52, # 3 Exhibit 53, # 4 Exhibit 54, # 5 Exhibit 55, # 6 Exhibit 56, # 7 Exhibit 57, # 8 Exhibit 58, # 9 Exhibit 59, # 10 Exhibit 60, # 11 Exhibit 61, # 12 Exhibit 62, # 13 Exhibit 63, # 14 Exhibit 64, # 15 Exhibit 65, # 16 Exhibit 66, # 17 Exhibit 67, # 18 Exhibit 68, # 19 Exhibit 69, # 20 Exhibit 70, # 21 Exhibit 71, # 22 Exhibit 72, # 23 Exhibit 73, # 24 Exhibit 74, # 25 Exhibit 75, # 26 Exhibit 76, # 27 Exhibit 77, # 28 Exhibit 78, # 29 Exhibit 79, # 30 Exhibit 80, # 31 Exhibit 81, # 32 Exhibit 82, # 33 Exhibit 83, # 34 Exhibit 84, # 35 Exhibit 85, # 36 Exhibit 86, # 37 Exhibit 87, # 38 Exhibit 88 part 1, # 39 Exhibit 88 part 2, # 40 Exhibit 89, # 41 Exhibit 90 part 1, # 42 Exhibit 90 part 2, # 43 Exhibit 91 part 1, # 44 Exhibit 91 part 2, # 45 Exhibit 92 part 1, # 46 Exhibit 92 part 2, # 47 Exhibit 93 part 1, # 48 Exhibit 93 part 2, # 49 Exhibit 93 part 3, # 50 Exhibit 93 part 4, # 51 Exhibit 94 part 1, # 52 Exhibit 94 part 2, # 53 Exhibit 94 part 3, # 54 Exhibit 94 part 4, # 55 Exhibit 95 part 1, # 56 Exhibit 95 part 2, # 57 Exhibit 96 part 1, # 58 Exhibit 96 part 2, # 59 Exhibit 97 part 1, # 60 Exhibit 97 part 2)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 55) (3)
Oct 16, 2020	6	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 51, # 2 Exhibit 52, # 3 Exhibit 53, # 4 Exhibit 54, # 5 Exhibit 55, # 6 Exhibit 56, # 7 Exhibit 57, # 8 Exhibit 58, # 9 Exhibit 59, # 10 Exhibit 60, # 11 Exhibit 61, # 12 Exhibit 62, # 13 Exhibit 63, # 14 Exhibit 64, # 15 Exhibit 65, # 16 Exhibit 66, # 17 Exhibit 67, # 18 Exhibit 68, # 19 Exhibit 69, # 20 Exhibit 70, # 21 Exhibit 71, # 22 Exhibit 72, # 23 Exhibit 73, # 24 Exhibit 74, # 25 Exhibit 75, # 26 Exhibit 76, # 27 Exhibit 77, # 28 Exhibit 78, # 29 Exhibit 79, # 30 Exhibit 80, # 31 Exhibit 81, # 32 Exhibit 82, # 33 Exhibit 83, # 34 Exhibit 84, # 35 Exhibit 85, # 36 Exhibit 86, # 37 Exhibit 87, # 38 Exhibit 88 part 1, # 39 Exhibit 88 part 2, # 40 Exhibit 89, # 41 Exhibit 90 part 1, # 42 Exhibit 90 part 2, # 43 Exhibit 91 part 1, # 44 Exhibit 91 part 2, # 45 Exhibit 92 part 1, # 46 Exhibit 92 part 2, # 47 Exhibit 93 part 1, # 48 Exhibit 93 part 2, # 49 Exhibit 93 part 3, # 50 Exhibit 93 part 4, # 51 Exhibit 94 part 1, # 52 Exhibit 94 part 2, # 53 Exhibit 94 part 3, # 54 Exhibit 94 part 4, # 55 Exhibit 95 part 1, # 56 Exhibit 95 part 2, # 57 Exhibit 96 part 1, # 58 Exhibit 96 part 2, # 59 Exhibit 97 part 1, # 60 Exhibit 97 part 2)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 56) (13)
Oct 16, 2020	6	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 51, # 2 Exhibit 52, # 3 Exhibit 53, # 4 Exhibit 54, # 5 Exhibit 55, # 6 Exhibit 56, # 7 Exhibit 57, # 8 Exhibit 58, # 9 Exhibit 59, # 10 Exhibit 60, # 11 Exhibit 61, # 12 Exhibit 62, # 13 Exhibit 63, # 14 Exhibit 64, # 15 Exhibit 65, # 16 Exhibit 66, # 17 Exhibit 67, # 18 Exhibit 68, # 19 Exhibit 69, # 20 Exhibit 70, # 21 Exhibit 71, # 22 Exhibit 72, # 23 Exhibit 73, # 24 Exhibit 74, # 25 Exhibit 75, # 26 Exhibit 76, # 27 Exhibit 77, # 28 Exhibit 78, # 29 Exhibit 79, # 30 Exhibit 80, # 31 Exhibit 81, # 32 Exhibit 82, # 33 Exhibit 83, # 34 Exhibit 84, # 35 Exhibit 85, # 36 Exhibit 86, # 37 Exhibit 87, # 38 Exhibit 88 part 1, # 39 Exhibit 88 part 2, # 40 Exhibit 89, # 41 Exhibit 90 part 1, # 42 Exhibit 90 part 2, # 43 Exhibit 91 part 1, # 44 Exhibit 91 part 2, # 45 Exhibit 92 part 1, # 46 Exhibit 92 part 2, # 47 Exhibit 93 part 1, # 48 Exhibit 93 part 2, # 49 Exhibit 93 part 3, # 50 Exhibit 93 part 4, # 51 Exhibit 94 part 1, # 52 Exhibit 94 part 2, # 53 Exhibit 94 part 3, # 54 Exhibit 94 part 4, # 55 Exhibit 95 part 1, # 56 Exhibit 95 part 2, # 57 Exhibit 96 part 1, # 58 Exhibit 96 part 2, # 59 Exhibit 97 part 1, # 60 Exhibit 97 part 2)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 57) (3)
Oct 16, 2020	6	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 51, # 2 Exhibit 52, # 3 Exhibit 53, # 4 Exhibit 54, # 5 Exhibit 55, # 6 Exhibit 56, # 7 Exhibit 57, # 8 Exhibit 58, # 9 Exhibit 59, # 10 Exhibit 60, # 11 Exhibit 61, # 12 Exhibit 62, # 13 Exhibit 63, # 14 Exhibit 64, # 15 Exhibit 65, # 16 Exhibit 66, # 17 Exhibit 67, # 18 Exhibit 68, # 19 Exhibit 69, # 20 Exhibit 70, # 21 Exhibit 71, # 22 Exhibit 72, # 23 Exhibit 73, # 24 Exhibit 74, # 25 Exhibit 75, # 26 Exhibit 76, # 27 Exhibit 77, # 28 Exhibit 78, # 29 Exhibit 79, # 30 Exhibit 80, # 31 Exhibit 81, # 32 Exhibit 82, # 33 Exhibit 83, # 34 Exhibit 84, # 35 Exhibit 85, # 36 Exhibit 86, # 37 Exhibit 87, # 38 Exhibit 88 part 1, # 39 Exhibit 88 part 2, # 40 Exhibit 89, # 41 Exhibit 90 part 1, # 42 Exhibit 90 part 2, # 43 Exhibit 91 part 1, # 44 Exhibit 91 part 2, # 45 Exhibit 92 part 1, # 46 Exhibit 92 part 2, # 47 Exhibit 93 part 1, # 48 Exhibit 93 part 2, # 49 Exhibit 93 part 3, # 50 Exhibit 93 part 4, # 51 Exhibit 94 part 1, # 52 Exhibit 94 part 2, # 53 Exhibit 94 part 3, # 54 Exhibit 94 part 4, # 55 Exhibit 95 part 1, # 56 Exhibit 95 part 2, # 57 Exhibit 96 part 1, # 58 Exhibit 96 part 2, # 59 Exhibit 97 part 1, # 60 Exhibit 97 part 2)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 58) (30)
Oct 16, 2020	6	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 51, # 2 Exhibit 52, # 3 Exhibit 53, # 4 Exhibit 54, # 5 Exhibit 55, # 6 Exhibit 56, # 7 Exhibit 57, # 8 Exhibit 58, # 9 Exhibit 59, # 10 Exhibit 60, # 11 Exhibit 61, # 12 Exhibit 62, # 13 Exhibit 63, # 14 Exhibit 64, # 15 Exhibit 65, # 16 Exhibit 66, # 17 Exhibit 67, # 18 Exhibit 68, # 19 Exhibit 69, # 20 Exhibit 70, # 21 Exhibit 71, # 22 Exhibit 72, # 23 Exhibit 73, # 24 Exhibit 74, # 25 Exhibit 75, # 26 Exhibit 76, # 27 Exhibit 77, # 28 Exhibit 78, # 29 Exhibit 79, # 30 Exhibit 80, # 31 Exhibit 81, # 32 Exhibit 82, # 33 Exhibit 83, # 34 Exhibit 84, # 35 Exhibit 85, # 36 Exhibit 86, # 37 Exhibit 87, # 38 Exhibit 88 part 1, # 39 Exhibit 88 part 2, # 40 Exhibit 89, # 41 Exhibit 90 part 1, # 42 Exhibit 90 part 2, # 43 Exhibit 91 part 1, # 44 Exhibit 91 part 2, # 45 Exhibit 92 part 1, # 46 Exhibit 92 part 2, # 47 Exhibit 93 part 1, # 48 Exhibit 93 part 2, # 49 Exhibit 93 part 3, # 50 Exhibit 93 part 4, # 51 Exhibit 94 part 1, # 52 Exhibit 94 part 2, # 53 Exhibit 94 part 3, # 54 Exhibit 94 part 4, # 55 Exhibit 95 part 1, # 56 Exhibit 95 part 2, # 57 Exhibit 96 part 1, # 58 Exhibit 96 part 2, # 59 Exhibit 97 part 1, # 60 Exhibit 97 part 2)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 59) (8)
Oct 16, 2020	6	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 51, # 2 Exhibit 52, # 3 Exhibit 53, # 4 Exhibit 54, # 5 Exhibit 55, # 6 Exhibit 56, # 7 Exhibit 57, # 8 Exhibit 58, # 9 Exhibit 59, # 10 Exhibit 60, # 11 Exhibit 61, # 12 Exhibit 62, # 13 Exhibit 63, # 14 Exhibit 64, # 15 Exhibit 65, # 16 Exhibit 66, # 17 Exhibit 67, # 18 Exhibit 68, # 19 Exhibit 69, # 20 Exhibit 70, # 21 Exhibit 71, # 22 Exhibit 72, # 23 Exhibit 73, # 24 Exhibit 74, # 25 Exhibit 75, # 26 Exhibit 76, # 27 Exhibit 77, # 28 Exhibit 78, # 29 Exhibit 79, # 30 Exhibit 80, # 31 Exhibit 81, # 32 Exhibit 82, # 33 Exhibit 83, # 34 Exhibit 84, # 35 Exhibit 85, # 36 Exhibit 86, # 37 Exhibit 87, # 38 Exhibit 88 part 1, # 39 Exhibit 88 part 2, # 40 Exhibit 89, # 41 Exhibit 90 part 1, # 42 Exhibit 90 part 2, # 43 Exhibit 91 part 1, # 44 Exhibit 91 part 2, # 45 Exhibit 92 part 1, # 46 Exhibit 92 part 2, # 47 Exhibit 93 part 1, # 48 Exhibit 93 part 2, # 49 Exhibit 93 part 3, # 50 Exhibit 93 part 4, # 51 Exhibit 94 part 1, # 52 Exhibit 94 part 2, # 53 Exhibit 94 part 3, # 54 Exhibit 94 part 4, # 55 Exhibit 95 part 1, # 56 Exhibit 95 part 2, # 57 Exhibit 96 part 1, # 58 Exhibit 96 part 2, # 59 Exhibit 97 part 1, # 60 Exhibit 97 part 2)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 60) (8)
Oct 16, 2020	6	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 51, # 2 Exhibit 52, # 3 Exhibit 53, # 4 Exhibit 54, # 5 Exhibit 55, # 6 Exhibit 56, # 7 Exhibit 57, # 8 Exhibit 58, # 9 Exhibit 59, # 10 Exhibit 60, # 11 Exhibit 61, # 12 Exhibit 62, # 13 Exhibit 63, # 14 Exhibit 64, # 15 Exhibit 65, # 16 Exhibit 66, # 17 Exhibit 67, # 18 Exhibit 68, # 19 Exhibit 69, # 20 Exhibit 70, # 21 Exhibit 71, # 22 Exhibit 72, # 23 Exhibit 73, # 24 Exhibit 74, # 25 Exhibit 75, # 26 Exhibit 76, # 27 Exhibit 77, # 28 Exhibit 78, # 29 Exhibit 79, # 30 Exhibit 80, # 31 Exhibit 81, # 32 Exhibit 82, # 33 Exhibit 83, # 34 Exhibit 84, # 35 Exhibit 85, # 36 Exhibit 86, # 37 Exhibit 87, # 38 Exhibit 88 part 1, # 39 Exhibit 88 part 2, # 40 Exhibit 89, # 41 Exhibit 90 part 1, # 42 Exhibit 90 part 2, # 43 Exhibit 91 part 1, # 44 Exhibit 91 part 2, # 45 Exhibit 92 part 1, # 46 Exhibit 92 part 2, # 47 Exhibit 93 part 1, # 48 Exhibit 93 part 2, # 49 Exhibit 93 part 3, # 50 Exhibit 93 part 4, # 51 Exhibit 94 part 1, # 52 Exhibit 94 part 2, # 53 Exhibit 94 part 3, # 54 Exhibit 94 part 4, # 55 Exhibit 95 part 1, # 56 Exhibit 95 part 2, # 57 Exhibit 96 part 1, # 58 Exhibit 96 part 2, # 59 Exhibit 97 part 1, # 60 Exhibit 97 part 2)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 61) (8)
Oct 16, 2020	6	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 51, # 2 Exhibit 52, # 3 Exhibit 53, # 4 Exhibit 54, # 5 Exhibit 55, # 6 Exhibit 56, # 7 Exhibit 57, # 8 Exhibit 58, # 9 Exhibit 59, # 10 Exhibit 60, # 11 Exhibit 61, # 12 Exhibit 62, # 13 Exhibit 63, # 14 Exhibit 64, # 15 Exhibit 65, # 16 Exhibit 66, # 17 Exhibit 67, # 18 Exhibit 68, # 19 Exhibit 69, # 20 Exhibit 70, # 21 Exhibit 71, # 22 Exhibit 72, # 23 Exhibit 73, # 24 Exhibit 74, # 25 Exhibit 75, # 26 Exhibit 76, # 27 Exhibit 77, # 28 Exhibit 78, # 29 Exhibit 79, # 30 Exhibit 80, # 31 Exhibit 81, # 32 Exhibit 82, # 33 Exhibit 83, # 34 Exhibit 84, # 35 Exhibit 85, # 36 Exhibit 86, # 37 Exhibit 87, # 38 Exhibit 88 part 1, # 39 Exhibit 88 part 2, # 40 Exhibit 89, # 41 Exhibit 90 part 1, # 42 Exhibit 90 part 2, # 43 Exhibit 91 part 1, # 44 Exhibit 91 part 2, # 45 Exhibit 92 part 1, # 46 Exhibit 92 part 2, # 47 Exhibit 93 part 1, # 48 Exhibit 93 part 2, # 49 Exhibit 93 part 3, # 50 Exhibit 93 part 4, # 51 Exhibit 94 part 1, # 52 Exhibit 94 part 2, # 53 Exhibit 94 part 3, # 54 Exhibit 94 part 4, # 55 Exhibit 95 part 1, # 56 Exhibit 95 part 2, # 57 Exhibit 96 part 1, # 58 Exhibit 96 part 2, # 59 Exhibit 97 part 1, # 60 Exhibit 97 part 2)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 62) (2)
Oct 16, 2020	6	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 51, # 2 Exhibit 52, # 3 Exhibit 53, # 4 Exhibit 54, # 5 Exhibit 55, # 6 Exhibit 56, # 7 Exhibit 57, # 8 Exhibit 58, # 9 Exhibit 59, # 10 Exhibit 60, # 11 Exhibit 61, # 12 Exhibit 62, # 13 Exhibit 63, # 14 Exhibit 64, # 15 Exhibit 65, # 16 Exhibit 66, # 17 Exhibit 67, # 18 Exhibit 68, # 19 Exhibit 69, # 20 Exhibit 70, # 21 Exhibit 71, # 22 Exhibit 72, # 23 Exhibit 73, # 24 Exhibit 74, # 25 Exhibit 75, # 26 Exhibit 76, # 27 Exhibit 77, # 28 Exhibit 78, # 29 Exhibit 79, # 30 Exhibit 80, # 31 Exhibit 81, # 32 Exhibit 82, # 33 Exhibit 83, # 34 Exhibit 84, # 35 Exhibit 85, # 36 Exhibit 86, # 37 Exhibit 87, # 38 Exhibit 88 part 1, # 39 Exhibit 88 part 2, # 40 Exhibit 89, # 41 Exhibit 90 part 1, # 42 Exhibit 90 part 2, # 43 Exhibit 91 part 1, # 44 Exhibit 91 part 2, # 45 Exhibit 92 part 1, # 46 Exhibit 92 part 2, # 47 Exhibit 93 part 1, # 48 Exhibit 93 part 2, # 49 Exhibit 93 part 3, # 50 Exhibit 93 part 4, # 51 Exhibit 94 part 1, # 52 Exhibit 94 part 2, # 53 Exhibit 94 part 3, # 54 Exhibit 94 part 4, # 55 Exhibit 95 part 1, # 56 Exhibit 95 part 2, # 57 Exhibit 96 part 1, # 58 Exhibit 96 part 2, # 59 Exhibit 97 part 1, # 60 Exhibit 97 part 2)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 63) (3)
Oct 16, 2020	6	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 51, # 2 Exhibit 52, # 3 Exhibit 53, # 4 Exhibit 54, # 5 Exhibit 55, # 6 Exhibit 56, # 7 Exhibit 57, # 8 Exhibit 58, # 9 Exhibit 59, # 10 Exhibit 60, # 11 Exhibit 61, # 12 Exhibit 62, # 13 Exhibit 63, # 14 Exhibit 64, # 15 Exhibit 65, # 16 Exhibit 66, # 17 Exhibit 67, # 18 Exhibit 68, # 19 Exhibit 69, # 20 Exhibit 70, # 21 Exhibit 71, # 22 Exhibit 72, # 23 Exhibit 73, # 24 Exhibit 74, # 25 Exhibit 75, # 26 Exhibit 76, # 27 Exhibit 77, # 28 Exhibit 78, # 29 Exhibit 79, # 30 Exhibit 80, # 31 Exhibit 81, # 32 Exhibit 82, # 33 Exhibit 83, # 34 Exhibit 84, # 35 Exhibit 85, # 36 Exhibit 86, # 37 Exhibit 87, # 38 Exhibit 88 part 1, # 39 Exhibit 88 part 2, # 40 Exhibit 89, # 41 Exhibit 90 part 1, # 42 Exhibit 90 part 2, # 43 Exhibit 91 part 1, # 44 Exhibit 91 part 2, # 45 Exhibit 92 part 1, # 46 Exhibit 92 part 2, # 47 Exhibit 93 part 1, # 48 Exhibit 93 part 2, # 49 Exhibit 93 part 3, # 50 Exhibit 93 part 4, # 51 Exhibit 94 part 1, # 52 Exhibit 94 part 2, # 53 Exhibit 94 part 3, # 54 Exhibit 94 part 4, # 55 Exhibit 95 part 1, # 56 Exhibit 95 part 2, # 57 Exhibit 96 part 1, # 58 Exhibit 96 part 2, # 59 Exhibit 97 part 1, # 60 Exhibit 97 part 2)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 64) (3)
Oct 16, 2020	6	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 51, # 2 Exhibit 52, # 3 Exhibit 53, # 4 Exhibit 54, # 5 Exhibit 55, # 6 Exhibit 56, # 7 Exhibit 57, # 8 Exhibit 58, # 9 Exhibit 59, # 10 Exhibit 60, # 11 Exhibit 61, # 12 Exhibit 62, # 13 Exhibit 63, # 14 Exhibit 64, # 15 Exhibit 65, # 16 Exhibit 66, # 17 Exhibit 67, # 18 Exhibit 68, # 19 Exhibit 69, # 20 Exhibit 70, # 21 Exhibit 71, # 22 Exhibit 72, # 23 Exhibit 73, # 24 Exhibit 74, # 25 Exhibit 75, # 26 Exhibit 76, # 27 Exhibit 77, # 28 Exhibit 78, # 29 Exhibit 79, # 30 Exhibit 80, # 31 Exhibit 81, # 32 Exhibit 82, # 33 Exhibit 83, # 34 Exhibit 84, # 35 Exhibit 85, # 36 Exhibit 86, # 37 Exhibit 87, # 38 Exhibit 88 part 1, # 39 Exhibit 88 part 2, # 40 Exhibit 89, # 41 Exhibit 90 part 1, # 42 Exhibit 90 part 2, # 43 Exhibit 91 part 1, # 44 Exhibit 91 part 2, # 45 Exhibit 92 part 1, # 46 Exhibit 92 part 2, # 47 Exhibit 93 part 1, # 48 Exhibit 93 part 2, # 49 Exhibit 93 part 3, # 50 Exhibit 93 part 4, # 51 Exhibit 94 part 1, # 52 Exhibit 94 part 2, # 53 Exhibit 94 part 3, # 54 Exhibit 94 part 4, # 55 Exhibit 95 part 1, # 56 Exhibit 95 part 2, # 57 Exhibit 96 part 1, # 58 Exhibit 96 part 2, # 59 Exhibit 97 part 1, # 60 Exhibit 97 part 2)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 65) (2)
Oct 16, 2020	6	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 51, # 2 Exhibit 52, # 3 Exhibit 53, # 4 Exhibit 54, # 5 Exhibit 55, # 6 Exhibit 56, # 7 Exhibit 57, # 8 Exhibit 58, # 9 Exhibit 59, # 10 Exhibit 60, # 11 Exhibit 61, # 12 Exhibit 62, # 13 Exhibit 63, # 14 Exhibit 64, # 15 Exhibit 65, # 16 Exhibit 66, # 17 Exhibit 67, # 18 Exhibit 68, # 19 Exhibit 69, # 20 Exhibit 70, # 21 Exhibit 71, # 22 Exhibit 72, # 23 Exhibit 73, # 24 Exhibit 74, # 25 Exhibit 75, # 26 Exhibit 76, # 27 Exhibit 77, # 28 Exhibit 78, # 29 Exhibit 79, # 30 Exhibit 80, # 31 Exhibit 81, # 32 Exhibit 82, # 33 Exhibit 83, # 34 Exhibit 84, # 35 Exhibit 85, # 36 Exhibit 86, # 37 Exhibit 87, # 38 Exhibit 88 part 1, # 39 Exhibit 88 part 2, # 40 Exhibit 89, # 41 Exhibit 90 part 1, # 42 Exhibit 90 part 2, # 43 Exhibit 91 part 1, # 44 Exhibit 91 part 2, # 45 Exhibit 92 part 1, # 46 Exhibit 92 part 2, # 47 Exhibit 93 part 1, # 48 Exhibit 93 part 2, # 49 Exhibit 93 part 3, # 50 Exhibit 93 part 4, # 51 Exhibit 94 part 1, # 52 Exhibit 94 part 2, # 53 Exhibit 94 part 3, # 54 Exhibit 94 part 4, # 55 Exhibit 95 part 1, # 56 Exhibit 95 part 2, # 57 Exhibit 96 part 1, # 58 Exhibit 96 part 2, # 59 Exhibit 97 part 1, # 60 Exhibit 97 part 2)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 66) (7)
Oct 16, 2020	6	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 51, # 2 Exhibit 52, # 3 Exhibit 53, # 4 Exhibit 54, # 5 Exhibit 55, # 6 Exhibit 56, # 7 Exhibit 57, # 8 Exhibit 58, # 9 Exhibit 59, # 10 Exhibit 60, # 11 Exhibit 61, # 12 Exhibit 62, # 13 Exhibit 63, # 14 Exhibit 64, # 15 Exhibit 65, # 16 Exhibit 66, # 17 Exhibit 67, # 18 Exhibit 68, # 19 Exhibit 69, # 20 Exhibit 70, # 21 Exhibit 71, # 22 Exhibit 72, # 23 Exhibit 73, # 24 Exhibit 74, # 25 Exhibit 75, # 26 Exhibit 76, # 27 Exhibit 77, # 28 Exhibit 78, # 29 Exhibit 79, # 30 Exhibit 80, # 31 Exhibit 81, # 32 Exhibit 82, # 33 Exhibit 83, # 34 Exhibit 84, # 35 Exhibit 85, # 36 Exhibit 86, # 37 Exhibit 87, # 38 Exhibit 88 part 1, # 39 Exhibit 88 part 2, # 40 Exhibit 89, # 41 Exhibit 90 part 1, # 42 Exhibit 90 part 2, # 43 Exhibit 91 part 1, # 44 Exhibit 91 part 2, # 45 Exhibit 92 part 1, # 46 Exhibit 92 part 2, # 47 Exhibit 93 part 1, # 48 Exhibit 93 part 2, # 49 Exhibit 93 part 3, # 50 Exhibit 93 part 4, # 51 Exhibit 94 part 1, # 52 Exhibit 94 part 2, # 53 Exhibit 94 part 3, # 54 Exhibit 94 part 4, # 55 Exhibit 95 part 1, # 56 Exhibit 95 part 2, # 57 Exhibit 96 part 1, # 58 Exhibit 96 part 2, # 59 Exhibit 97 part 1, # 60 Exhibit 97 part 2)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 67) (3)
Oct 16, 2020	6	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 51, # 2 Exhibit 52, # 3 Exhibit 53, # 4 Exhibit 54, # 5 Exhibit 55, # 6 Exhibit 56, # 7 Exhibit 57, # 8 Exhibit 58, # 9 Exhibit 59, # 10 Exhibit 60, # 11 Exhibit 61, # 12 Exhibit 62, # 13 Exhibit 63, # 14 Exhibit 64, # 15 Exhibit 65, # 16 Exhibit 66, # 17 Exhibit 67, # 18 Exhibit 68, # 19 Exhibit 69, # 20 Exhibit 70, # 21 Exhibit 71, # 22 Exhibit 72, # 23 Exhibit 73, # 24 Exhibit 74, # 25 Exhibit 75, # 26 Exhibit 76, # 27 Exhibit 77, # 28 Exhibit 78, # 29 Exhibit 79, # 30 Exhibit 80, # 31 Exhibit 81, # 32 Exhibit 82, # 33 Exhibit 83, # 34 Exhibit 84, # 35 Exhibit 85, # 36 Exhibit 86, # 37 Exhibit 87, # 38 Exhibit 88 part 1, # 39 Exhibit 88 part 2, # 40 Exhibit 89, # 41 Exhibit 90 part 1, # 42 Exhibit 90 part 2, # 43 Exhibit 91 part 1, # 44 Exhibit 91 part 2, # 45 Exhibit 92 part 1, # 46 Exhibit 92 part 2, # 47 Exhibit 93 part 1, # 48 Exhibit 93 part 2, # 49 Exhibit 93 part 3, # 50 Exhibit 93 part 4, # 51 Exhibit 94 part 1, # 52 Exhibit 94 part 2, # 53 Exhibit 94 part 3, # 54 Exhibit 94 part 4, # 55 Exhibit 95 part 1, # 56 Exhibit 95 part 2, # 57 Exhibit 96 part 1, # 58 Exhibit 96 part 2, # 59 Exhibit 97 part 1, # 60 Exhibit 97 part 2)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 68) (4)
Oct 16, 2020	6	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 51, # 2 Exhibit 52, # 3 Exhibit 53, # 4 Exhibit 54, # 5 Exhibit 55, # 6 Exhibit 56, # 7 Exhibit 57, # 8 Exhibit 58, # 9 Exhibit 59, # 10 Exhibit 60, # 11 Exhibit 61, # 12 Exhibit 62, # 13 Exhibit 63, # 14 Exhibit 64, # 15 Exhibit 65, # 16 Exhibit 66, # 17 Exhibit 67, # 18 Exhibit 68, # 19 Exhibit 69, # 20 Exhibit 70, # 21 Exhibit 71, # 22 Exhibit 72, # 23 Exhibit 73, # 24 Exhibit 74, # 25 Exhibit 75, # 26 Exhibit 76, # 27 Exhibit 77, # 28 Exhibit 78, # 29 Exhibit 79, # 30 Exhibit 80, # 31 Exhibit 81, # 32 Exhibit 82, # 33 Exhibit 83, # 34 Exhibit 84, # 35 Exhibit 85, # 36 Exhibit 86, # 37 Exhibit 87, # 38 Exhibit 88 part 1, # 39 Exhibit 88 part 2, # 40 Exhibit 89, # 41 Exhibit 90 part 1, # 42 Exhibit 90 part 2, # 43 Exhibit 91 part 1, # 44 Exhibit 91 part 2, # 45 Exhibit 92 part 1, # 46 Exhibit 92 part 2, # 47 Exhibit 93 part 1, # 48 Exhibit 93 part 2, # 49 Exhibit 93 part 3, # 50 Exhibit 93 part 4, # 51 Exhibit 94 part 1, # 52 Exhibit 94 part 2, # 53 Exhibit 94 part 3, # 54 Exhibit 94 part 4, # 55 Exhibit 95 part 1, # 56 Exhibit 95 part 2, # 57 Exhibit 96 part 1, # 58 Exhibit 96 part 2, # 59 Exhibit 97 part 1, # 60 Exhibit 97 part 2)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 69) (4)
Oct 16, 2020	6	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 51, # 2 Exhibit 52, # 3 Exhibit 53, # 4 Exhibit 54, # 5 Exhibit 55, # 6 Exhibit 56, # 7 Exhibit 57, # 8 Exhibit 58, # 9 Exhibit 59, # 10 Exhibit 60, # 11 Exhibit 61, # 12 Exhibit 62, # 13 Exhibit 63, # 14 Exhibit 64, # 15 Exhibit 65, # 16 Exhibit 66, # 17 Exhibit 67, # 18 Exhibit 68, # 19 Exhibit 69, # 20 Exhibit 70, # 21 Exhibit 71, # 22 Exhibit 72, # 23 Exhibit 73, # 24 Exhibit 74, # 25 Exhibit 75, # 26 Exhibit 76, # 27 Exhibit 77, # 28 Exhibit 78, # 29 Exhibit 79, # 30 Exhibit 80, # 31 Exhibit 81, # 32 Exhibit 82, # 33 Exhibit 83, # 34 Exhibit 84, # 35 Exhibit 85, # 36 Exhibit 86, # 37 Exhibit 87, # 38 Exhibit 88 part 1, # 39 Exhibit 88 part 2, # 40 Exhibit 89, # 41 Exhibit 90 part 1, # 42 Exhibit 90 part 2, # 43 Exhibit 91 part 1, # 44 Exhibit 91 part 2, # 45 Exhibit 92 part 1, # 46 Exhibit 92 part 2, # 47 Exhibit 93 part 1, # 48 Exhibit 93 part 2, # 49 Exhibit 93 part 3, # 50 Exhibit 93 part 4, # 51 Exhibit 94 part 1, # 52 Exhibit 94 part 2, # 53 Exhibit 94 part 3, # 54 Exhibit 94 part 4, # 55 Exhibit 95 part 1, # 56 Exhibit 95 part 2, # 57 Exhibit 96 part 1, # 58 Exhibit 96 part 2, # 59 Exhibit 97 part 1, # 60 Exhibit 97 part 2)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 70) (4)
Oct 16, 2020	6	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 51, # 2 Exhibit 52, # 3 Exhibit 53, # 4 Exhibit 54, # 5 Exhibit 55, # 6 Exhibit 56, # 7 Exhibit 57, # 8 Exhibit 58, # 9 Exhibit 59, # 10 Exhibit 60, # 11 Exhibit 61, # 12 Exhibit 62, # 13 Exhibit 63, # 14 Exhibit 64, # 15 Exhibit 65, # 16 Exhibit 66, # 17 Exhibit 67, # 18 Exhibit 68, # 19 Exhibit 69, # 20 Exhibit 70, # 21 Exhibit 71, # 22 Exhibit 72, # 23 Exhibit 73, # 24 Exhibit 74, # 25 Exhibit 75, # 26 Exhibit 76, # 27 Exhibit 77, # 28 Exhibit 78, # 29 Exhibit 79, # 30 Exhibit 80, # 31 Exhibit 81, # 32 Exhibit 82, # 33 Exhibit 83, # 34 Exhibit 84, # 35 Exhibit 85, # 36 Exhibit 86, # 37 Exhibit 87, # 38 Exhibit 88 part 1, # 39 Exhibit 88 part 2, # 40 Exhibit 89, # 41 Exhibit 90 part 1, # 42 Exhibit 90 part 2, # 43 Exhibit 91 part 1, # 44 Exhibit 91 part 2, # 45 Exhibit 92 part 1, # 46 Exhibit 92 part 2, # 47 Exhibit 93 part 1, # 48 Exhibit 93 part 2, # 49 Exhibit 93 part 3, # 50 Exhibit 93 part 4, # 51 Exhibit 94 part 1, # 52 Exhibit 94 part 2, # 53 Exhibit 94 part 3, # 54 Exhibit 94 part 4, # 55 Exhibit 95 part 1, # 56 Exhibit 95 part 2, # 57 Exhibit 96 part 1, # 58 Exhibit 96 part 2, # 59 Exhibit 97 part 1, # 60 Exhibit 97 part 2)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 71) (10)
Oct 16, 2020	6	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 51, # 2 Exhibit 52, # 3 Exhibit 53, # 4 Exhibit 54, # 5 Exhibit 55, # 6 Exhibit 56, # 7 Exhibit 57, # 8 Exhibit 58, # 9 Exhibit 59, # 10 Exhibit 60, # 11 Exhibit 61, # 12 Exhibit 62, # 13 Exhibit 63, # 14 Exhibit 64, # 15 Exhibit 65, # 16 Exhibit 66, # 17 Exhibit 67, # 18 Exhibit 68, # 19 Exhibit 69, # 20 Exhibit 70, # 21 Exhibit 71, # 22 Exhibit 72, # 23 Exhibit 73, # 24 Exhibit 74, # 25 Exhibit 75, # 26 Exhibit 76, # 27 Exhibit 77, # 28 Exhibit 78, # 29 Exhibit 79, # 30 Exhibit 80, # 31 Exhibit 81, # 32 Exhibit 82, # 33 Exhibit 83, # 34 Exhibit 84, # 35 Exhibit 85, # 36 Exhibit 86, # 37 Exhibit 87, # 38 Exhibit 88 part 1, # 39 Exhibit 88 part 2, # 40 Exhibit 89, # 41 Exhibit 90 part 1, # 42 Exhibit 90 part 2, # 43 Exhibit 91 part 1, # 44 Exhibit 91 part 2, # 45 Exhibit 92 part 1, # 46 Exhibit 92 part 2, # 47 Exhibit 93 part 1, # 48 Exhibit 93 part 2, # 49 Exhibit 93 part 3, # 50 Exhibit 93 part 4, # 51 Exhibit 94 part 1, # 52 Exhibit 94 part 2, # 53 Exhibit 94 part 3, # 54 Exhibit 94 part 4, # 55 Exhibit 95 part 1, # 56 Exhibit 95 part 2, # 57 Exhibit 96 part 1, # 58 Exhibit 96 part 2, # 59 Exhibit 97 part 1, # 60 Exhibit 97 part 2)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 72) (5)
Oct 16, 2020	6	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 51, # 2 Exhibit 52, # 3 Exhibit 53, # 4 Exhibit 54, # 5 Exhibit 55, # 6 Exhibit 56, # 7 Exhibit 57, # 8 Exhibit 58, # 9 Exhibit 59, # 10 Exhibit 60, # 11 Exhibit 61, # 12 Exhibit 62, # 13 Exhibit 63, # 14 Exhibit 64, # 15 Exhibit 65, # 16 Exhibit 66, # 17 Exhibit 67, # 18 Exhibit 68, # 19 Exhibit 69, # 20 Exhibit 70, # 21 Exhibit 71, # 22 Exhibit 72, # 23 Exhibit 73, # 24 Exhibit 74, # 25 Exhibit 75, # 26 Exhibit 76, # 27 Exhibit 77, # 28 Exhibit 78, # 29 Exhibit 79, # 30 Exhibit 80, # 31 Exhibit 81, # 32 Exhibit 82, # 33 Exhibit 83, # 34 Exhibit 84, # 35 Exhibit 85, # 36 Exhibit 86, # 37 Exhibit 87, # 38 Exhibit 88 part 1, # 39 Exhibit 88 part 2, # 40 Exhibit 89, # 41 Exhibit 90 part 1, # 42 Exhibit 90 part 2, # 43 Exhibit 91 part 1, # 44 Exhibit 91 part 2, # 45 Exhibit 92 part 1, # 46 Exhibit 92 part 2, # 47 Exhibit 93 part 1, # 48 Exhibit 93 part 2, # 49 Exhibit 93 part 3, # 50 Exhibit 93 part 4, # 51 Exhibit 94 part 1, # 52 Exhibit 94 part 2, # 53 Exhibit 94 part 3, # 54 Exhibit 94 part 4, # 55 Exhibit 95 part 1, # 56 Exhibit 95 part 2, # 57 Exhibit 96 part 1, # 58 Exhibit 96 part 2, # 59 Exhibit 97 part 1, # 60 Exhibit 97 part 2)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 73) (10)
Oct 16, 2020	6	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 51, # 2 Exhibit 52, # 3 Exhibit 53, # 4 Exhibit 54, # 5 Exhibit 55, # 6 Exhibit 56, # 7 Exhibit 57, # 8 Exhibit 58, # 9 Exhibit 59, # 10 Exhibit 60, # 11 Exhibit 61, # 12 Exhibit 62, # 13 Exhibit 63, # 14 Exhibit 64, # 15 Exhibit 65, # 16 Exhibit 66, # 17 Exhibit 67, # 18 Exhibit 68, # 19 Exhibit 69, # 20 Exhibit 70, # 21 Exhibit 71, # 22 Exhibit 72, # 23 Exhibit 73, # 24 Exhibit 74, # 25 Exhibit 75, # 26 Exhibit 76, # 27 Exhibit 77, # 28 Exhibit 78, # 29 Exhibit 79, # 30 Exhibit 80, # 31 Exhibit 81, # 32 Exhibit 82, # 33 Exhibit 83, # 34 Exhibit 84, # 35 Exhibit 85, # 36 Exhibit 86, # 37 Exhibit 87, # 38 Exhibit 88 part 1, # 39 Exhibit 88 part 2, # 40 Exhibit 89, # 41 Exhibit 90 part 1, # 42 Exhibit 90 part 2, # 43 Exhibit 91 part 1, # 44 Exhibit 91 part 2, # 45 Exhibit 92 part 1, # 46 Exhibit 92 part 2, # 47 Exhibit 93 part 1, # 48 Exhibit 93 part 2, # 49 Exhibit 93 part 3, # 50 Exhibit 93 part 4, # 51 Exhibit 94 part 1, # 52 Exhibit 94 part 2, # 53 Exhibit 94 part 3, # 54 Exhibit 94 part 4, # 55 Exhibit 95 part 1, # 56 Exhibit 95 part 2, # 57 Exhibit 96 part 1, # 58 Exhibit 96 part 2, # 59 Exhibit 97 part 1, # 60 Exhibit 97 part 2)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 74) (3)
Oct 16, 2020	6	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 51, # 2 Exhibit 52, # 3 Exhibit 53, # 4 Exhibit 54, # 5 Exhibit 55, # 6 Exhibit 56, # 7 Exhibit 57, # 8 Exhibit 58, # 9 Exhibit 59, # 10 Exhibit 60, # 11 Exhibit 61, # 12 Exhibit 62, # 13 Exhibit 63, # 14 Exhibit 64, # 15 Exhibit 65, # 16 Exhibit 66, # 17 Exhibit 67, # 18 Exhibit 68, # 19 Exhibit 69, # 20 Exhibit 70, # 21 Exhibit 71, # 22 Exhibit 72, # 23 Exhibit 73, # 24 Exhibit 74, # 25 Exhibit 75, # 26 Exhibit 76, # 27 Exhibit 77, # 28 Exhibit 78, # 29 Exhibit 79, # 30 Exhibit 80, # 31 Exhibit 81, # 32 Exhibit 82, # 33 Exhibit 83, # 34 Exhibit 84, # 35 Exhibit 85, # 36 Exhibit 86, # 37 Exhibit 87, # 38 Exhibit 88 part 1, # 39 Exhibit 88 part 2, # 40 Exhibit 89, # 41 Exhibit 90 part 1, # 42 Exhibit 90 part 2, # 43 Exhibit 91 part 1, # 44 Exhibit 91 part 2, # 45 Exhibit 92 part 1, # 46 Exhibit 92 part 2, # 47 Exhibit 93 part 1, # 48 Exhibit 93 part 2, # 49 Exhibit 93 part 3, # 50 Exhibit 93 part 4, # 51 Exhibit 94 part 1, # 52 Exhibit 94 part 2, # 53 Exhibit 94 part 3, # 54 Exhibit 94 part 4, # 55 Exhibit 95 part 1, # 56 Exhibit 95 part 2, # 57 Exhibit 96 part 1, # 58 Exhibit 96 part 2, # 59 Exhibit 97 part 1, # 60 Exhibit 97 part 2)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 75) (5)
Oct 16, 2020	6	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 51, # 2 Exhibit 52, # 3 Exhibit 53, # 4 Exhibit 54, # 5 Exhibit 55, # 6 Exhibit 56, # 7 Exhibit 57, # 8 Exhibit 58, # 9 Exhibit 59, # 10 Exhibit 60, # 11 Exhibit 61, # 12 Exhibit 62, # 13 Exhibit 63, # 14 Exhibit 64, # 15 Exhibit 65, # 16 Exhibit 66, # 17 Exhibit 67, # 18 Exhibit 68, # 19 Exhibit 69, # 20 Exhibit 70, # 21 Exhibit 71, # 22 Exhibit 72, # 23 Exhibit 73, # 24 Exhibit 74, # 25 Exhibit 75, # 26 Exhibit 76, # 27 Exhibit 77, # 28 Exhibit 78, # 29 Exhibit 79, # 30 Exhibit 80, # 31 Exhibit 81, # 32 Exhibit 82, # 33 Exhibit 83, # 34 Exhibit 84, # 35 Exhibit 85, # 36 Exhibit 86, # 37 Exhibit 87, # 38 Exhibit 88 part 1, # 39 Exhibit 88 part 2, # 40 Exhibit 89, # 41 Exhibit 90 part 1, # 42 Exhibit 90 part 2, # 43 Exhibit 91 part 1, # 44 Exhibit 91 part 2, # 45 Exhibit 92 part 1, # 46 Exhibit 92 part 2, # 47 Exhibit 93 part 1, # 48 Exhibit 93 part 2, # 49 Exhibit 93 part 3, # 50 Exhibit 93 part 4, # 51 Exhibit 94 part 1, # 52 Exhibit 94 part 2, # 53 Exhibit 94 part 3, # 54 Exhibit 94 part 4, # 55 Exhibit 95 part 1, # 56 Exhibit 95 part 2, # 57 Exhibit 96 part 1, # 58 Exhibit 96 part 2, # 59 Exhibit 97 part 1, # 60 Exhibit 97 part 2)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 76) (4)
Oct 16, 2020	6	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 51, # 2 Exhibit 52, # 3 Exhibit 53, # 4 Exhibit 54, # 5 Exhibit 55, # 6 Exhibit 56, # 7 Exhibit 57, # 8 Exhibit 58, # 9 Exhibit 59, # 10 Exhibit 60, # 11 Exhibit 61, # 12 Exhibit 62, # 13 Exhibit 63, # 14 Exhibit 64, # 15 Exhibit 65, # 16 Exhibit 66, # 17 Exhibit 67, # 18 Exhibit 68, # 19 Exhibit 69, # 20 Exhibit 70, # 21 Exhibit 71, # 22 Exhibit 72, # 23 Exhibit 73, # 24 Exhibit 74, # 25 Exhibit 75, # 26 Exhibit 76, # 27 Exhibit 77, # 28 Exhibit 78, # 29 Exhibit 79, # 30 Exhibit 80, # 31 Exhibit 81, # 32 Exhibit 82, # 33 Exhibit 83, # 34 Exhibit 84, # 35 Exhibit 85, # 36 Exhibit 86, # 37 Exhibit 87, # 38 Exhibit 88 part 1, # 39 Exhibit 88 part 2, # 40 Exhibit 89, # 41 Exhibit 90 part 1, # 42 Exhibit 90 part 2, # 43 Exhibit 91 part 1, # 44 Exhibit 91 part 2, # 45 Exhibit 92 part 1, # 46 Exhibit 92 part 2, # 47 Exhibit 93 part 1, # 48 Exhibit 93 part 2, # 49 Exhibit 93 part 3, # 50 Exhibit 93 part 4, # 51 Exhibit 94 part 1, # 52 Exhibit 94 part 2, # 53 Exhibit 94 part 3, # 54 Exhibit 94 part 4, # 55 Exhibit 95 part 1, # 56 Exhibit 95 part 2, # 57 Exhibit 96 part 1, # 58 Exhibit 96 part 2, # 59 Exhibit 97 part 1, # 60 Exhibit 97 part 2)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 77) (2)
Oct 16, 2020	6	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 51, # 2 Exhibit 52, # 3 Exhibit 53, # 4 Exhibit 54, # 5 Exhibit 55, # 6 Exhibit 56, # 7 Exhibit 57, # 8 Exhibit 58, # 9 Exhibit 59, # 10 Exhibit 60, # 11 Exhibit 61, # 12 Exhibit 62, # 13 Exhibit 63, # 14 Exhibit 64, # 15 Exhibit 65, # 16 Exhibit 66, # 17 Exhibit 67, # 18 Exhibit 68, # 19 Exhibit 69, # 20 Exhibit 70, # 21 Exhibit 71, # 22 Exhibit 72, # 23 Exhibit 73, # 24 Exhibit 74, # 25 Exhibit 75, # 26 Exhibit 76, # 27 Exhibit 77, # 28 Exhibit 78, # 29 Exhibit 79, # 30 Exhibit 80, # 31 Exhibit 81, # 32 Exhibit 82, # 33 Exhibit 83, # 34 Exhibit 84, # 35 Exhibit 85, # 36 Exhibit 86, # 37 Exhibit 87, # 38 Exhibit 88 part 1, # 39 Exhibit 88 part 2, # 40 Exhibit 89, # 41 Exhibit 90 part 1, # 42 Exhibit 90 part 2, # 43 Exhibit 91 part 1, # 44 Exhibit 91 part 2, # 45 Exhibit 92 part 1, # 46 Exhibit 92 part 2, # 47 Exhibit 93 part 1, # 48 Exhibit 93 part 2, # 49 Exhibit 93 part 3, # 50 Exhibit 93 part 4, # 51 Exhibit 94 part 1, # 52 Exhibit 94 part 2, # 53 Exhibit 94 part 3, # 54 Exhibit 94 part 4, # 55 Exhibit 95 part 1, # 56 Exhibit 95 part 2, # 57 Exhibit 96 part 1, # 58 Exhibit 96 part 2, # 59 Exhibit 97 part 1, # 60 Exhibit 97 part 2)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 78) (4)
Oct 16, 2020	6	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 51, # 2 Exhibit 52, # 3 Exhibit 53, # 4 Exhibit 54, # 5 Exhibit 55, # 6 Exhibit 56, # 7 Exhibit 57, # 8 Exhibit 58, # 9 Exhibit 59, # 10 Exhibit 60, # 11 Exhibit 61, # 12 Exhibit 62, # 13 Exhibit 63, # 14 Exhibit 64, # 15 Exhibit 65, # 16 Exhibit 66, # 17 Exhibit 67, # 18 Exhibit 68, # 19 Exhibit 69, # 20 Exhibit 70, # 21 Exhibit 71, # 22 Exhibit 72, # 23 Exhibit 73, # 24 Exhibit 74, # 25 Exhibit 75, # 26 Exhibit 76, # 27 Exhibit 77, # 28 Exhibit 78, # 29 Exhibit 79, # 30 Exhibit 80, # 31 Exhibit 81, # 32 Exhibit 82, # 33 Exhibit 83, # 34 Exhibit 84, # 35 Exhibit 85, # 36 Exhibit 86, # 37 Exhibit 87, # 38 Exhibit 88 part 1, # 39 Exhibit 88 part 2, # 40 Exhibit 89, # 41 Exhibit 90 part 1, # 42 Exhibit 90 part 2, # 43 Exhibit 91 part 1, # 44 Exhibit 91 part 2, # 45 Exhibit 92 part 1, # 46 Exhibit 92 part 2, # 47 Exhibit 93 part 1, # 48 Exhibit 93 part 2, # 49 Exhibit 93 part 3, # 50 Exhibit 93 part 4, # 51 Exhibit 94 part 1, # 52 Exhibit 94 part 2, # 53 Exhibit 94 part 3, # 54 Exhibit 94 part 4, # 55 Exhibit 95 part 1, # 56 Exhibit 95 part 2, # 57 Exhibit 96 part 1, # 58 Exhibit 96 part 2, # 59 Exhibit 97 part 1, # 60 Exhibit 97 part 2)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 79) (3)
Oct 16, 2020	6	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 51, # 2 Exhibit 52, # 3 Exhibit 53, # 4 Exhibit 54, # 5 Exhibit 55, # 6 Exhibit 56, # 7 Exhibit 57, # 8 Exhibit 58, # 9 Exhibit 59, # 10 Exhibit 60, # 11 Exhibit 61, # 12 Exhibit 62, # 13 Exhibit 63, # 14 Exhibit 64, # 15 Exhibit 65, # 16 Exhibit 66, # 17 Exhibit 67, # 18 Exhibit 68, # 19 Exhibit 69, # 20 Exhibit 70, # 21 Exhibit 71, # 22 Exhibit 72, # 23 Exhibit 73, # 24 Exhibit 74, # 25 Exhibit 75, # 26 Exhibit 76, # 27 Exhibit 77, # 28 Exhibit 78, # 29 Exhibit 79, # 30 Exhibit 80, # 31 Exhibit 81, # 32 Exhibit 82, # 33 Exhibit 83, # 34 Exhibit 84, # 35 Exhibit 85, # 36 Exhibit 86, # 37 Exhibit 87, # 38 Exhibit 88 part 1, # 39 Exhibit 88 part 2, # 40 Exhibit 89, # 41 Exhibit 90 part 1, # 42 Exhibit 90 part 2, # 43 Exhibit 91 part 1, # 44 Exhibit 91 part 2, # 45 Exhibit 92 part 1, # 46 Exhibit 92 part 2, # 47 Exhibit 93 part 1, # 48 Exhibit 93 part 2, # 49 Exhibit 93 part 3, # 50 Exhibit 93 part 4, # 51 Exhibit 94 part 1, # 52 Exhibit 94 part 2, # 53 Exhibit 94 part 3, # 54 Exhibit 94 part 4, # 55 Exhibit 95 part 1, # 56 Exhibit 95 part 2, # 57 Exhibit 96 part 1, # 58 Exhibit 96 part 2, # 59 Exhibit 97 part 1, # 60 Exhibit 97 part 2)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 80) (3)
Oct 16, 2020	6	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 51, # 2 Exhibit 52, # 3 Exhibit 53, # 4 Exhibit 54, # 5 Exhibit 55, # 6 Exhibit 56, # 7 Exhibit 57, # 8 Exhibit 58, # 9 Exhibit 59, # 10 Exhibit 60, # 11 Exhibit 61, # 12 Exhibit 62, # 13 Exhibit 63, # 14 Exhibit 64, # 15 Exhibit 65, # 16 Exhibit 66, # 17 Exhibit 67, # 18 Exhibit 68, # 19 Exhibit 69, # 20 Exhibit 70, # 21 Exhibit 71, # 22 Exhibit 72, # 23 Exhibit 73, # 24 Exhibit 74, # 25 Exhibit 75, # 26 Exhibit 76, # 27 Exhibit 77, # 28 Exhibit 78, # 29 Exhibit 79, # 30 Exhibit 80, # 31 Exhibit 81, # 32 Exhibit 82, # 33 Exhibit 83, # 34 Exhibit 84, # 35 Exhibit 85, # 36 Exhibit 86, # 37 Exhibit 87, # 38 Exhibit 88 part 1, # 39 Exhibit 88 part 2, # 40 Exhibit 89, # 41 Exhibit 90 part 1, # 42 Exhibit 90 part 2, # 43 Exhibit 91 part 1, # 44 Exhibit 91 part 2, # 45 Exhibit 92 part 1, # 46 Exhibit 92 part 2, # 47 Exhibit 93 part 1, # 48 Exhibit 93 part 2, # 49 Exhibit 93 part 3, # 50 Exhibit 93 part 4, # 51 Exhibit 94 part 1, # 52 Exhibit 94 part 2, # 53 Exhibit 94 part 3, # 54 Exhibit 94 part 4, # 55 Exhibit 95 part 1, # 56 Exhibit 95 part 2, # 57 Exhibit 96 part 1, # 58 Exhibit 96 part 2, # 59 Exhibit 97 part 1, # 60 Exhibit 97 part 2)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 81) (2)
Oct 16, 2020	6	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 51, # 2 Exhibit 52, # 3 Exhibit 53, # 4 Exhibit 54, # 5 Exhibit 55, # 6 Exhibit 56, # 7 Exhibit 57, # 8 Exhibit 58, # 9 Exhibit 59, # 10 Exhibit 60, # 11 Exhibit 61, # 12 Exhibit 62, # 13 Exhibit 63, # 14 Exhibit 64, # 15 Exhibit 65, # 16 Exhibit 66, # 17 Exhibit 67, # 18 Exhibit 68, # 19 Exhibit 69, # 20 Exhibit 70, # 21 Exhibit 71, # 22 Exhibit 72, # 23 Exhibit 73, # 24 Exhibit 74, # 25 Exhibit 75, # 26 Exhibit 76, # 27 Exhibit 77, # 28 Exhibit 78, # 29 Exhibit 79, # 30 Exhibit 80, # 31 Exhibit 81, # 32 Exhibit 82, # 33 Exhibit 83, # 34 Exhibit 84, # 35 Exhibit 85, # 36 Exhibit 86, # 37 Exhibit 87, # 38 Exhibit 88 part 1, # 39 Exhibit 88 part 2, # 40 Exhibit 89, # 41 Exhibit 90 part 1, # 42 Exhibit 90 part 2, # 43 Exhibit 91 part 1, # 44 Exhibit 91 part 2, # 45 Exhibit 92 part 1, # 46 Exhibit 92 part 2, # 47 Exhibit 93 part 1, # 48 Exhibit 93 part 2, # 49 Exhibit 93 part 3, # 50 Exhibit 93 part 4, # 51 Exhibit 94 part 1, # 52 Exhibit 94 part 2, # 53 Exhibit 94 part 3, # 54 Exhibit 94 part 4, # 55 Exhibit 95 part 1, # 56 Exhibit 95 part 2, # 57 Exhibit 96 part 1, # 58 Exhibit 96 part 2, # 59 Exhibit 97 part 1, # 60 Exhibit 97 part 2)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 82) (5)
Oct 16, 2020	6	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 51, # 2 Exhibit 52, # 3 Exhibit 53, # 4 Exhibit 54, # 5 Exhibit 55, # 6 Exhibit 56, # 7 Exhibit 57, # 8 Exhibit 58, # 9 Exhibit 59, # 10 Exhibit 60, # 11 Exhibit 61, # 12 Exhibit 62, # 13 Exhibit 63, # 14 Exhibit 64, # 15 Exhibit 65, # 16 Exhibit 66, # 17 Exhibit 67, # 18 Exhibit 68, # 19 Exhibit 69, # 20 Exhibit 70, # 21 Exhibit 71, # 22 Exhibit 72, # 23 Exhibit 73, # 24 Exhibit 74, # 25 Exhibit 75, # 26 Exhibit 76, # 27 Exhibit 77, # 28 Exhibit 78, # 29 Exhibit 79, # 30 Exhibit 80, # 31 Exhibit 81, # 32 Exhibit 82, # 33 Exhibit 83, # 34 Exhibit 84, # 35 Exhibit 85, # 36 Exhibit 86, # 37 Exhibit 87, # 38 Exhibit 88 part 1, # 39 Exhibit 88 part 2, # 40 Exhibit 89, # 41 Exhibit 90 part 1, # 42 Exhibit 90 part 2, # 43 Exhibit 91 part 1, # 44 Exhibit 91 part 2, # 45 Exhibit 92 part 1, # 46 Exhibit 92 part 2, # 47 Exhibit 93 part 1, # 48 Exhibit 93 part 2, # 49 Exhibit 93 part 3, # 50 Exhibit 93 part 4, # 51 Exhibit 94 part 1, # 52 Exhibit 94 part 2, # 53 Exhibit 94 part 3, # 54 Exhibit 94 part 4, # 55 Exhibit 95 part 1, # 56 Exhibit 95 part 2, # 57 Exhibit 96 part 1, # 58 Exhibit 96 part 2, # 59 Exhibit 97 part 1, # 60 Exhibit 97 part 2)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 83) (3)
Oct 16, 2020	6	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 51, # 2 Exhibit 52, # 3 Exhibit 53, # 4 Exhibit 54, # 5 Exhibit 55, # 6 Exhibit 56, # 7 Exhibit 57, # 8 Exhibit 58, # 9 Exhibit 59, # 10 Exhibit 60, # 11 Exhibit 61, # 12 Exhibit 62, # 13 Exhibit 63, # 14 Exhibit 64, # 15 Exhibit 65, # 16 Exhibit 66, # 17 Exhibit 67, # 18 Exhibit 68, # 19 Exhibit 69, # 20 Exhibit 70, # 21 Exhibit 71, # 22 Exhibit 72, # 23 Exhibit 73, # 24 Exhibit 74, # 25 Exhibit 75, # 26 Exhibit 76, # 27 Exhibit 77, # 28 Exhibit 78, # 29 Exhibit 79, # 30 Exhibit 80, # 31 Exhibit 81, # 32 Exhibit 82, # 33 Exhibit 83, # 34 Exhibit 84, # 35 Exhibit 85, # 36 Exhibit 86, # 37 Exhibit 87, # 38 Exhibit 88 part 1, # 39 Exhibit 88 part 2, # 40 Exhibit 89, # 41 Exhibit 90 part 1, # 42 Exhibit 90 part 2, # 43 Exhibit 91 part 1, # 44 Exhibit 91 part 2, # 45 Exhibit 92 part 1, # 46 Exhibit 92 part 2, # 47 Exhibit 93 part 1, # 48 Exhibit 93 part 2, # 49 Exhibit 93 part 3, # 50 Exhibit 93 part 4, # 51 Exhibit 94 part 1, # 52 Exhibit 94 part 2, # 53 Exhibit 94 part 3, # 54 Exhibit 94 part 4, # 55 Exhibit 95 part 1, # 56 Exhibit 95 part 2, # 57 Exhibit 96 part 1, # 58 Exhibit 96 part 2, # 59 Exhibit 97 part 1, # 60 Exhibit 97 part 2)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 84) (2)
Oct 16, 2020	6	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 51, # 2 Exhibit 52, # 3 Exhibit 53, # 4 Exhibit 54, # 5 Exhibit 55, # 6 Exhibit 56, # 7 Exhibit 57, # 8 Exhibit 58, # 9 Exhibit 59, # 10 Exhibit 60, # 11 Exhibit 61, # 12 Exhibit 62, # 13 Exhibit 63, # 14 Exhibit 64, # 15 Exhibit 65, # 16 Exhibit 66, # 17 Exhibit 67, # 18 Exhibit 68, # 19 Exhibit 69, # 20 Exhibit 70, # 21 Exhibit 71, # 22 Exhibit 72, # 23 Exhibit 73, # 24 Exhibit 74, # 25 Exhibit 75, # 26 Exhibit 76, # 27 Exhibit 77, # 28 Exhibit 78, # 29 Exhibit 79, # 30 Exhibit 80, # 31 Exhibit 81, # 32 Exhibit 82, # 33 Exhibit 83, # 34 Exhibit 84, # 35 Exhibit 85, # 36 Exhibit 86, # 37 Exhibit 87, # 38 Exhibit 88 part 1, # 39 Exhibit 88 part 2, # 40 Exhibit 89, # 41 Exhibit 90 part 1, # 42 Exhibit 90 part 2, # 43 Exhibit 91 part 1, # 44 Exhibit 91 part 2, # 45 Exhibit 92 part 1, # 46 Exhibit 92 part 2, # 47 Exhibit 93 part 1, # 48 Exhibit 93 part 2, # 49 Exhibit 93 part 3, # 50 Exhibit 93 part 4, # 51 Exhibit 94 part 1, # 52 Exhibit 94 part 2, # 53 Exhibit 94 part 3, # 54 Exhibit 94 part 4, # 55 Exhibit 95 part 1, # 56 Exhibit 95 part 2, # 57 Exhibit 96 part 1, # 58 Exhibit 96 part 2, # 59 Exhibit 97 part 1, # 60 Exhibit 97 part 2)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 85) (2)
Oct 16, 2020	6	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 51, # 2 Exhibit 52, # 3 Exhibit 53, # 4 Exhibit 54, # 5 Exhibit 55, # 6 Exhibit 56, # 7 Exhibit 57, # 8 Exhibit 58, # 9 Exhibit 59, # 10 Exhibit 60, # 11 Exhibit 61, # 12 Exhibit 62, # 13 Exhibit 63, # 14 Exhibit 64, # 15 Exhibit 65, # 16 Exhibit 66, # 17 Exhibit 67, # 18 Exhibit 68, # 19 Exhibit 69, # 20 Exhibit 70, # 21 Exhibit 71, # 22 Exhibit 72, # 23 Exhibit 73, # 24 Exhibit 74, # 25 Exhibit 75, # 26 Exhibit 76, # 27 Exhibit 77, # 28 Exhibit 78, # 29 Exhibit 79, # 30 Exhibit 80, # 31 Exhibit 81, # 32 Exhibit 82, # 33 Exhibit 83, # 34 Exhibit 84, # 35 Exhibit 85, # 36 Exhibit 86, # 37 Exhibit 87, # 38 Exhibit 88 part 1, # 39 Exhibit 88 part 2, # 40 Exhibit 89, # 41 Exhibit 90 part 1, # 42 Exhibit 90 part 2, # 43 Exhibit 91 part 1, # 44 Exhibit 91 part 2, # 45 Exhibit 92 part 1, # 46 Exhibit 92 part 2, # 47 Exhibit 93 part 1, # 48 Exhibit 93 part 2, # 49 Exhibit 93 part 3, # 50 Exhibit 93 part 4, # 51 Exhibit 94 part 1, # 52 Exhibit 94 part 2, # 53 Exhibit 94 part 3, # 54 Exhibit 94 part 4, # 55 Exhibit 95 part 1, # 56 Exhibit 95 part 2, # 57 Exhibit 96 part 1, # 58 Exhibit 96 part 2, # 59 Exhibit 97 part 1, # 60 Exhibit 97 part 2)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 86) (2)
Oct 16, 2020	6	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 51, # 2 Exhibit 52, # 3 Exhibit 53, # 4 Exhibit 54, # 5 Exhibit 55, # 6 Exhibit 56, # 7 Exhibit 57, # 8 Exhibit 58, # 9 Exhibit 59, # 10 Exhibit 60, # 11 Exhibit 61, # 12 Exhibit 62, # 13 Exhibit 63, # 14 Exhibit 64, # 15 Exhibit 65, # 16 Exhibit 66, # 17 Exhibit 67, # 18 Exhibit 68, # 19 Exhibit 69, # 20 Exhibit 70, # 21 Exhibit 71, # 22 Exhibit 72, # 23 Exhibit 73, # 24 Exhibit 74, # 25 Exhibit 75, # 26 Exhibit 76, # 27 Exhibit 77, # 28 Exhibit 78, # 29 Exhibit 79, # 30 Exhibit 80, # 31 Exhibit 81, # 32 Exhibit 82, # 33 Exhibit 83, # 34 Exhibit 84, # 35 Exhibit 85, # 36 Exhibit 86, # 37 Exhibit 87, # 38 Exhibit 88 part 1, # 39 Exhibit 88 part 2, # 40 Exhibit 89, # 41 Exhibit 90 part 1, # 42 Exhibit 90 part 2, # 43 Exhibit 91 part 1, # 44 Exhibit 91 part 2, # 45 Exhibit 92 part 1, # 46 Exhibit 92 part 2, # 47 Exhibit 93 part 1, # 48 Exhibit 93 part 2, # 49 Exhibit 93 part 3, # 50 Exhibit 93 part 4, # 51 Exhibit 94 part 1, # 52 Exhibit 94 part 2, # 53 Exhibit 94 part 3, # 54 Exhibit 94 part 4, # 55 Exhibit 95 part 1, # 56 Exhibit 95 part 2, # 57 Exhibit 96 part 1, # 58 Exhibit 96 part 2, # 59 Exhibit 97 part 1, # 60 Exhibit 97 part 2)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 87) (3)
Oct 16, 2020	6	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 51, # 2 Exhibit 52, # 3 Exhibit 53, # 4 Exhibit 54, # 5 Exhibit 55, # 6 Exhibit 56, # 7 Exhibit 57, # 8 Exhibit 58, # 9 Exhibit 59, # 10 Exhibit 60, # 11 Exhibit 61, # 12 Exhibit 62, # 13 Exhibit 63, # 14 Exhibit 64, # 15 Exhibit 65, # 16 Exhibit 66, # 17 Exhibit 67, # 18 Exhibit 68, # 19 Exhibit 69, # 20 Exhibit 70, # 21 Exhibit 71, # 22 Exhibit 72, # 23 Exhibit 73, # 24 Exhibit 74, # 25 Exhibit 75, # 26 Exhibit 76, # 27 Exhibit 77, # 28 Exhibit 78, # 29 Exhibit 79, # 30 Exhibit 80, # 31 Exhibit 81, # 32 Exhibit 82, # 33 Exhibit 83, # 34 Exhibit 84, # 35 Exhibit 85, # 36 Exhibit 86, # 37 Exhibit 87, # 38 Exhibit 88 part 1, # 39 Exhibit 88 part 2, # 40 Exhibit 89, # 41 Exhibit 90 part 1, # 42 Exhibit 90 part 2, # 43 Exhibit 91 part 1, # 44 Exhibit 91 part 2, # 45 Exhibit 92 part 1, # 46 Exhibit 92 part 2, # 47 Exhibit 93 part 1, # 48 Exhibit 93 part 2, # 49 Exhibit 93 part 3, # 50 Exhibit 93 part 4, # 51 Exhibit 94 part 1, # 52 Exhibit 94 part 2, # 53 Exhibit 94 part 3, # 54 Exhibit 94 part 4, # 55 Exhibit 95 part 1, # 56 Exhibit 95 part 2, # 57 Exhibit 96 part 1, # 58 Exhibit 96 part 2, # 59 Exhibit 97 part 1, # 60 Exhibit 97 part 2)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 88 part 1) (30)
Oct 16, 2020	6	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 51, # 2 Exhibit 52, # 3 Exhibit 53, # 4 Exhibit 54, # 5 Exhibit 55, # 6 Exhibit 56, # 7 Exhibit 57, # 8 Exhibit 58, # 9 Exhibit 59, # 10 Exhibit 60, # 11 Exhibit 61, # 12 Exhibit 62, # 13 Exhibit 63, # 14 Exhibit 64, # 15 Exhibit 65, # 16 Exhibit 66, # 17 Exhibit 67, # 18 Exhibit 68, # 19 Exhibit 69, # 20 Exhibit 70, # 21 Exhibit 71, # 22 Exhibit 72, # 23 Exhibit 73, # 24 Exhibit 74, # 25 Exhibit 75, # 26 Exhibit 76, # 27 Exhibit 77, # 28 Exhibit 78, # 29 Exhibit 79, # 30 Exhibit 80, # 31 Exhibit 81, # 32 Exhibit 82, # 33 Exhibit 83, # 34 Exhibit 84, # 35 Exhibit 85, # 36 Exhibit 86, # 37 Exhibit 87, # 38 Exhibit 88 part 1, # 39 Exhibit 88 part 2, # 40 Exhibit 89, # 41 Exhibit 90 part 1, # 42 Exhibit 90 part 2, # 43 Exhibit 91 part 1, # 44 Exhibit 91 part 2, # 45 Exhibit 92 part 1, # 46 Exhibit 92 part 2, # 47 Exhibit 93 part 1, # 48 Exhibit 93 part 2, # 49 Exhibit 93 part 3, # 50 Exhibit 93 part 4, # 51 Exhibit 94 part 1, # 52 Exhibit 94 part 2, # 53 Exhibit 94 part 3, # 54 Exhibit 94 part 4, # 55 Exhibit 95 part 1, # 56 Exhibit 95 part 2, # 57 Exhibit 96 part 1, # 58 Exhibit 96 part 2, # 59 Exhibit 97 part 1, # 60 Exhibit 97 part 2)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 88 part 2) (30)
Oct 16, 2020	6	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 51, # 2 Exhibit 52, # 3 Exhibit 53, # 4 Exhibit 54, # 5 Exhibit 55, # 6 Exhibit 56, # 7 Exhibit 57, # 8 Exhibit 58, # 9 Exhibit 59, # 10 Exhibit 60, # 11 Exhibit 61, # 12 Exhibit 62, # 13 Exhibit 63, # 14 Exhibit 64, # 15 Exhibit 65, # 16 Exhibit 66, # 17 Exhibit 67, # 18 Exhibit 68, # 19 Exhibit 69, # 20 Exhibit 70, # 21 Exhibit 71, # 22 Exhibit 72, # 23 Exhibit 73, # 24 Exhibit 74, # 25 Exhibit 75, # 26 Exhibit 76, # 27 Exhibit 77, # 28 Exhibit 78, # 29 Exhibit 79, # 30 Exhibit 80, # 31 Exhibit 81, # 32 Exhibit 82, # 33 Exhibit 83, # 34 Exhibit 84, # 35 Exhibit 85, # 36 Exhibit 86, # 37 Exhibit 87, # 38 Exhibit 88 part 1, # 39 Exhibit 88 part 2, # 40 Exhibit 89, # 41 Exhibit 90 part 1, # 42 Exhibit 90 part 2, # 43 Exhibit 91 part 1, # 44 Exhibit 91 part 2, # 45 Exhibit 92 part 1, # 46 Exhibit 92 part 2, # 47 Exhibit 93 part 1, # 48 Exhibit 93 part 2, # 49 Exhibit 93 part 3, # 50 Exhibit 93 part 4, # 51 Exhibit 94 part 1, # 52 Exhibit 94 part 2, # 53 Exhibit 94 part 3, # 54 Exhibit 94 part 4, # 55 Exhibit 95 part 1, # 56 Exhibit 95 part 2, # 57 Exhibit 96 part 1, # 58 Exhibit 96 part 2, # 59 Exhibit 97 part 1, # 60 Exhibit 97 part 2)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 89) (30)
Oct 16, 2020	6	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 51, # 2 Exhibit 52, # 3 Exhibit 53, # 4 Exhibit 54, # 5 Exhibit 55, # 6 Exhibit 56, # 7 Exhibit 57, # 8 Exhibit 58, # 9 Exhibit 59, # 10 Exhibit 60, # 11 Exhibit 61, # 12 Exhibit 62, # 13 Exhibit 63, # 14 Exhibit 64, # 15 Exhibit 65, # 16 Exhibit 66, # 17 Exhibit 67, # 18 Exhibit 68, # 19 Exhibit 69, # 20 Exhibit 70, # 21 Exhibit 71, # 22 Exhibit 72, # 23 Exhibit 73, # 24 Exhibit 74, # 25 Exhibit 75, # 26 Exhibit 76, # 27 Exhibit 77, # 28 Exhibit 78, # 29 Exhibit 79, # 30 Exhibit 80, # 31 Exhibit 81, # 32 Exhibit 82, # 33 Exhibit 83, # 34 Exhibit 84, # 35 Exhibit 85, # 36 Exhibit 86, # 37 Exhibit 87, # 38 Exhibit 88 part 1, # 39 Exhibit 88 part 2, # 40 Exhibit 89, # 41 Exhibit 90 part 1, # 42 Exhibit 90 part 2, # 43 Exhibit 91 part 1, # 44 Exhibit 91 part 2, # 45 Exhibit 92 part 1, # 46 Exhibit 92 part 2, # 47 Exhibit 93 part 1, # 48 Exhibit 93 part 2, # 49 Exhibit 93 part 3, # 50 Exhibit 93 part 4, # 51 Exhibit 94 part 1, # 52 Exhibit 94 part 2, # 53 Exhibit 94 part 3, # 54 Exhibit 94 part 4, # 55 Exhibit 95 part 1, # 56 Exhibit 95 part 2, # 57 Exhibit 96 part 1, # 58 Exhibit 96 part 2, # 59 Exhibit 97 part 1, # 60 Exhibit 97 part 2)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 90 part 1) (30)
Oct 16, 2020	6	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 51, # 2 Exhibit 52, # 3 Exhibit 53, # 4 Exhibit 54, # 5 Exhibit 55, # 6 Exhibit 56, # 7 Exhibit 57, # 8 Exhibit 58, # 9 Exhibit 59, # 10 Exhibit 60, # 11 Exhibit 61, # 12 Exhibit 62, # 13 Exhibit 63, # 14 Exhibit 64, # 15 Exhibit 65, # 16 Exhibit 66, # 17 Exhibit 67, # 18 Exhibit 68, # 19 Exhibit 69, # 20 Exhibit 70, # 21 Exhibit 71, # 22 Exhibit 72, # 23 Exhibit 73, # 24 Exhibit 74, # 25 Exhibit 75, # 26 Exhibit 76, # 27 Exhibit 77, # 28 Exhibit 78, # 29 Exhibit 79, # 30 Exhibit 80, # 31 Exhibit 81, # 32 Exhibit 82, # 33 Exhibit 83, # 34 Exhibit 84, # 35 Exhibit 85, # 36 Exhibit 86, # 37 Exhibit 87, # 38 Exhibit 88 part 1, # 39 Exhibit 88 part 2, # 40 Exhibit 89, # 41 Exhibit 90 part 1, # 42 Exhibit 90 part 2, # 43 Exhibit 91 part 1, # 44 Exhibit 91 part 2, # 45 Exhibit 92 part 1, # 46 Exhibit 92 part 2, # 47 Exhibit 93 part 1, # 48 Exhibit 93 part 2, # 49 Exhibit 93 part 3, # 50 Exhibit 93 part 4, # 51 Exhibit 94 part 1, # 52 Exhibit 94 part 2, # 53 Exhibit 94 part 3, # 54 Exhibit 94 part 4, # 55 Exhibit 95 part 1, # 56 Exhibit 95 part 2, # 57 Exhibit 96 part 1, # 58 Exhibit 96 part 2, # 59 Exhibit 97 part 1, # 60 Exhibit 97 part 2)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 90 part 2) (30)
Oct 16, 2020	6	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 51, # 2 Exhibit 52, # 3 Exhibit 53, # 4 Exhibit 54, # 5 Exhibit 55, # 6 Exhibit 56, # 7 Exhibit 57, # 8 Exhibit 58, # 9 Exhibit 59, # 10 Exhibit 60, # 11 Exhibit 61, # 12 Exhibit 62, # 13 Exhibit 63, # 14 Exhibit 64, # 15 Exhibit 65, # 16 Exhibit 66, # 17 Exhibit 67, # 18 Exhibit 68, # 19 Exhibit 69, # 20 Exhibit 70, # 21 Exhibit 71, # 22 Exhibit 72, # 23 Exhibit 73, # 24 Exhibit 74, # 25 Exhibit 75, # 26 Exhibit 76, # 27 Exhibit 77, # 28 Exhibit 78, # 29 Exhibit 79, # 30 Exhibit 80, # 31 Exhibit 81, # 32 Exhibit 82, # 33 Exhibit 83, # 34 Exhibit 84, # 35 Exhibit 85, # 36 Exhibit 86, # 37 Exhibit 87, # 38 Exhibit 88 part 1, # 39 Exhibit 88 part 2, # 40 Exhibit 89, # 41 Exhibit 90 part 1, # 42 Exhibit 90 part 2, # 43 Exhibit 91 part 1, # 44 Exhibit 91 part 2, # 45 Exhibit 92 part 1, # 46 Exhibit 92 part 2, # 47 Exhibit 93 part 1, # 48 Exhibit 93 part 2, # 49 Exhibit 93 part 3, # 50 Exhibit 93 part 4, # 51 Exhibit 94 part 1, # 52 Exhibit 94 part 2, # 53 Exhibit 94 part 3, # 54 Exhibit 94 part 4, # 55 Exhibit 95 part 1, # 56 Exhibit 95 part 2, # 57 Exhibit 96 part 1, # 58 Exhibit 96 part 2, # 59 Exhibit 97 part 1, # 60 Exhibit 97 part 2)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 91 part 1) (30)
Oct 16, 2020	6	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 51, # 2 Exhibit 52, # 3 Exhibit 53, # 4 Exhibit 54, # 5 Exhibit 55, # 6 Exhibit 56, # 7 Exhibit 57, # 8 Exhibit 58, # 9 Exhibit 59, # 10 Exhibit 60, # 11 Exhibit 61, # 12 Exhibit 62, # 13 Exhibit 63, # 14 Exhibit 64, # 15 Exhibit 65, # 16 Exhibit 66, # 17 Exhibit 67, # 18 Exhibit 68, # 19 Exhibit 69, # 20 Exhibit 70, # 21 Exhibit 71, # 22 Exhibit 72, # 23 Exhibit 73, # 24 Exhibit 74, # 25 Exhibit 75, # 26 Exhibit 76, # 27 Exhibit 77, # 28 Exhibit 78, # 29 Exhibit 79, # 30 Exhibit 80, # 31 Exhibit 81, # 32 Exhibit 82, # 33 Exhibit 83, # 34 Exhibit 84, # 35 Exhibit 85, # 36 Exhibit 86, # 37 Exhibit 87, # 38 Exhibit 88 part 1, # 39 Exhibit 88 part 2, # 40 Exhibit 89, # 41 Exhibit 90 part 1, # 42 Exhibit 90 part 2, # 43 Exhibit 91 part 1, # 44 Exhibit 91 part 2, # 45 Exhibit 92 part 1, # 46 Exhibit 92 part 2, # 47 Exhibit 93 part 1, # 48 Exhibit 93 part 2, # 49 Exhibit 93 part 3, # 50 Exhibit 93 part 4, # 51 Exhibit 94 part 1, # 52 Exhibit 94 part 2, # 53 Exhibit 94 part 3, # 54 Exhibit 94 part 4, # 55 Exhibit 95 part 1, # 56 Exhibit 95 part 2, # 57 Exhibit 96 part 1, # 58 Exhibit 96 part 2, # 59 Exhibit 97 part 1, # 60 Exhibit 97 part 2)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 91 part 2) (30)
Oct 16, 2020	6	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 51, # 2 Exhibit 52, # 3 Exhibit 53, # 4 Exhibit 54, # 5 Exhibit 55, # 6 Exhibit 56, # 7 Exhibit 57, # 8 Exhibit 58, # 9 Exhibit 59, # 10 Exhibit 60, # 11 Exhibit 61, # 12 Exhibit 62, # 13 Exhibit 63, # 14 Exhibit 64, # 15 Exhibit 65, # 16 Exhibit 66, # 17 Exhibit 67, # 18 Exhibit 68, # 19 Exhibit 69, # 20 Exhibit 70, # 21 Exhibit 71, # 22 Exhibit 72, # 23 Exhibit 73, # 24 Exhibit 74, # 25 Exhibit 75, # 26 Exhibit 76, # 27 Exhibit 77, # 28 Exhibit 78, # 29 Exhibit 79, # 30 Exhibit 80, # 31 Exhibit 81, # 32 Exhibit 82, # 33 Exhibit 83, # 34 Exhibit 84, # 35 Exhibit 85, # 36 Exhibit 86, # 37 Exhibit 87, # 38 Exhibit 88 part 1, # 39 Exhibit 88 part 2, # 40 Exhibit 89, # 41 Exhibit 90 part 1, # 42 Exhibit 90 part 2, # 43 Exhibit 91 part 1, # 44 Exhibit 91 part 2, # 45 Exhibit 92 part 1, # 46 Exhibit 92 part 2, # 47 Exhibit 93 part 1, # 48 Exhibit 93 part 2, # 49 Exhibit 93 part 3, # 50 Exhibit 93 part 4, # 51 Exhibit 94 part 1, # 52 Exhibit 94 part 2, # 53 Exhibit 94 part 3, # 54 Exhibit 94 part 4, # 55 Exhibit 95 part 1, # 56 Exhibit 95 part 2, # 57 Exhibit 96 part 1, # 58 Exhibit 96 part 2, # 59 Exhibit 97 part 1, # 60 Exhibit 97 part 2)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 92 part 1) (30)
Oct 16, 2020	6	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 51, # 2 Exhibit 52, # 3 Exhibit 53, # 4 Exhibit 54, # 5 Exhibit 55, # 6 Exhibit 56, # 7 Exhibit 57, # 8 Exhibit 58, # 9 Exhibit 59, # 10 Exhibit 60, # 11 Exhibit 61, # 12 Exhibit 62, # 13 Exhibit 63, # 14 Exhibit 64, # 15 Exhibit 65, # 16 Exhibit 66, # 17 Exhibit 67, # 18 Exhibit 68, # 19 Exhibit 69, # 20 Exhibit 70, # 21 Exhibit 71, # 22 Exhibit 72, # 23 Exhibit 73, # 24 Exhibit 74, # 25 Exhibit 75, # 26 Exhibit 76, # 27 Exhibit 77, # 28 Exhibit 78, # 29 Exhibit 79, # 30 Exhibit 80, # 31 Exhibit 81, # 32 Exhibit 82, # 33 Exhibit 83, # 34 Exhibit 84, # 35 Exhibit 85, # 36 Exhibit 86, # 37 Exhibit 87, # 38 Exhibit 88 part 1, # 39 Exhibit 88 part 2, # 40 Exhibit 89, # 41 Exhibit 90 part 1, # 42 Exhibit 90 part 2, # 43 Exhibit 91 part 1, # 44 Exhibit 91 part 2, # 45 Exhibit 92 part 1, # 46 Exhibit 92 part 2, # 47 Exhibit 93 part 1, # 48 Exhibit 93 part 2, # 49 Exhibit 93 part 3, # 50 Exhibit 93 part 4, # 51 Exhibit 94 part 1, # 52 Exhibit 94 part 2, # 53 Exhibit 94 part 3, # 54 Exhibit 94 part 4, # 55 Exhibit 95 part 1, # 56 Exhibit 95 part 2, # 57 Exhibit 96 part 1, # 58 Exhibit 96 part 2, # 59 Exhibit 97 part 1, # 60 Exhibit 97 part 2)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 92 part 2) (30)
Oct 16, 2020	6	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 51, # 2 Exhibit 52, # 3 Exhibit 53, # 4 Exhibit 54, # 5 Exhibit 55, # 6 Exhibit 56, # 7 Exhibit 57, # 8 Exhibit 58, # 9 Exhibit 59, # 10 Exhibit 60, # 11 Exhibit 61, # 12 Exhibit 62, # 13 Exhibit 63, # 14 Exhibit 64, # 15 Exhibit 65, # 16 Exhibit 66, # 17 Exhibit 67, # 18 Exhibit 68, # 19 Exhibit 69, # 20 Exhibit 70, # 21 Exhibit 71, # 22 Exhibit 72, # 23 Exhibit 73, # 24 Exhibit 74, # 25 Exhibit 75, # 26 Exhibit 76, # 27 Exhibit 77, # 28 Exhibit 78, # 29 Exhibit 79, # 30 Exhibit 80, # 31 Exhibit 81, # 32 Exhibit 82, # 33 Exhibit 83, # 34 Exhibit 84, # 35 Exhibit 85, # 36 Exhibit 86, # 37 Exhibit 87, # 38 Exhibit 88 part 1, # 39 Exhibit 88 part 2, # 40 Exhibit 89, # 41 Exhibit 90 part 1, # 42 Exhibit 90 part 2, # 43 Exhibit 91 part 1, # 44 Exhibit 91 part 2, # 45 Exhibit 92 part 1, # 46 Exhibit 92 part 2, # 47 Exhibit 93 part 1, # 48 Exhibit 93 part 2, # 49 Exhibit 93 part 3, # 50 Exhibit 93 part 4, # 51 Exhibit 94 part 1, # 52 Exhibit 94 part 2, # 53 Exhibit 94 part 3, # 54 Exhibit 94 part 4, # 55 Exhibit 95 part 1, # 56 Exhibit 95 part 2, # 57 Exhibit 96 part 1, # 58 Exhibit 96 part 2, # 59 Exhibit 97 part 1, # 60 Exhibit 97 part 2)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 93 part 1) (30)
Oct 16, 2020	6	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 51, # 2 Exhibit 52, # 3 Exhibit 53, # 4 Exhibit 54, # 5 Exhibit 55, # 6 Exhibit 56, # 7 Exhibit 57, # 8 Exhibit 58, # 9 Exhibit 59, # 10 Exhibit 60, # 11 Exhibit 61, # 12 Exhibit 62, # 13 Exhibit 63, # 14 Exhibit 64, # 15 Exhibit 65, # 16 Exhibit 66, # 17 Exhibit 67, # 18 Exhibit 68, # 19 Exhibit 69, # 20 Exhibit 70, # 21 Exhibit 71, # 22 Exhibit 72, # 23 Exhibit 73, # 24 Exhibit 74, # 25 Exhibit 75, # 26 Exhibit 76, # 27 Exhibit 77, # 28 Exhibit 78, # 29 Exhibit 79, # 30 Exhibit 80, # 31 Exhibit 81, # 32 Exhibit 82, # 33 Exhibit 83, # 34 Exhibit 84, # 35 Exhibit 85, # 36 Exhibit 86, # 37 Exhibit 87, # 38 Exhibit 88 part 1, # 39 Exhibit 88 part 2, # 40 Exhibit 89, # 41 Exhibit 90 part 1, # 42 Exhibit 90 part 2, # 43 Exhibit 91 part 1, # 44 Exhibit 91 part 2, # 45 Exhibit 92 part 1, # 46 Exhibit 92 part 2, # 47 Exhibit 93 part 1, # 48 Exhibit 93 part 2, # 49 Exhibit 93 part 3, # 50 Exhibit 93 part 4, # 51 Exhibit 94 part 1, # 52 Exhibit 94 part 2, # 53 Exhibit 94 part 3, # 54 Exhibit 94 part 4, # 55 Exhibit 95 part 1, # 56 Exhibit 95 part 2, # 57 Exhibit 96 part 1, # 58 Exhibit 96 part 2, # 59 Exhibit 97 part 1, # 60 Exhibit 97 part 2)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 93 part 2) (30)
Oct 16, 2020	6	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 51, # 2 Exhibit 52, # 3 Exhibit 53, # 4 Exhibit 54, # 5 Exhibit 55, # 6 Exhibit 56, # 7 Exhibit 57, # 8 Exhibit 58, # 9 Exhibit 59, # 10 Exhibit 60, # 11 Exhibit 61, # 12 Exhibit 62, # 13 Exhibit 63, # 14 Exhibit 64, # 15 Exhibit 65, # 16 Exhibit 66, # 17 Exhibit 67, # 18 Exhibit 68, # 19 Exhibit 69, # 20 Exhibit 70, # 21 Exhibit 71, # 22 Exhibit 72, # 23 Exhibit 73, # 24 Exhibit 74, # 25 Exhibit 75, # 26 Exhibit 76, # 27 Exhibit 77, # 28 Exhibit 78, # 29 Exhibit 79, # 30 Exhibit 80, # 31 Exhibit 81, # 32 Exhibit 82, # 33 Exhibit 83, # 34 Exhibit 84, # 35 Exhibit 85, # 36 Exhibit 86, # 37 Exhibit 87, # 38 Exhibit 88 part 1, # 39 Exhibit 88 part 2, # 40 Exhibit 89, # 41 Exhibit 90 part 1, # 42 Exhibit 90 part 2, # 43 Exhibit 91 part 1, # 44 Exhibit 91 part 2, # 45 Exhibit 92 part 1, # 46 Exhibit 92 part 2, # 47 Exhibit 93 part 1, # 48 Exhibit 93 part 2, # 49 Exhibit 93 part 3, # 50 Exhibit 93 part 4, # 51 Exhibit 94 part 1, # 52 Exhibit 94 part 2, # 53 Exhibit 94 part 3, # 54 Exhibit 94 part 4, # 55 Exhibit 95 part 1, # 56 Exhibit 95 part 2, # 57 Exhibit 96 part 1, # 58 Exhibit 96 part 2, # 59 Exhibit 97 part 1, # 60 Exhibit 97 part 2)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 93 part 3) (30)
Oct 16, 2020	6	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 51, # 2 Exhibit 52, # 3 Exhibit 53, # 4 Exhibit 54, # 5 Exhibit 55, # 6 Exhibit 56, # 7 Exhibit 57, # 8 Exhibit 58, # 9 Exhibit 59, # 10 Exhibit 60, # 11 Exhibit 61, # 12 Exhibit 62, # 13 Exhibit 63, # 14 Exhibit 64, # 15 Exhibit 65, # 16 Exhibit 66, # 17 Exhibit 67, # 18 Exhibit 68, # 19 Exhibit 69, # 20 Exhibit 70, # 21 Exhibit 71, # 22 Exhibit 72, # 23 Exhibit 73, # 24 Exhibit 74, # 25 Exhibit 75, # 26 Exhibit 76, # 27 Exhibit 77, # 28 Exhibit 78, # 29 Exhibit 79, # 30 Exhibit 80, # 31 Exhibit 81, # 32 Exhibit 82, # 33 Exhibit 83, # 34 Exhibit 84, # 35 Exhibit 85, # 36 Exhibit 86, # 37 Exhibit 87, # 38 Exhibit 88 part 1, # 39 Exhibit 88 part 2, # 40 Exhibit 89, # 41 Exhibit 90 part 1, # 42 Exhibit 90 part 2, # 43 Exhibit 91 part 1, # 44 Exhibit 91 part 2, # 45 Exhibit 92 part 1, # 46 Exhibit 92 part 2, # 47 Exhibit 93 part 1, # 48 Exhibit 93 part 2, # 49 Exhibit 93 part 3, # 50 Exhibit 93 part 4, # 51 Exhibit 94 part 1, # 52 Exhibit 94 part 2, # 53 Exhibit 94 part 3, # 54 Exhibit 94 part 4, # 55 Exhibit 95 part 1, # 56 Exhibit 95 part 2, # 57 Exhibit 96 part 1, # 58 Exhibit 96 part 2, # 59 Exhibit 97 part 1, # 60 Exhibit 97 part 2)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 93 part 4) (30)
Oct 16, 2020	6	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 51, # 2 Exhibit 52, # 3 Exhibit 53, # 4 Exhibit 54, # 5 Exhibit 55, # 6 Exhibit 56, # 7 Exhibit 57, # 8 Exhibit 58, # 9 Exhibit 59, # 10 Exhibit 60, # 11 Exhibit 61, # 12 Exhibit 62, # 13 Exhibit 63, # 14 Exhibit 64, # 15 Exhibit 65, # 16 Exhibit 66, # 17 Exhibit 67, # 18 Exhibit 68, # 19 Exhibit 69, # 20 Exhibit 70, # 21 Exhibit 71, # 22 Exhibit 72, # 23 Exhibit 73, # 24 Exhibit 74, # 25 Exhibit 75, # 26 Exhibit 76, # 27 Exhibit 77, # 28 Exhibit 78, # 29 Exhibit 79, # 30 Exhibit 80, # 31 Exhibit 81, # 32 Exhibit 82, # 33 Exhibit 83, # 34 Exhibit 84, # 35 Exhibit 85, # 36 Exhibit 86, # 37 Exhibit 87, # 38 Exhibit 88 part 1, # 39 Exhibit 88 part 2, # 40 Exhibit 89, # 41 Exhibit 90 part 1, # 42 Exhibit 90 part 2, # 43 Exhibit 91 part 1, # 44 Exhibit 91 part 2, # 45 Exhibit 92 part 1, # 46 Exhibit 92 part 2, # 47 Exhibit 93 part 1, # 48 Exhibit 93 part 2, # 49 Exhibit 93 part 3, # 50 Exhibit 93 part 4, # 51 Exhibit 94 part 1, # 52 Exhibit 94 part 2, # 53 Exhibit 94 part 3, # 54 Exhibit 94 part 4, # 55 Exhibit 95 part 1, # 56 Exhibit 95 part 2, # 57 Exhibit 96 part 1, # 58 Exhibit 96 part 2, # 59 Exhibit 97 part 1, # 60 Exhibit 97 part 2)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 94 part 1) (30)
Oct 16, 2020	6	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 51, # 2 Exhibit 52, # 3 Exhibit 53, # 4 Exhibit 54, # 5 Exhibit 55, # 6 Exhibit 56, # 7 Exhibit 57, # 8 Exhibit 58, # 9 Exhibit 59, # 10 Exhibit 60, # 11 Exhibit 61, # 12 Exhibit 62, # 13 Exhibit 63, # 14 Exhibit 64, # 15 Exhibit 65, # 16 Exhibit 66, # 17 Exhibit 67, # 18 Exhibit 68, # 19 Exhibit 69, # 20 Exhibit 70, # 21 Exhibit 71, # 22 Exhibit 72, # 23 Exhibit 73, # 24 Exhibit 74, # 25 Exhibit 75, # 26 Exhibit 76, # 27 Exhibit 77, # 28 Exhibit 78, # 29 Exhibit 79, # 30 Exhibit 80, # 31 Exhibit 81, # 32 Exhibit 82, # 33 Exhibit 83, # 34 Exhibit 84, # 35 Exhibit 85, # 36 Exhibit 86, # 37 Exhibit 87, # 38 Exhibit 88 part 1, # 39 Exhibit 88 part 2, # 40 Exhibit 89, # 41 Exhibit 90 part 1, # 42 Exhibit 90 part 2, # 43 Exhibit 91 part 1, # 44 Exhibit 91 part 2, # 45 Exhibit 92 part 1, # 46 Exhibit 92 part 2, # 47 Exhibit 93 part 1, # 48 Exhibit 93 part 2, # 49 Exhibit 93 part 3, # 50 Exhibit 93 part 4, # 51 Exhibit 94 part 1, # 52 Exhibit 94 part 2, # 53 Exhibit 94 part 3, # 54 Exhibit 94 part 4, # 55 Exhibit 95 part 1, # 56 Exhibit 95 part 2, # 57 Exhibit 96 part 1, # 58 Exhibit 96 part 2, # 59 Exhibit 97 part 1, # 60 Exhibit 97 part 2)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 94 part 2) (30)
Oct 16, 2020	6	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 51, # 2 Exhibit 52, # 3 Exhibit 53, # 4 Exhibit 54, # 5 Exhibit 55, # 6 Exhibit 56, # 7 Exhibit 57, # 8 Exhibit 58, # 9 Exhibit 59, # 10 Exhibit 60, # 11 Exhibit 61, # 12 Exhibit 62, # 13 Exhibit 63, # 14 Exhibit 64, # 15 Exhibit 65, # 16 Exhibit 66, # 17 Exhibit 67, # 18 Exhibit 68, # 19 Exhibit 69, # 20 Exhibit 70, # 21 Exhibit 71, # 22 Exhibit 72, # 23 Exhibit 73, # 24 Exhibit 74, # 25 Exhibit 75, # 26 Exhibit 76, # 27 Exhibit 77, # 28 Exhibit 78, # 29 Exhibit 79, # 30 Exhibit 80, # 31 Exhibit 81, # 32 Exhibit 82, # 33 Exhibit 83, # 34 Exhibit 84, # 35 Exhibit 85, # 36 Exhibit 86, # 37 Exhibit 87, # 38 Exhibit 88 part 1, # 39 Exhibit 88 part 2, # 40 Exhibit 89, # 41 Exhibit 90 part 1, # 42 Exhibit 90 part 2, # 43 Exhibit 91 part 1, # 44 Exhibit 91 part 2, # 45 Exhibit 92 part 1, # 46 Exhibit 92 part 2, # 47 Exhibit 93 part 1, # 48 Exhibit 93 part 2, # 49 Exhibit 93 part 3, # 50 Exhibit 93 part 4, # 51 Exhibit 94 part 1, # 52 Exhibit 94 part 2, # 53 Exhibit 94 part 3, # 54 Exhibit 94 part 4, # 55 Exhibit 95 part 1, # 56 Exhibit 95 part 2, # 57 Exhibit 96 part 1, # 58 Exhibit 96 part 2, # 59 Exhibit 97 part 1, # 60 Exhibit 97 part 2)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 94 part 3) (30)
Oct 16, 2020	6	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 51, # 2 Exhibit 52, # 3 Exhibit 53, # 4 Exhibit 54, # 5 Exhibit 55, # 6 Exhibit 56, # 7 Exhibit 57, # 8 Exhibit 58, # 9 Exhibit 59, # 10 Exhibit 60, # 11 Exhibit 61, # 12 Exhibit 62, # 13 Exhibit 63, # 14 Exhibit 64, # 15 Exhibit 65, # 16 Exhibit 66, # 17 Exhibit 67, # 18 Exhibit 68, # 19 Exhibit 69, # 20 Exhibit 70, # 21 Exhibit 71, # 22 Exhibit 72, # 23 Exhibit 73, # 24 Exhibit 74, # 25 Exhibit 75, # 26 Exhibit 76, # 27 Exhibit 77, # 28 Exhibit 78, # 29 Exhibit 79, # 30 Exhibit 80, # 31 Exhibit 81, # 32 Exhibit 82, # 33 Exhibit 83, # 34 Exhibit 84, # 35 Exhibit 85, # 36 Exhibit 86, # 37 Exhibit 87, # 38 Exhibit 88 part 1, # 39 Exhibit 88 part 2, # 40 Exhibit 89, # 41 Exhibit 90 part 1, # 42 Exhibit 90 part 2, # 43 Exhibit 91 part 1, # 44 Exhibit 91 part 2, # 45 Exhibit 92 part 1, # 46 Exhibit 92 part 2, # 47 Exhibit 93 part 1, # 48 Exhibit 93 part 2, # 49 Exhibit 93 part 3, # 50 Exhibit 93 part 4, # 51 Exhibit 94 part 1, # 52 Exhibit 94 part 2, # 53 Exhibit 94 part 3, # 54 Exhibit 94 part 4, # 55 Exhibit 95 part 1, # 56 Exhibit 95 part 2, # 57 Exhibit 96 part 1, # 58 Exhibit 96 part 2, # 59 Exhibit 97 part 1, # 60 Exhibit 97 part 2)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 94 part 4) (30)
Oct 16, 2020	6	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 51, # 2 Exhibit 52, # 3 Exhibit 53, # 4 Exhibit 54, # 5 Exhibit 55, # 6 Exhibit 56, # 7 Exhibit 57, # 8 Exhibit 58, # 9 Exhibit 59, # 10 Exhibit 60, # 11 Exhibit 61, # 12 Exhibit 62, # 13 Exhibit 63, # 14 Exhibit 64, # 15 Exhibit 65, # 16 Exhibit 66, # 17 Exhibit 67, # 18 Exhibit 68, # 19 Exhibit 69, # 20 Exhibit 70, # 21 Exhibit 71, # 22 Exhibit 72, # 23 Exhibit 73, # 24 Exhibit 74, # 25 Exhibit 75, # 26 Exhibit 76, # 27 Exhibit 77, # 28 Exhibit 78, # 29 Exhibit 79, # 30 Exhibit 80, # 31 Exhibit 81, # 32 Exhibit 82, # 33 Exhibit 83, # 34 Exhibit 84, # 35 Exhibit 85, # 36 Exhibit 86, # 37 Exhibit 87, # 38 Exhibit 88 part 1, # 39 Exhibit 88 part 2, # 40 Exhibit 89, # 41 Exhibit 90 part 1, # 42 Exhibit 90 part 2, # 43 Exhibit 91 part 1, # 44 Exhibit 91 part 2, # 45 Exhibit 92 part 1, # 46 Exhibit 92 part 2, # 47 Exhibit 93 part 1, # 48 Exhibit 93 part 2, # 49 Exhibit 93 part 3, # 50 Exhibit 93 part 4, # 51 Exhibit 94 part 1, # 52 Exhibit 94 part 2, # 53 Exhibit 94 part 3, # 54 Exhibit 94 part 4, # 55 Exhibit 95 part 1, # 56 Exhibit 95 part 2, # 57 Exhibit 96 part 1, # 58 Exhibit 96 part 2, # 59 Exhibit 97 part 1, # 60 Exhibit 97 part 2)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 95 part 1) (30)
Oct 16, 2020	6	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 51, # 2 Exhibit 52, # 3 Exhibit 53, # 4 Exhibit 54, # 5 Exhibit 55, # 6 Exhibit 56, # 7 Exhibit 57, # 8 Exhibit 58, # 9 Exhibit 59, # 10 Exhibit 60, # 11 Exhibit 61, # 12 Exhibit 62, # 13 Exhibit 63, # 14 Exhibit 64, # 15 Exhibit 65, # 16 Exhibit 66, # 17 Exhibit 67, # 18 Exhibit 68, # 19 Exhibit 69, # 20 Exhibit 70, # 21 Exhibit 71, # 22 Exhibit 72, # 23 Exhibit 73, # 24 Exhibit 74, # 25 Exhibit 75, # 26 Exhibit 76, # 27 Exhibit 77, # 28 Exhibit 78, # 29 Exhibit 79, # 30 Exhibit 80, # 31 Exhibit 81, # 32 Exhibit 82, # 33 Exhibit 83, # 34 Exhibit 84, # 35 Exhibit 85, # 36 Exhibit 86, # 37 Exhibit 87, # 38 Exhibit 88 part 1, # 39 Exhibit 88 part 2, # 40 Exhibit 89, # 41 Exhibit 90 part 1, # 42 Exhibit 90 part 2, # 43 Exhibit 91 part 1, # 44 Exhibit 91 part 2, # 45 Exhibit 92 part 1, # 46 Exhibit 92 part 2, # 47 Exhibit 93 part 1, # 48 Exhibit 93 part 2, # 49 Exhibit 93 part 3, # 50 Exhibit 93 part 4, # 51 Exhibit 94 part 1, # 52 Exhibit 94 part 2, # 53 Exhibit 94 part 3, # 54 Exhibit 94 part 4, # 55 Exhibit 95 part 1, # 56 Exhibit 95 part 2, # 57 Exhibit 96 part 1, # 58 Exhibit 96 part 2, # 59 Exhibit 97 part 1, # 60 Exhibit 97 part 2)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 95 part 2) (30)
Oct 16, 2020	6	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 51, # 2 Exhibit 52, # 3 Exhibit 53, # 4 Exhibit 54, # 5 Exhibit 55, # 6 Exhibit 56, # 7 Exhibit 57, # 8 Exhibit 58, # 9 Exhibit 59, # 10 Exhibit 60, # 11 Exhibit 61, # 12 Exhibit 62, # 13 Exhibit 63, # 14 Exhibit 64, # 15 Exhibit 65, # 16 Exhibit 66, # 17 Exhibit 67, # 18 Exhibit 68, # 19 Exhibit 69, # 20 Exhibit 70, # 21 Exhibit 71, # 22 Exhibit 72, # 23 Exhibit 73, # 24 Exhibit 74, # 25 Exhibit 75, # 26 Exhibit 76, # 27 Exhibit 77, # 28 Exhibit 78, # 29 Exhibit 79, # 30 Exhibit 80, # 31 Exhibit 81, # 32 Exhibit 82, # 33 Exhibit 83, # 34 Exhibit 84, # 35 Exhibit 85, # 36 Exhibit 86, # 37 Exhibit 87, # 38 Exhibit 88 part 1, # 39 Exhibit 88 part 2, # 40 Exhibit 89, # 41 Exhibit 90 part 1, # 42 Exhibit 90 part 2, # 43 Exhibit 91 part 1, # 44 Exhibit 91 part 2, # 45 Exhibit 92 part 1, # 46 Exhibit 92 part 2, # 47 Exhibit 93 part 1, # 48 Exhibit 93 part 2, # 49 Exhibit 93 part 3, # 50 Exhibit 93 part 4, # 51 Exhibit 94 part 1, # 52 Exhibit 94 part 2, # 53 Exhibit 94 part 3, # 54 Exhibit 94 part 4, # 55 Exhibit 95 part 1, # 56 Exhibit 95 part 2, # 57 Exhibit 96 part 1, # 58 Exhibit 96 part 2, # 59 Exhibit 97 part 1, # 60 Exhibit 97 part 2)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 96 part 1) (30)
Oct 16, 2020	6	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 51, # 2 Exhibit 52, # 3 Exhibit 53, # 4 Exhibit 54, # 5 Exhibit 55, # 6 Exhibit 56, # 7 Exhibit 57, # 8 Exhibit 58, # 9 Exhibit 59, # 10 Exhibit 60, # 11 Exhibit 61, # 12 Exhibit 62, # 13 Exhibit 63, # 14 Exhibit 64, # 15 Exhibit 65, # 16 Exhibit 66, # 17 Exhibit 67, # 18 Exhibit 68, # 19 Exhibit 69, # 20 Exhibit 70, # 21 Exhibit 71, # 22 Exhibit 72, # 23 Exhibit 73, # 24 Exhibit 74, # 25 Exhibit 75, # 26 Exhibit 76, # 27 Exhibit 77, # 28 Exhibit 78, # 29 Exhibit 79, # 30 Exhibit 80, # 31 Exhibit 81, # 32 Exhibit 82, # 33 Exhibit 83, # 34 Exhibit 84, # 35 Exhibit 85, # 36 Exhibit 86, # 37 Exhibit 87, # 38 Exhibit 88 part 1, # 39 Exhibit 88 part 2, # 40 Exhibit 89, # 41 Exhibit 90 part 1, # 42 Exhibit 90 part 2, # 43 Exhibit 91 part 1, # 44 Exhibit 91 part 2, # 45 Exhibit 92 part 1, # 46 Exhibit 92 part 2, # 47 Exhibit 93 part 1, # 48 Exhibit 93 part 2, # 49 Exhibit 93 part 3, # 50 Exhibit 93 part 4, # 51 Exhibit 94 part 1, # 52 Exhibit 94 part 2, # 53 Exhibit 94 part 3, # 54 Exhibit 94 part 4, # 55 Exhibit 95 part 1, # 56 Exhibit 95 part 2, # 57 Exhibit 96 part 1, # 58 Exhibit 96 part 2, # 59 Exhibit 97 part 1, # 60 Exhibit 97 part 2)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 96 part 2) (30)
Oct 16, 2020	6	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 51, # 2 Exhibit 52, # 3 Exhibit 53, # 4 Exhibit 54, # 5 Exhibit 55, # 6 Exhibit 56, # 7 Exhibit 57, # 8 Exhibit 58, # 9 Exhibit 59, # 10 Exhibit 60, # 11 Exhibit 61, # 12 Exhibit 62, # 13 Exhibit 63, # 14 Exhibit 64, # 15 Exhibit 65, # 16 Exhibit 66, # 17 Exhibit 67, # 18 Exhibit 68, # 19 Exhibit 69, # 20 Exhibit 70, # 21 Exhibit 71, # 22 Exhibit 72, # 23 Exhibit 73, # 24 Exhibit 74, # 25 Exhibit 75, # 26 Exhibit 76, # 27 Exhibit 77, # 28 Exhibit 78, # 29 Exhibit 79, # 30 Exhibit 80, # 31 Exhibit 81, # 32 Exhibit 82, # 33 Exhibit 83, # 34 Exhibit 84, # 35 Exhibit 85, # 36 Exhibit 86, # 37 Exhibit 87, # 38 Exhibit 88 part 1, # 39 Exhibit 88 part 2, # 40 Exhibit 89, # 41 Exhibit 90 part 1, # 42 Exhibit 90 part 2, # 43 Exhibit 91 part 1, # 44 Exhibit 91 part 2, # 45 Exhibit 92 part 1, # 46 Exhibit 92 part 2, # 47 Exhibit 93 part 1, # 48 Exhibit 93 part 2, # 49 Exhibit 93 part 3, # 50 Exhibit 93 part 4, # 51 Exhibit 94 part 1, # 52 Exhibit 94 part 2, # 53 Exhibit 94 part 3, # 54 Exhibit 94 part 4, # 55 Exhibit 95 part 1, # 56 Exhibit 95 part 2, # 57 Exhibit 96 part 1, # 58 Exhibit 96 part 2, # 59 Exhibit 97 part 1, # 60 Exhibit 97 part 2)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 97 part 1) (30)
Oct 16, 2020	6	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 51, # 2 Exhibit 52, # 3 Exhibit 53, # 4 Exhibit 54, # 5 Exhibit 55, # 6 Exhibit 56, # 7 Exhibit 57, # 8 Exhibit 58, # 9 Exhibit 59, # 10 Exhibit 60, # 11 Exhibit 61, # 12 Exhibit 62, # 13 Exhibit 63, # 14 Exhibit 64, # 15 Exhibit 65, # 16 Exhibit 66, # 17 Exhibit 67, # 18 Exhibit 68, # 19 Exhibit 69, # 20 Exhibit 70, # 21 Exhibit 71, # 22 Exhibit 72, # 23 Exhibit 73, # 24 Exhibit 74, # 25 Exhibit 75, # 26 Exhibit 76, # 27 Exhibit 77, # 28 Exhibit 78, # 29 Exhibit 79, # 30 Exhibit 80, # 31 Exhibit 81, # 32 Exhibit 82, # 33 Exhibit 83, # 34 Exhibit 84, # 35 Exhibit 85, # 36 Exhibit 86, # 37 Exhibit 87, # 38 Exhibit 88 part 1, # 39 Exhibit 88 part 2, # 40 Exhibit 89, # 41 Exhibit 90 part 1, # 42 Exhibit 90 part 2, # 43 Exhibit 91 part 1, # 44 Exhibit 91 part 2, # 45 Exhibit 92 part 1, # 46 Exhibit 92 part 2, # 47 Exhibit 93 part 1, # 48 Exhibit 93 part 2, # 49 Exhibit 93 part 3, # 50 Exhibit 93 part 4, # 51 Exhibit 94 part 1, # 52 Exhibit 94 part 2, # 53 Exhibit 94 part 3, # 54 Exhibit 94 part 4, # 55 Exhibit 95 part 1, # 56 Exhibit 95 part 2, # 57 Exhibit 96 part 1, # 58 Exhibit 96 part 2, # 59 Exhibit 97 part 1, # 60 Exhibit 97 part 2)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 97 part 2) (30)
Oct 16, 2020	3	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Exhibit 40, # 41 Exhibit 41, # 42 Exhibit 42, # 43 Exhibit 43, # 44 Exhibit 44, # 45 Exhibit 45, # 46 Exhibit 46, # 47 Exhibit 47, # 48 Exhibit 48, # 49 Exhibit 49, # 50 Exhibit 50)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 1) (30)
Oct 16, 2020	3	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Exhibit 40, # 41 Exhibit 41, # 42 Exhibit 42, # 43 Exhibit 43, # 44 Exhibit 44, # 45 Exhibit 45, # 46 Exhibit 46, # 47 Exhibit 47, # 48 Exhibit 48, # 49 Exhibit 49, # 50 Exhibit 50)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 2) (30)
Oct 16, 2020	3	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Exhibit 40, # 41 Exhibit 41, # 42 Exhibit 42, # 43 Exhibit 43, # 44 Exhibit 44, # 45 Exhibit 45, # 46 Exhibit 46, # 47 Exhibit 47, # 48 Exhibit 48, # 49 Exhibit 49, # 50 Exhibit 50)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 3) (30)
Oct 16, 2020	3	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Exhibit 40, # 41 Exhibit 41, # 42 Exhibit 42, # 43 Exhibit 43, # 44 Exhibit 44, # 45 Exhibit 45, # 46 Exhibit 46, # 47 Exhibit 47, # 48 Exhibit 48, # 49 Exhibit 49, # 50 Exhibit 50)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 4) (2)
Oct 16, 2020	3	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Exhibit 40, # 41 Exhibit 41, # 42 Exhibit 42, # 43 Exhibit 43, # 44 Exhibit 44, # 45 Exhibit 45, # 46 Exhibit 46, # 47 Exhibit 47, # 48 Exhibit 48, # 49 Exhibit 49, # 50 Exhibit 50)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 5) (2)
Oct 16, 2020	3	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Exhibit 40, # 41 Exhibit 41, # 42 Exhibit 42, # 43 Exhibit 43, # 44 Exhibit 44, # 45 Exhibit 45, # 46 Exhibit 46, # 47 Exhibit 47, # 48 Exhibit 48, # 49 Exhibit 49, # 50 Exhibit 50)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 6) (5)
Oct 16, 2020	3	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Exhibit 40, # 41 Exhibit 41, # 42 Exhibit 42, # 43 Exhibit 43, # 44 Exhibit 44, # 45 Exhibit 45, # 46 Exhibit 46, # 47 Exhibit 47, # 48 Exhibit 48, # 49 Exhibit 49, # 50 Exhibit 50)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 7) (5)
Oct 16, 2020	3	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Exhibit 40, # 41 Exhibit 41, # 42 Exhibit 42, # 43 Exhibit 43, # 44 Exhibit 44, # 45 Exhibit 45, # 46 Exhibit 46, # 47 Exhibit 47, # 48 Exhibit 48, # 49 Exhibit 49, # 50 Exhibit 50)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 8) (5)
Oct 16, 2020	3	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Exhibit 40, # 41 Exhibit 41, # 42 Exhibit 42, # 43 Exhibit 43, # 44 Exhibit 44, # 45 Exhibit 45, # 46 Exhibit 46, # 47 Exhibit 47, # 48 Exhibit 48, # 49 Exhibit 49, # 50 Exhibit 50)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 9) (4)
Oct 16, 2020	3	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Exhibit 40, # 41 Exhibit 41, # 42 Exhibit 42, # 43 Exhibit 43, # 44 Exhibit 44, # 45 Exhibit 45, # 46 Exhibit 46, # 47 Exhibit 47, # 48 Exhibit 48, # 49 Exhibit 49, # 50 Exhibit 50)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 10) (3)
Oct 16, 2020	3	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Exhibit 40, # 41 Exhibit 41, # 42 Exhibit 42, # 43 Exhibit 43, # 44 Exhibit 44, # 45 Exhibit 45, # 46 Exhibit 46, # 47 Exhibit 47, # 48 Exhibit 48, # 49 Exhibit 49, # 50 Exhibit 50)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 11) (3)
Oct 16, 2020	3	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Exhibit 40, # 41 Exhibit 41, # 42 Exhibit 42, # 43 Exhibit 43, # 44 Exhibit 44, # 45 Exhibit 45, # 46 Exhibit 46, # 47 Exhibit 47, # 48 Exhibit 48, # 49 Exhibit 49, # 50 Exhibit 50)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 12) (3)
Oct 16, 2020	3	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Exhibit 40, # 41 Exhibit 41, # 42 Exhibit 42, # 43 Exhibit 43, # 44 Exhibit 44, # 45 Exhibit 45, # 46 Exhibit 46, # 47 Exhibit 47, # 48 Exhibit 48, # 49 Exhibit 49, # 50 Exhibit 50)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 13) (7)
Oct 16, 2020	3	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Exhibit 40, # 41 Exhibit 41, # 42 Exhibit 42, # 43 Exhibit 43, # 44 Exhibit 44, # 45 Exhibit 45, # 46 Exhibit 46, # 47 Exhibit 47, # 48 Exhibit 48, # 49 Exhibit 49, # 50 Exhibit 50)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 14) (2)
Oct 16, 2020	3	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Exhibit 40, # 41 Exhibit 41, # 42 Exhibit 42, # 43 Exhibit 43, # 44 Exhibit 44, # 45 Exhibit 45, # 46 Exhibit 46, # 47 Exhibit 47, # 48 Exhibit 48, # 49 Exhibit 49, # 50 Exhibit 50)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 15) (3)
Oct 16, 2020	3	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Exhibit 40, # 41 Exhibit 41, # 42 Exhibit 42, # 43 Exhibit 43, # 44 Exhibit 44, # 45 Exhibit 45, # 46 Exhibit 46, # 47 Exhibit 47, # 48 Exhibit 48, # 49 Exhibit 49, # 50 Exhibit 50)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 16) (2)
Oct 16, 2020	3	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Exhibit 40, # 41 Exhibit 41, # 42 Exhibit 42, # 43 Exhibit 43, # 44 Exhibit 44, # 45 Exhibit 45, # 46 Exhibit 46, # 47 Exhibit 47, # 48 Exhibit 48, # 49 Exhibit 49, # 50 Exhibit 50)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 17) (5)
Oct 16, 2020	3	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Exhibit 40, # 41 Exhibit 41, # 42 Exhibit 42, # 43 Exhibit 43, # 44 Exhibit 44, # 45 Exhibit 45, # 46 Exhibit 46, # 47 Exhibit 47, # 48 Exhibit 48, # 49 Exhibit 49, # 50 Exhibit 50)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 18) (4)
Oct 16, 2020	3	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Exhibit 40, # 41 Exhibit 41, # 42 Exhibit 42, # 43 Exhibit 43, # 44 Exhibit 44, # 45 Exhibit 45, # 46 Exhibit 46, # 47 Exhibit 47, # 48 Exhibit 48, # 49 Exhibit 49, # 50 Exhibit 50)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 19) (16)
Oct 16, 2020	3	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Exhibit 40, # 41 Exhibit 41, # 42 Exhibit 42, # 43 Exhibit 43, # 44 Exhibit 44, # 45 Exhibit 45, # 46 Exhibit 46, # 47 Exhibit 47, # 48 Exhibit 48, # 49 Exhibit 49, # 50 Exhibit 50)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 20) (9)
Oct 16, 2020	3	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Exhibit 40, # 41 Exhibit 41, # 42 Exhibit 42, # 43 Exhibit 43, # 44 Exhibit 44, # 45 Exhibit 45, # 46 Exhibit 46, # 47 Exhibit 47, # 48 Exhibit 48, # 49 Exhibit 49, # 50 Exhibit 50)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 21) (4)
Oct 16, 2020	3	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Exhibit 40, # 41 Exhibit 41, # 42 Exhibit 42, # 43 Exhibit 43, # 44 Exhibit 44, # 45 Exhibit 45, # 46 Exhibit 46, # 47 Exhibit 47, # 48 Exhibit 48, # 49 Exhibit 49, # 50 Exhibit 50)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 22) (7)
Oct 16, 2020	3	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Exhibit 40, # 41 Exhibit 41, # 42 Exhibit 42, # 43 Exhibit 43, # 44 Exhibit 44, # 45 Exhibit 45, # 46 Exhibit 46, # 47 Exhibit 47, # 48 Exhibit 48, # 49 Exhibit 49, # 50 Exhibit 50)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 23) (4)
Oct 16, 2020	3	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Exhibit 40, # 41 Exhibit 41, # 42 Exhibit 42, # 43 Exhibit 43, # 44 Exhibit 44, # 45 Exhibit 45, # 46 Exhibit 46, # 47 Exhibit 47, # 48 Exhibit 48, # 49 Exhibit 49, # 50 Exhibit 50)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 24) (9)
Oct 16, 2020	3	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Exhibit 40, # 41 Exhibit 41, # 42 Exhibit 42, # 43 Exhibit 43, # 44 Exhibit 44, # 45 Exhibit 45, # 46 Exhibit 46, # 47 Exhibit 47, # 48 Exhibit 48, # 49 Exhibit 49, # 50 Exhibit 50)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 25) (4)
Oct 16, 2020	3	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Exhibit 40, # 41 Exhibit 41, # 42 Exhibit 42, # 43 Exhibit 43, # 44 Exhibit 44, # 45 Exhibit 45, # 46 Exhibit 46, # 47 Exhibit 47, # 48 Exhibit 48, # 49 Exhibit 49, # 50 Exhibit 50)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 26) (3)
Oct 16, 2020	3	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Exhibit 40, # 41 Exhibit 41, # 42 Exhibit 42, # 43 Exhibit 43, # 44 Exhibit 44, # 45 Exhibit 45, # 46 Exhibit 46, # 47 Exhibit 47, # 48 Exhibit 48, # 49 Exhibit 49, # 50 Exhibit 50)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 27) (4)
Oct 16, 2020	3	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Exhibit 40, # 41 Exhibit 41, # 42 Exhibit 42, # 43 Exhibit 43, # 44 Exhibit 44, # 45 Exhibit 45, # 46 Exhibit 46, # 47 Exhibit 47, # 48 Exhibit 48, # 49 Exhibit 49, # 50 Exhibit 50)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 28) (3)
Oct 16, 2020	3	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Exhibit 40, # 41 Exhibit 41, # 42 Exhibit 42, # 43 Exhibit 43, # 44 Exhibit 44, # 45 Exhibit 45, # 46 Exhibit 46, # 47 Exhibit 47, # 48 Exhibit 48, # 49 Exhibit 49, # 50 Exhibit 50)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 29) (3)
Oct 16, 2020	3	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Exhibit 40, # 41 Exhibit 41, # 42 Exhibit 42, # 43 Exhibit 43, # 44 Exhibit 44, # 45 Exhibit 45, # 46 Exhibit 46, # 47 Exhibit 47, # 48 Exhibit 48, # 49 Exhibit 49, # 50 Exhibit 50)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 30) (3)
Oct 16, 2020	3	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Exhibit 40, # 41 Exhibit 41, # 42 Exhibit 42, # 43 Exhibit 43, # 44 Exhibit 44, # 45 Exhibit 45, # 46 Exhibit 46, # 47 Exhibit 47, # 48 Exhibit 48, # 49 Exhibit 49, # 50 Exhibit 50)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 31) (26)
Oct 16, 2020	3	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Exhibit 40, # 41 Exhibit 41, # 42 Exhibit 42, # 43 Exhibit 43, # 44 Exhibit 44, # 45 Exhibit 45, # 46 Exhibit 46, # 47 Exhibit 47, # 48 Exhibit 48, # 49 Exhibit 49, # 50 Exhibit 50)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 32) (4)
Oct 16, 2020	3	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Exhibit 40, # 41 Exhibit 41, # 42 Exhibit 42, # 43 Exhibit 43, # 44 Exhibit 44, # 45 Exhibit 45, # 46 Exhibit 46, # 47 Exhibit 47, # 48 Exhibit 48, # 49 Exhibit 49, # 50 Exhibit 50)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 33) (4)
Oct 16, 2020	3	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Exhibit 40, # 41 Exhibit 41, # 42 Exhibit 42, # 43 Exhibit 43, # 44 Exhibit 44, # 45 Exhibit 45, # 46 Exhibit 46, # 47 Exhibit 47, # 48 Exhibit 48, # 49 Exhibit 49, # 50 Exhibit 50)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 34) (4)
Oct 16, 2020	3	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Exhibit 40, # 41 Exhibit 41, # 42 Exhibit 42, # 43 Exhibit 43, # 44 Exhibit 44, # 45 Exhibit 45, # 46 Exhibit 46, # 47 Exhibit 47, # 48 Exhibit 48, # 49 Exhibit 49, # 50 Exhibit 50)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 35) (5)
Oct 16, 2020	3	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Exhibit 40, # 41 Exhibit 41, # 42 Exhibit 42, # 43 Exhibit 43, # 44 Exhibit 44, # 45 Exhibit 45, # 46 Exhibit 46, # 47 Exhibit 47, # 48 Exhibit 48, # 49 Exhibit 49, # 50 Exhibit 50)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 36) (5)
Oct 16, 2020	3	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Exhibit 40, # 41 Exhibit 41, # 42 Exhibit 42, # 43 Exhibit 43, # 44 Exhibit 44, # 45 Exhibit 45, # 46 Exhibit 46, # 47 Exhibit 47, # 48 Exhibit 48, # 49 Exhibit 49, # 50 Exhibit 50)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 37) (6)
Oct 16, 2020	3	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Exhibit 40, # 41 Exhibit 41, # 42 Exhibit 42, # 43 Exhibit 43, # 44 Exhibit 44, # 45 Exhibit 45, # 46 Exhibit 46, # 47 Exhibit 47, # 48 Exhibit 48, # 49 Exhibit 49, # 50 Exhibit 50)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 38) (3)
Oct 16, 2020	3	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Exhibit 40, # 41 Exhibit 41, # 42 Exhibit 42, # 43 Exhibit 43, # 44 Exhibit 44, # 45 Exhibit 45, # 46 Exhibit 46, # 47 Exhibit 47, # 48 Exhibit 48, # 49 Exhibit 49, # 50 Exhibit 50)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 39) (2)
Oct 16, 2020	3	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Exhibit 40, # 41 Exhibit 41, # 42 Exhibit 42, # 43 Exhibit 43, # 44 Exhibit 44, # 45 Exhibit 45, # 46 Exhibit 46, # 47 Exhibit 47, # 48 Exhibit 48, # 49 Exhibit 49, # 50 Exhibit 50)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 40) (2)
Oct 16, 2020	3	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Exhibit 40, # 41 Exhibit 41, # 42 Exhibit 42, # 43 Exhibit 43, # 44 Exhibit 44, # 45 Exhibit 45, # 46 Exhibit 46, # 47 Exhibit 47, # 48 Exhibit 48, # 49 Exhibit 49, # 50 Exhibit 50)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 41) (13)
Oct 16, 2020	3	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Exhibit 40, # 41 Exhibit 41, # 42 Exhibit 42, # 43 Exhibit 43, # 44 Exhibit 44, # 45 Exhibit 45, # 46 Exhibit 46, # 47 Exhibit 47, # 48 Exhibit 48, # 49 Exhibit 49, # 50 Exhibit 50)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 42) (30)
Oct 16, 2020	3	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Exhibit 40, # 41 Exhibit 41, # 42 Exhibit 42, # 43 Exhibit 43, # 44 Exhibit 44, # 45 Exhibit 45, # 46 Exhibit 46, # 47 Exhibit 47, # 48 Exhibit 48, # 49 Exhibit 49, # 50 Exhibit 50)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 43) (10)
Oct 16, 2020	3	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Exhibit 40, # 41 Exhibit 41, # 42 Exhibit 42, # 43 Exhibit 43, # 44 Exhibit 44, # 45 Exhibit 45, # 46 Exhibit 46, # 47 Exhibit 47, # 48 Exhibit 48, # 49 Exhibit 49, # 50 Exhibit 50)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 44) (8)
Oct 16, 2020	3	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Exhibit 40, # 41 Exhibit 41, # 42 Exhibit 42, # 43 Exhibit 43, # 44 Exhibit 44, # 45 Exhibit 45, # 46 Exhibit 46, # 47 Exhibit 47, # 48 Exhibit 48, # 49 Exhibit 49, # 50 Exhibit 50)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 45) (2)
Oct 16, 2020	3	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Exhibit 40, # 41 Exhibit 41, # 42 Exhibit 42, # 43 Exhibit 43, # 44 Exhibit 44, # 45 Exhibit 45, # 46 Exhibit 46, # 47 Exhibit 47, # 48 Exhibit 48, # 49 Exhibit 49, # 50 Exhibit 50)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 46) (9)
Oct 16, 2020	3	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Exhibit 40, # 41 Exhibit 41, # 42 Exhibit 42, # 43 Exhibit 43, # 44 Exhibit 44, # 45 Exhibit 45, # 46 Exhibit 46, # 47 Exhibit 47, # 48 Exhibit 48, # 49 Exhibit 49, # 50 Exhibit 50)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 47) (7)
Oct 16, 2020	3	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Exhibit 40, # 41 Exhibit 41, # 42 Exhibit 42, # 43 Exhibit 43, # 44 Exhibit 44, # 45 Exhibit 45, # 46 Exhibit 46, # 47 Exhibit 47, # 48 Exhibit 48, # 49 Exhibit 49, # 50 Exhibit 50)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 48) (6)
Oct 16, 2020	3	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Exhibit 40, # 41 Exhibit 41, # 42 Exhibit 42, # 43 Exhibit 43, # 44 Exhibit 44, # 45 Exhibit 45, # 46 Exhibit 46, # 47 Exhibit 47, # 48 Exhibit 48, # 49 Exhibit 49, # 50 Exhibit 50)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 49) (7)
Oct 16, 2020	3	ATTACHMENT Exhibits to 1 Complaint by Ravgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Exhibit 40, # 41 Exhibit 41, # 42 Exhibit 42, # 43 Exhibit 43, # 44 Exhibit 44, # 45 Exhibit 45, # 46 Exhibit 46, # 47 Exhibit 47, # 48 Exhibit 48, # 49 Exhibit 49, # 50 Exhibit 50)(Dacus, Deron) (Entered: 10/16/2020) (Exhibit 50) (8)
Sep 22, 2020	5	Standing Order Regarding Notice of Readiness In Patent Cases. Signed by Judge Alan D Albright. (lad) (Entered: 10/16/2020) (4)

Lawsuits

Ravgen, Inc. v. Laboratory Corporation of America Holdings > Documents